Gene: BCL2

596
Bcl-2|PPP1R50
BCL2, apoptosis regulator
protein-coding
18q21.33
Ensembl:ENSG00000171791 MIM:151430 Vega:OTTHUMG00000132791 UniprotKB:P10415
NG_009361.1
PubMed
0   ANCO-SNPs
CD|ND|AD
48   
NA (AD)  NA (ND)   (Frontal_Cortex)
4.657e-1 (AD)  2.209e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg23707289chr18:60988099BCL2Promoter5.595e-4Alcohol use disorders26763658
cg23756272chr18:60904418BCL21.200e-11Smoking27651444
cg12459502chr18:60904237BCL21.500e-9Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
DOCK70.853
CACHD10.85
PITPNC10.849
MAP3K50.846
GPT20.842
UNG0.841
SLC1A30.836
APPL20.831
NTRK20.826
TMEM470.825

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.49
OR4F29-0.459
SULT2B1-0.359
QRFPR-0.317
CD244-0.312
SCARA5-0.31
DUSP27-0.307
CETP-0.298
SYNGR4-0.279
GADL1-0.276

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB01050IbuprofenSmall Molecule15687-27-1ApprovedTarget
DB01229PaclitaxelSmall Molecule33069-62-4ApprovedTarget
DB01248DocetaxelSmall Molecule114977-28-5Approved|InvestigationalTarget
DB01367RasagilineSmall Molecule136236-51-6ApprovedTarget
DB05281S-8184Small Molecule-InvestigationalTarget
DB05297Paclitaxel docosahexaenoic acidSmall Molecule199796-52-6InvestigationalTarget
DB06307ApoptoneSmall Molecule183387-50-0InvestigationalTarget
DB06756Glycine betaineSmall Molecule107-43-7Approved|NutraceuticalTarget
DB08871EribulinSmall Molecule253128-41-5Approved|InvestigationalTarget
DB09213DexibuprofenSmall Molecule51146-56-6Approved|InvestigationalTarget
DB09401IsosorbideSmall Molecule652-67-5Approved|InvestigationalTarget
DB11581VenetoclaxSmall Molecule1257044-40-8Approved|InvestigationalTarget
DB12191ObatoclaxSmall Molecule803712-67-6InvestigationalTarget
DB12340NavitoclaxSmall Molecule923564-51-6InvestigationalTarget
ID Drug Name Action PubMed
C02809810-hydroxycamptothecinBCL2 protein affects the susceptibility to 10-hydroxycamptothecin16603448
C55429110-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one"10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in decreased expression of BCL2 protein"20833157
C55429110-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one"CASP8 protein affects the susceptibility to [10-methoxy-2,2-dimethyl-2,6-dihydropyrano(3,2-c)quinolin-5-one results in decreased expression of BCL2 protein]"20833157
C5525301,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane"1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased expression of BCL2 protein"20660371|2603571
C5525301,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane"NR4A1 protein inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased expression of BCL2 protein]"20660371
C478160(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane"(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane results in decreased expression of BCL2 protein"15982805
C478160(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane"[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of BCL2 protein"28757135
C0703791,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]"19540902
C0703791,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cytochalasin B results in decreased expression of BCL2 protein]"27640744
C5172321,2-dibromo-4-(1,2-dibromoethyl)cyclohexane"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane results in increased expression of BCL2 mRNA"24375616
D0140131,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt"1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased expression of BCL2 protein]"17395010
C5524201-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane"1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in decreased expression of BCL2 protein"20674558
C5524201-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane"Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in decreased expression of BCL2 protein]"20674558
C0006039621-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one"1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]"29111459
C0553831,3,5-tribromobenzene"1,3,5-tribromobenzene analog results in increased expression of BCL2 mRNA"26318274
C0793931,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole"1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]"16980304
C0793931,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole"1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein"16980304
C0793931,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole"[1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates"16980304
C0389831,3-dimethylthiourea"1,3-dimethylthiourea results in decreased expression of BCL2 mRNA"10567332
C47781915-deoxyprostaglandin J215-deoxyprostaglandin J2 affects the expression of BCL2 protein16912651
C0956531,5-dihydroxyisoquinoline"[1,5-dihydroxyisoquinoline co-treated with Tretinoin] results in decreased expression of BCL2 protein"10713328
C07258116-hydroxycleroda-3,13(14)-dien-15,16-olide"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of BCL2 protein"23628706
C07258116-hydroxycleroda-3,13(14)-dien-15,16-olide"16-hydroxycleroda-3,13(14)-dien-15,16-olide results in decreased expression of BCL2 protein"23628706
C11912918alpha-glycyrrhetinic acid18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]28414158
C54708819-hydroxy-1alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide"19-hydroxy-1alpha,6-diacetoxy-6,7-seco-ent-kaur-16-en-15-one-7,20-olide inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein]"19765580
C0479481'-acetoxychavicol acetate1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2 protein]15905586
C5131151-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester inhibits the reaction [VEGFA protein results in increased expression of BCL2 protein]21769449
C5131151-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester results in decreased expression of BCL2 protein16806087|1753597
C5131151-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester inhibits the reaction [VEGFA protein results in increased expression of BCL2 protein]]"21769449
C0371651-phenazinecarboxylic acid1-phenazinecarboxylic acid analog binds to BCL2 protein25765238
C5321622-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [U 0126 results in decreased expression of BCL2 protein]"22101421
C5321622-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased expression of BCL2 protein"22101421
C5321622-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine"U 0126 promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased expression of BCL2 protein]"22101421
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of BCL2 mRNA19933214
C5740372-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one"2-(1-hydroxy-4-oxocyclohexa-2,5-dienyl)pyran-4-one results in decreased expression of BCL2"24300195
C0948592,2',3,3',4,6'-hexachlorobiphenyl"2,2',3,3',4,6'-hexachlorobiphenyl results in decreased expression of BCL2 mRNA"17445852
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 mRNA"22543052
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein"22543052
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of BCL2"25697951
C5112952,2',4,4'-tetrabromodiphenyl ether"ERN1 protein affects the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 mRNA]"22543052
C5112952,2',4,4'-tetrabromodiphenyl ether"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein"25639565
C5112952,2',4,4'-tetrabromodiphenyl ether"epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein]]"25639565
C5112952,2',4,4'-tetrabromodiphenyl ether"troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein]"25639565
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Luteolin results in decreased expression of BCL2 protein]27474067
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BCL2 protein]"19747539
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [docetaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein]14506750
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of BCL2 protein17097560
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of BCL2 protein] which results in increased susceptibility to ABT-73717097560
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ST8SIA1 protein results in increased expression of BCL2 protein]11574545
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Particulate Matter results in decreased expression of BCL2 protein]26472149
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of BCL2 protein26472149
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP3 protein]19786087
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein]19786087
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein]19786087
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin affects the localization of BAX protein]]]19786087
C0939732-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin results in increased expression of TNFRSF10A protein]]]19786087
C0192732,2-bis(4-glycidyloxyphenyl)propane"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester inhibits the reaction [VEGFA protein results in increased expression of BCL2 protein]]"21769449
C4049102,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane"2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of BCL2 protein"15525693
C4465202-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone"2-(2-hydroxyethylsulfanyl)-3-methyl-1,4-naphthoquinone results in decreased expression of BCL2"16077967
C5290542-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol"[2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol co-treated with vildagliptin] inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]"28807765
C5290542-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol"2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]"28807765
C0930262,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside"2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]"21497157
C0930262,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside"2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"23911879
C0930262,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside"2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside promotes the reaction [Doxorubicin results in increased expression of BCL2 protein]"19890356
C0445782,3,5,6-tetrachlorohydroquinone"2,3,5,6-tetrachlorohydroquinone results in decreased expression of BCL2 protein"11064002
C5583952-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone"2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]"27523796
C5583952-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone"zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]"27523796
C0294972,3-bis(3'-hydroxybenzyl)butyrolactone"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA"19167446
C4861822,3-bis(4-hydroxyphenyl)-propionitrile"2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA"19264808
C4861822,3-bis(4-hydroxyphenyl)-propionitrile"2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein"19264808
C4861822,3-bis(4-hydroxyphenyl)-propionitrile"ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 protein]"19264808
C4861822,3-bis(4-hydroxyphenyl)-propionitrile"ESR2 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of BCL2 mRNA]"19264808
C4861822,3-bis(4-hydroxyphenyl)-propionitrile"2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein]"24216299
C5054492,3-dimercaptosuccinic acid monocyclohexyl ester"[2,3-dimercaptosuccinic acid monocyclohexyl ester co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546
C5054492,3-dimercaptosuccinic acid monocyclohexyl ester"2,3-dimercaptosuccinic acid monocyclohexyl ester inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546|2337609
C5054492,3-dimercaptosuccinic acid monocyclohexyl ester"Succimer promotes the reaction [2,3-dimercaptosuccinic acid monocyclohexyl ester inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]]"23376091
C0140242,4,5,2',4',5'-hexachlorobiphenyl"2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of BCL2 protein"20638727
C0140242,4,5,2',4',5'-hexachlorobiphenyl"2,4,5,2',4',5'-hexachlorobiphenyl affects the cleavage of BCL2 protein"25659934
C0140242,4,5,2',4',5'-hexachlorobiphenyl"2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of BCL2 protein"21291966
C0140242,4,5,2',4',5'-hexachlorobiphenyl"[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BCL2 protein"21291966
C0098282,4,5,2',5'-pentachlorobiphenyl"2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]"20840854
C0098282,4,5,2',5'-pentachlorobiphenyl"2,4,5,2',5'-pentachlorobiphenyl affects the cleavage of BCL2 protein"25659934
C0098282,4,5,2',5'-pentachlorobiphenyl"[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BCL2 protein"21291966
C0098282,4,5,2',5'-pentachlorobiphenyl"2,4,5,2',5'-pentachlorobiphenyl results in decreased expression of BCL2 protein"21291966
C1045642-(4-acetoxyphenyl)-2-chloro-N-methylethylamineBCL2 protein results in decreased susceptibility to 2-(4-acetoxyphenyl)-2-chloro-N-methylethylamine19997594
C5431502-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]"19345205
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein]27032576
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2 mRNA22046442
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2 protein22046442
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]28185818
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BCL2 protein20386985|2113073
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BCL2 mRNA22046442
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]]20856197
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]]20856197
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]]20856197
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]]20856197
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased expression of and results in increased activity of BAX protein]]20856197
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneBCL2 protein results in decreased susceptibility to [Doxorubicin co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one]20856197
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]]25895139
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]]23352507
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]25955216
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in increased phosphorylation of BCL2 protein]29186614
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]21803128
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]]28465020
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]]23201927
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium bisulfide results in increased expression of BCL2 protein]21800153
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]21803128
C0859112-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased phosphorylation of BCL2 protein16018989
C4086042-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C4086042-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]14724571
C4086042-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole results in increased expression of BCL2 mRNA14685156
C0899462,4-thiazolidinedione"2,4-thiazolidinedione results in decreased expression of BCL2 protein"15916743
C450643(2)-5,6,7,8,4'-pentamethoxyflavanone"(2)-5,6,7,8,4'-pentamethoxyflavanone results in decreased expression of BCL2 mRNA"19450678
C450643(2)-5,6,7,8,4'-pentamethoxyflavanone"(2)-5,6,7,8,4'-pentamethoxyflavanone results in decreased expression of BCL2 protein"19450678
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein"21214929
C4882882,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid"[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein"21214929
C0112692,5-hexanedione"2,5-hexanedione results in decreased expression of BCL2 mRNA"21901545
C0112692,5-hexanedione"2,5-hexanedione results in decreased expression of BCL2 protein"21901545
C0112692,5-hexanedione"2,5-hexanedione results in increased expression of BCL2 protein"17492505
C55788225-methoxyldammarane-3,12,20-triol"25-methoxyldammarane-3,12,20-triol results in decreased expression of BCL2 protein"21924252
C0495842-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of BCL2 mRNA"23810796
C0495842-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of BCL2 protein"18174961|2381079
C0495842-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine"[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in increased expression of BCL2 protein"11751460
C0369902-amino-3,8-dimethylimidazo(4,5-f)quinoxaline"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of BCL2 mRNA"23810796
C0369902-amino-3,8-dimethylimidazo(4,5-f)quinoxaline"2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline results in increased expression of BCL2 protein"23810796
C5464602-amino-3-methyl-3H-imidazo(4,5-f)quinoline"2-amino-3-methyl-3H-imidazo(4,5-f)quinoline results in increased expression of BCL2 mRNA"23810796
C5464602-amino-3-methyl-3H-imidazo(4,5-f)quinoline"2-amino-3-methyl-3H-imidazo(4,5-f)quinoline results in increased expression of BCL2 protein"23810796
C0121772-aminofluorene[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein20452335
C0121772-aminofluorenezerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein]20452335
C0038982-anisidine2-anisidine results in decreased expression of BCL2 mRNA28089782
C4843272'-benzoyloxycinnamaldehyde2'-benzoyloxycinnamaldehyde results in decreased expression of BCL2 protein14660655
C4574992-chloro-5-nitrobenzanilide2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in decreased expression of BCL2 protein]17461445
C4574992-chloro-5-nitrobenzanilide2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 mRNA]17531121
C4574992-chloro-5-nitrobenzanilide2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 protein]17531121
C4574992-chloro-5-nitrobenzanilide2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]24954035
C4574992-chloro-5-nitrobenzanilideHesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]]24954035
C0312782-chloroethyl ethyl sulfide2-chloroethyl ethyl sulfide results in decreased expression of BCL2 mRNA12208782
C0900342-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide results in decreased expression of BCL2 protein10854059
C0340472-cresol2-cresol results in increased expression of BCL2 mRNA21705299
C0340472-cresolSodium Selenite inhibits the reaction [2-cresol results in increased expression of BCL2 mRNA]21705299
C518368(2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide"(2E)-N,N-dibutyl-3-(4-hydroxy-3-methoxyphenyl)acrylamide results in decreased expression of BCL2"17352252
C0879392''-galloylhyperin2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]28213291
C0498262-methoxyacetaldehyde2-methoxyacetaldehyde promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]10221278
C0228302-methoxyestradiol2-methoxyestradiol results in decreased expression of BCL2 protein17418156
C0228302-methoxyestradiol2-methoxyestradiol results in decreased expression of BCL216011306
C5009592-selenium-bridged beta-cyclodextrin2-selenium-bridged beta-cyclodextrin affects the expression of BCL2 protein15843033
C5240632-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one"2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-one inhibits the reaction [[F3 protein co-treated with F7 protein] results in increased expression of BCL2 protein]"18325115
C0188552-tert-butylhydroquinone2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]26878773
C0188552-tert-butylhydroquinone2-tert-butylhydroquinone results in increased expression of BCL2 protein22275372
C0188552-tert-butylhydroquinone2-tert-butylhydroquinone promotes the reaction [NFE2L2 protein binds to BCL2 promoter]22275372
C0188552-tert-butylhydroquinone2-tert-butylhydroquinone results in increased expression of BCL2 mRNA22275372
C0188552-tert-butylhydroquinone2-tert-butylhydroquinone results in increased expression of BCL2 protein22275372
C0188552-tert-butylhydroquinone[2-tert-butylhydroquinone results in increased stability of NFE2L2 protein] which results in increased expression of BCL2 protein22275372
C0188552-tert-butylhydroquinoneNFE2L2 mutant form inhibits the reaction [2-tert-butylhydroquinone results in increased expression of BCL2 mRNA]22275372
C0188552-tert-butylhydroquinone2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in decreased expression of BCL2 protein]28583816
C0163923,3'-diindolylmethane"3,3'-diindolylmethane analog results in decreased expression of BCL2 protein"16051428
C0163923,3'-diindolylmethane"3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein]"16580691
C0163923,3'-diindolylmethane"3,3'-diindolylmethane results in decreased expression of BCL2 protein"16580691|2229029
C0163923,3'-diindolylmethane"3,3'-diindolylmethane analog results in decreased expression of BCL2 mRNA"26593444
C0230353,4,5,3',4'-pentachlorobiphenyl"3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]"20840854
C4228633,4,5,4'-tetrahydroxystilbene"3,4,5,4'-tetrahydroxystilbene results in decreased expression of BCL2 mRNA"11181455
C4824923,4,5,4'-tetramethoxystilbene"3,4,5,4'-tetramethoxystilbene affects the expression of and affects the phosphorylation of BCL2 protein"15668717
C4824923,4,5,4'-tetramethoxystilbene"3,4,5,4'-tetramethoxystilbene affects the expression of BCL2 mRNA"15668717
C4824923,4,5,4'-tetramethoxystilbene"3,4,5,4'-tetramethoxystilbene results in decreased expression of BCL2 mRNA"22687606
C4824923,4,5,4'-tetramethoxystilbene"3,4,5,4'-tetramethoxystilbene results in decreased expression of BCL2 protein"23770989
C0454213,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of BCL2 mRNA"23810796
C0454213,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine"3,4,8-trimethylimidazo(4,5-f)quinoxalin-2-amine results in increased expression of BCL2 protein"23810796
C0059753,4-dihydroxyphenylethanol"3,4-dihydroxyphenylethanol results in increased phosphorylation of BCL2 protein"12482581
C0350553,4-dihydroxyphenyllactic acid"3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]"29128606
C4340033-(4-methylphenylsulfonyl)-2-propenenitrile3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C5257623,5-dicaffeoylquinic acid methyl ester"3,5-dicaffeoylquinic acid methyl ester inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA]"25451577
C5062823,5-dimethoxy-4'-hydroxystilbene"[3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]"17135264
C5062823,5-dimethoxy-4'-hydroxystilbene"[3,5-dimethoxy-4'-hydroxystilbene results in decreased phosphorylation of CREB1 protein] which results in decreased expression of BCL2 mRNA"17135264
C5062823,5-dimethoxy-4'-hydroxystilbene"3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of BCL2 mRNA]"17135264
C0909373-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein]19481069
C0909373-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole results in decreased expression of BCL2 protein19481069
C0909373-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole"3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of BCL2 mRNA]"17135264
C0909373-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Quercetin results in decreased expression of BCL2 mRNA]17135264
C0909373-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole[cobaltous chloride co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in decreased expression of BCL2 mRNA24265542
C0179063-dinitrobenzene3-dinitrobenzene results in decreased expression of BCL2 mRNA19477251
C0179063-dinitrobenzene3-dinitrobenzene results in decreased expression of BCL2 protein19477251
C0179063-dinitrobenzene3-dinitrobenzene results in increased expression of BCL2 mRNA16025311
C5054173-hydrogenkwadaphnin[3-hydrogenkwadaphnin co-treated with Hypoxanthine] results in decreased expression of BCL2 protein21396949
C5054173-hydrogenkwadaphnin[3-hydrogenkwadaphnin co-treated with Hypoxanthine] results in increased expression of BCL2 protein21396949
C5542893-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester"3-hydroxylup-20(29)-ene-27,28-dioic acid dimethyl ester results in decreased expression of BCL2 protein"20670616
C0526103-hydroxypregn-4-en-20-one3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA]19931389
C0526103-hydroxypregn-4-en-20-one3-hydroxypregn-4-en-20-one results in decreased expression of BCL2 mRNA19931389
C5424653-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine3-keto-N-aminoethylaminoethylcaproyldihydrocinnamoyl cyclopamine results in decreased expression of BCL2 mRNA21625222
C0259463-methyladenine[3-methyladenine co-treated with Amiodarone] results in decreased expression of BCL2 protein23912912
C0259463-methyladenine3-methyladenine inhibits the reaction [arsenic trioxide results in decreased expression of BCL2]25110043
C0473683-methylquercetin3-methylquercetin results in decreased expression of BCL2 mRNA22992727
C0473683-methylquercetin3-methylquercetin results in decreased expression of BCL2 protein22992727
C0153923-nitropropionic acid3-nitropropionic acid results in decreased expression of BCL2 mRNA21945202
C0153923-nitropropionic acidBCL2 protein promotes the reaction [BDNF protein results in decreased susceptibility to 3-nitropropionic acid]19428112
C0153923-nitropropionic acidnaringin inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 mRNA]21945202
C0153923-nitropropionic acid[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein15571979
C5810043-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile"3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein"24036456
C5810043-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile"Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
C5810043-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile"Glutathione inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
C5810043-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile"pyrazolanthrone inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
C5810043-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile"SB 203580 inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
C504089(3Z)-3-(1H-pyrrol-2-yl)-methyllidene)-1-(1-(piperidylmethyl)-1,3-dihydro-2H-indol-2-one mesylate"(3Z)-3-(1H-pyrrol-2-yl)-methyllidene)-1-(1-(piperidylmethyl)-1,3-dihydro-2H-indol-2-one mesylate affects the expression of BCL2 protein"20495136
C4967514-(1H-imidazol-1-yl)retinoic acid4-(1H-imidazol-1-yl)retinoic acid results in decreased expression of BCL2 protein17145897
C0388644-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of BCL2"16909596
C0388644-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of BCL2 protein"16109544
C4711094(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline"1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt inhibits the reaction [4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased expression of BCL2 protein]"17395010
C4711094(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline"4(2'-aminoethyl)amino-1,8-dimethylimidazo(1,2-a)quinoxaline results in decreased expression of BCL2 protein"17395010
C4861844,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol"4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of BCL2 mRNA"19264808
C4861844,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol"4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of BCL2 protein"19264808
C4861844,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol"ESR2 protein affects the reaction [4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of BCL2 mRNA]"19264808
C4861844,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol"4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein]"24216299
C5174874-(4-bromophenyl)-2,3-dihydro-N,3-bis(3,4,5-trimethoxyphenyl)-2-oxoidmi-dazole-1-carboxamide"4-(4-bromophenyl)-2,3-dihydro-N,3-bis(3,4,5-trimethoxyphenyl)-2-oxoidmi-dazole-1-carboxamide results in decreased expression of BCL2 protein"16900371
C0909424-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
C4053544,5,6,7-tetrabromobenzotriazole"[4,5,6,7-tetrabromobenzotriazole co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein"16489027
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C5688624-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline"4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-3H-cyclopenta(c)quinoline results in decreased expression of BCL2 protein"24161432
C0865384-amino-1,8-naphthalimide"4-amino-1,8-naphthalimide inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein]"25972196
C4943564-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA]"21878650
C4943564-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]"25453207
C4943564-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione promotes the reaction [Valproic Acid inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]]"25453207
C5080854'-demethyldesoxypodophyllotoxin4'-demethyldesoxypodophyllotoxin analog results in decreased expression of BCL2 protein25446499
C5843684'-methoxy licoflavanone4'-methoxy licoflavanone results in decreased expression of BCL2 protein23850732
C4988264-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide results in decreased expression of BCL2 protein26549707
C0789564-methylthioamphetamine4-methylthioamphetamine results in decreased expression of BCL2 mRNA23820845
C0789564-methylthioamphetamine"[N-Methyl-3,4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA"23820845
C0194984-nitroanilineBCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]]11577002
C0165834-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA16582591|1683574
C0165834-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein18508827|2177627
C0165834-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneBungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA]16835749
C0165834-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneSN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein]18508827
C0165834-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneU 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein]18508827
C0415944-nonylphenol4-nonylphenol results in increased expression of BCL2 mRNA15461258
C0415944-nonylphenol4-nonylphenol results in decreased expression of BCL2 mRNA27087316|2710977
C0415944-nonylphenol4-nonylphenol results in decreased expression of BCL2 protein26804764|2710977
C0757734-phenylbutyric acid"4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]"27816613
C0757734-phenylbutyric acid"4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]"27816613
C0757734-phenylbutyric acid"Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]"27816613
C4664205,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride"5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]"21397656
C5031195-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone5-((4-methylphenyl)methylene)-2-(phenylamino)-4(5H)-thiazolone results in increased phosphorylation of BCL2 protein16179969
C5732335,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one results in decreased expression of BCL2 protein"26405812
C0806695,7-dihydroxy-6-methoxy-2-phenylchromen-4-one"5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one results in decreased expression of BCL2 protein"19135124
C4114255-aminoisoquinolinone2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]]23352507
C4114255-aminoisoquinolinone5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]23352507
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]"26054749
C0417156-anilino-5,8-quinolinedione"6-anilino-5,8-quinolinedione inhibits the reaction [sodium bichromate results in increased ubiquitination of BCL2 protein]"18544562
C0417156-anilino-5,8-quinolinedione"6-anilino-5,8-quinolinedione results in decreased expression of BCL2 protein"18544562
C5847556-bromo-8-ethoxy-3-nitro-2H-chromene6-bromo-8-ethoxy-3-nitro-2H-chromene results in decreased expression of BCL2 protein24831963
C0464146-codeinone6-codeinone results in decreased expression of BCL2 protein12894543
C0106436-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Humic Substances results in decreased expression of BCL2 protein]"18683188
C0106436-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in increased expression of BCL2 protein]"16799065
C0106436-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein]"16799065
C0538766-isopropoxy-9-oxoxanthene-2-carboxylic acid[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAD protein binds to BCL2 protein]19407222
C0538766-isopropoxy-9-oxoxanthene-2-carboxylic acid[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAX protein binds to BCL2 protein]19407222
C0538766-isopropoxy-9-oxoxanthene-2-carboxylic acid[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of BCL2 protein19407222
C1214656-methyl-2-(phenylethynyl)pyridine6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
C5838836-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone"6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased phosphorylation of BCL2 protein"23212307
C5838836-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone"pyrazolanthrone inhibits the reaction [6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased phosphorylation of BCL2 protein]"23212307
C5319376-O-angeloylenolin6-O-angeloylenolin results in decreased expression of BCL2 protein21192922
C5805996-OH-BDE-476-OH-BDE-47 results in decreased expression of BCL2 mRNA27589474
C4118687-diethylamino-4-methyl coumarin7-diethylamino-4-methyl coumarin results in increased expression of BCL2 mRNA21538407
C0314777-hydroxycoumarin7-hydroxycoumarin results in decreased expression of BCL2 protein15964220
C1177897-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
C0548527-hydroxystaurosporine7-hydroxystaurosporine results in decreased expression of BCL2 protein10887097
C0030017-ketocholesterol7-ketocholesterol results in decreased expression of BCL2 protein25845326
C0030017-ketocholesterolAcetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]25845326
C0030017-ketocholesterolBAY 11-7085 inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]25845326
C0030017-ketocholesterolquercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]25845326
C5568018-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione"8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]"20946892
C0428349,10-anthraquinone"9,10-anthraquinone analog results in decreased expression of BCL2 mRNA"26915975
C0428349,10-anthraquinone"9,10-anthraquinone analog results in decreased expression of BCL2 protein"26915975
C0053999,10-phenanthrenequinone"9,10-phenanthrenequinone results in decreased expression of BCL2 protein"29108775
C0257249-methoxycamptothecin9-methoxycamptothecin results in increased expression of BCL2 mRNA23369935
C501332ABT-737[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of BCL2 protein] which results in increased susceptibility to ABT-73717097560
C501332ABT-737ABT-737 inhibits the reaction [BAX protein binds to BCL2 protein]17097560
C501332ABT-737ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein]17097560|1720071
C501332ABT-737[ABT-737 inhibits the reaction [BCL2L11 protein binds to BCL2 protein]] promotes the reaction [BCL2L11 protein results in increased activity of BAX protein]17200714
C501332ABT-737[ABT-737 results in decreased activity of BCL2 protein] which results in increased susceptibility to fosbretabulin24321340
C501332ABT-737[BCL2L11 protein binds to BCL2 protein] which affects the susceptibility to ABT-73717200714
C501332ABT-737BCL2 protein inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP3 protein]]20104024
C501332ABT-737BCL2 protein inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP3 protein]]20104024
C501332ABT-737BCL2 protein modified form results in decreased susceptibility to ABT-73717097560
C501332ABT-737ABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to Valproic Acid]19060243
C501332ABT-737ABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to vorinostat]19060243
C501332ABT-737ABT-737 binds to BCL2 protein17097560|2188062
C501332ABT-737ABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to Erlotinib Hydrochloride]23894143
C501332ABT-737ABT-737 results in decreased activity of BCL2 protein24321340|2695460
C542662AC 93253AC 93253 results in decreased expression of BCL2 mRNA25912555
D000079AcetaldehydeAcetaldehyde results in decreased expression of BCL2 mRNA16814256
D000079AcetaldehydeADIPOQ protein inhibits the reaction [Acetaldehyde results in decreased expression of BCL2 mRNA]16814256
D000082AcetaminophenAcetaminophen results in decreased expression of BCL2 mRNA9444671
D000082AcetaminophenAcetaminophen results in increased expression of BCL2 mRNA26690555|2906747
D000082AcetaminophenAcetaminophen promotes the reaction [saikosaponin results in increased expression of BCL2 mRNA]25265579
D000082AcetaminophenAcetaminophen results in decreased expression of BCL2 protein18467506|2293991
D000082AcetaminophenAcetaminophen results in increased expression of BCL2 mRNA12540782
D000082AcetaminophenAcetaminophen results in increased expression of BCL2 protein25319358
D000082Acetaminophendioscin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]22939915
D000082AcetaminophenKITL protein inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]18467506
D000082Acetaminophen"O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of BCL2 mRNA]"12540782
D000082Acetaminophenschizandrol B promotes the reaction [Acetaminophen results in increased expression of BCL2 protein]25319358
D000082AcetaminophenAcetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA]19265712
D000082AcetaminophenAcetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein]19265712
D000082AcetaminophenAcetaminophen results in decreased expression of BCL2 mRNA22093918
D000082AcetaminophenAcetaminophen results in decreased expression of BCL2 protein22093918|2676794
D000082AcetaminophenAcetaminophen results in increased expression of BCL2 protein modified form20166895
D000082AcetaminophenHesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 mRNA]22093918
D000082AcetaminophenHesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]22093918
D000082Acetaminophenmorin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]26767949
D000082Acetaminophenpyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
D000082AcetaminophenTaurine inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
D000082AcetaminophenAcetaminophen results in increased expression of BCL2 protein modified form20166895
D000082Acetaminophenpyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
D000082AcetaminophenTaurine inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
C056165acetovanilloneacetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]22431579
C094432acetyl-11-ketoboswellic acidacetyl-11-ketoboswellic acid results in decreased expression of BCL2 protein20692244
C487680acetylbritannilatoneacetylbritannilatone analog results in decreased expression of BCL2 protein27262408
C487680acetylbritannilatoneacetylbritannilatone analog results in increased phosphorylation of BCL2 protein27262408
C487680acetylbritannilatoneacetylbritannilatone analog results in increased phosphorylation of BCL2 protein27262408
D000111Acetylcysteine"4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]"27816613
D000111Acetylcysteine"Acetylcysteine inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
D000111AcetylcysteineAcetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [resveratrol results in decreased expression of BCL2 protein]]26772155
D000111AcetylcysteineAcetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]26772155
D000111AcetylcysteineAcetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein]11341981
D000111AcetylcysteineAcetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein]21310227
D000111AcetylcysteineAcetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of BCL2 protein]22578287
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17542780
D000111AcetylcysteineAcetylcysteine inhibits the reaction [gingerol results in decreased expression of BCL2 protein]25034532
D000111AcetylcysteineAcetylcysteine inhibits the reaction [nickel acetate results in decreased expression of BCL2 protein]22245127
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein]28804952
D000111AcetylcysteineAcetylcysteine inhibits the reaction [resveratrol promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]]26772155
D000111AcetylcysteineAcetylcysteine inhibits the reaction [resveratrol results in decreased expression of BCL2 protein]26772155
D000111AcetylcysteineAcetylcysteine inhibits the reaction [salvin results in decreased expression of BCL2 protein]28918123
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]19082730
D000111AcetylcysteineAcetylcysteine inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein]19954742
D000111Acetylcysteine"Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BCL2 protein]"22704995
D000111AcetylcysteineAcetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]23711929
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein]19679660
D000111Acetylcysteine"Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]"27816613
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein]21600978
D000111Acetylcysteine"Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]"27816613
D000111AcetylcysteineAcetylcysteine results in decreased expression of BCL2 protein17395010
D000111Acetylcysteine"Acetylcysteine results in decreased susceptibility to [1-(3',4',5'-trimethoxyphenyl)-3-(3'',4''-dimethoxy-2'-hydroxyphenyl)propane results in decreased expression of BCL2 protein]"20674558
D000111AcetylcysteineBCL2 results in decreased susceptibility to Acetylcysteine17395010
D000111AcetylcysteineAcetylcysteine inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]24909818
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]21616140
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Methylmercury Compounds results in decreased expression of BCL2 mRNA]21549813
D000111AcetylcysteineAcetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]]21616140
D000111AcetylcysteineAcetylcysteine inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]25845326
D000111AcetylcysteineAcetylcysteine inhibits the reaction [arsenite results in increased expression of BCL2 protein]18077580
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA]22085843
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein]22085843
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein]17041759
D000111AcetylcysteineAcetylcysteine inhibits the reaction [tributyltin results in decreased expression of BCL2 protein]26079211
D000111Acetylcysteine[Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein29109043
D000111Acetylcysteine[Acetylcysteine co-treated with fumonisin B1] results in increased expression of BCL2 protein29109043
D000111Acetylcysteine[Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein29109043
D000111Acetylcysteine[Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein29109043
D000111Acetylcysteine[Acetylcysteine co-treated with Zearalenone] results in increased expression of BCL2 protein29109043
D000111AcetylcysteineAcetylcysteine inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]19135140
D000111AcetylcysteineAcetylcysteine inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]29109043
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]29109043
D000111AcetylcysteineAcetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]29109043
D000111AcetylcysteineAcetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]29109043
D012794Sialic AcidsSialic Acids inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]24973090
D000143AcidsAcids results in increased expression of BCL2 protein18512153
D000143Acidssorafenib inhibits the reaction [Acids results in increased expression of BCL2 protein]18512153
C018425acifluorfenBCL2 protein results in decreased susceptibility to acifluorfen15475374
D017255AcitretinAcitretin results in decreased expression of BCL2 protein16109552|1619628
D000157AconitineAconitine results in decreased expression of BCL2 protein24840785
D000171AcroleinAcrolein results in decreased expression of BCL2 protein24376112
D000171Acroleincapsazepine inhibits the reaction [Acrolein results in decreased expression of BCL2 protein]24376112
D000171AcroleinGlutathione inhibits the reaction [Acrolein results in decreased expression of BCL2 protein]24376112
D020106AcrylamideAcrylamide results in decreased expression of BCL2 mRNA28959563
D000181AcrylonitrileAcrylonitrile results in decreased expression of BCL2 protein16173056
C016957adenosine-3',5'-cyclic phosphorothioate"adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Bucladesine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]"16822680
D000255Adenosine Triphosphate[Adenosine Triphosphate binds to P2RY11 protein] which results in decreased expression of BCL2 protein21503959
D000255Adenosine TriphosphateAdenosine Triphosphate results in increased expression of BCL2 protein17997382
D000255Adenosine Triphosphatetetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased expression of BCL2 protein]17997382
C016601afimoxifeneafimoxifene results in decreased expression of BCL2 mRNA19698761
C016601afimoxifene[annonacin co-treated with afimoxifene] results in decreased expression of BCL2 protein21840388
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of BCL2 mRNA25261862
D016604Aflatoxin B1Sodium Selenite inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]25261862
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of BCL2 protein22743290
D016604Aflatoxin B1Methoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein]22743290
D016604Aflatoxin B1Nicotine inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein]22743290
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of BCL2 mRNA19770486|2544575
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of BCL2 protein26968497
D016604Aflatoxin B1deoxynivalenol promotes the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]25445755
D016604Aflatoxin B1Aflatoxin B1 results in decreased expression of BCL2 mRNA27288928|2844241
D016604Aflatoxin B1[Curcumin analog co-treated with Hydrogels] inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]27288928
C412373AG 1879AG 1879 results in decreased expression of BCL2 mRNA15175350
C412373AG 1879AG 1879 results in decreased expression of BCL2 protein15175350
C412373AG 1879[Tamoxifen co-treated with AG 1879] results in increased expression of BCL2 protein17186241
C046926AH 23848[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAD protein binds to BCL2 protein]19407222
C046926AH 23848[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAX protein binds to BCL2 protein]19407222
C046926AH 23848[6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] results in decreased expression of BCL2 protein19407222
C031143AICA ribonucleotideAICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]26989860
D000393Air PollutantsAir Pollutants results in decreased expression of BCL2 mRNA28389379
D000393Air PollutantsAir Pollutants results in decreased expression of BCL2 protein28389379
C000188alachloralachlor results in increased expression of BCL2 protein10545406
C000188alachlorBCL2 protein results in decreased susceptibility to alachlor12730627
C000188alachlorfulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein]10545406
C000188alachlorPK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor]12730627
C004363alantolactonealantolactone results in decreased expression of BCL2 protein24252419
C004363alantolactonealantolactone results in increased expression of BCL2 protein22721982
C012708alborixinalborixin results in decreased expression of BCL2 protein27378626
D000420AlbuterolAlbuterol results in decreased expression of BCL211802967
C103303alitretinoinalitretinoin results in decreased expression of BCL216909596
C103303alitretinoinalitretinoin results in decreased expression of BCL2 protein12189556|1610954
C103303alitretinoinBCL2 protein results in decreased susceptibility to alitretinoin12189556
D000487AllethrinAllethrin results in decreased expression of BCL2 protein24055895
D000487AllethrinAllethrin results in decreased expression of BCL2 protein25072698
D000496AlloxanAlloxan results in decreased expression of BCL2 protein21982801|2213823
D000496AlloxanTaurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein]22138235|2309280
C023698allyl chlorideallyl chloride results in decreased expression of BCL2 protein17194518
C038491allyl sulfide[allyl sulfide co-treated with resveratrol] results in decreased expression of BCL2 mRNA18512326
C038491allyl sulfideallyl sulfide results in decreased expression of BCL2 mRNA17647244
C038491allyl sulfideallyl sulfide promotes the reaction [Bleomycin results in increased expression of BCL2 protein]23656969
C518327aloe emodinaloe emodin results in decreased expression of BCL2 mRNA22210228
C518327aloe emodinaloe emodin results in decreased expression of BCL2 protein19928967
C062701aloperinealoperine results in increased expression of BCL2 mRNA11218852
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in decreased expression of BCL2 mRNA27732882
D000517alpha-Chlorohydrinalpha-Chlorohydrin results in decreased expression of BCL2 protein27732882|2807010
C095512alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased expression of BCL2 protein"20197088
C095512alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Quercetin analog results in decreased expression of BCL2 protein]"23907460
C095512alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased expression of BCL2 mRNA"16048438
D0435825-alpha-Dihydroprogesterone3-hydroxypregn-4-en-20-one inhibits the reaction [5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA]19931389
D0435825-alpha-Dihydroprogesterone5-alpha-Dihydroprogesterone results in increased expression of BCL2 mRNA19931389
D013196Dihydrotestosterone[Dihydrotestosterone co-treated with Curcumin co-treated with Quercetin] results in increased expression of BCL2 protein27132804
D013196DihydrotestosteroneDihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]16407456
D024502alpha-Tocopherolalpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]11805214
D024502alpha-Tocopherolalpha-Tocopherol analog results in decreased expression of BCL2 mRNA20686688
D024502alpha-Tocopherolalpha-Tocopherol analog results in decreased expression of BCL2 protein20686688
D024502alpha-Tocopherolbenzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]20686688
D024502alpha-TocopherolDDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]20686688
D024502alpha-Tocopherolsalubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]20686688
D024502alpha-TocopherolTNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]20686688
D024502alpha-Tocopherolalpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]16005924
D024502alpha-Tocopherol"alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein]"16135673
C000154alpinumisoflavonealpinumisoflavone results in decreased expression of BCL2 protein23850732
C010845aluminum chloridealuminum chloride results in decreased expression of BCL2 protein28623112
C010845aluminum chlorideChlorogenic Acid inhibits the reaction [aluminum chloride results in decreased expression of BCL2 protein]28623112
C010845aluminum chloridealuminum chloride results in decreased expression of BCL2 mRNA16535832|1709693
C010845aluminum chloridealuminum chloride results in decreased expression of BCL2 protein17096939
C010845aluminum chloridealuminum chloride results in increased expression of BCL2 mRNA25263842
C010845aluminum chloridealuminum chloride results in increased expression of BCL2 protein17967740
C104223aluminum lactatealuminum lactate affects the localization of BCL2 protein26944603
C104223aluminum lactateQuercetin inhibits the reaction [aluminum lactate affects the localization of BCL2 protein]26944603
C067527aluminum maltolatealuminum maltolate results in decreased expression of BCL2 mRNA24878590
C067527aluminum maltolatealuminum maltolate results in decreased expression of BCL2 protein24878590
C067527aluminum maltolatealuminum maltolate results in decreased expression of BCL2 mRNA15537749
C067527aluminum maltolatealuminum maltolate results in decreased expression of BCL2 protein10591516|1138238
C067527aluminum maltolateGDNF protein inhibits the reaction [aluminum maltolate results in decreased expression of BCL2 protein]11592846
C077990alvocidib[alvocidib co-treated with gemcitabine] results in decreased expression of BCL2 protein15770523
C077990alvocidibalvocidib results in decreased expression of BCL2 mRNA15972445
C077990alvocidibalvocidib results in decreased expression of BCL2 protein10887097|1258903
C077990alvocidibalvocidib results in increased expression of BCL210995888
C077990alvocidibBCL2 protein mutant form inhibits the reaction [alvocidib affects the localization of CYCS protein]12170773
C077990alvocidibBCL2 protein mutant form inhibits the reaction [alvocidib results in increased activity of CASP3 protein]12170773
C077990alvocidibBCL2 protein mutant form inhibits the reaction [alvocidib results in increased activity of CASP9 protein]12170773
C077990alvocidibBCL2 protein mutant form inhibits the reaction [alvocidib results in increased cleavage of BID protein]12170773
C077990alvocidibBCL2 protein mutant form inhibits the reaction [alvocidib results in increased cleavage of PARP1 protein]12170773
C077990alvocidibBCL2 protein mutant form results in decreased susceptibility to alvocidib12170773
C077990alvocidibBCL2 protein results in decreased susceptibility to alvocidib12517783
C077990alvocidibBCL2 protein results in decreased susceptibility to [alvocidib co-treated with Epothilones]12517783
C077990alvocidibalvocidib results in decreased expression of BCL2 protein12734434
C011164amentoflavone2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]28185818
C011164amentoflavoneamentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]28185818
C011164amentoflavone"amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"28185818
D004999Amifostine[Amifostine co-treated with Doxorubicin] results in decreased expression of BCL2 mRNA15985719
D000596Amino AcidsAmino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein]25309793
D000596Amino AcidsH 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein]]25309793
D000602Amino Acids, Peptides, and Proteins"Amino Acids, Peptides, and Proteins results in decreased expression of BCL2 protein"23313464
D000602Amino Acids, Peptides, and Proteins"praeruptorin C inhibits the reaction [Amino Acids, Peptides, and Proteins results in decreased expression of BCL2 protein]"23313464
D000622Aminolevulinic AcidAminolevulinic Acid analog results in decreased expression of BCL2 mRNA20676910
D006710HomocysteineHomocysteine results in decreased expression of BCL2 protein16757814
D006710HomocysteineZeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein]16757814
D000628Aminophylline[Aminophylline co-treated with gemcitabine] results in decreased expression of BCL2 protein15645133
D000629AminopropionitrileAminopropionitrile results in decreased expression of BCL2 protein24614111
D019804MesalamineMesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA]24637189
D019804MesalamineMesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein]24637189
D000638Amiodarone[3-methyladenine co-treated with Amiodarone] results in decreased expression of BCL2 protein23912912
D000638AmiodaroneAmiodarone results in decreased expression of BCL2 protein21224497
D000639AmitriptylineAmitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]19135049
D017311AmlodipineAmlodipine inhibits the reaction [AGT results in decreased expression of BCL2 mRNA]21376258
D017311AmlodipineAmlodipine inhibits the reaction [AGT results in decreased expression of BCL2 protein]21376258
D017311AmlodipineAmlodipine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17234320
D017311AmlodipineAmlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein]19698708
D000643Ammonium ChlorideAmmonium Chloride affects the expression of BCL2 mRNA16483693
D003913DextroamphetamineDextroamphetamine results in decreased expression of BCL2 mRNA23820845
D003913Dextroamphetamine"[N-Methyl-3,4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA"23820845
D000661AmphetamineAmphetamine results in decreased expression of BCL2 protein15731293
D000677AmsacrineBCL2 protein results in decreased susceptibility to Amsacrine10920913
C416531AN 215AN 215 analog results in decreased expression of BCL216003723
C088115anacardic acidanacardic acid inhibits the reaction [TNF protein results in increased expression of BCL2 protein]18349320
C030419andrographolide[andrographolide co-treated with Cisplatin] results in decreased expression of BCL2 mRNA24563380
C030419andrographolideandrographolide results in decreased expression of BCL2 protein23845849
D000806Angiotensin-Converting Enzyme InhibitorsAngiotensin-Converting Enzyme Inhibitors inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]22429817
D000841Anisomycin[Colistin co-treated with Anisomycin] results in increased phosphorylation of BCL2 protein28842171
C053442annonacin[annonacin co-treated with afimoxifene] results in decreased expression of BCL2 protein21840388
C053442annonacinannonacin results in decreased expression of BCL2 protein21840388
C540917anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione"anthraceno(1,2-c)(1,2,5)selenadiazolo-6,11-dione results in decreased expression of BCL2 protein"19146838
C529696anthracenylmethyl homospermidineanthracenylmethyl homospermidine results in decreased expression of BCL2 protein19595733
D000880AnthraquinonesAnthraquinones analog results in decreased expression of BCL2 protein19686834
D000968Antimycin ABCL2 protein results in decreased susceptibility to Antimycin A12730627
D000968Antimycin APK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A]12730627
D000978Antiparkinson AgentsAntiparkinson Agents inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]21807080
C558369antrocinantrocin results in decreased expression of BCL2 mRNA21158420
C558369antrocinantrocin results in decreased expression of BCL2 protein21158420
C102351apicidinapicidin results in decreased expression of BCL2 protein18313654|1907061
D047310ApigeninApigenin results in decreased expression of BCL2 protein15486995
D047310ApigeninBCL2 protein results in decreased susceptibility to Apigenin15486995
D047310Apigenin[polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in decreased expression of BCL2 mRNA24070738
D047310Apigenin[polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in decreased expression of BCL2 protein24070738
D047310Apigenin[TNFSF10 protein results in increased susceptibility to Apigenin] which results in decreased expression of BCL2 protein29247770
D047310ApigeninApigenin inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]25557508
D016718Arachidonic Acid"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]"19540902
D016718Arachidonic Acid4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
D016718Arachidonic Acid[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein19620254
D016718Arachidonic AcidArachidonic Acid results in decreased expression of BCL2 protein19540902|1972012
D016718Arachidonic Acidbenzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
D016718Arachidonic AcidMAPK14 mutant form inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
D016718Arachidonic AcidMAPK8 mutant form inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
D016718Arachidonic Acidpyrazolanthrone inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
D016718Arachidonic Acidresveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein]19620254
D001115ArecolineArecoline results in decreased expression of BCL2 protein22108589
C000228aristolochic acid Iaristolochic acid I results in decreased expression of BCL2 protein26656393
C061640arjunolic acidarjunolic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]21420465
C061640arjunolic acidarjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2 protein]19682444
C028617aroclor 1248aroclor 1248 results in decreased expression of BCL2 protein16263226
D001151ArsenicArsenic affects the methylation of BCL2 gene25304211
D001151ArsenicArsenic results in decreased expression of BCL2 protein26385919
D001151ArsenicArsenic results in increased expression of BCL2 mRNA27838757
D001151ArsenicArsenic results in increased expression of BCL2 protein12899209
D001151Arsenicnavitoclax promotes the reaction [Arsenic results in decreased expression of BCL2 protein]26385919
D001151ArsenicNFE2L2 mutant form promotes the reaction [Arsenic results in decreased expression of BCL2 protein]26385919
D001151ArsenicSQSTM1 mutant form promotes the reaction [Arsenic results in decreased expression of BCL2 protein]26385919
D001151ArsenicArsenic affects the expression of BCL2 protein27289040
D001151ArsenicArsenic results in increased expression of BCL2 protein11756236
C025657arsenic acidarsenic acid results in increased expression of BCL2 mRNA8946558
C058317arsenic disulfidearsenic disulfide affects the expression of BCL2 mRNA24026139
C058317arsenic disulfidearsenic disulfide affects the expression of BCL2 protein24026139
C058317arsenic disulfide[arsenic disulfide co-treated with indirubin] results in decreased expression of BCL2 mRNA25789073
C058317arsenic disulfidearsenic disulfide results in decreased expression of BCL2 mRNA25789073
C058317arsenic disulfidearsenic disulfide results in decreased expression of BCL2 protein24192507|2498928
C058317arsenic disulfidearsenic disulfide results in increased expression of BCL2 mRNA24648990
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein23542815
C006632arsenic trioxideLy-364947 inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23542815
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA24905690
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA27746373
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA28454103
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein28454103
C006632arsenic trioxide2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C006632arsenic trioxide3-methyladenine inhibits the reaction [arsenic trioxide results in decreased expression of BCL2]25110043
C006632arsenic trioxide"4-amino-1,8-naphthalimide inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein]"25972196
C006632arsenic trioxideAcetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [resveratrol results in decreased expression of BCL2 protein]]26772155
C006632arsenic trioxideAcetylcysteine inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]26772155
C006632arsenic trioxideAcetylcysteine inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C006632arsenic trioxideAcetylcysteine inhibits the reaction [resveratrol promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]]26772155
C006632arsenic trioxidearsenic trioxide affects the expression of BCL2 protein12962562|1601043
C006632arsenic trioxidearsenic trioxide affects the folding of BCL2 protein20403207
C006632arsenic trioxide[arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein24126434
C006632arsenic trioxide[arsenic trioxide co-treated with BCL2 mutant form] results in increased expression of BCL2 protein14642526|1464252
C006632arsenic trioxide[arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL2 mRNA20471514
C006632arsenic trioxide[arsenic trioxide co-treated with Curcumin] affects the expression of BCL2 protein27430728
C006632arsenic trioxide[arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 mRNA24738333
C006632arsenic trioxide[arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 protein24738333
C006632arsenic trioxide[arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2 protein20950636
C006632arsenic trioxide[arsenic trioxide co-treated with PML protein] results in decreased expression of BCL220377131
C006632arsenic trioxidearsenic trioxide inhibits the reaction [BCL2 protein binds to BAX protein]18412143
C006632arsenic trioxidearsenic trioxide inhibits the reaction [BCL2 protein binds to BAX protein binds to VDAC1 protein]17374990
C006632arsenic trioxidearsenic trioxide promotes the reaction [Genistein results in decreased expression of BCL2 protein]20219070
C006632arsenic trioxidearsenic trioxide promotes the reaction [matrine results in decreased expression of BCL2 protein]23700110
C006632arsenic trioxidearsenic trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA]20416161
C006632arsenic trioxidearsenic trioxide promotes the reaction [resveratrol results in decreased expression of BCL2 protein]26772155
C006632arsenic trioxidearsenic trioxide promotes the reaction [TGFB1 protein results in decreased expression of BCL2 protein]20723295
C006632arsenic trioxidearsenic trioxide results in decreased expression of and affects the localization of BCL2 protein17374990
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL221473291|2251983
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA11775218|1285987
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein10340400|1085045
C006632arsenic trioxidearsenic trioxide results in increased cleavage of BCL2 protein11739184
C006632arsenic trioxidearsenic trioxide results in increased degradation of BCL2 protein19468689
C006632arsenic trioxidearsenic trioxide results in increased expression of BCL2 mRNA16966277
C006632arsenic trioxidearsenic trioxide results in increased expression of BCL2 protein18022205|1920809
C006632arsenic trioxidearsenic trioxide results in increased phosphorylation of BCL2 protein12181429|1841214
C006632arsenic trioxide[arsenic trioxide results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]18412143
C006632arsenic trioxideBCL2 inhibits the reaction [[arsenic trioxide co-treated with TNF protein] results in decreased expression of CFLAR protein]17673311
C006632arsenic trioxideBCL2 inhibits the reaction [[arsenic trioxide co-treated with TNF protein] results in increased activity of CASP8 protein]17673311
C006632arsenic trioxideBCL2 mutant form results in increased susceptibility to arsenic trioxide14642526
C006632arsenic trioxideBCL2 protein affects the susceptibility to arsenic trioxide10648417|1872648
C006632arsenic trioxideBCL2 protein inhibits the reaction [[arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein]21889928
C006632arsenic trioxideBCL2 protein inhibits the reaction [[arsenic trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein]18359480
C006632arsenic trioxideBCL2 protein inhibits the reaction [arsenic trioxide inhibits the reaction [BCL2 protein binds to BAX protein]]18412143
C006632arsenic trioxideBCL2 protein inhibits the reaction [arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]]21889928
C006632arsenic trioxideBCL2 protein inhibits the reaction [arsenic trioxide results in decreased expression of MYC mRNA]11775218
C006632arsenic trioxideBCL2 protein inhibits the reaction [arsenic trioxide results in increased activity of BAX protein]15735709
C006632arsenic trioxideBCL2 protein inhibits the reaction [arsenic trioxide results in increased activity of CASP3 protein]12168106
C006632arsenic trioxideBCL2 protein inhibits the reaction [lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein]]21889928
C006632arsenic trioxideBCL2 protein results in decreased susceptibility to arsenic trioxide11775218|1216810
C006632arsenic trioxideBCL2 results in decreased susceptibility to arsenic trioxide18412143
C006632arsenic trioxide[Bortezomib co-treated with arsenic trioxide] affects the expression of BCL2 protein18718063
C006632arsenic trioxide[Bortezomib co-treated with arsenic trioxide] results in decreased expression of BCL2 protein24377552
C006632arsenic trioxideDithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein]18022205
C006632arsenic trioxide[Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2 protein21078540
C006632arsenic trioxideGenistein promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]20219070
C006632arsenic trioxideGH1 protein promotes the reaction [arsenic trioxide results in decreased expression of BCL2 mRNA]23851143
C006632arsenic trioxideHOMER3 protein affects the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23725168
C006632arsenic trioxide[Hydrogen Peroxide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein15142122
C006632arsenic trioxideMAPK14 mutant form inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C006632arsenic trioxideMAPK8 mutant form inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C006632arsenic trioxideMAPK9 mutant form inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C006632arsenic trioxidematrine promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23700110
C006632arsenic trioxide[paricalcitol co-treated with arsenic trioxide] results in decreased expression of BCL215781666
C006632arsenic trioxidepyrazolanthrone inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C006632arsenic trioxideresveratrol promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]26772155
C006632arsenic trioxideSB 203580 promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]16818652
C006632arsenic trioxide[silybin co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA21969006
C006632arsenic trioxide[tetraarsenic tetrasulfide co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA26110921
C006632arsenic trioxide[tetraarsenic tetrasulfide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein26110921
C006632arsenic trioxide[Tretinoin co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA15894607
C006632arsenic trioxide[Valproic Acid co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA25815518
C006632arsenic trioxide[Valproic Acid co-treated with arsenic trioxide] results in decreased expression of BCL2 protein25815518
C006632arsenic trioxide[vorinostat co-treated with arsenic trioxide] results in decreased expression of BCL2 protein27189198
C006632arsenic trioxidewortmannin inhibits the reaction [[Hydrogen Peroxide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein]15142122
C006632arsenic trioxide"arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BCL2 protein]"28587418
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA24157283|2578710
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein10721769|2156524
C006632arsenic trioxidearsenic trioxide results in increased cleavage of BCL2 protein15761769
C006632arsenic trioxidearsenic trioxide results in increased expression of BCL2 protein10712780
C006632arsenic trioxide"Drugs, Chinese Herbal promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]"28587418
C006632arsenic trioxide[Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2 protein21078540
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein12609071
C006632arsenic trioxide2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]]23201927
C006632arsenic trioxidearsenic trioxide affects the expression of BCL2 mRNA18618274
C006632arsenic trioxidearsenic trioxide affects the expression of BCL2 protein12725324
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA21145380
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein19260322|2320192
C006632arsenic trioxidearsenic trioxide results in increased expression of BCL2 mRNA17487067
C006632arsenic trioxideLy-364947 inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23542815
C006632arsenic trioxidepifithrin inhibits the reaction [arsenic trioxide results in increased expression of BCL2 mRNA]17487067
C006632arsenic trioxidesalvianolic acid A inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]28391263
C006632arsenic trioxidesalvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23201927
C006632arsenic trioxide[arsenic trioxide co-treated with Itraconazole] results in decreased expression of BCL227784375
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL211890109
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 mRNA19379560
C006632arsenic trioxidearsenic trioxide results in decreased expression of BCL2 protein12939460|1937956
C006632arsenic trioxideBCL2 protein inhibits the reaction [arsenic trioxide results in increased activity of TOP1 protein]15178684
C015001arsenitearsenite results in decreased expression of BCL2 mRNA alternative form20083129
C015001arsenitearsenite results in decreased expression of BCL2 protein20083129|2667707
C015001arsenitearsenite results in increased expression of BCL2 mRNA28444938
C015001arsenitearsenite results in increased expression of BCL2 protein28444938
C015001arseniteHeparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein]26677073
C015001arseniteThapsigargin promotes the reaction [arsenite results in decreased expression of BCL2 protein]26677073
C015001arseniteAcetylcysteine inhibits the reaction [arsenite results in increased expression of BCL2 protein]18077580
C015001arsenitearsenite results in increased expression of BCL2 protein18077580
C039726artesunateartesunate results in decreased expression of BCL2 protein24704559
C039726artesunate"[1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein"29031619
C012195asaroneasarone results in decreased expression of BCL2 mRNA29174417
D001194AsbestosAsbestos results in increased expression of BCL2 mRNA22076105|2239824
D017638Asbestos, Crocidolite"[Asbestos, Crocidolite results in decreased susceptibility to Asbestos, Crocidolite] which results in increased expression of BCL2 protein"22608188
D017638Asbestos, Crocidolite"Asbestos, Crocidolite results in increased expression of BCL2 mRNA"12909582
D001205Ascorbic Acid[arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein24126434
D001205Ascorbic Acid[Ascorbic Acid co-treated with Quartz] results in increased expression of BCL2 mRNA27381660
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]17166419
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2 mRNA]22245848
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2 protein]22245848
D001205Ascorbic AcidAscorbic Acid results in decreased expression of BCL2 mRNA21919647
D001205Ascorbic AcidBCL2 protein results in increased abundance of Ascorbic Acid15449323
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [Humic Substances results in decreased expression of BCL2 protein]18683188
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2 protein]21262251
D001205Ascorbic AcidAscorbic Acid inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]18758938
D001205Ascorbic AcidAscorbic Acid promotes the reaction [lead acetate results in increased expression of BCL2 protein]17959157
C017032asiatic acid"asiatic acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BCL2 protein]"29108773
D001218Aspartame[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA25009784
D001218Aspartame[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein25009784
C108637aspartyl-glutamyl-valyl-aspartalaspartyl-glutamyl-valyl-aspartal inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11160861
C475509aspartyl-glutamyl-valyl-aspartyl-p-nitroanilideBCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]]11577002
C010302aspidin BBaspidin BB results in decreased expression of BCL2 protein23628508
D001241AspirinAspirin inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]23799623
D001241AspirinAspirin results in decreased expression of BCL2 mRNA16199534|1856417
D001241AspirinAspirin results in decreased expression of BCL2 protein12490308|1463644
D001241AspirinAspirin results in increased expression of BCL2 mRNA17342322
D001241AspirinAspirin results in increased expression of BCL2 protein18636671
D001241AspirinBCL2 protein inhibits the reaction [Aspirin promotes the reaction [TNFSF10 protein results in increased cleavage of PARP1 protein]]16199534
D001241AspirinBCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP3 protein]16199534
D001241AspirinBCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with Aspirin] results in increased cleavage of and results in increased activity of CASP9 protein]16199534
D001241AspirinAspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D001241AspirinAspirin results in decreased expression of BCL2 protein20886344
D001241AspirinAspirin inhibits the reaction [Azoxymethane results in increased expression of BCL2 mRNA]20043115
D001241Aspirin[Diethylcarbamazine co-treated with Aspirin] results in decreased expression of BCL2 protein20362029
D016589AstemizoleAstemizole results in decreased expression of BCL2 mRNA20221588
C082414astin Bastin B results in decreased expression of BCL2 protein25219577
D000069059Atorvastatin CalciumAtorvastatin Calcium results in decreased expression of BCL2 mRNA16470222
D000069059Atorvastatin CalciumAtorvastatin Calcium results in decreased expression of BCL2 protein16470222
D000069059Atorvastatin CalciumRHOA mutant form inhibits the reaction [Atorvastatin Calcium results in decreased expression of BCL2 protein]16470222
C026304atranorinatranorin results in decreased expression of BCL2 protein22285236
C098644atrasentanatrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]22431579
D001280AtrazineAtrazine results in decreased expression of BCL2 mRNA20036412
D001280AtrazineAtrazine results in decreased expression of BCL2 mRNA21333729
D001280AtrazineAtrazine results in decreased expression of BCL2 protein21333729
D001280Atrazinekolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 mRNA]21333729
D001280Atrazinekolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 protein]21333729
D001280AtrazineAtrazine affects the expression of BCL221726175
D001280AtrazineAtrazine affects the expression of BCL2 mRNA26075868
D001280Atrazinekolaviron inhibits the reaction [Atrazine affects the expression of BCL2]21726175
D001310AuranofinBCL2 protein inhibits the reaction [Auranofin results in increased activity of CASP3 protein]18789312
D001374AzacitidineAzacitidine results in decreased expression of BCL2 mRNA15547111
D001374AzacitidineAzacitidine results in decreased expression of BCL2 protein15547111
D001374Azacitidinepifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA]15547111
D001374Azacitidinepifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein]15547111
C010329azadirachtinazadirachtin results in decreased expression of BCL2 mRNA20429769
C010329azadirachtinazadirachtin results in decreased expression of BCL2 protein20429769
D001386AzidesBCL2 protein inhibits the reaction [Azides affects the localization of BAX protein]21160028
D001386AzidesBCL2 protein inhibits the reaction [Azides results in increased activity of BAX protein]21160028
D001386AzidesBCL2 protein results in decreased susceptibility to Azides21160028
D001388AziridinesAziridines analog results in decreased expression of BCL2 protein15174162
C547126AZM551248AZM551248 results in decreased expression of BCL2 mRNA22323515
D001397AzoxymethaneAspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D001397Azoxymethane[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein25449198
D001397AzoxymethaneCamptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D001397AzoxymethanePlant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D001397AzoxymethaneAspirin inhibits the reaction [Azoxymethane results in increased expression of BCL2 mRNA]20043115
D001397AzoxymethaneAzoxymethane affects the expression of BCL2 protein22467055
D001397AzoxymethaneAzoxymethane results in increased expression of BCL2 mRNA20043115
D001397AzoxymethaneLinoleic Acid affects the reaction [Azoxymethane affects the expression of BCL2 protein]22467055
D001397Azoxymethane[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]22467055
C006680baicaleinbaicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]20850421
C038044baicalinbaicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein]25423838
C012765bakuchiolbakuchiol results in decreased expression of BCL2 protein27033605
C012765bakuchiolbakuchiol results in decreased expression of BCL2 protein17292878
C060988baohuoside Ibaohuoside I results in decreased expression of BCL2 protein22687635
C028559bathocuproine sulfonatebathocuproine sulfonate results in decreased expression of BCL2 protein24614111
C017049bathophenanthroline disulfonic acidbathophenanthroline disulfonic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]20096349
C416282BAY 11-7085BAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA]16407826
C416282BAY 11-7085BAY 11-7085 inhibits the reaction [RNF34 protein results in increased expression of BCL2 protein]16407826
C416282BAY 11-7085BAY 11-7085 inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]25845326
C580697BDMC-ABDMC-A results in decreased expression of BCL2 mRNA24365254
C580697BDMC-ABDMC-A results in decreased expression of BCL2 protein24365254
C004456beauvericinbeauvericin results in increased expression of BCL2 mRNA29203277
D001514Bee VenomsBee Venoms results in decreased expression of BCL2 protein15922390
D001514Bee VenomsBee Venoms inhibits the reaction [propionic acid results in decreased expression of BCL2 mRNA]26048086
D001514Bee VenomsBee Venoms results in increased expression of BCL2 mRNA26048086
D001514Bee Venoms[Bleomycin co-treated with Bee Venoms] results in decreased expression of BCL2 mRNA24822179
C487081belinostatbelinostat results in decreased expression of BCL2 mRNA26272509
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C044946benazeprilbenazepril results in increased expression of BCL2 protein20026869
D001542BenomylBenomyl inhibits the reaction [BCL2 protein binds to BAX protein]16903866
D001542BenomylBenomyl results in increased phosphorylation of BCL2 protein16903866
C005177benserazide, levodopa drug combination"benserazide, levodopa drug combination inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"28185818
C005177benserazide, levodopa drug combination"benserazide, levodopa drug combination inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]"27053303
D001546BentoniteBentonite promotes the reaction [[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of BCL2 mRNA]25296281
D001554BenzeneBenzene results in decreased expression of BCL2 mRNA18724895|1916216
D001554BenzeneBenzene results in increased expression of BCL2 protein20850422
D001554BenzeneBenzene affects the expression of BCL2 mRNA11896287
D001554BenzeneTRP53 protein affects the reaction [Benzene results in increased expression of BCL2 mRNA]11896287
D001554BenzeneBenzene results in decreased expression of BCL2 mRNA21143203
D001554Benzenedecitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA]21143203
D001554Benzenetrichostatin A inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA]21143203
C072019benzo(a)pyrene diolepoxide Ibenzo(a)pyrene diolepoxide I results in decreased expression of BCL2 mRNA27694624
C006703benzo(b)fluoranthenebenzo(b)fluoranthene results in increased expression of BCL2 protein21776270
D019324beta-Naphthoflavonebeta-Naphthoflavone results in increased expression of BCL2 mRNA22687991
D019324beta-Naphthoflavone[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA21295105
D019817Benzoic AcidBenzoic Acid analog inhibits the reaction [STAT3 protein binds to BCL2 promoter]26088127
D053119BenzophenanthridinesBenzophenanthridines analog results in decreased expression of BCL2 mRNA23117580
D001564Benzo(a)pyrene"2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]"20840854
D001564Benzo(a)pyrene"3,4,5,3',4'-pentachlorobiphenyl inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]"20840854
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with Nitrogen Oxides] results in increased expression of BCL2 protein16041517
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with resveratrol] results in decreased expression of BCL2 mRNA24289642
D001564Benzo(a)pyrene[Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of BCL2 mRNA24289642
D001564Benzo(a)pyreneBenzo(a)pyrene inhibits the reaction [Estradiol results in increased expression of BCL2 protein]18174961
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of BCL2 mRNA11782367|2006483
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of BCL2 protein20840854
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of BCL2 protein18174961|2085042
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of BCL2 protein9395224
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of BCL2 mRNA19770486
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of BCL2 protein28032951
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of BCL2 mRNA18656336|2222880
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of BCL2 protein21964900
D001564Benzo(a)pyreneepicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]18656336
D001564Benzo(a)pyreneepigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]18656336
D001564Benzo(a)pyrenePlant Extracts inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]28032951
D001564Benzo(a)pyrenetheaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]18656336
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of BCL2 protein23510837
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BCL2 mRNA"28593498
D003374CoumarinsCoumarins analog results in decreased expression of BCL2 protein25231984
D052160BenzothiazolesBenzothiazoles metabolite results in decreased expression of BCL2 mRNA23339777
C403753benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketonebenzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]20686688
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [evodiamine results in increased cleavage of BCL2 protein]20005289
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL220100472
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein20449726
C072553benzyloxycarbonylleucyl-leucyl-leucine aldehydebenzyloxycarbonyl-valyl-alanyl-aspartic acid promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein]20449726
C517629benzyloxycarbonyl-valyl-alanyl-aspartic acidbenzyloxycarbonyl-valyl-alanyl-aspartic acid promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2 protein]20449726
D001599Berberine[Berberine co-treated with Niacinamide] results in decreased expression of BCL2 protein26712469
D001599BerberineBerberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]23954465
D001599BerberineBerberine results in decreased expression of BCL2 mRNA20656010
D001599BerberineBerberine results in decreased expression of BCL2 protein16505103|2065601
D001599BerberineBerberine results in increased expression of BCL2 protein23954465
D001599BerberineBerberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein]24751971|2560069
D001599BerberineBerberine results in increased expression of BCL2 protein25600690
C033363beta-1,3-glucan"beta-1,3-glucan results in increased expression of BCL2 mRNA"17690738
C033363beta-1,3-glucan"[resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA"17690738
C000617228beta-2-himachalen-6-olbeta-2-himachalen-6-ol results in decreased expression of BCL2 protein28782499
D019207beta Carotenebeta Carotene results in decreased expression of BCL2 protein26733226
D004958EstradiolARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]20305694
D004958EstradiolARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]20305694
D004958EstradiolBenzo(a)pyrene inhibits the reaction [Estradiol results in increased expression of BCL2 protein]18174961
D004958Estradioldecitabine inhibits the reaction [Estradiol affects the expression of BCL2 mRNA]22082530
D004958Estradioldibenzoylmethane inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]16051634
D004958EstradiolEGF protein inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]24758408
D004958EstradiolESR1 protein affects the reaction [Estradiol results in increased expression of BCL2 mRNA]19264808
D004958EstradiolESR1 protein affects the reaction [Estradiol results in increased expression of BCL2 protein]19264808
D004958EstradiolESR2 protein affects the reaction [Estradiol results in increased expression of BCL2 mRNA]19264808
D004958EstradiolEstradiol affects the expression of BCL2 mRNA11896290|2208253
D004958EstradiolEstradiol results in decreased expression of BCL2 mRNA20945400
D004958EstradiolEstradiol results in decreased expression of BCL2 protein20945400
D004958Estradiol[Estradiol results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA22403704
D004958EstradiolEstradiol results in increased expression of BCL2 mRNA11356682|1589789
D004958Estradiol[Estradiol results in increased expression of BCL2 mRNA] which results in increased susceptibility to Cisplatin28323900
D004958Estradiol[Estradiol results in increased expression of BCL2 mRNA] which results in increased susceptibility to Doxorubicin28323900
D004958EstradiolEstradiol results in increased expression of BCL2 protein10455518|1054540
D004958EstradiolEthidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]15897899
D004958Estradiolethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [Estradiol results in increased expression of BCL2 protein]19796866
D004958Estradiolfulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]10545406|1587070
D004958Estradiol[Lindane co-treated with Estradiol] results in increased expression of BCL2 protein18174961
D004958EstradiolMIR21 mRNA mutant form promotes the reaction [Estradiol results in increased expression of BCL2 protein]23052036
D004958EstradiolTamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]16051634
D004958EstradiolTamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]20305694
D004958EstradiolYC137 inhibits the reaction [ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]]20305694
D004958EstradiolYC137 inhibits the reaction [ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]]20305694
D004958EstradiolEstradiol results in decreased expression of BCL2 mRNA25210133
D004958EstradiolEstradiol results in increased expression of BCL2 mRNA17578864
D004958Estradiol[mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA24412242
D004958Estradiol[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein22465879
D004958EstradiolEstradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein]14659978
D004958EstradiolEstradiol results in increased expression of BCL2 protein16951259
D004958Estradiol[fulvestrant co-treated with Estradiol] results in increased expression of BCL2 protein16951259
D004958Estradiol[Methylnitrosourea co-treated with Estradiol] results in increased expression of BCL2 mRNA20732338
D004958Estradiol[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA20732338
D001622BetaineBetaine analog binds to BCL2 protein25765238
D001622BetaineBetaine results in increased expression of BCL2 protein25080425
C008157beta-iononebeta-ionone results in decreased expression of BCL2 protein23100158
C026609beta-solamarinebeta-solamarine results in decreased expression of BCL2 protein17619073|2064704
D001629BezafibrateBezafibrate inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein]12704018
D001629BezafibrateBezafibrate results in decreased expression of BCL2 mRNA12704018
D001629BezafibrateBezafibrate results in increased expression of BCL216316343
D001632BibenzylsBibenzyls inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]27180985
C053541bicalutamidebicalutamide results in increased expression of BCL211845989
C099952bifenthrinbifenthrin results in decreased expression of BCL2 mRNA26071804|2791626
C004541biochanin Abiochanin A results in decreased expression of BCL2 protein12791511
D001688Biological ProductsBiological Products results in decreased expression of BCL2 protein28219700
C543008bis(4-hydroxyphenyl)sulfone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA28628672
C006780bisphenol Abisphenol A affects the expression of BCL2 protein27561114
C006780bisphenol Abisphenol A results in increased expression of BCL2 mRNA27561114
C006780bisphenol Abisphenol A affects the expression of BCL2 protein24156707
C006780bisphenol Abisphenol A results in decreased expression of BCL2 mRNA26363213
C006780bisphenol Abisphenol A results in decreased expression of BCL2 protein21277958
C006780bisphenol A[bisphenol A results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA22403704
C006780bisphenol Abisphenol A results in increased expression of BCL2 mRNA15461258|2768578
C006780bisphenol Abisphenol A results in increased expression of BCL2 protein19270784|1979686
C006780bisphenol A[Doxorubicin co-treated with bisphenol A] results in increased expression of BCL2 protein19270784
C006780bisphenol Aethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [bisphenol A results in increased expression of BCL2 protein]19796866
C006780bisphenol AAcetylcysteine inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]24909818
C006780bisphenol Abisphenol A affects the expression of BCL2 mRNA26746108
C006780bisphenol Abisphenol A promotes the reaction [Streptozocin results in decreased expression of BCL2 protein]24781736
C006780bisphenol Abisphenol A results in decreased expression of BCL2 mRNA11906184|2651296
C006780bisphenol Abisphenol A results in decreased expression of BCL2 protein11906184|2226910
C006780bisphenol Abisphenol A results in increased expression of BCL2 mRNA23928317|2559470
C006780bisphenol Abisphenol A results in increased expression of BCL2 protein23900028|2460488
C006780bisphenol AGinsenosides inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]22269103
C006780bisphenol AKN 62 inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]24905940
C006780bisphenol Aoligomycin A inhibits the reaction [bisphenol A results in increased expression of BCL2 protein]24909818
C006780bisphenol A[Streptozocin co-treated with bisphenol A] results in increased expression of BCL2 mRNA24781736
C006780bisphenol AU 0126 inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]22269103
C006780bisphenol AW 7 inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]24905940
C006780bisphenol Abisphenol A results in decreased expression of BCL2 mRNA25181051|2546156
C006780bisphenol Abisphenol A results in decreased expression of BCL2 protein16909604|2332866
C006780bisphenol Abisphenol A results in increased methylation of BCL2 gene28505145
C006780bisphenol ACurcumin inhibits the reaction [bisphenol A results in decreased expression of BCL2 mRNA]25963729
C006780bisphenol Abisphenol A results in decreased expression of BCL2 mRNA28819136
C005961bis(tri-n-butyltin)oxidebis(tri-n-butyltin)oxide results in decreased expression of BCL2 mRNA17553608
D057886Bleaching AgentsBleaching Agents results in increased expression of BCL2 mRNA21538407
D001761Bleomycin[Polyphenols co-treated with Bleomycin] results in increased expression of BCL2 mRNA26800624
D001761Bleomycin[Tea co-treated with Bleomycin] results in increased expression of BCL2 mRNA26800624
D001761Bleomycinallyl sulfide promotes the reaction [Bleomycin results in increased expression of BCL2 protein]23656969
D001761Bleomycin[Bleomycin co-treated with Bee Venoms] results in decreased expression of BCL2 mRNA24822179
D001761BleomycinBleomycin results in decreased expression of BCL2 mRNA24822179|2609321
D001761BleomycinBleomycin results in increased expression of BCL2 protein23656969
D001761BleomycinPhytochemicals inhibits the reaction [Bleomycin results in decreased expression of BCL2 mRNA]26093215
D001786Blood Glucose[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein24058562
D001786Blood Glucosesodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]24058562
C005066borrelidinBCL2 protein results in decreased susceptibility to borrelidin24155182
D000069286Bortezomib[arsenic trioxide co-treated with Bortezomib] results in decreased expression of BCL2 mRNA20471514
D000069286BortezomibBCL2 affects the reaction [Bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein]17326159
D000069286Bortezomib[Bortezomib co-treated with arsenic trioxide] affects the expression of BCL2 protein18718063
D000069286Bortezomib[Bortezomib co-treated with arsenic trioxide] results in decreased expression of BCL2 protein24377552
D000069286Bortezomib[Bortezomib co-treated with Butyrates] results in increased cleavage of BCL2 protein15173093
D000069286Bortezomib[Bortezomib co-treated with Daunorubicin] results in decreased expression of BCL2 mRNA21302442
D000069286Bortezomib[Bortezomib co-treated with vorinostat] results in increased cleavage of BCL2 protein15173093
D000069286BortezomibBortezomib results in decreased expression of BCL2 mRNA16022909|1644637
D000069286BortezomibBortezomib results in decreased expression of BCL2 protein16022909|1644637
D000069286BortezomibBortezomib results in increased cleavage of BCL2 protein modified form16118318
D000069286BortezomibBortezomib results in increased expression of BCL2 mRNA17895889
D000069286BortezomibBortezomib results in increased expression of BCL2 protein20051518
D000069286Bortezomib[geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2 protein15781649
D000069286Bortezomiblonafarnib promotes the reaction [Bortezomib results in increased cleavage of BCL2 protein modified form]16118318
D000069286Bortezomib[vorinostat co-treated with Bortezomib] results in decreased expression of BCL2 protein17351739
D000069286BortezomibBortezomib results in decreased expression of BCL2 protein15131062
C000595192BP-1-102BP-1-102 analog inhibits the reaction [STAT3 protein binds to BCL2 promoter]26088127
C000595192BP-1-102BP-1-102 analog results in decreased expression of BCL2 protein26088127
C083116BQ 485[BQ 485 binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein14736733
C086539BQ 788[cyclo(Trp-Asp-Pro-Val-Leu) co-treated with BQ 788] inhibits the reaction [EDN1 protein results in increased expression of BCL2 protein]20369390
C089020brassininbrassinin analog results in decreased expression of BCL2 mRNA24747292
C023623brassinolidebrassinolide results in decreased expression of BCL2 protein17557751|2083315
C044362brazilinbrazilin results in decreased expression of BCL2 protein28063998
D0151248-Bromo Cyclic Adenosine Monophosphate8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of BCL211802967
C514835bromotetrandrine[bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BCL2 protein19421372
C514835bromotetrandrinebromotetrandrine promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]19421372
C514835bromotetrandrinebromotetrandrine promotes the reaction [[Magnetite Nanoparticles co-treated with Daunorubicin] results in decreased expression of BCL2 protein]19421372
C514835bromotetrandrinebromotetrandrine promotes the reaction [Magnetite Nanoparticles promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]]19421372
C514835bromotetrandrine[Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 mRNA21720514
C514835bromotetrandrine[Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 protein21720514
C514835bromotetrandrine[Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BCL2 mRNA21720514
C514835bromotetrandrine[Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BCL2 protein21720514
C514835bromotetrandrine[Magnetite Nanoparticles co-treated with Daunorubicin] promotes the reaction [bromotetrandrine results in decreased expression of BCL2 protein]19421372
C514835bromotetrandrineMagnetite Nanoparticles promotes the reaction [bromotetrandrine promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]]19421372
C083806brucinebrucine results in decreased expression of BCL2 protein16443926
D019819BudesonideBudesonide results in decreased expression of BCL2 protein15475437
C022777bufalinbufalin results in decreased expression of BCL2 mRNA7658701
C022777bufalinbufalin results in decreased expression of BCL2 protein27444971
D002038BungarotoxinsBungarotoxins inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 mRNA]16835749
C040918buteinbutein results in decreased expression of BCL2 protein11055382
D019328Buthionine SulfoximineAcetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein]11341981
D019328Buthionine Sulfoximine[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein11341981
D019328Buthionine SulfoximineButhionine Sulfoximine results in decreased expression of BCL2 mRNA17989939
D019328Buthionine SulfoximineButhionine Sulfoximine results in decreased expression of BCL2 protein18552690
D019328Buthionine SulfoximineSodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA]17989939
D019328Buthionine SulfoximineButhionine Sulfoximine promotes the reaction [cyanoginosin LR results in decreased expression of BCL2 protein]25410294
C027561butylbenzyl phthalate[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA28013214
D020122tert-Butylhydroperoxide"1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]"29111459
D020122tert-Butylhydroperoxide"3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]"29128606
D020122tert-ButylhydroperoxideGenistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]15288519
D020122tert-ButylhydroperoxideLY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]29111459
D020122tert-ButylhydroperoxidePeptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]23994092
D020122tert-ButylhydroperoxidePlant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]27050144
D020122tert-ButylhydroperoxideQuercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]27050144
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of BCL2 protein12782109|1528851
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of BCL2 protein20510348
D020122tert-ButylhydroperoxideAICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]26989860
D020122tert-ButylhydroperoxideCurcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]15569404
D020122tert-ButylhydroperoxideFenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]26989860
D020122tert-ButylhydroperoxidePlant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]19772912
D020122tert-ButylhydroperoxidePlant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]19772912
D020122tert-ButylhydroperoxideSilymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]19772912
D020122tert-ButylhydroperoxideSilymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]19772912
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide affects the localization of BCL2 protein19772912
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of BCL2 mRNA22659508
D020122tert-Butylhydroperoxidetert-Butylhydroperoxide results in decreased expression of BCL2 protein15569404|1977291
C018475butyraldehydebutyraldehyde results in decreased expression of BCL2 mRNA26079696
D002087Butyrates[Bortezomib co-treated with Butyrates] results in increased cleavage of BCL2 protein15173093
D002087ButyratesButyrates results in decreased expression of BCL2 protein20346929
D020148Butyric Acid"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D020148Butyric Acid"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D020148Butyric Acid"Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D020148Butyric Acid"Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D002101Cacodylic AcidCacodylic Acid results in increased expression of BCL2 mRNA22246474
D002101Cacodylic AcidCacodylic Acid results in increased expression of BCL2 protein22246474
D002104CadmiumCadmium results in decreased expression of BCL225805271
D002104CadmiumBCL2 protein results in decreased susceptibility to Cadmium11781163
D002104CadmiumCadmium results in increased expression of BCL2 mRNA21694771
D002104CadmiumCadmium results in decreased expression of BCL2 protein22356713|2642477
D002104Cadmiumflavocoxid inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]26424772
D002104Cadmium2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]25955216
D002104CadmiumBCL2 results in decreased susceptibility to Cadmium12189181
D002104CadmiumCadmium results in decreased expression of BCL2 mRNA23577223|2580879
D002104CadmiumCadmium results in decreased expression of BCL2 protein20455018|2357722
D002104CadmiumCadmium results in increased expression of BCL2 protein11781163|2374131
D002104CadmiumLithium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]20455018
D002104CadmiumAcetylcysteine inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]19135140
D002104CadmiumCadmium results in decreased expression of BCL2 protein19135140
D002104CadmiumCadmium results in increased expression of BCL2 mRNA11781163
D002104CadmiumCadmium results in increased expression of BCL2 protein11781163
D002104CadmiumSelenium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]19135140
C028031cadmium acetatecadmium acetate results in increased expression of BCL2 protein15450950
C028031cadmium acetatecadmium acetate results in decreased expression of BCL2 mRNA27717697
C028031cadmium acetatecadmium acetate results in decreased expression of BCL2 protein24577723|2504395
C028031cadmium acetatepuerarin inhibits the reaction [cadmium acetate results in decreased expression of BCL2 mRNA]27717697
C028031cadmium acetatepuerarin inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]27717697
C028031cadmium acetatepyrazolanthrone inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]24577723|2504395
C028031cadmium acetateU 0126 inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]24577723|2504395
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 mRNA21262342|2483900
D019256Cadmium ChlorideQuercetin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]21262342
D019256Cadmium ChlorideSelenium inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]25035189
D019256Cadmium ChlorideAcetylcysteine inhibits the reaction [[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein]11341981
D019256Cadmium ChlorideCadmium Chloride affects the expression of BCL2 mRNA23941782
D019256Cadmium ChlorideCadmium Chloride affects the expression of BCL2 protein23941782
D019256Cadmium ChlorideCadmium Chloride affects the reaction [Fluorouracil affects the expression of BCL2 protein]23941782
D019256Cadmium Chloride[Cadmium Chloride co-treated with Buthionine Sulfoximine] results in increased expression of BCL2 protein11341981
D019256Cadmium ChlorideCadmium Chloride inhibits the reaction [NFE2L2 protein binds to BCL2 promoter]25157103
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 mRNA26525392
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 protein23485651|2429116
D019256Cadmium ChlorideCadmium Chloride results in increased expression of BCL2 protein25111876
D019256Cadmium ChlorideFluorouracil affects the reaction [Cadmium Chloride affects the expression of BCL2 mRNA]23941782
D019256Cadmium Chloridenaringin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]28422390
D019256Cadmium Chloridenavitoclax promotes the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]25157103
D019256Cadmium ChlorideNFE2L2 mutant form promotes the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]25157103
D019256Cadmium Chloridearjunolic acid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]21420465
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 mRNA15501611|1749941
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 protein17706638|1988757
D019256Cadmium ChlorideCadmium Chloride results in increased expression of BCL2 protein25111876
D019256Cadmium Chlorideflavocoxid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26424772
D019256Cadmium Chloridepifithrin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]19887573
D019256Cadmium Chloridepiperidine inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]17706638
D019256Cadmium ChlorideTRP53 protein promotes the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]19887573
D019256Cadmium Chloride[Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein25031709
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 mRNA23405080|2449264
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 protein26462792|2738977
D019256Cadmium ChlorideCadmium Chloride results in increased expression of BCL211170127
D019256Cadmium Chloride[Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of BCL2 protein25719599
D019256Cadmium ChlorideGrape Seed Proanthocyanidins inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26462792
D019256Cadmium ChlorideQuercetin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]27389774
D019256Cadmium Chlorideresveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]24492640
D019256Cadmium Chloride[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein26396915
D019256Cadmium ChlorideCadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]26607349
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of BCL2 protein26607349
D019256Cadmium ChlorideCadmium Chloride results in increased expression of BCL2 protein23575899
D019256Cadmium ChlorideMIR125A mRNA inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26607349
D019256Cadmium ChlorideSodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]26607349
D019256Cadmium ChlorideSodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26607349
C034939cadmium sulfidecadmium sulfide results in decreased expression of BCL2 mRNA27866839
C028337cadmium telluridecadmium telluride analog results in decreased expression of BCL2 protein23485651
C028337cadmium telluridecadmium telluride results in decreased expression of BCL2 protein21291946
C053400cafestolBCL2 protein results in decreased susceptibility to cafestol21334318
C053400cafestolcafestol results in decreased expression of BCL2 protein21334318
C080866cagA protein, Helicobacter pylori"cagA protein, Helicobacter pylori results in increased expression of BCL2 protein"26427350
C080866cagA protein, Helicobacter pylori"ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in increased expression of BCL2 protein]"26427350
C471767cajanolcajanol results in decreased expression of BCL2 protein20638373
C471767cajanol[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein20638373
C471767cajanol[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP3 protein20638373
C471767cajanol[[[cajanol results in decreased expression of BCL2 protein] co-treated with [cajanol results in increased expression of BAX protein]] affects the localization of CYCS protein] which results in increased activity of CASP9 protein20638373
D002122Calcium ChlorideCalcium Chloride results in decreased expression of BCL2 mRNA27746373
C533734calycopterincalycopterin results in decreased susceptibility to [Hydrogen Peroxide results in decreased expression of BCL2 protein]22081883
C102405camalexincamalexin metabolite results in decreased expression of BCL2 mRNA23339777
D002166Camptothecin3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole promotes the reaction [Camptothecin results in decreased expression of BCL2 protein]19481069
D002166CamptothecinBCL2 results in decreased susceptibility to Camptothecin10896673
D002166CamptothecinCamptothecin results in decreased expression of BCL2 mRNA24726431
D002166CamptothecinCamptothecin results in decreased expression of BCL2 protein10692111|1948106
D002166CamptothecinCamptothecin results in increased expression of BCL2 mRNA24726431
D002166CamptothecinCamptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
C077793candesartan cilexetilcandesartan cilexetil results in increased expression of BCL2 protein22120037
D002193CantharidinCantharidin results in decreased expression of BCL2 protein16117893|2711341
D002211CapsaicinBCL2 protein results in decreased susceptibility to Capsaicin9580328
D002211CapsaicinCapsaicin results in decreased expression of BCL219002586
D002211CapsaicinCapsaicin results in decreased expression of BCL2 protein11275362|1750500
D002211CapsaicinCapsaicin results in increased expression of BCL2 mRNA19502594|2131094
D002211CapsaicinCapsaicin results in decreased expression of BCL2 protein15595419|1729550
C071423capsazepinecapsazepine inhibits the reaction [Acrolein results in decreased expression of BCL2 protein]24376112
C104525caraway oilcaraway oil inhibits the reaction [Ethanol affects the expression of BCL2 mRNA]25859307
C104525caraway oilcaraway oil inhibits the reaction [Ethanol affects the expression of BCL2 protein]25859307
D002217CarbacholCarbachol inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein]10758335
D002217CarbacholCarbachol results in increased expression of BCL2 protein19200344
D002217CarbacholCarbachol results in increased expression of BCL2 protein17708838
D002219CarbamatesCarbamates affects the expression of BCL2 mRNA21303328
D002220CarbamazepineCarbamazepine results in increased expression of BCL2 mRNA18719996
D002220CarbamazepineCarbamazepine results in increased expression of BCL2 protein18719996
C006698carbendazimcarbendazim results in decreased expression of BCL2 mRNA26055223
D002229CarbenoxoloneCarbenoxolone affects the expression of BCL2 mRNA23678415
D002246Carbon DisulfideCarbon Disulfide results in decreased expression of BCL2 mRNA24080331
D002246Carbon DisulfideCarbon Disulfide results in decreased expression of BCL2 protein24080331
D002251Carbon TetrachlorideCarbon Tetrachloride results in decreased expression of BCL2 mRNA23279844
D002251Carbon TetrachlorideCarbon Tetrachloride results in decreased expression of BCL2 protein23994094|2544572
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of BCL2 mRNA25827057
D002251Carbon TetrachlorideCarbon Tetrachloride results in increased expression of BCL2 protein25432964
D002251Carbon TetrachlorideDinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]]25432964
D002251Carbon TetrachlorideFlavonoids inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]23279844
D002251Carbon TetrachlorideLipids inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]25445725
D002251Carbon TetrachloridePlant Extracts inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]23279844
D002251Carbon TetrachloridePlant Extracts inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]23994094
D002251Carbon TetrachloridePTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]25432964
D002251Carbon TetrachlorideSaponins inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]23994094
D002251Carbon TetrachlorideSC 560 promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]25432964
D002251Carbon Tetrachloride[Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA18156304
D002251Carbon TetrachlorideCarbon Tetrachloride results in decreased expression of BCL2 mRNA26062544
D002251Carbon Tetrachloride[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA16426832
D002251Carbon Tetrachloridepuerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]16426832
D002251Carbon TetrachlorideRutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]26062544
C111238carboxycinnamic acid bishydroxamidecarboxycinnamic acid bishydroxamide results in decreased expression of BCL2 protein15897598
C514968carboxymethyl-chitosancarboxymethyl-chitosan analog promotes the reaction [Curcumin promotes the reaction [AGT protein modified form results in increased expression of BCL2 protein]]26612707
C514968carboxymethyl-chitosancarboxymethyl-chitosan analog promotes the reaction [Curcumin results in increased expression of BCL2 protein]26612707
C038590cardanolcardanol results in increased expression of BCL2 mRNA26694491
D054715CardiotoxinsCardiotoxins results in increased expression of BCL2 protein17786558
D054715CardiotoxinsCardiotoxins results in increased phosphorylation of BCL2 protein17786558
D054715Cardiotoxinspimagedine inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein]17786558
D054715Cardiotoxinspyrazolanthrone inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein]17786558
D002330CarmustineBCL2 protein affects the susceptibility to Carmustine15332326|1843078
D002330CarmustineCarmustine results in decreased expression of BCL2 protein15332326|2092032
D002330Carmustine[Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein16187019
D002331Carnitine2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Carnitine results in increased phosphorylation of BCL2 protein]29186614
D002331CarnitineCarnitine inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA]23213347
D002331CarnitineCarnitine results in increased phosphorylation of BCL2 protein29186614
D002336CarnosineCarnosine inhibits the reaction [Sodium Nitrite results in decreased expression of BCL2 protein]28266762
C043211carvedilolcarvedilol affects the expression of BCL2 protein22000973
C043211carvedilolcarvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]15380674
C043211carvedilolcarvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]26036690
C043211carvedilolcarvedilol inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2 protein]25245570
C043211carvedilolcarvedilol results in increased expression of BCL2 mRNA16780994|1690947
C054133casticincasticin results in decreased expression of BCL2 protein27862857
D002392CatechinCatechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D002392CatechinCatechin results in decreased expression of BCL2 mRNA23706674
D002392CatechinCatechin results in decreased expression of BCL2 protein23706674
D002392CatechinCatechin affects the expression of BCL2 mRNA26363153
D002392CatechinQuercetin affects the reaction [Catechin affects the expression of BCL2 mRNA]26363153
D002392CatechinCatechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]18611398
D002392CatechinCatechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18611398
C038959CBV protocolBCL2 protein results in decreased susceptibility to CBV protocol8781438
C038959CBV protocolCBV protocol results in increased expression of BCL2 protein8781438
D000068579CelecoxibBCL2 protein inhibits the reaction [ABT-737 promotes the reaction [Celecoxib results in increased cleavage of CASP3 protein]]20104024
D000068579CelecoxibBCL2 protein inhibits the reaction [Celecoxib promotes the reaction [ABT-737 results in increased cleavage of CASP3 protein]]20104024
D000068579CelecoxibBCL2 protein inhibits the reaction [Celecoxib results in increased cleavage of CASP3 protein]20104024
D000068579CelecoxibCelecoxib promotes the reaction [docetaxel results in increased expression of BCL2 protein]15688368
D000068579CelecoxibCelecoxib promotes the reaction [tetracycline CMT-3 results in increased expression of BCL2 protein]15688368
D000068579CelecoxibCelecoxib results in decreased expression of BCL2 protein15911099|1639187
D000068579CelecoxibCelecoxib results in increased expression of BCL2 mRNA17342322
D000068579Celecoxibtetraarsenic tetrasulfide promotes the reaction [Celecoxib results in decreased expression of BCL2 protein]26586936
D000068579CelecoxibCelecoxib promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein]16230411
D000068579CelecoxibCelecoxib results in decreased expression of BCL217510421
C532683CellfoodCellfood results in decreased expression of BCL2 protein24598211
C030583ceric oxideceric oxide results in decreased expression of BCL2 protein24987704
C062876cetrorelixcetrorelix results in decreased expression of BCL2 protein21062912
C062876cetrorelixcetrorelix results in decreased expression of BCL2 mRNA18829022
D047188ChalconesChalcones results in decreased expression of BCL2 protein23562496
C095591chan suchan su results in decreased expression of BCL2 protein16012733
C016299chelerythrinechelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]]12690470
C062047chelidoninechelidonine affects the expression of BCL2 mRNA25265580
C588229chikusetsusaponin Vchikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]25073091
D048271Chitosan[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein18567086
D048271Chitosan[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]28732690
D002699ChlorambucilChlorambucil results in decreased expression of BCL2 mRNA8822937
D002699ChlorambucilChlorambucil results in decreased expression of BCL2 protein11699414|8822937
D002699ChlorambucilIL4 protein inhibits the reaction [Chlorambucil results in decreased expression of BCL2 protein]8822937
D007631ChlordeconeChlordecone results in increased expression of BCL2 mRNA17578864
C006972chloroacetic acidchloroacetic acid results in decreased expression of BCL2 mRNA23103613
C006972chloroacetic acidSB 203580 inhibits the reaction [chloroacetic acid results in decreased expression of BCL2 mRNA]23103613
D017338CladribineBCL2 affects the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP9 protein]15516989
D017338CladribineBCL2 inhibits the reaction [Cladribine results in increased cleavage of and results in increased activity of CASP3 protein]15516989
D017338CladribineBCL2 inhibits the reaction [Cladribine results in increased cleavage of CASP8 protein]15516989
D017338Cladribine[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein15582267
D017338Cladribine[Cladribine co-treated with Cyclophosphamide] results in decreased expression of BCL2 protein15582267
D017338CladribineCladribine results in decreased expression of BCL2 protein15582267
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 mRNA16322545
D020111Chlorodiphenyl (54% Chlorine)"2,3-bis(4-hydroxyphenyl)-propionitrile promotes the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein]"24216299
D020111Chlorodiphenyl (54% Chlorine)"4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein]"24216299
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of BCL2 protein24216299
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 mRNA23281070
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 protein23281070
D020111Chlorodiphenyl (54% Chlorine)Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 mRNA]23281070
D020111Chlorodiphenyl (54% Chlorine)Quercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 protein]23281070
D002726Chlorogenic AcidChlorogenic Acid inhibits the reaction [aluminum chloride results in decreased expression of BCL2 protein]28623112
D002726Chlorogenic AcidChlorogenic Acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]28479099
D002737ChloropreneChloroprene results in decreased expression of BCL2 mRNA23125180
D002738ChloroquineChloroquine inhibits the reaction [formosanin C results in decreased expression of BCL2 protein]27180204
C023676chloroquine diphosphatechloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]29133031
C023676chloroquine diphosphatechloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]29133031
C023676chloroquine diphosphateDoxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]29133031
D004390ChlorpyrifosChlorpyrifos results in decreased expression of BCL2 mRNA18155347
D004390ChlorpyrifosChlorpyrifos results in decreased expression of BCL2 mRNA27117976
C000474cholestane-3,5,6-triol"cholestane-3,5,6-triol results in increased expression of BCL2 mRNA"16039982
C000474cholestane-3,5,6-triol"Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of BCL2 mRNA]"16039982
D002784CholesterolCholesterol analog results in decreased expression of BCL2 mRNA19477266
D002791Cholesterol, Dietary"[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of BCL2 protein"27394961
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL220938992
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCL2 gene20938992
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2 mRNA20938992
D002840Chromates"[1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates"16980304
D002840Chromates[dipropylenetriamine-NONOate results in increased nitrosation of and results in decreased ubiquitination of and results in decreased degradation of BCL2 protein] which results in decreased susceptibility to Chromates16980304
D002840Chromates[Nitroprusside results in increased nitrosation of and results in decreased ubiquitination of and results in decreased degradation of BCL2 protein] which results in decreased susceptibility to Chromates16980304
D002840Chromates[pimagedine results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates16980304
C022990chromic chloridechromic chloride results in decreased expression of BCL2 protein14741615
C023600chromic oxidechromic oxide affects the expression of BCL2 protein26086747
C074702chromium hexavalent ionBCL2 protein affects the susceptibility to chromium hexavalent ion19556603
C074702chromium hexavalent ionchromium hexavalent ion results in increased expression of BCL2 protein22666341|2544843
C074702chromium hexavalent ionLuteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2 protein]25448439
C043561chrysinBCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein]16215670
C043561chrysinBCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]16215670
C043561chrysinBCL2 protein inhibits the reaction [chrysin results in increased cleavage of and results in increased activity of CASP3 protein]16215670
C043561chrysinBCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein]16215670
C043561chrysinBCL2 protein results in decreased susceptibility to chrysin16215670
C043561chrysinchrysin inhibits the reaction [Cisplatin results in increased expression of BCL2 protein]25770930
C043561chrysinchrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA]29247772
C472594chrysophsinchrysophsin analog results in increased expression of BCL2 mRNA26335193
C472594chrysophsin[Epirubicin analog co-treated with chrysophsin analog] results in increased expression of BCL2 mRNA26335193
C472594chrysophsin[Epirubicin co-treated with chrysophsin] results in increased expression of BCL2 mRNA26335193
C059262cidofovircidofovir results in decreased expression of BCL212700662
C000598873CIGB-552 peptideCIGB-552 peptide results in decreased expression of BCL2 protein23401744
C000598873CIGB-552 peptideCOMMD1 mutant form inhibits the reaction [CIGB-552 peptide results in decreased expression of BCL2 protein]23401744
C039671ciglitazoneciglitazone results in decreased expression of BCL2 protein15492468
C045645cilostazolcilostazol inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]16822680
C045645cilostazolcilostazol results in decreased expression of BCL2 protein20131233
C045645cilostazolcilostazol affects the expression of BCL2 protein15978173
D002927CimetidineCimetidine results in decreased expression of BCL2 protein20127008
D002927CimetidineCimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]27983966
C012843cinnamic aldehydecinnamic aldehyde analog results in decreased expression of BCL2 protein17510524
C012843cinnamic aldehydecinnamic aldehyde results in decreased expression of BCL2 protein15566391|1596431
C012843cinnamic aldehydeVitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein]15566391
C002471cinobufagincinobufagin results in decreased expression of BCL2 protein23164673
D002939CiprofloxacinBCL2 protein inhibits the reaction [Ciprofloxacin results in increased localization of BAX protein]11832715
D002939Ciprofloxacin[Etoposide co-treated with Ciprofloxacin] results in decreased expression of BCL2 protein12063570
D019343Citric Acid[Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein16624386
D019343Citric Acid[Silver analog co-treated with Citric Acid] results in increased expression of BCL2 mRNA27021274
D002953CitrininCitrinin affects the expression of BCL2 protein22771370
D002953CitrininCitrinin results in decreased expression of BCL2 protein21622943
C011730clayclay analog results in decreased expression of BCL2 mRNA26721448
C011730clayclay results in decreased expression of BCL2 mRNA26721448
D002994Clofibrate"Clofibrate inhibits the reaction [[Fatty Acids, Nonesterified binds to ALB protein] which results in decreased expression of BCL2 protein]"21338618
D002998ClonazepamClonazepam results in increased expression of BCL2 protein17456340
D003000ClonidineClonidine results in decreased expression of BCL2 protein28115640
D003024ClozapineClozapine results in increased expression of BCL2 mRNA15126120
D003024ClozapineClozapine results in increased expression of BCL2 protein15126120
C529348CNB 001"CNB 001 inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"24995576
D003035CobaltCobalt results in decreased expression of BCL2 protein21598295
C007095cobaltiprotoporphyrincobaltiprotoporphyrin affects the expression of BCL2 protein25171655
C007095cobaltiprotoporphyrinNFE2L2 protein affects the reaction [cobaltiprotoporphyrin affects the expression of BCL2 protein]25171655
C018021cobaltous chloridecobaltous chloride inhibits the reaction [Cyclosporine results in decreased expression of BCL2 protein]22343435
C018021cobaltous chloridecobaltous chloride promotes the reaction [HIF1A protein results in increased expression of BCL2 mRNA]19128456
C018021cobaltous chloridecobaltous chloride results in decreased expression of BCL2 mRNA17786326
C018021cobaltous chloridecobaltous chloride results in decreased expression of BCL2 protein14741615|1778632
C018021cobaltous chloridecobaltous chloride results in increased expression of BCL2 protein16827160
C018021cobaltous chlorideHIPK2 protein inhibits the reaction [cobaltous chloride promotes the reaction [HIF1A protein results in increased expression of BCL2 mRNA]]19128456
C018021cobaltous chloridezinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 mRNA]17786326
C018021cobaltous chloridezinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 protein]17786326
C018021cobaltous chloridezinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BCL2 mRNA]19714248
C018021cobaltous chloride[cobaltous chloride co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in decreased expression of BCL2 mRNA24265542
C018021cobaltous chloridecobaltous chloride results in decreased expression of BCL2 mRNA24265542
C018021cobaltous chloridecobaltous chloride results in decreased expression of BCL2 protein19520152
C060728cobalt oxidecobalt oxide results in decreased expression of BCL2 protein25437709
C060728cobalt oxidecobalt oxide results in decreased expression of BCL2 protein25437709
D003042CocaineCocaine affects the expression of BCL2 mRNA15681117
D003042Cocaine6-methyl-2-(phenylethynyl)pyridine inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
D003042Cocaine7-(hydroxyimino)cyclopropan(b)chromen-1a-carbxoylic acid ethyl ester inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
D003042CocaineCocaine results in decreased expression of BCL2 mRNA19183502
D003042CocaineCocaine results in decreased expression of BCL2 protein11392460|1536508
D003042CocaineCocaine results in increased expression of BCL2 protein17084983|1897485
D003042CocaineCocaine results in increased phosphorylation of BCL2 protein19879923
D003042CocaineDizocilpine Maleate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
D003042Cocaineethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
D003042CocaineSCH 23390 inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
D009243NADNAD results in increased expression of BCL2 protein12390773
C024989coenzyme Q10coenzyme Q10 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]27087047
C024989coenzyme Q10coenzyme Q10 results in increased expression of BCL2 mRNA18817789
D003078ColchicineColchicine results in decreased expression of BCL2 protein22342440
D003078ColchicineColchicine inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]22446813
D003091Colistin2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]]28465020
D003091Colistin[Colistin co-treated with Anisomycin] results in increased phosphorylation of BCL2 protein28842171
D003091ColistinColistin results in decreased expression of BCL2 protein28465020
D003091ColistinColistin results in increased phosphorylation of BCL2 protein28842171
D003091Colistinrhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]28465020
D003300Copper[Copper co-treated with Disulfiram] results in decreased expression of BCL2 protein23033007
D003300CopperCopper results in decreased expression of BCL2 mRNA16391388|1696271
D003300CopperCopper results in decreased expression of BCL2 protein16962711
D003300CopperCopper analog results in decreased expression of BCL2 protein22000994
D003300CopperAcetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA]22085843
D003300CopperAcetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein]22085843
D003300Copper[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA22085843
D003300Copper[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein22085843
C464760copper-1,10-phenanthroline"copper-1,10-phenanthroline results in decreased expression of BCL2 protein"24638265
D019327Copper SulfateCopper Sulfate inhibits the reaction [Trientine results in increased expression of BCL2 protein]14513838
D019327Copper SulfateCopper Sulfate results in decreased expression of BCL2 mRNA19549813
D019327Copper SulfateCopper Sulfate results in decreased expression of BCL2 mRNA25216733
C058120cordycepinAcetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2 protein]21310227
C058120cordycepincordycepin results in decreased expression of BCL2 mRNA28987792
C058120cordycepincordycepin results in decreased expression of BCL2 protein21310227
C113861corosolic acidcorosolic acid results in decreased expression of BCL2 mRNA28506699
C113861corosolic acidcorosolic acid results in decreased expression of BCL2 protein28506699
D003373Coumaric AcidsCoumaric Acids results in decreased expression of BCL2 protein25824411
C030123coumarincoumarin results in decreased expression of BCL2 protein15964220
D003375CoumestrolCoumestrol binds to BCL2 protein28986287
D003375Coumestrol"[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BCL2 mRNA"19167446
D003375CoumestrolCoumestrol results in decreased expression of BCL2 protein20623010|2898628
C010561crocetincrocetin inhibits the reaction [cupric oxide results in decreased expression of BCL2 mRNA]25701151
D004205Cromolyn Sodium[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]28732690
D003436Croton Oil"[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA"20537511
D003436Croton Oil"[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein"20537511
D003436Croton Oil"Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]"20537511
D003436Croton Oil"Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]"20537511
C102326cucurbitacin Ecucurbitacin E results in decreased expression of BCL2 protein27106530
C102326cucurbitacin Ecucurbitacin E results in decreased expression of BCL2 protein27363783
C542041cudraflavone Bcudraflavone B results in decreased expression of BCL2 protein23881456
C542041cudraflavone Bresveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein]23881456
C542041cudraflavone Bsirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein]23881456
C029892cupric chloride[Disulfiram co-treated with cupric chloride] results in decreased expression of BCL2 protein21911303
C029892cupric chloridecupric chloride results in decreased expression of BCL2 protein23313662|2417044
C029892cupric chloride[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA20920558
C029892cupric chloride[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein20920558
C029892cupric chloridepyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA]20920558
C029892cupric chloridepyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein]20920558
C030973cupric oxidecrocetin inhibits the reaction [cupric oxide results in decreased expression of BCL2 mRNA]25701151
C030973cupric oxidecupric oxide results in decreased expression of BCL2 mRNA25701151
D003471CuprizoneCuprizone results in increased expression of BCL2 mRNA25704630
D003474Curcumin[arsenic trioxide co-treated with Curcumin] affects the expression of BCL2 protein27430728
D003474CurcuminCurcumin analog results in decreased expression of BCL2 mRNA17671737|1925021
D003474Curcumin[Curcumin co-treated with Isoflavones] results in decreased expression of BCL2 protein18640131
D003474Curcumin[Curcumin co-treated with Sirolimus] results in decreased expression of BCL219373661
D003474CurcuminCurcumin inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]14724571
D003474CurcuminCurcumin inhibits the reaction [Nicotine results in increased expression of BCL2 protein]20727180
D003474CurcuminCurcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]23452621
D003474CurcuminCurcumin inhibits the reaction [Paclitaxel results in increased expression of BCL2 protein]16243823
D003474CurcuminCurcumin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]16219905
D003474CurcuminCurcumin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]17640567
D003474CurcuminCurcumin results in decreased expression of BCL2 mRNA17332930|1759621
D003474CurcuminCurcumin results in decreased expression of BCL2 protein12497104|1602308
D003474Curcumin[Curcumin results in increased expression of SERPINB5] which results in decreased expression of BCL2 protein19944674
D003474CurcuminCurcumin results in increased ubiquitination of and results in increased degradation of BCL2 protein20127174
D003474Curcumin[Dihydrotestosterone co-treated with Curcumin co-treated with Quercetin] results in increased expression of BCL2 protein27132804
D003474CurcuminGlutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]]17640567
D003474Curcuminmanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Curcumin results in increased ubiquitination of and results in increased degradation of BCL2 protein]20127174
D003474CurcuminTNFSF10 protein promotes the reaction [Curcumin results in decreased expression of BCL2 protein]18226269
D003474Curcumin[Curcumin co-treated with gemcitabine] results in decreased expression of BCL2 protein17440100
D003474CurcuminCurcumin results in decreased expression of BCL2 mRNA21397623
D003474CurcuminCurcumin results in decreased expression of BCL2 protein18829502|2139762
D003474CurcuminCurcumin results in increased expression of BCL2 protein21793155|2271404
D003474Curcumin2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 mRNA]17531121
D003474Curcumin2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in decreased expression of BCL2 protein]17531121
D003474Curcumincarboxymethyl-chitosan analog promotes the reaction [Curcumin promotes the reaction [AGT protein modified form results in increased expression of BCL2 protein]]26612707
D003474Curcumincarboxymethyl-chitosan analog promotes the reaction [Curcumin results in increased expression of BCL2 protein]26612707
D003474Curcumin[Curcumin analog co-treated with Hydrogels] inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]27288928
D003474CurcuminCurcumin inhibits the reaction [bisphenol A results in decreased expression of BCL2 mRNA]25963729
D003474CurcuminCurcumin inhibits the reaction [Peroxynitrous Acid results in decreased expression of BCL2 mRNA]20869986
D003474CurcuminCurcumin inhibits the reaction [Peroxynitrous Acid results in decreased expression of BCL2 protein]20869986
D003474CurcuminCurcumin inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]24952339
D003474CurcuminCurcumin inhibits the reaction [Streptozocin affects the expression of BCL2 protein]25541178
D003474CurcuminCurcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]15569404
D003474CurcuminCurcumin promotes the reaction [AGT protein modified form results in increased expression of BCL2 protein]26612707
D003474CurcuminCurcumin results in decreased expression of BCL2 mRNA17531121
D003474CurcuminCurcumin results in decreased expression of BCL2 protein17531121
D003474CurcuminCurcumin results in increased expression of BCL2 mRNA25963729
D003474CurcuminCurcumin results in increased expression of BCL2 protein26612707
D003474CurcuminCurcumin results in decreased expression of BCL218462866
D003474Curcumin[resveratrol co-treated with Curcumin] inhibits the reaction [IL1B protein results in decreased expression of BCL2 protein]19889203
C038459curdlancurdlan results in decreased expression of BCL2 mRNA23543010
D003484Cyanamide[Ethanol co-treated with Cyanamide] results in increased expression of BCL2 mRNA12003908
C057862cyanoginosin LRcyanoginosin LR results in decreased expression of BCL2 protein24594009
C057862cyanoginosin LRQuercetin inhibits the reaction [cyanoginosin LR results in decreased expression of BCL2 protein]24594009
C057862cyanoginosin LR[cyanoginosin LR results in increased abundance of Reactive Oxygen Species] which results in increased expression of BCL2 mRNA24376844
C057862cyanoginosin LRcyanoginosin LR results in decreased expression of BCL2 protein18214937
C057862cyanoginosin LRcyanoginosin LR results in increased expression of and results in increased phosphorylation of BCL2 protein26506538
C057862cyanoginosin LRcyanoginosin LR results in increased expression of BCL216624733
C057862cyanoginosin LRcyanoginosin LR results in increased phosphorylation of BCL2 protein27352821
C057862cyanoginosin LRcyanoginosin LR results in increased phosphorylation of BCL2 protein23891578
C057862cyanoginosin LRButhionine Sulfoximine promotes the reaction [cyanoginosin LR results in decreased expression of BCL2 protein]25410294
C057862cyanoginosin LRcyanoginosin LR results in decreased expression of BCL2 protein25410294
C560272cyclohexanecarboxylic acid (3-(2,5-dimethylbenzyloxy)-4-(methanesulfonylmethylamino)phenyl)amide"cyclohexanecarboxylic acid (3-(2,5-dimethylbenzyloxy)-4-(methanesulfonylmethylamino)phenyl)amide results in decreased expression of BCL2 protein"21458568
D003513CycloheximideBCL2 protein inhibits the reaction [[Cycloheximide co-treated with TNFSF10 protein] results in increased activity of CASP3 protein]22343715
D003513CycloheximideCycloheximide inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11726273
C000541cyclopaminecyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]27481074
C000541cyclopaminecyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]27481074
D003520CyclophosphamideBCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP3 protein]11723234
D003520CyclophosphamideBCL2 protein inhibits the reaction [Cyclophosphamide results in increased activity of CASP9 protein]11723234
D003520Cyclophosphamide[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein15582267
D003520Cyclophosphamide[Cladribine co-treated with Cyclophosphamide] results in decreased expression of BCL2 protein15582267
D003520CyclophosphamideCyclophosphamide results in increased expression of BCL2 mRNA14503796
D003520Cyclophosphamide[Doxorubicin co-treated with Cyclophosphamide] affects the expression of BCL2 mRNA16322899
D003520Cyclophosphamide[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D003520CyclophosphamideCyclophosphamide results in decreased expression of BCL2 mRNA25446862
D003520CyclophosphamidePlant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA]25446862
D016572Cyclosporinecobaltous chloride inhibits the reaction [Cyclosporine results in decreased expression of BCL2 protein]22343435
D016572Cyclosporine[Cyclosporine co-treated with NGF protein] results in decreased expression of BCL2 mRNA24244623
D016572CyclosporineCyclosporine promotes the reaction [Paclitaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein]12086014
D016572CyclosporineCyclosporine results in decreased expression of BCL2 mRNA12086014
D016572CyclosporineCyclosporine results in decreased expression of BCL2 protein12086014|2234343
D016572CyclosporineCyclosporine results in increased methylation of BCL2 promoter27989131
D016572CyclosporineCyclosporine results in increased expression of BCL2 protein10205001
D016572CyclosporineCyclosporine affects the expression of BCL225299210
C072247cyclo(Trp-Asp-Pro-Val-Leu)[cyclo(Trp-Asp-Pro-Val-Leu) co-treated with BQ 788] inhibits the reaction [EDN1 protein results in increased expression of BCL2 protein]20369390
C072247cyclo(Trp-Asp-Pro-Val-Leu)[cyclo(Trp-Asp-Pro-Val-Leu) binds to and results in decreased activity of EDNRA protein] which results in decreased expression of BCL2 protein14736733
C089595cylindrospermopsincylindrospermopsin results in decreased expression of BCL2 mRNA23726867
C017160cypermethrincypermethrin results in increased expression of BCL2 mRNA20965546
C017160cypermethrincypermethrin results in increased expression of BCL2 mRNA27704156
C017160cypermethrincypermethrin results in decreased expression of BCL2 mRNA22528246
C017160cypermethrincypermethrin results in decreased expression of BCL2 protein22048644
C017160cypermethrinHBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2 protein]22048644
D003561CytarabineBCL2 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein]8840993
D003561CytarabineBCL2 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein]8840993
D003561CytarabineCytarabine results in decreased expression of BCL2 mRNA1450413
D003561CytarabineCytarabine results in decreased expression of BCL2 protein16129037|1749052
D003561CytarabineCytarabine results in increased degradation of BCL2 protein12853972
D003561Cytarabine[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D003561Cytarabineedelfosine promotes the reaction [Cytarabine results in decreased expression of BCL2 protein]9295281
D003571Cytochalasin B"1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Cytochalasin B results in decreased expression of BCL2 protein]"27640744
D003571Cytochalasin BCytochalasin B results in decreased expression of BCL2 protein27640744
D003609DactinomycinBCL2 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein]11880364
D003609DactinomycinDactinomycin inhibits the reaction [IL1B results in increased expression of BCL2 protein]16492401
D003609DactinomycinDactinomycin inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11726273
D003609DactinomycinDactinomycin inhibits the reaction [TNF results in increased expression of BCL2 protein]16492401
D003609DactinomycinDactinomycin results in decreased expression of BCL2 mRNA17581298
D003609DactinomycinDactinomycin results in decreased expression of BCL2 protein12927789
D003609DactinomycinMorphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]12927789
D003609DactinomycinNaloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]]12927789
C004742daidzeindaidzein results in decreased expression of BCL2 protein12791511
C004315danthrondanthron results in decreased expression of BCL2 protein21126053
D003620DantroleneDantrolene results in increased expression of BCL2 protein10854250
C080598dapoxetinedapoxetine inhibits the reaction [Testosterone results in increased expression of BCL2 protein]27687055
D000069439DasatinibBCL2 protein inhibits the reaction [[Dasatinib co-treated with NVP-AEW541] promotes the reaction [BAX protein binds to BAX protein]]20664932
D000069439Dasatinib[Dasatinib co-treated with NVP-AEW541] results in decreased expression of BCL2 protein20664932
D000069439DasatinibDasatinib results in decreased expression of BCL2 mRNA20629079
D000069439DasatinibDasatinib results in decreased expression of BCL2 protein18550857|2062907
D003630DaunorubicinBCL2 results in decreased susceptibility to Daunorubicin21595920
D003630Daunorubicin[Bortezomib co-treated with Daunorubicin] results in decreased expression of BCL2 mRNA21302442
D003630Daunorubicin[bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BCL2 protein19421372
D003630Daunorubicinbromotetrandrine promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]19421372
D003630Daunorubicinbromotetrandrine promotes the reaction [[Magnetite Nanoparticles co-treated with Daunorubicin] results in decreased expression of BCL2 protein]19421372
D003630Daunorubicinbromotetrandrine promotes the reaction [Magnetite Nanoparticles promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]]19421372
D003630DaunorubicinDaunorubicin affects the expression of BCL2 mRNA27780733
D003630Daunorubicin[Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 mRNA21720514
D003630Daunorubicin[Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 protein21720514
D003630Daunorubicin[Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BCL2 mRNA21720514
D003630Daunorubicin[Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BCL2 protein21720514
D003630Daunorubicin[Daunorubicin co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 mRNA19918366
D003630DaunorubicinDaunorubicin results in decreased expression of BCL2 mRNA19421372
D003630Daunorubicin[Magnetite Nanoparticles co-treated with Daunorubicin] promotes the reaction [bromotetrandrine results in decreased expression of BCL2 protein]19421372
D003630Daunorubicin[Magnetite Nanoparticles co-treated with Daunorubicin] results in decreased expression of BCL2 protein19421372
D003630DaunorubicinMagnetite Nanoparticles promotes the reaction [bromotetrandrine promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]]19421372
D003630DaunorubicinMagnetite Nanoparticles promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]19421372
D003634DDT[DDT results in increased activity of ESR1 protein] which results in increased expression of BCL2 mRNA22403704
D003634DDTDDT results in decreased expression of BCL2 protein28263910
C010902decabromobiphenyl etherdecabromobiphenyl ether results in decreased expression of BCL2 mRNA26206603
C010902decabromobiphenyl etherdecabromobiphenyl ether results in decreased expression of BCL2 protein28572024
C017180decamethrindecamethrin results in decreased expression of BCL2 protein12628584
C017180decamethrindecamethrin results in decreased expression of BCL2 protein10771154|1872489
C017180decamethrindecamethrin results in increased expression of BCL2 protein10771154
C017180decamethrinMelatonin inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]18724894
C017180decamethrinoleuropein inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]28595958
C017180decamethrinPlant Extracts inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]28595958
C014347decitabine[decitabine co-treated with epigallocatechin gallate] affects the expression of BCL2 mRNA18250043
C014347decitabinedecitabine inhibits the reaction [Estradiol affects the expression of BCL2 mRNA]22082530
C014347decitabinedecitabine inhibits the reaction [tetraethoxysilane analog results in increased methylation of BCL2 promoter]27362941
C014347decitabinedecitabine results in decreased expression of BCL2 mRNA22082530
C014347decitabinedecitabine results in decreased expression of BCL2 protein18636160
C014347decitabinedecitabine results in increased expression of BCL2 mRNA21515334
C014347decitabinedecitabine results in increased expression of BCL2 mRNA27915011
C014347decitabinedecitabine inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA]21143203
C014347decitabine[Paraquat co-treated with decitabine] results in decreased expression of BCL2 protein22796470
C072799declopramideBCL2 protein inhibits the reaction [declopramide results in increased activity of CASP9 protein]11953831
C072799declopramideBCL2 protein results in decreased susceptibility to declopramide11953831
C107676deguelindeguelin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]22623043
C107676deguelindeguelin results in decreased expression of BCL2 mRNA19365708|2262304
C107676deguelindeguelin results in decreased expression of BCL2 protein19365708|2659250
D003683Dehydroascorbic Acid[Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein20166893
D003683Dehydroascorbic AcidDehydroascorbic Acid results in increased expression of BCL2 protein20166893
D003687DehydroepiandrosteroneDehydroepiandrosterone results in decreased expression of BCL2 protein21062263
D003687DehydroepiandrosteroneDehydroepiandrosterone results in increased expression of BCL2 protein16407456
D003687DehydroepiandrosteroneDexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]16407456
D003687DehydroepiandrosteroneDihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]16407456
D003687DehydroepiandrosteronePertussis Toxin inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]16407456
C509625dehydroepiandrosterone-bovine serum albumindehydroepiandrosterone-bovine serum albumin results in increased expression of BCL2 protein16407456
C509625dehydroepiandrosterone-bovine serum albuminPertussis Toxin inhibits the reaction [dehydroepiandrosterone-bovine serum albumin results in increased expression of BCL2 protein]16407456
D019314Dehydroepiandrosterone SulfateDehydroepiandrosterone Sulfate results in increased expression of BCL2 protein16407456
D019314Dehydroepiandrosterone SulfatePertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein]16407456
C017185delphinidindelphinidin results in decreased expression of BCL2 protein15740068
C017185delphinidindelphinidin results in increased expression of BCL2 protein19818742
C100698demethoxyfumitremorgin Cdemethoxyfumitremorgin C results in decreased expression of BCL2 protein28359723
C576677demycarosyl-3D-digitoxosylmithramycin SKdemycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA26079942
C576677demycarosyl-3D-digitoxosylmithramycin SKDeoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA]26079942
C075597Dendroaspis natriuretic peptideDendroaspis natriuretic peptide results in decreased expression of BCL2 protein15803858
D003840Deoxycholic AcidBCL2 protein results in decreased susceptibility to Deoxycholic Acid12507930
D003847DeoxyglucoseDeoxyglucose affects the reaction [demycarosyl-3D-digitoxosylmithramycin SK affects the expression of BCL2 mRNA]26079942
C007262deoxynivalenolAscorbic Acid inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]17166419
C007262deoxynivalenoldeoxynivalenol results in decreased expression of BCL2 mRNA22269384
C007262deoxynivalenoldeoxynivalenol results in decreased expression of BCL2 protein17166419
C007262deoxynivalenoldeoxynivalenol results in increased expression of BCL2 mRNA22269384
C007262deoxynivalenoldeoxynivalenol promotes the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]25445755
C007262deoxynivalenol[Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein29109043
C007262deoxynivalenol[Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein29109043
C007262deoxynivalenolAcetylcysteine inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]29109043
C007262deoxynivalenolAcetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]29109043
C007262deoxynivalenoldeoxynivalenol results in decreased expression of BCL2 mRNA25701311|2910904
C007262deoxynivalenoldeoxynivalenol results in decreased expression of BCL2 protein29109043
C007262deoxynivalenol[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA29109043
C007262deoxynivalenol[fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein29109043
C007262deoxynivalenolfumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]29109043
C007262deoxynivalenolfumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]29109043
C007262deoxynivalenolZearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]29109043
C007262deoxynivalenolZearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]]29109043
D003891DesipramineDesipramine results in increased expression of BCL2 mRNA17510525
D003891DesipramineDesipramine results in increased expression of BCL2 protein17510525
C040424destruxin Bdestruxin B results in decreased expression of BCL223751424
C040424destruxin Bdestruxin B results in decreased expression of BCL2 protein22465936|2443401
C040424destruxin Bsorafenib promotes the reaction [destruxin B results in decreased expression of BCL2 protein]24434019
D003907DexamethasoneBCL2 protein results in decreased susceptibility to Dexamethasone16505121
D003907DexamethasoneBCL2 protein results in increased susceptibility to Dexamethasone10200551
D003907DexamethasoneDexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]21940343
D003907DexamethasoneDexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]21940343
D003907DexamethasoneDexamethasone inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]21420233
D003907DexamethasoneDexamethasone results in increased expression of BCL221244764
D003907DexamethasoneDexamethasone results in increased expression of BCL2 protein11319611
D003907Dexamethasone[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D003907Dexamethasone[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA28628672
D003907DexamethasoneMifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2]21244764
D003907DexamethasoneMycophenolic Acid inhibits the reaction [BCL2 protein results in decreased susceptibility to Dexamethasone]16505121
D003907Dexamethasone[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA15867202
D003907Dexamethasone[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein15867202
D003907Dexamethasone"[2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine co-treated with [Dexamethasone co-treated with INS protein co-treated with PRL protein]] results in increased expression of BCL2 protein"11751460
D003907DexamethasoneBCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of CAT protein]17180084
D003907DexamethasoneBCL2 gene inhibits the reaction [Dexamethasone results in decreased activity of NQO1 protein]17180084
D003907DexamethasoneBCL2 protein results in decreased susceptibility to Dexamethasone19997594
D003907DexamethasoneDexamethasone results in decreased expression of BCL2 mRNA16644695|7517174
D003907DexamethasoneDexamethasone results in decreased expression of BCL2 protein16644695
D003907DexamethasoneDexamethasone results in increased expression of BCL2 mRNA21041162
D003907DexamethasoneMifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA]16644695
D003907DexamethasoneMifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]16644695
D003907DexamethasoneDexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]16407456
D003907DexamethasoneDexamethasone results in decreased expression of BCL2 mRNA19080409
D003907DexamethasoneDexamethasone results in decreased expression of BCL2 protein19080409
D003907DexamethasoneDexamethasone results in increased expression of BCL2 protein11319611
D003907DexamethasoneDexamethasone inhibits the reaction [TNF results in decreased expression of BCL2 protein]12054739
D020927DexmedetomidineDexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of BCL2 protein]20003127
D016264Dextran SulfateAspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D016264Dextran Sulfate[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein25449198
D016264Dextran SulfateCamptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D016264Dextran SulfatePlant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
C539263di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone"di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone affects the expression of BCL2 protein"24532803
C028009diallyl disulfidediallyl disulfide results in decreased expression of BCL2 mRNA17647244
C028009diallyl disulfidediallyl disulfide results in decreased expression of BCL2 protein14522920
C028009diallyl disulfidediallyl disulfide results in decreased expression of BCL2 protein16052692
C042577diallyl trisulfideAcetylcysteine inhibits the reaction [diallyl trisulfide results in decreased expression of BCL2 protein]22578287
C042577diallyl trisulfidediallyl trisulfide results in decreased expression of BCL222595511
C042577diallyl trisulfidediallyl trisulfide results in decreased expression of BCL2 mRNA19823037|2441587
C042577diallyl trisulfidediallyl trisulfide results in decreased expression of BCL2 protein17513609|2005583
D016190CarboplatinCarboplatin results in decreased expression of BCL2 mRNA15576332|1599681
D016190CarboplatinCarboplatin results in decreased expression of BCL2 protein15996812|9664115
D003973Diatrizoate[Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein17173243
D003974Diatrizoate MeglumineDiatrizoate Meglumine results in increased expression of BCL2 protein17173243
D003974Diatrizoate MeglumineDiatrizoate Meglumine results in decreased expression of BCL2 mRNA28412091
D003974Diatrizoate MeglumineLansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA]28412091
D003976DiazinonDiazinon results in decreased expression of BCL2 mRNA27920530
D003976DiazinonMagnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D003976Diazinon[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D003976DiazinonSelenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D003976DiazinonDiazinon affects the expression of BCL2 mRNA22546817
D003981DiazoxideDiazoxide inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]20650802
C061481dibenzoylmethanedibenzoylmethane inhibits the reaction [ESR1 protein binds to BCL2 enhancer]16051634
C061481dibenzoylmethanedibenzoylmethane inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]16051634
C088674dibromoacetic aciddibromoacetic acid results in decreased expression of BCL2 mRNA18628252
C542282dibutyldi(4-chlorobenzohydroxamato)tin(IV)dibutyldi(4-chlorobenzohydroxamato)tin(IV) results in decreased expression of BCL2 protein23041257
D003993Dibutyl PhthalateDDIT3 protein promotes the reaction [Dibutyl Phthalate results in decreased expression of BCL2 protein]26804720
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of BCL2 mRNA23242528
D003993Dibutyl PhthalateDibutyl Phthalate results in decreased expression of BCL2 protein26804720
D003993Dibutyl PhthalateDibutyl Phthalate results in increased expression of BCL2 mRNA21266533
D003993Dibutyl Phthalate[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA28013214
D003994Bucladesine"adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Bucladesine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]"16822680
D003994BucladesineBucladesine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]16822680
D003994BucladesineBucladesine results in decreased expression of BCL2 protein10697531
D003999Dichloroacetic AcidDichloroacetic Acid results in decreased expression of BCL2 protein22705712
D0151013,3'-Dichlorobenzidine"3,3'-Dichlorobenzidine affects the expression of BCL2 protein"24604609
D002945CisplatinABCB1 protein inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]22269388
D002945Cisplatin[andrographolide co-treated with Cisplatin] results in decreased expression of BCL2 mRNA24563380
D002945CisplatinBCL2 inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]21618512
D002945CisplatinBCL2 inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]21618512
D002945CisplatinBCL2 inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein]21618512
D002945CisplatinBCL2 protein affects the susceptibility to Cisplatin25611565
D002945CisplatinBCL2 protein inhibits the reaction [Cisplatin affects the localization of BAX protein]16009487
D002945CisplatinBCL2 protein inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP3 protein]17574045
D002945CisplatinBCL2 protein inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP8 protein]17574045
D002945CisplatinBCL2 protein inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in increased activity of CASP9 protein]17574045
D002945CisplatinBCL2 protein results in decreased susceptibility to Cisplatin16009487|2016257
D002945CisplatinBCL2 protein results in decreased susceptibility to [Cisplatin co-treated with Etoposide]15917659
D002945CisplatinBCL2 results in decreased susceptibility to Cisplatin10896673|2161851
D002945Cisplatinchrysin inhibits the reaction [Cisplatin results in increased expression of BCL2 protein]25770930
D002945CisplatinCisplatin affects the expression of BCL2 protein24799992
D002945Cisplatin"[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA"21214929
D002945Cisplatin"[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
D002945Cisplatin"[[[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
D002945Cisplatin[Cisplatin co-treated with Pemetrexed co-treated with Valproic Acid] results in decreased expression of BCL2 protein19351772
D002945Cisplatin[Cisplatin co-treated with Pemetrexed co-treated with vorinostat] results in decreased expression of BCL2 protein19351772
D002945Cisplatin[Cisplatin co-treated with Quercetin] results in decreased expression of BCL2 protein16082193
D002945CisplatinCisplatin promotes the reaction [jinfukang results in decreased expression of BCL2 mRNA]27392435
D002945CisplatinCisplatin promotes the reaction [Metformin results in decreased expression of BCL2 protein]21388661
D002945CisplatinCisplatin results in decreased expression of BCL223287709
D002945CisplatinCisplatin results in decreased expression of BCL2 mRNA17404015|2087807
D002945CisplatinCisplatin results in decreased expression of BCL2 protein10891529|1451278
D002945Cisplatin[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of BCL2 protein21130731
D002945CisplatinCisplatin results in increased expression of BCL2 protein17619073|2456338
D002945Cisplatin[Cisplatin results in increased expression of MIR630] which results in decreased expression of BCL2 mRNA21274007
D002945Cisplatin[CXCL8 results in increased expression of BCL2 mRNA] which results in decreased susceptibility to Cisplatin21742513
D002945Cisplatin[CXCL8 results in increased expression of BCL2 protein] which results in decreased susceptibility to Cisplatin21742513
D002945CisplatinDexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]21940343
D002945CisplatinDexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]21940343
D002945Cisplatin[Estradiol results in increased expression of BCL2 mRNA] which results in increased susceptibility to Cisplatin28323900
D002945CisplatinING4 protein promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]21052098
D002945Cisplatinjinfukang promotes the reaction [Cisplatin results in decreased expression of BCL2 mRNA]27392435
D002945CisplatinMelatonin inhibits the reaction [Cisplatin affects the expression of BCL2 protein]24799992
D002945Cisplatin[MIR497 results in decreased expression of BCL2 protein] which results in increased susceptibility to Cisplatin21258880
D002945CisplatinNoscapine promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]20674069
D002945Cisplatin[Paclitaxel results in increased phosphorylation of BCL2 protein] which results in increased susceptibility to Cisplatin12709826
D002945Cisplatin[Proadifen co-treated with Cisplatin] results in decreased expression of BCL2 protein26721606
D002945Cisplatin[Quercetin results in increased susceptibility to Cisplatin] which results in decreased expression of BCL2 protein16619537|2561156
D002945Cisplatintetraarsenic tetrasulfide promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]26586936
D002945Cisplatin[Theophylline co-treated with Cisplatin] results in decreased expression of BCL2 protein10891529|1564513
D002945Cisplatin[TNFSF10 protein co-treated with Cisplatin] results in decreased expression of BCL2 protein21252285
D002945Cisplatin[tubeimoside I co-treated with Cisplatin] results in decreased expression of BCL2 protein21687949
D002945CisplatinY 27632 inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]20878077
D002945Cisplatin"[YAP1 protein promotes the reaction [[Cisplatin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein"21214929
D002945CisplatinABCB1 protein inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]22269388
D002945CisplatinAcetylcysteine inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]21616140
D002945CisplatinAcetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]]21616140
D002945CisplatinBCL2 protein affects the susceptibility to Cisplatin15746559
D002945Cisplatin[Cisplatin co-treated with TNF protein] results in decreased expression of BCL2 mRNA23103562
D002945CisplatinCisplatin results in decreased expression of BCL2 mRNA20883750
D002945CisplatinCisplatin results in decreased expression of BCL2 protein20566416|2088375
D002945CisplatinCisplatin results in increased expression of BCL2 mRNA19833167
D002945CisplatinCisplatin results in increased expression of BCL2 protein25665769
D002945CisplatinIL6 gene mutant form promotes the reaction [Cisplatin results in increased expression of BCL2 mRNA]19833167
D002945Cisplatinrosemarinic acid inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]21526214
D002945Cisplatinsalubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]21616140
D002945CisplatinStreptozocin inhibits the reaction [Cisplatin results in increased expression of BCL2 protein]25665769
D002945CisplatinBCL2 protein results in decreased susceptibility to Cisplatin15315938
D002945Cisplatinchelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]]12690470
D002945CisplatinCisplatin results in decreased expression of BCL221795690
D002945CisplatinCisplatin results in decreased expression of BCL2 mRNA23603837
D002945CisplatinCisplatin results in decreased expression of BCL2 protein12690470|2518474
D002945CisplatinCisplatin results in increased expression of BCL2 protein28414026
D002945CisplatinCisplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein19428505
D002945Cisplatin[CTNNA1 protein affects the susceptibility to Cisplatin] which results in decreased expression of BCL2 protein27989596
D002945CisplatinEicosanoids analog inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]23603837
D002945Cisplatinfisetin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]25184746
D002945Cisplatinformononetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein]28414026
D002945CisplatinFSCN2 protein inhibits the reaction [[CTNNA1 protein affects the susceptibility to Cisplatin] which results in decreased expression of BCL2 protein]27989596
D002945CisplatinGrape Seed Proanthocyanidins inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]28371137
D002945CisplatinSB 203580 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
D002945Cisplatinsodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]12690470
D002945CisplatinU 0126 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
D002945Cisplatinuranyl acetate inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]12690470
D002945CisplatinBCL2 affects the susceptibility to Cisplatin21981718
D002945CisplatinBCL2 protein inhibits the reaction [Cisplatin affects the localization of CYCS protein]21527773
D002945CisplatinBCL2 protein results in decreased susceptibility to Cisplatin21527773
D003633Dichlorodiphenyl DichloroethyleneDichlorodiphenyl Dichloroethylene results in increased expression of BCL2 mRNA19545618
D003633Dichlorodiphenyl DichloroethyleneDichlorodiphenyl Dichloroethylene results in increased expression of BCL2 protein19545618
C000944dicrotophosdicrotophos results in decreased expression of BCL2 protein28302478
D018119StavudineStavudine results in decreased expression of BCL2 protein9007205
C499970dideoxypetrosynol Adideoxypetrosynol A results in decreased expression of BCL2 protein15547680
D019259Lamivudine[Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA18313992
C552234didymindidymin results in decreased expression of BCL2 protein27899290
C552234didyminlocostatin inhibits the reaction [didymin results in decreased expression of BCL2 protein]27899290
D004026DieldrinBCL2 protein inhibits the reaction [Dieldrin results in increased activity of CASP3 protein]15033812|1518301
D004026DieldrinBCL2 protein inhibits the reaction [Dieldrin results in increased activity of PRKCD protein]15033812
D004026DieldrinBCL2 protein results in decreased susceptibility to Dieldrin15183012
D004041Dietary FatsDietary Fats inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2 protein]25440059
D004041Dietary FatsDietary Fats results in decreased expression of BCL2 mRNA27260466
D004041Dietary Fats[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA28916335
D004041Dietary Fats[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein28916335
D004041Dietary FatsQuercetin inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]27260466
D004041Dietary Fatsresveratrol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]27260466
D004041Dietary FatsThioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]27260466
D004041Dietary Fatstroxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA]28916335
D004041Dietary Fatstroxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein]28916335
D004041Dietary Fats"[2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol co-treated with vildagliptin] inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]"28807765
D004041Dietary Fats"2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]"28807765
D004041Dietary FatsDietary Fats results in decreased expression of BCL2 protein28807765
D004041Dietary Fatsvildagliptin inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]28807765
D004049Diethylcarbamazine[Diethylcarbamazine co-treated with Aspirin] results in decreased expression of BCL2 protein20362029
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in decreased expression of BCL2 mRNA22155658
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of BCL2 mRNA15923092
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of BCL2 protein15923092|9395224
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in decreased expression of BCL2 protein26678702
D004051Diethylhexyl PhthalateDiethylhexyl Phthalate results in increased expression of BCL2 mRNA25701202
D004051Diethylhexyl Phthalate[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA28013214
C014476diethyl maleate[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA22564015
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of BCL2 protein21776270
D004052DiethylnitrosamineBCL2 protein inhibits the reaction [TGFA protein results in increased susceptibility to Diethylnitrosamine]12000706
D004052DiethylnitrosamineBCL2 protein results in decreased susceptibility to Diethylnitrosamine12000706
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of BCL2 mRNA24535843
D004052Diethylnitrosamine[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein20452335
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein11915028
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BCL2 mRNA21295105
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA23830814
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of BCL2 mRNA15682466|2239330
D004052DiethylnitrosamineDiethylnitrosamine results in increased expression of BCL2 protein19073162|1993151
D004052Diethylnitrosaminefumagillin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]15682466
D004052DiethylnitrosamineIFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein]11915028
D004052Diethylnitrosaminemorin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]19931519
D004052DiethylnitrosaminePlant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]22393308
D004052DiethylnitrosaminePlant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]22393308
D004052Diethylnitrosamineresveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]19073162
D004052DiethylnitrosamineThioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA]23830814
D004052Diethylnitrosaminezerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein]20452335
C007379diethyl phthalate[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA28013214
D004054DiethylstilbestrolDiethylstilbestrol results in decreased expression of BCL2 mRNA15545218
D004054DiethylstilbestrolDiethylstilbestrol results in increased expression of BCL2 mRNA17943652
D004054DiethylstilbestrolDiethylstilbestrol results in decreased expression of BCL2 protein17009535
C011612diethyl sulfatediethyl sulfate results in decreased expression of BCL2 protein23830811
D004075DiglyceridesDiglycerides results in increased expression of BCL2 protein9295281
D017323Dihematoporphyrin EtherCelecoxib promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein]16230411
D017323Dihematoporphyrin EtherDihematoporphyrin Ether results in increased cleavage of BCL2 protein16230411
D017323Dihematoporphyrin EtherN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein]16230411
D002117CalcitriolCalcitriol affects the expression of BCL2 protein16080513
D002117Calcitriol[Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA15955619
D002117Calcitriol[Calcitriol co-treated with Tretinoin] results in decreased expression of BCL2 protein10713328
D002117CalcitriolCalcitriol results in decreased expression of BCL28593782
D002117CalcitriolCalcitriol results in decreased expression of BCL2 mRNA15955619|2159239
D002117CalcitriolCalcitriol results in decreased expression of BCL2 protein10614618|1247936
D002117CalcitriolCalcitriol results in increased expression of BCL2 mRNA21542014
D002117CalcitriolCalcitriol results in increased expression of BCL2 protein21542014
D002117Calcitriol[Testosterone co-treated with Calcitriol] results in decreased expression of BCL2 mRNA21592394
D002117CalcitriolCalcitriol results in increased expression of BCL219603526
D002117CalcitriolCalcitriol results in increased expression of BCL2 protein17570329
C025605diisobutyl phthalate[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA28013214
C012125diisononyl phthalate[diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in increased expression of BCL2 mRNA28013214
C577929dimethylaminomicheliolidedimethylaminomicheliolide results in decreased expression of BCL2 mRNA25658946
C577929dimethylaminomicheliolidedimethylaminomicheliolide results in decreased expression of BCL2 mRNA25658946
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA"21294050
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein"21294050
D0151279,10-Dimethyl-1,2-benzanthracene"Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"21294050
D0151279,10-Dimethyl-1,2-benzanthracene"Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"21294050
D0151279,10-Dimethyl-1,2-benzanthracene"[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA"20537511
D0151279,10-Dimethyl-1,2-benzanthracene"[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein"20537511
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA"20103723|2547886
D0151279,10-Dimethyl-1,2-benzanthracene"9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein"18791811|2547886
D0151279,10-Dimethyl-1,2-benzanthracene"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"Butyric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"20103723
D0151279,10-Dimethyl-1,2-benzanthracene"Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]"20537511
D0151279,10-Dimethyl-1,2-benzanthracene"Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]"20537511
D0151279,10-Dimethyl-1,2-benzanthracene"Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D0151279,10-Dimethyl-1,2-benzanthracene"[Plant Extracts co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"20103723
D0151279,10-Dimethyl-1,2-benzanthracene"resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"18791811
D0198131,2-Dimethylhydrazine"[1,2-Dimethylhydrazine co-treated with artesunate] results in decreased expression of BCL2 protein"29031619
D0198131,2-Dimethylhydrazine"1,2-Dimethylhydrazine results in increased expression of BCL2 protein"15309441|2910877
D0198131,2-Dimethylhydrazine"asiatic acid inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BCL2 protein]"29108773
D0198131,2-Dimethylhydrazine"Olive Oil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BCL2 protein]"15309441
D004127Dimethylhydrazines[Cromolyn Sodium co-treated with Chitosan] inhibits the reaction [Dimethylhydrazines results in increased expression of BCL2 protein]28732690
D004127DimethylhydrazinesDimethylhydrazines results in increased expression of BCL2 protein28732690
C018522dimethyl-N-acetylmuramyl-alanylglutamatedimethyl-N-acetylmuramyl-alanylglutamate results in decreased expression of BCL2 protein16806111
C018522dimethyl-N-acetylmuramyl-alanylglutamategypenoside inhibits the reaction [dimethyl-N-acetylmuramyl-alanylglutamate results in decreased expression of BCL2 protein]16806111
D004128DimethylnitrosamineDimethylnitrosamine results in decreased expression of BCL2 protein14659978
D004128DimethylnitrosamineEstradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein]14659978
D004128Dimethylnitrosamineidoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein]14659978
D004137DinitrochlorobenzeneDinitrochlorobenzene affects the expression of BCL2 mRNA28219650
D004137DinitrochlorobenzeneNFE2L2 protein promotes the reaction [Dinitrochlorobenzene results in increased expression of BCL2 mRNA]28219650
C019357dioscindioscin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]22939915
D004144DiosgeninDiosgenin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]16331273
D004144DiosgeninDiosgenin results in decreased expression of BCL2 protein16331273
D004145Diosmin[Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein21477647
C493087diphenylarsinic aciddiphenylarsinic acid results in increased expression of BCL2 mRNA23999541
C453079dipropylenetriamine-NONOate[dipropylenetriamine-NONOate results in increased nitrosation of and results in decreased ubiquitination of and results in decreased degradation of BCL2 protein] which results in decreased susceptibility to Chromates16980304
D004178DiquatDiquat affects the expression of BCL2 mRNA26785375|2705728
D004178Diquatprocyanidin B2 affects the reaction [Diquat affects the expression of BCL2 mRNA]27057282
D004221Disulfiram[arsenic trioxide co-treated with Ascorbic Acid co-treated with Disulfiram] results in decreased expression of BCL2 protein24126434
D004221Disulfiram[Copper co-treated with Disulfiram] results in decreased expression of BCL2 protein23033007
D004221Disulfiram[Disulfiram co-treated with cupric chloride] results in decreased expression of BCL2 protein21911303
D004227Dithionite2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]21803128
D004227Dithionite2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]21803128
D004227Dithionite[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein21803128
D004227DithioniteQuercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]21803128
D004229DithiothreitolDithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein]18022205
D016291Dizocilpine MaleateDizocilpine Maleate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
D016291Dizocilpine MaleateDizocilpine Maleate results in decreased expression of BCL2 protein10859492
C521792DMU-212DMU-212 results in decreased expression of BCL2 mRNA22687606
C521792DMU-212DMU-212 results in decreased expression of BCL2 protein24055891
D004280DobutamineDobutamine results in decreased expression of BCL2 protein15052282
C067311docetaxel2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [docetaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein]14506750
C067311docetaxel2-(4-nitrophenyl)-4-(4-fluorophenyl)-5-(4-pyridinyl)-1H-imidazole inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]14724571
C067311docetaxelBCL2 inhibits the reaction [docetaxel affects the folding of and results in increased activity of BAK1 protein]17308071
C067311docetaxelBCL2 inhibits the reaction [docetaxel results in increased cleavage of and results in increased activity of CASP3 protein]17308071
C067311docetaxelCelecoxib promotes the reaction [docetaxel results in increased expression of BCL2 protein]15688368
C067311docetaxelCurcumin inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]14724571
C067311docetaxeldocetaxel results in increased expression of BCL2 protein15688368
C067311docetaxeldocetaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein14506750
C067311docetaxeldocetaxel results in increased phosphorylation of BCL2 protein14724571|1731784
C067311docetaxelpyrazolanthrone inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]14724571|1731784
C067311docetaxelU 0126 inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]17317842
C067311docetaxelU 0126 promotes the reaction [docetaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein]14506750
C067311docetaxel[zoledronic acid co-treated with docetaxel] results in decreased expression of BCL2 protein19103299
C067311docetaxelBCL2 affects the susceptibility to docetaxel10606283
C067311docetaxeldocetaxel results in increased phosphorylation of BCL2 protein10606283
C067311docetaxel[docetaxel results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]10606283
D004281Docosahexaenoic Acids[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA19015929
D004281Docosahexaenoic AcidsDocosahexaenoic Acids results in decreased expression of BCL219116882
D004281Docosahexaenoic AcidsDocosahexaenoic Acids results in decreased expression of BCL2 protein11090257
D004281Docosahexaenoic AcidsDocosahexaenoic Acids inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]12714668
D004281Docosahexaenoic AcidsDocosahexaenoic Acids results in increased expression of BCL2 protein12714668
C012301domoic aciddomoic acid affects the expression of BCL2 mRNA18293405
C076946donepezildonepezil inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]19345205
D007980LevodopaLevodopa results in increased activity of BCL2 protein20670675
D004298DopamineDopamine results in decreased expression of BCL2 protein17603292
D004298Dopamineresveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein]17603292
D017292DoxazosinBCL2 inhibits the reaction [Doxazosin results in decreased expression of VEGFA]12576871
D004317DoxorubicinAcetylcysteine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17542780
D004317Doxorubicin[Amifostine co-treated with Doxorubicin] results in decreased expression of BCL2 mRNA15985719
D004317Doxorubicin[arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 mRNA24738333
D004317Doxorubicin[arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 protein24738333
D004317DoxorubicinBCL2 protein affects the susceptibility to Doxorubicin16322301|1645038
D004317DoxorubicinBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased expression of and results in increased activity of BAX protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]]20856197
D004317DoxorubicinBCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased expression of and results in increased activity of BAX protein]]20856197
D004317DoxorubicinBCL2 protein results in decreased susceptibility to Doxorubicin8781438
D004317DoxorubicinBCL2 protein results in decreased susceptibility to [Doxorubicin co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one]20856197
D004317DoxorubicinBCL2 protein results in decreased susceptibility to [Doxorubicin co-treated with PI103]20856197
D004317DoxorubicinDoxorubicin affects the expression of BCL2 mRNA16705698|2379264
D004317Doxorubicin"[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 mRNA"21214929
D004317Doxorubicin"[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
D004317Doxorubicin"[[[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased phosphorylation of ABL1 protein] which results in increased expression of TP73 protein] which results in decreased expression of BCL2 protein"21214929
D004317Doxorubicin[Doxorubicin co-treated with bisphenol A] results in increased expression of BCL2 protein19270784
D004317Doxorubicin[Doxorubicin co-treated with Cyclophosphamide] affects the expression of BCL2 mRNA16322899
D004317Doxorubicin[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D004317Doxorubicin[Doxorubicin co-treated with Melatonin] results in decreased expression of BCL2 protein20333787
D004317Doxorubicin[Doxorubicin co-treated with resveratrol] results in decreased expression of BCL2 mRNA26969377
D004317Doxorubicin[Doxorubicin co-treated with resveratrol] results in decreased expression of BCL2 protein26969377
D004317Doxorubicin[Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein9815696
D004317DoxorubicinDoxorubicin promotes the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]16168113
D004317DoxorubicinDoxorubicin results in decreased expression of BCL2 mRNA12505058|1600197
D004317DoxorubicinDoxorubicin results in decreased expression of BCL2 protein11779855|1689018
D004317DoxorubicinDoxorubicin results in increased expression of BCL2 mRNA15939500|1975717
D004317DoxorubicinDoxorubicin results in increased expression of BCL2 protein15571967|1927078
D004317Doxorubicin[Estradiol results in increased expression of BCL2 mRNA] which results in increased susceptibility to Doxorubicin28323900
D004317Doxorubicin[F3 protein affects the expression of BCL2 protein] which affects the susceptibility to Doxorubicin18325115
D004317Doxorubicin[[F3 protein co-treated with F7 protein] results in increased expression of BCL2 protein] which results in decreased susceptibility to Doxorubicin18325115
D004317DoxorubicinGSTA1 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]16890185
D004317DoxorubicinIFNA1 protein promotes the reaction [Doxorubicin results in decreased expression of BCL2 protein]17959036
D004317DoxorubicinMorphine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17542780
D004317Doxorubicinpluronic block copolymer p85 inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA]15939500
D004317DoxorubicinSirolimus inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein]15571967
D004317DoxorubicinTamoxifen promotes the reaction [Doxorubicin results in increased expression of BCL2 mRNA]19757172
D004317Doxorubicin"[YAP1 protein promotes the reaction [[Doxorubicin co-treated with 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid] results in increased expression of TP73 protein]] which results in decreased expression of BCL2 protein"21214929
D004317DoxorubicinBDKRB1 protein affects the reaction [Doxorubicin results in decreased expression of BCL2 protein]18627295
D004317DoxorubicinDoxorubicin inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]15538571
D004317DoxorubicinDoxorubicin results in decreased expression of BCL2 protein15811867|1767318
D004317DoxorubicinDoxorubicin results in increased expression of BCL2 mRNA15505089|1971424
D004317DoxorubicinDoxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17673183
D004317DoxorubicinPSMB10 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]25896364
D004317DoxorubicinPSMB8 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]25896364
D004317DoxorubicinPSMB9 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]25896364
D004317Doxorubicinresveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]22763982
D004317DoxorubicinSildenafil Citrate inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]15811867
D004317DoxorubicinTadalafil inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]20543097
D004317Doxorubicinzinc chloride inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA]19714248
D004317Doxorubicinzinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]22763982
D004317Doxorubicin[zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein19789217
D004317Doxorubicin"2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside promotes the reaction [Doxorubicin results in increased expression of BCL2 protein]"19890356
D004317DoxorubicinAmlodipine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17234320
D004317Doxorubicincarvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]15380674
D004317Doxorubicincarvedilol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]26036690
D004317DoxorubicinCatechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]18611398
D004317DoxorubicinCatechin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18611398
D004317Doxorubicinchloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]29133031
D004317Doxorubicincoenzyme Q10 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]27087047
D004317DoxorubicinDoxorubicin affects the expression of BCL2 mRNA24742701
D004317DoxorubicinDoxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]29133031
D004317DoxorubicinDoxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]29133031
D004317DoxorubicinDoxorubicin promotes the reaction [TP53 protein binds to BCL2 promoter]22155320
D004317DoxorubicinDoxorubicin results in decreased expression of BCL2 mRNA12505058|1538067
D004317DoxorubicinDoxorubicin results in decreased expression of BCL2 protein14736733|1723432
D004317DoxorubicinDoxorubicin results in increased expression of BCL2 protein11291592|1752033
D004317DoxorubicinEPO protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17924179
D004317DoxorubicinFebuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]26036690
D004317DoxorubicinGHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]18400355
D004317DoxorubicinGinkgo biloba extract inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18632596
D004317Doxorubicinpifithrin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18775851
D004317DoxorubicinProanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]18611398
D004317DoxorubicinProanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18611398
D004317DoxorubicinPropofol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]22015447
D004317DoxorubicinQuercetin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]24902966
D004317Doxorubicinrhodioloside inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]24072175
D004317Doxorubicinsalvianolic acid B inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]28495616
D004317DoxorubicinTNF protein affects the reaction [GHRL protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]]18400355
D004317DoxorubicinU 0126 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18775851
D004317DoxorubicinWithanolides inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein]17520333
D004317DoxorubicinBCL2 affects the susceptibility to Doxorubicin21981718
D004317DoxorubicinEDN1 protein inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]14736733
D004318DoxycyclineDoxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17673183
C060327dracorhodindracorhodin analog results in decreased expression of BCL2 protein15684474
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal promotes the reaction [Zidovudine results in decreased expression of BCL2 mRNA]"17696246
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal results in decreased expression of BCL2 protein"19295228|2331583
D004365Drugs, Chinese Herbal"arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BCL2 protein]"28587418
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]"27983966
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]"28757890
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]"28587418
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal results in decreased expression of BCL2 protein"28587418
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]"19524685
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]"19524685
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]"22446813
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]"15587404
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]"15587404
D004365Drugs, Chinese Herbal"Drugs, Chinese Herbal results in increased expression of BCL2 protein"15998571
C515537E-2-(4'-methoxybenzylidene)-benzusuberoneE-2-(4'-methoxybenzylidene)-benzusuberone results in decreased expression of BCL2 protein20450969
C022999echinocystic acidechinocystic acid affects the reaction [Isoproterenol affects the expression of BCL2 mRNA]19573579
C026659edelfosineedelfosine inhibits the reaction [Nicotine results in increased phosphorylation of BCL2 protein]12421819
C026659edelfosineedelfosine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]9295281
C026659edelfosineedelfosine promotes the reaction [Cytarabine results in decreased expression of BCL2 protein]9295281
D015777EicosanoidsEicosanoids analog inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]23603837
C413879EKB 569EKB 569 results in decreased expression of BCL2 mRNA22242139
C004934eleostearic acideleostearic acid results in decreased expression of BCL2 protein15961301
D004610Ellagic AcidEllagic Acid results in increased expression of BCL2 protein22386815
D004610Ellagic Acid"[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"20103723
C034192ellipticineellipticine results in decreased expression of BCL2 protein16027529
C010945embelinembelin results in decreased expression of BCL2 protein24694877
D004642Emodin2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one affects the reaction [Emodin affects the expression of BCL2 protein]27032576
D004642EmodinEmodin affects the expression of BCL2 protein27032576
D004642EmodinEmodin results in decreased expression of BCL2 mRNA23848338
D004642EmodinEmodin results in decreased expression of BCL2 protein23848338
D004642EmodinSB 203580 affects the reaction [Emodin affects the expression of BCL2 protein]27032576
D004642EmodinU 0126 affects the reaction [Emodin affects the expression of BCL2 protein]27032576
D004642EmodinEmodin affects the expression of BCL2 protein19549930
D004656EnalaprilEnalapril results in increased expression of BCL2 protein21153712
D015773EnalaprilatEnalaprilat results in increased expression of BCL2 mRNA17342403
D004726EndosulfanEndosulfan results in increased expression of BCL2 protein10821422
C530049ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate"ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate results in decreased expression of BCL2 protein"19509257
C118739entinostatentinostat results in decreased expression of BCL2 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C118739entinostatentinostat results in decreased expression of BCL2 protein21041383
D045762Enzymes and Coenzymes[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D015251Epirubicin[Epirubicin analog co-treated with chrysophsin analog] results in increased expression of BCL2 mRNA26335193
D015251EpirubicinEpirubicin analog results in increased expression of BCL2 mRNA26335193
D015251Epirubicin[Epirubicin co-treated with chrysophsin] results in increased expression of BCL2 mRNA26335193
D015251EpirubicinEpirubicin results in increased expression of BCL2 mRNA14503796|2386790
D015251EpirubicinEpirubicin results in decreased expression of BCL2 protein26646421
D015251Epirubicinpaeonol inhibits the reaction [Epirubicin results in decreased expression of BCL2 protein]26646421
C062669epicatechin gallateepicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]18656336
C045651epigallocatechin gallate[arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2 protein20950636
C045651epigallocatechin gallateCAT protein inhibits the reaction [epigallocatechin gallate analog results in decreased expression of BCL2 protein]16115949
C045651epigallocatechin gallate[decitabine co-treated with epigallocatechin gallate] affects the expression of BCL2 mRNA18250043
C045651epigallocatechin gallateepigallocatechin gallate affects the expression of BCL2 protein15975156
C045651epigallocatechin gallateepigallocatechin gallate analog results in decreased expression of BCL2 protein16115949
C045651epigallocatechin gallateepigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
C045651epigallocatechin gallateepigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]12672908
C045651epigallocatechin gallateepigallocatechin gallate results in decreased expression of BCL2 protein15657356|2014961
C045651epigallocatechin gallateepigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]18656336
C045651epigallocatechin gallateepigallocatechin gallate affects the expression of BCL2 protein22000973
D034261EpothilonesBCL2 protein results in decreased susceptibility to [alvocidib co-treated with Epothilones]12517783
D034261EpothilonesBCL2 protein results in decreased susceptibility to Epothilones12517783
C078846epoxomicin"epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein]]"25639565
D000069347Erlotinib HydrochlorideErlotinib Hydrochloride results in increased expression of BCL2 mRNA23894143
D000069347Erlotinib HydrochlorideErlotinib Hydrochloride results in increased expression of BCL2 protein23894143
D000069347Erlotinib HydrochlorideNiclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2 protein]23894143
D000069347Erlotinib Hydrochloride[Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2 protein]] which results in increased susceptibility to Erlotinib Hydrochloride23894143
D000069347Erlotinib HydrochlorideABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to Erlotinib Hydrochloride]23894143
D000069347Erlotinib HydrochlorideBCL2 protein results in decreased susceptibility to Erlotinib Hydrochloride23894143
C472787erucylphospho-N,N,N-trimethylpropylammonium"BCL2 protein results in decreased susceptibility to erucylphospho-N,N,N-trimethylpropylammonium"20177898
C472787erucylphospho-N,N,N-trimethylpropylammonium"erucylphospho-N,N,N-trimethylpropylammonium results in increased degradation of BCL2 protein"20177898
D004918Erythromycin EstolateErythromycin Estolate results in increased expression of BCL2 mRNA12883083
C007628esculetinesculetin affects the expression of BCL2 protein24995577
C007628esculetinesculetin results in decreased expression of BCL2 protein26388407
C007628esculetin2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP3 protein]19786087
C007628esculetin2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein]19786087
C007628esculetin2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein]19786087
C007628esculetin2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin affects the localization of BAX protein]]]19786087
C007628esculetin2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin results in increased expression of TNFRSF10A protein]]]19786087
C007628esculetinBCL2 protein inhibits the reaction [esculetin affects the localization of BAX protein]19786087
C007628esculetinBCL2 protein inhibits the reaction [esculetin results in increased expression of TNFRSF10A protein]19786087
C007628esculetinBCL2 protein inhibits the reaction [esculetin results in increased phosphorylation of MAPK8 protein]19786087
C007628esculetinBCL2 protein results in decreased susceptibility to esculetin19786087
C007628esculetin[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP3 protein19786087
C007628esculetin[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein19786087
C007628esculetin[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein19786087
C007628esculetinethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin affects the localization of BAX protein]]19786087
C007628esculetinethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin results in increased expression of TNFRSF10A protein]]19786087
C074283estradiol 3-benzoateestradiol 3-benzoate results in increased expression of BCL2 mRNA24316378
C074283estradiol 3-benzoateestradiol 3-benzoate results in increased expression of BCL2 protein24316378
C074283estradiol 3-benzoateQuercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mRNA]24316378
C074283estradiol 3-benzoateQuercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein]24316378
C015854estradiol valerate[norethindrone enanthate co-treated with estradiol valerate] results in decreased expression of BCL2 mRNA18829022
C015854estradiol valerate[Progesterone co-treated with estradiol valerate] results in decreased expression of BCL2 mRNA18829022
D004961EstramustineEstramustine results in increased phosphorylation of BCL2 protein11763419
D004967EstrogensEstrogens results in increased expression of BCL2 protein16007339
D004967EstrogensEstrogens inhibits the reaction [Glucocorticoids results in decreased expression of BCL2]16007339
D004966Estrogens, Conjugated (USP)"[Progesterone co-treated with Estrogens, Conjugated (USP)] results in increased expression of BCL2 protein"15779298
C088768estrone-3-O-sulfamateestrone-3-O-sulfamate analog results in increased phosphorylation of BCL2 protein14991574
D000431Ethanol"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA]"21878650
D000431EthanolALDH2 protein inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]19429258
D000431EthanolEthanol inhibits the reaction [FOXO3 protein results in increased expression of BCL2 mRNA]26470730
D000431EthanolEthanol inhibits the reaction [FOXO3 protein results in increased expression of BCL2 protein]26470730
D000431EthanolEthanol promotes the reaction [FOXO3 protein binds to BCL2 promoter]26470730
D000431EthanolEthanol results in decreased expression of BCL2 mRNA21878650
D000431EthanolEthanol results in increased expression of BCL2 protein21410490
D000431Ethanol[Ethanol results in increased phosphorylation of FOXO3 protein] which results in decreased expression of BCL2 mRNA26470730
D000431Ethanol[Ethanol results in increased phosphorylation of FOXO3 protein] which results in decreased expression of BCL2 protein26470730
D000431EthanolLithium inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA]21878650
D000431EthanolSirolimus promotes the reaction [Ethanol results in increased expression of BCL2 protein]21410490
D000431Ethanolwortmannin inhibits the reaction [Ethanol results in increased expression of BCL2 protein]21410490
D000431EthanolCimetidine inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]27983966
D000431Ethanol"Drugs, Chinese Herbal inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]"27983966
D000431EthanolEthanol results in decreased expression of BCL2 mRNA22535522
D000431EthanolEthanol results in decreased expression of BCL2 protein19429258|2798396
D000431Ethanolcaraway oil inhibits the reaction [Ethanol affects the expression of BCL2 mRNA]25859307
D000431Ethanolcaraway oil inhibits the reaction [Ethanol affects the expression of BCL2 protein]25859307
D000431EthanolColchicine inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]22446813
D000431Ethanol"Drugs, Chinese Herbal inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]"22446813
D000431EthanolEthanol affects the expression of BCL2 mRNA25859307|2908558
D000431EthanolEthanol affects the expression of BCL2 protein25859307
D000431EthanolEthanol affects the localization of BCL2 protein16035105
D000431EthanolEthanol affects the reaction [BAX protein binds to BCL2 protein]16035105
D000431Ethanol[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA16426832
D000431Ethanol[Ethanol co-treated with Cyanamide] results in increased expression of BCL2 mRNA12003908
D000431EthanolEthanol results in decreased expression of BCL2 mRNA15353170|2123478
D000431EthanolEthanol results in decreased expression of BCL2 protein25289771|2844237
D000431EthanolEthanol results in increased expression of BCL2 mRNA22446813|2327357
D000431EthanolGenistein inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]23274713
D000431Ethanolhomoorientin inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]22446813
D000431Ethanolnymphayol inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]25289771
D000431Ethanolpuerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]16426832
D000431Ethanolthymoquinone affects the reaction [Ethanol affects the expression of BCL2 mRNA]29085585
D000431Ethanolthymoquinone inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]29085585
D000431Ethanolzingerone inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]28442378
D004996EthidiumEthidium inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]15897899
D004997Ethinyl EstradiolEthinyl Estradiol promotes the reaction [Streptozocin results in decreased expression of BCL2 protein]24781736
D004997Ethinyl Estradiol[Streptozocin co-treated with Ethinyl Estradiol] results in increased expression of BCL2 mRNA24781736
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of BCL2 protein12857939
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein results in decreased susceptibility to naringenin]19124070
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [bisphenol A results in increased expression of BCL2 protein]19796866
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [Estradiol results in increased expression of BCL2 protein]19796866
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP3 protein]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin affects the localization of BAX protein]]]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin results in increased expression of TNFRSF10A protein]]]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP3 protein19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP8 protein19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate[ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate co-treated with BCL2 protein co-treated with esculetin] results in increased activity of CASP9 protein19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin affects the localization of BAX protein]]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein inhibits the reaction [esculetin results in increased expression of TNFRSF10A protein]]19786087
C456800ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylateethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate results in decreased activity of BCL2 protein11964319|1517535
C492670ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate"ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzo(1,8)naphthyridine-3-carboxylate results in increased expression of BCL2 protein"15111641
C004912ethylbenzeneethylbenzene results in decreased expression of BCL2 mRNA20156836|2124156
C004912ethylbenzeneethylbenzene results in decreased expression of BCL2 protein20137408|2015683
C024565ethylene dichlorideethylene dichloride results in decreased expression of BCL2 mRNA28973639
C024565ethylene dichlorideethylene dichloride results in decreased expression of BCL2 protein28973639
C002994ethylene dimethanesulfonateethylene dimethanesulfonate results in decreased expression of BCL2 mRNA22711419
D017308EtodolacEtodolac results in decreased expression of BCL2 mRNA16046235|1610487
D017308EtodolacEtodolac results in decreased expression of BCL2 protein16046235|1610487
D005047EtoposideBCL2 protein inhibits the reaction [Etoposide results in increased activity of CASP3 protein]8840993
D005047EtoposideBCL2 protein inhibits the reaction [Etoposide results in increased degradation of PARP1 protein]8840993
D005047EtoposideBCL2 protein results in decreased susceptibility to [Cisplatin co-treated with Etoposide]15917659
D005047Etoposide[Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein9815696
D005047Etoposide[Etoposide co-treated with Ciprofloxacin] results in decreased expression of BCL2 protein12063570
D005047EtoposideBCL2 protein affects the reaction [[Etoposide results in increased activity of GSK3B protein] which results in increased activity of CASP3 protein]19408126
D005047EtoposideEtoposide results in decreased expression of BCL2 mRNA19408126
D005047EtoposideEtoposide results in decreased expression of BCL2 protein19408126
D005047Etoposide[G(M3) Ganglioside results in increased expression of BCL2 protein] which results in decreased susceptibility to Etoposide16571667
D005047EtoposideLithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 mRNA]19408126
D005047EtoposideLithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 protein]19408126
D005047EtoposideBCL2 protein results in decreased susceptibility to Etoposide23123298
D005054EugenolEugenol results in decreased expression of BCL2 mRNA21939359
D005054Eugenol[Eugenol results in increased activity of sulforafan] which results in decreased expression of BCL221382956
D005054Eugenol[sulforafan results in increased activity of Eugenol] which results in decreased expression of BCL221382956
D005054Eugenol"Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 mRNA]"20537511
D005054Eugenol"Eugenol inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of BCL2 protein]"20537511
D005054EugenolEugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]20434464
D005054EugenolEugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]20434464
C433928EUK-134EUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]25005833
C433928EUK-134EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein]25005833
C580814EUK-172EUK-172 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]23041154
C049639evodiaminebenzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [evodiamine results in increased cleavage of BCL2 protein]20005289
C049639evodiamineevodiamine inhibits the reaction [TNF protein results in increased expression of BCL2 protein]15710601
C049639evodiamineevodiamine results in increased cleavage of BCL2 protein20005289
D018683Excitatory Amino Acid AgentsExcitatory Amino Acid Agents results in increased expression of BCL2 protein21858143
D018690Excitatory Amino Acid AgonistsExcitatory Amino Acid Agonists results in decreased expression of BCL2 protein19224577
D018690Excitatory Amino Acid Agonistsnotoginsenoside R1 inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein]19224577
D015025ZearalenoneZearalenone results in decreased expression of BCL2 protein28011299
D015025ZearalenoneZearalenone results in increased expression of BCL2 mRNA28965971
D015025ZearalenoneZearalenone results in decreased expression of BCL2 mRNA24412631
D015025ZearalenoneZearalenone results in decreased expression of BCL2 protein21767629|2808994
D015025Zearalenone[Acetylcysteine co-treated with Zearalenone co-treated with deoxynivalenol] results in increased expression of BCL2 protein29109043
D015025Zearalenone[Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein29109043
D015025Zearalenone[Acetylcysteine co-treated with Zearalenone] results in increased expression of BCL2 protein29109043
D015025ZearalenoneAcetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]29109043
D015025ZearalenoneAcetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]29109043
D015025Zearalenone[fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein29109043
D015025Zearalenone[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA29109043
D015025Zearalenonefumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]29109043
D015025Zearalenonefumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]29109043
D015025ZearalenoneZearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]29109043
D015025ZearalenoneZearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]]29109043
D015025ZearalenoneZearalenone inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]29109043
D015025ZearalenoneZearalenone results in decreased expression of BCL2 mRNA29109043
C018541falcarinolfalcarinol results in increased expression of BCL2 protein19800326
C049347fasudilfasudil inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]22429817
C049347fasudilfasudil results in increased expression of BCL2 protein17761835
D005230Fatty Acids, Nonesterified"Clofibrate inhibits the reaction [[Fatty Acids, Nonesterified binds to ALB protein] which results in decreased expression of BCL2 protein]"21338618
D005230Fatty Acids, Nonesterified"[Fatty Acids, Nonesterified binds to ALB protein] which results in decreased expression of BCL2 protein"21338618
D000069465FebuxostatFebuxostat inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]26036690
D005278FenitrothionFenitrothion results in increased expression of BCL2 mRNA21298709
D011345FenofibrateFenofibrate results in decreased expression of BCL2 mRNA15843896
D011345FenofibrateFenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]26989860
D005290Ferric CompoundsFerric Compounds results in decreased expression of BCL2 mRNA24035972
D005290Ferric CompoundsFerric Compounds results in decreased expression of BCL2 protein24035972
C000499ferric oxideferric oxide analog results in increased expression of BCL2 protein25086211
C000499ferric oxideferric oxide analog results in increased phosphorylation of BCL2 protein22995439
C008169ferric oxide, saccharated"ferric oxide, saccharated results in decreased expression of BCL2 protein"16957011
C421458ferric-sorbitol-citrateferric-sorbitol-citrate results in decreased expression of BCL217257079
C020748ferrous sulfate2-tert-butylhydroquinone inhibits the reaction [ferrous sulfate results in decreased expression of BCL2 protein]28583816
C020748ferrous sulfateferrous sulfate results in decreased expression of BCL2 protein28583816
D018120FinasterideFinasteride inhibits the reaction [Testosterone results in increased expression of BCL2 protein]25714330|2768705
C082360fipronilfipronil results in decreased expression of BCL2 protein21296133
C017875fisetin[fisetin co-treated with Paclitaxel] results in increased expression of BCL2 mRNA26884726
C017875fisetinfisetin results in decreased expression of BCL2 protein28181380
C017875fisetinfisetin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]25184746
D005411Flame RetardantsFlame Retardants results in decreased expression of BCL2 mRNA19356805
D044950FlavanonesFlavanones results in decreased expression of BCL2 protein25446852
C544478flavocoxidflavocoxid inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26424772
C544478flavocoxidflavocoxid inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]26424772
D047309FlavonesFlavones analog results in increased expression of BCL2 mRNA20674374
D047309FlavonesFlavones results in increased expression of BCL2 protein15998571
D005419FlavonoidsFlavonoids inhibits the reaction [AGT protein results in decreased expression of BCL2 mRNA]23994555
D005419FlavonoidsFlavonoids inhibits the reaction [AGT protein results in decreased expression of BCL2 protein]23994555
D005419FlavonoidsFlavonoids inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]]23994555
D005419FlavonoidsFlavonoids inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of AGTRAP protein]]23994555
D005419FlavonoidsFlavonoids inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of BAX mRNA]]23994555
D005419FlavonoidsFlavonoids inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of CYBA mRNA]]23994555
D005419FlavonoidsFlavonoids inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of CYBA protein]]23994555
D005419FlavonoidsFlavonoids results in decreased expression of BCL2 mRNA24036141
D005419FlavonoidsFlavonoids results in decreased expression of BCL2 protein23063593|2403614
D005419FlavonoidsFlavonoids inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]23279844
D005419FlavonoidsFlavonoids results in increased expression of BCL223994555
D044948FlavonolsBCL2 protein results in increased susceptibility to Flavonols28235426
C075780fluazinamfluazinam results in decreased expression of BCL2 protein21907236
C024352fludarabineBCL2 affects the reaction [fludarabine results in increased cleavage of and results in increased activity of CASP9 protein]15516989
C024352fludarabineBCL2 inhibits the reaction [fludarabine results in increased cleavage of and results in increased activity of CASP3 protein]15516989
C024352fludarabineBCL2 inhibits the reaction [fludarabine results in increased cleavage of CASP8 protein]15516989
C108339fludioxonilfludioxonil results in decreased expression of BCL2 protein23052036
C108339fludioxonilfludioxonil results in increased expression of BCL2 mRNA23052036
C108339fludioxonilMIR21 mRNA mutant form inhibits the reaction [fludioxonil results in decreased expression of BCL2 protein]23052036
D0150732-Acetylaminofluorene2-Acetylaminofluorene results in increased expression of BCL2 mRNA19167416|2221319
D0150732-Acetylaminofluorene[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein11915028
D0150732-AcetylaminofluoreneIFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2 protein]11915028
D005437FlucytosineFlucytosine results in decreased expression of BCL2 protein15592511
D005472FluorouracilBAY 11-7085 inhibits the reaction [[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA]16407826
D005472FluorouracilBCL2 protein affects the susceptibility to Fluorouracil15177426|1633217
D005472FluorouracilBCL2 protein results in decreased susceptibility to Fluorouracil17439414
D005472FluorouracilCadmium Chloride affects the reaction [Fluorouracil affects the expression of BCL2 protein]23941782
D005472Fluorouracil[Docosahexaenoic Acids co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA19015929
D005472FluorouracilFluorouracil affects the expression of BCL2 protein23941782
D005472FluorouracilFluorouracil affects the reaction [Cadmium Chloride affects the expression of BCL2 mRNA]23941782
D005472Fluorouracil[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in decreased expression of BCL2 protein15754201
D005472Fluorouracil[Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 mRNA16391804
D005472Fluorouracil[Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 protein16391804
D005472Fluorouracil[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 mRNA16407826
D005472Fluorouracil[Fluorouracil co-treated with RNF34 protein] results in increased expression of BCL2 protein16596200
D005472FluorouracilFluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA]19084572
D005472FluorouracilFluorouracil results in decreased expression of BCL29388485
D005472FluorouracilFluorouracil results in decreased expression of BCL2 mRNA15996812|1655759
D005472FluorouracilFluorouracil results in decreased expression of BCL2 protein15754201|1599681
D005472FluorouracilFluorouracil results in increased expression of BCL2 mRNA14503796
D005472FluorouracilFluorouracil results in increased phosphorylation of BCL2 protein7654318
D005472Fluorouracilgemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]16929163
D005472Fluorouracilgemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]16929163
D005472Fluorouracil[SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA28599477
D005472Fluorouracil[SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 protein28599477
D005472FluorouracilSM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]28599477
D005472Fluorouracil[wogonin co-treated with Fluorouracil] results in decreased expression of BCL2 protein20570612
D005472Fluorouracil[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein18567086
D005472FluorouracilFluorouracil results in decreased expression of BCL2 protein18567086|2084488
D005472FluorouracilIL1RN protein inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]20844880
D005472FluorouracilFluorouracil results in increased expression of BCL2 mRNA16888818
D005472FluorouracilFluorouracil results in decreased expression of BCL220633010
D005473FluoxetineBCL2 protein results in decreased susceptibility to Fluoxetine16076491
D005473FluoxetineFluoxetine results in decreased expression of BCL2 mRNA21497159
D005473FluoxetineFluoxetine results in decreased expression of BCL2 protein19298536
C034161flupirtineflupirtine results in increased expression of BCL2 protein9804146
D005485FlutamideFlutamide results in increased expression of BCL2 mRNA20850791
D005485FlutamideFlutamide results in increased expression of BCL2 protein20850791
D005492Folic AcidFolic Acid affects the expression of BCL2 mRNA16611376
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL220938992
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCL2 gene20938992
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2 mRNA20938992
D005492Folic AcidPTHLH protein inhibits the reaction [Folic Acid results in increased expression of BCL2 protein]16672315
D005492Folic Acid[Carbon Tetrachloride co-treated with Folic Acid] results in decreased expression of BCL2 mRNA18156304
D005492Folic AcidFolic Acid affects the expression of BCL2 protein16933212
D005492Folic Acid[Folic Acid co-treated with Isoflavones] results in increased expression of BCL2 protein20060418
D005492Folic Acid[Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein16933212
D005557FormaldehydeFormaldehyde results in decreased expression of BCL2 protein24140967
D005557FormaldehydeFormaldehyde results in increased expression of BCL2 protein20347000
D005557FormaldehydePRDX2 protein inhibits the reaction [Formaldehyde results in increased expression of BCL2 protein]20347000
D005557FormaldehydeFormaldehyde results in increased expression of BCL2 protein16888403
C007768formononetinformononetin results in decreased expression of BCL2 mRNA23867903
C007768formononetinformononetin promotes the reaction [Cisplatin results in increased expression of BCL2 protein]28414026
C067584formosanin CChloroquine inhibits the reaction [formosanin C results in decreased expression of BCL2 protein]27180204
C067584formosanin Cformosanin C results in decreased expression of BCL2 protein27180204
D000068759Formoterol FumarateFormoterol Fumarate results in decreased expression of BCL2 mRNA14687023
D000068759Formoterol FumarateFormoterol Fumarate results in decreased expression of BCL2 protein14687023
C058728fosbretabulin[ABT-737 results in decreased activity of BCL2 protein] which results in increased susceptibility to fosbretabulin24321340
C058728fosbretabulinfosbretabulin analog results in decreased expression of BCL2 protein25529822
C058728fosbretabulinfosbretabulin results in increased phosphorylation of BCL2 protein24321340
C058728fosbretabulinpyrazolanthrone inhibits the reaction [fosbretabulin results in increased phosphorylation of BCL2 protein]24321340
D005632Fructose[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA28916335
D005632Fructose[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein28916335
D005632FructoseFructose results in decreased expression of BCL2 protein27531227
D005632Fructosetroxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA]28916335
D005632Fructosetroxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein]28916335
D005632FructoseFructose results in increased expression of BCL2 protein17883899
D005632FructoseKangen-karyu inhibits the reaction [Fructose results in increased expression of BCL2 protein]17883899
C070081fulvestrantARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]20305694
C070081fulvestrantfulvestrant inhibits the reaction [alachlor results in increased expression of BCL2 protein]10545406
C070081fulvestrantfulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]10545406|1587070
C070081fulvestrant"fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of BCL2 protein]"10545406
C070081fulvestrantYC137 inhibits the reaction [ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]]20305694
C070081fulvestrant[fulvestrant co-treated with Estradiol] results in increased expression of BCL2 protein16951259
C070081fulvestrantfulvestrant results in increased expression of BCL2 protein16951259
C026211fumagillinfumagillin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]15682466
C056933fumonisin B1[Acetylcysteine co-treated with fumonisin B1 co-treated with deoxynivalenol] results in increased expression of BCL2 protein29109043
C056933fumonisin B1[Acetylcysteine co-treated with fumonisin B1] results in increased expression of BCL2 protein29109043
C056933fumonisin B1[Acetylcysteine co-treated with Zearalenone co-treated with fumonisin B1] results in increased expression of BCL2 protein29109043
C056933fumonisin B1Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA]29109043
C056933fumonisin B1Acetylcysteine inhibits the reaction [[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA]29109043
C056933fumonisin B1Acetylcysteine inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]29109043
C056933fumonisin B1[fumonisin B1 co-treated with deoxynivalenol] results in decreased expression of BCL2 mRNA29109043
C056933fumonisin B1[fumonisin B1 co-treated with Zearalenone co-treated with deoxynivalenol] results in decreased expression of BCL2 protein29109043
C056933fumonisin B1[fumonisin B1 co-treated with Zearalenone] results in decreased expression of BCL2 mRNA29109043
C056933fumonisin B1fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]29109043
C056933fumonisin B1fumonisin B1 inhibits the reaction [Zearalenone inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 mRNA]]29109043
C056933fumonisin B1fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]29109043
C056933fumonisin B1Zearalenone inhibits the reaction [fumonisin B1 inhibits the reaction [deoxynivalenol results in decreased expression of BCL2 protein]]29109043
C056933fumonisin B1Zearalenone inhibits the reaction [fumonisin B1 promotes the reaction [Zearalenone results in decreased expression of BCL2 mRNA]]29109043
C039281furanfuran results in increased expression of BCL2 mRNA22079235
D005665FurosemideFurosemide affects the expression of BCL2 mRNA17497460
C002469fusarenon-Xfusarenon-X results in decreased expression of BCL2 mRNA24983900
C002469fusarenon-Xfusarenon-X results in increased expression of BCL2 mRNA24983900
D005688Galactosaminebaicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]20850421
D005688Galactosamine[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein20558151
D005688Galactosaminegentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein]20558151
D005688Galactosamine[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form20850421
D005688GalactosamineSilymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]20850421
D005688GalactosamineGalactosamine results in decreased expression of BCL2 mRNA24565947
D005688GalactosamineGalactosamine results in decreased expression of BCL2 protein22118634
D005688Galactosamineglycine propionyl carnitine inhibits the reaction [Galactosamine results in decreased expression of BCL2 mRNA]24565947
D005688Galactosaminemangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein]22118634
D005690GalactoseGalactose results in decreased expression of BCL2 protein23036742
D005690GalactosePhycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]23036742
D005690GalactoseGalactose results in decreased expression of BCL2 protein25892055
D005690GalactoseSaponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein]25892055
C037032galangingalangin results in decreased expression of BCL2 protein25450235
D005707Gallic AcidGallic Acid inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]21420233
D005707Gallic AcidGallic Acid results in decreased expression of BCL2 protein22245431
D005707Gallic AcidGallic Acid results in decreased expression of BCL2 protein19723098
D005707Gallic Acidresveratrol inhibits the reaction [Gallic Acid results in decreased expression of BCL2 protein]19723098
C052659gambogic acidFluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA]19084572
C052659gambogic acidgambogic acid affects the expression of BCL2 protein19433130
C052659gambogic acidgambogic acid results in decreased expression of BCL2 mRNA15968715|1908457
C052659gambogic acid[Verapamil co-treated with gambogic acid] results in decreased expression of BCL2 protein24373880
C025473gamma-sitosterolgamma-sitosterol results in decreased expression of BCL2 mRNA14612938
C025473gamma-sitosterolgamma-sitosterol results in decreased expression of BCL2 protein14612938
D015774GanciclovirGanciclovir results in decreased expression of BCL2 protein15592511
C054597garcinolgarcinol results in decreased expression of BCL2 protein16052481
C000591222gardenin Bgardenin B results in decreased expression of BCL2 protein27423764
C045345gastrodingastrodin promotes the reaction [RELA protein binds to BCL2 promoter]23578476
C045345gastrodingastrodin results in increased expression of BCL2 mRNA23578476
C001277geldanamycin[geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2 protein15781649
C001277geldanamycingeldanamycin results in decreased expression of BCL2 protein28673683
C056507gemcitabine[alvocidib co-treated with gemcitabine] results in decreased expression of BCL2 protein15770523
C056507gemcitabine[Aminophylline co-treated with gemcitabine] results in decreased expression of BCL2 protein15645133
C056507gemcitabinegemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]16929163
C056507gemcitabinegemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BCL2 protein]16929163
C056507gemcitabinegemcitabine results in decreased expression of BCL2 protein15476743
C056507gemcitabine[ICI 118551 co-treated with gemcitabine] results in decreased expression of BCL2 protein21570961
C056507gemcitabine[Mastic Resin co-treated with gemcitabine] results in decreased expression of BCL2 protein20523344
C056507gemcitabine[Theophylline co-treated with gemcitabine] results in decreased expression of BCL2 protein15645133
C056507gemcitabineU 0126 inhibits the reaction [gemcitabine results in decreased expression of BCL2 protein]15476743
C056507gemcitabine[Curcumin co-treated with gemcitabine] results in decreased expression of BCL2 protein17440100
C007834genipingenipin results in decreased expression of BCL2 mRNA22245672
C007835geniposidegeniposide metabolite results in decreased expression of BCL2 mRNA22245672
C007835geniposidegeniposide metabolite results in decreased expression of BCL2 protein22245672
D019833Genisteinarsenic trioxide promotes the reaction [Genistein results in decreased expression of BCL2 protein]20219070
D019833Genistein[Calcitriol co-treated with Genistein] results in decreased expression of BCL2 mRNA15955619
D019833Genistein[Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2 protein21078540
D019833Genistein[Genistein co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein19497411
D019833GenisteinGenistein inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]15907805
D019833GenisteinGenistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]15288519
D019833GenisteinGenistein promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]20219070
D019833GenisteinGenistein results in decreased expression of BCL2 protein12791511|2021907
D019833Genistein[Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2 protein21078540
D019833GenisteinGenistein results in decreased expression of BCL2 protein21078540
D019833GenisteinGenistein inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]23274713
D019833GenisteinGenistein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]26797587
D019833GenisteinGenistein results in decreased expression of BCL2 mRNA21782745
D005839GentamicinsBCL2 protein results in decreased susceptibility to Gentamicins19151550
D005839GentamicinsAmlodipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein]19698708
D005839GentamicinsGentamicins affects the expression of BCL2 mRNA26779593
D005839GentamicinsGentamicins results in decreased expression of BCL2 protein19698708
D005839GentamicinsNifedipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein]19698708
D005839GentamicinsNitrendipine promotes the reaction [Gentamicins results in decreased expression of BCL2 protein]19698708
D005839GentamicinsSodium Fluoride affects the reaction [Gentamicins affects the expression of BCL2 mRNA]26779593
C012997gentiopicrosidegentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein]20558151
C007836geraniol"geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 mRNA]"24768735
C007836geraniol"geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 protein]"24768735
C002963geranylgeranyl pyrophosphategeranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of BCL2 mRNA]18031796
C007845gingerolAcetylcysteine inhibits the reaction [gingerol results in decreased expression of BCL2 protein]25034532
C007845gingerol[gingerol co-treated with Hydrogen Peroxide] results in increased expression of BCL2 protein27451028
C007845gingerolgingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]18030663
C007845gingerolgingerol results in decreased expression of BCL2 mRNA19481070
C007845gingerolgingerol results in decreased expression of BCL2 protein18030663|1948107
C007845gingerolgingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]18030663
C077458ginkgetinginkgetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]25968939
C077458ginkgetin"ginkgetin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"25968939
C063170Ginkgo biloba extractGinkgo biloba extract inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18632596
C481151ginkgolide Kginkgolide K results in increased expression of BCL2 protein22120026
C049863ginsenoside Rdginsenoside Rd inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA]26111763
C049864ginsenoside Reginsenoside Re results in increased expression of BCL2 mRNA15621629
C049864ginsenoside Reginsenoside Re results in increased expression of BCL2 protein15621629
C026474ginsenoside Rg2ginsenoside Rg2 inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein]28756148
C097367ginsenoside Rg3"ginsenoside Rg3 inhibits the reaction [cagA protein, Helicobacter pylori results in increased expression of BCL2 protein]"26427350
C055305ginsenoside Rh2ginsenoside Rh2 results in decreased expression of BCL2 protein26482938
D036145GinsenosidesGinsenosides inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]22269103
C055124glaucocalyxin Aglaucocalyxin A results in decreased expression of BCL2 protein20851175
D005907GliclazideGliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]18088078
D005938GlucocorticoidsGlucocorticoids results in decreased expression of BCL2 protein15748212
D005938GlucocorticoidsEstrogens inhibits the reaction [Glucocorticoids results in decreased expression of BCL2]16007339
D005938GlucocorticoidsGlucocorticoids results in decreased expression of BCL216007339
D005944GlucosamineGlucosamine results in decreased expression of BCL2 protein20803707
D005947GlucoseBerberine inhibits the reaction [Glucose results in decreased expression of BCL2 protein]23954465
D005947GlucoseCatechin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D005947Glucoseepigallocatechin gallate inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D005947GlucoseGliclazide inhibits the reaction [Glucose results in decreased expression of BCL2 protein]18088078
D005947GlucoseGlucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]21413024
D005947GlucoseGlucose results in decreased expression of BCL2 protein18088078|2395446
D005947GlucoseGlucose results in increased degradation of and results in decreased expression of BCL2 protein19557821
D005947GlucoseLuteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D005947Glucosemanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]18088078
D005947GlucoseNS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]21413024
D005947GlucoseQuercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D005947Glucose[resveratrol co-treated with Glucose] results in increased expression of BCL2 protein24218232
D005947GlucoseRutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D005947GlucoseTamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]21413024
D005947Glucosecyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]27481074
D005947Glucosecyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]27481074
D005947GlucoseMIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]23108914
D005947Glucose[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA23108914
D005947Glucose[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein23108914|2468224
D005947Glucose[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA27481074
D005947Glucosepolydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]27481074
D005947Glucoseresveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24682241
D005947GlucoseU 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24682241
D005947Glucose"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]"25305180
D005947Glucose2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]21803128
D005947Glucose2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]21803128
D005947Glucose"(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]"26054749
D005947Glucose[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein21803128
D005947GlucoseGlucose affects the expression of BCL2 mRNA24349266
D005947GlucoseGlucose affects the expression of BCL2 protein22524206
D005947GlucoseGlucose results in decreased expression of BCL2 mRNA21818840|2319236
D005947GlucoseGlucose results in decreased expression of BCL2 protein23192364|2605474
D005947Glucose[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]22467055
D005947Glucosenaringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]23192364
D005947Glucosenaringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]23192364
D005947Glucosenotoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]25305180
D005947Glucose[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein25305180
D005947Glucose[Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA23637816
D005947GlucoseQuercetin affects the reaction [Glucose affects the expression of BCL2 protein]22524206
D005947GlucoseQuercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]21803128
D005947Glucoseresveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]26054749
D005947Glucosesesamin affects the reaction [Glucose affects the expression of BCL2 protein]22524206
D005947GlucoseSTIM1 protein affects the reaction [Glucose results in decreased expression of BCL2 protein]27234048
D005947Glucose[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein24840287
D005947Glucoseresveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24840287
D005978Glutathione"Glutathione inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
D005978GlutathioneGlutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]]17640567
D005978GlutathioneBCL2 protein results in decreased export of Glutathione15561710
D005978Glutathione[diethyl maleate results in decreased abundance of Glutathione] which results in increased expression of BCL2 mRNA22564015
D005978GlutathioneGlutathione inhibits the reaction [Acrolein results in decreased expression of BCL2 protein]24376112
D005905GlyburideGlyburide inhibits the reaction [sodium bisulfide results in increased expression of BCL2 protein]21800153
C004312glycidolglycidol results in decreased expression of BCL2 mRNA24915197
C000588486glycine propionyl carnitineglycine propionyl carnitine inhibits the reaction [Galactosamine results in decreased expression of BCL2 mRNA]24565947
C010974glyphosateglyphosate results in increased expression of BCL2 protein24073338
C010974glyphosate[Surface-Active Agents co-treated with glyphosate] results in decreased expression of BCL2 protein23099315
D005679G(M3) Ganglioside[G(M3) Ganglioside results in increased expression of BCL2 protein] which results in decreased susceptibility to Etoposide16571667
D006046Gold[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA25846798
D006046Gold[Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein27470402
D006046Gold"[Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein"27836789
D017612Gold CompoundsGold Compounds results in decreased expression of BCL2 protein20209498
C103280goniothalamingoniothalamin results in decreased expression of BCL2 protein18771661
D017273GoserelinGoserelin results in increased expression of BCL2 protein16973256
D006072GossypolGossypol analog binds to BCL2 protein16020667
C511402Grape Seed ProanthocyanidinsGrape Seed Proanthocyanidins affects the expression of BCL212587719
C511402Grape Seed ProanthocyanidinsGrape Seed Proanthocyanidins inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]25242411
C511402Grape Seed Proanthocyanidins[Grape Seed Proanthocyanidins co-treated with Cadmium Chloride] affects the expression of BCL2 protein25719599
C511402Grape Seed ProanthocyanidinsGrape Seed Proanthocyanidins inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26462792
C511402Grape Seed ProanthocyanidinsGrape Seed Proanthocyanidins inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]28371137
D006108Graphite[Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BCL2 protein25446327
C058858grifolingrifolin results in decreased expression of BCL2 protein15949805
D006146GuanidinesBCL2 protein affects the susceptibility to Guanidines analog23147571
D005937Glucaric Acid"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D005937Glucaric Acid"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D005937Glucaric Acid"Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D005937Glucaric Acid"Glucaric Acid inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
C474918gypenosidegypenoside inhibits the reaction [dimethyl-N-acetylmuramyl-alanylglutamate results in decreased expression of BCL2 protein]16806111
C120727gyrophoric acidgyrophoric acid results in decreased expression of BCL2 protein22285236
C529376GYY 4137GYY 4137 results in decreased expression of BCL2 protein25205294
C411572H 1356H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2 protein]]25309793
D006220HaloperidolHaloperidol results in increased expression of BCL2 protein17069804
D006427HeminHemin results in decreased expression of BCL2 protein27815112
D006493HeparinHeparin inhibits the reaction [arsenite results in decreased expression of BCL2 protein]26677073
D006493HeparinHeparin results in increased expression of BCL2 protein11787776|1520508
D006533HeptachlorHeptachlor results in increased expression of BCL2 protein14678745
C013015hesperetinhesperetin affects the expression of BCL2 protein15975156
C013015hesperetinhesperetin analog results in decreased expression of BCL2 protein22142698
C013015hesperetinhesperetin results in decreased expression of BCL2 protein22142698
C013015hesperetinhesperetin analog results in decreased expression of BCL2 mRNA20564462
D006569HesperidinHesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]]24954035
D006569HesperidinHesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 mRNA]22093918
D006569HesperidinHesperidin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]22093918
D006569HesperidinHesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]24954035
C089796hexabromocyclododecanehexabromocyclododecane results in decreased expression of BCL2 mRNA19356805
D006582HexachloropheneHexachlorophene results in decreased expression of BCL2 mRNA25497112
C014026hexamethylene bisacetamidehexamethylene bisacetamide affects the expression of BCL215543656
C538724HhAntag691[GLI1 mRNA co-treated with GLI2 mRNA] affects the reaction [HhAntag691 results in decreased expression of BCL2 protein]22087285
C538724HhAntag691HhAntag691 results in decreased expression of BCL2 protein22087285
C501367hispanolonehispanolone analog results in decreased expression of BCL2 protein25930665
C070164homocastasteronehomocastasterone results in decreased expression of BCL2 protein20833159
C001652homoharringtoninehomoharringtonine results in decreased expression of BCL2 protein23980369
C057912homoorientinhomoorientin inhibits the reaction [Ethanol results in increased expression of BCL2 mRNA]22446813
D017313FenretinideBCL2 protein affects the susceptibility to Fenretinide7811993
D017313Fenretinide[Fenretinide co-treated with Carmustine] results in decreased expression of BCL2 protein16187019
D017313FenretinideFenretinide inhibits the reaction [TNF protein results in increased expression of BCL2 protein]16230421
D017313FenretinideFenretinide results in decreased expression of BCL2 mRNA7811993
D017313FenretinideFenretinide results in decreased expression of BCL2 protein16187019|1623042
D017313FenretinideFenretinide results in decreased expression of BCL2 mRNA28973697
C012351HT-2 toxinBentonite promotes the reaction [[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of BCL2 mRNA]25296281
C012351HT-2 toxin[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of BCL2 mRNA25296281
D006812Humic Substances"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Humic Substances results in decreased expression of BCL2 protein]"18683188
D006812Humic SubstancesAscorbic Acid inhibits the reaction [Humic Substances results in decreased expression of BCL2 protein]18683188
D006812Humic SubstancesHumic Substances results in decreased expression of BCL2 protein18683188
C050426huperzine Ahuperzine A affects the expression of BCL215956816
D020100Hydrogels[Curcumin analog co-treated with Hydrogels] inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]27288928
D006861Hydrogen Peroxide2''-galloylhyperin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]28213291
D006861Hydrogen Peroxidebathophenanthroline disulfonic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]20096349
D006861Hydrogen PeroxideBCL2 protein results in decreased susceptibility to Hydrogen Peroxide9989825
D006861Hydrogen Peroxideepigallocatechin gallate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]12672908
D006861Hydrogen PeroxideEUK-134 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]25005833
D006861Hydrogen PeroxideEUK-172 inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]23041154
D006861Hydrogen Peroxide[gingerol co-treated with Hydrogen Peroxide] results in increased expression of BCL2 protein27451028
D006861Hydrogen PeroxideHIF1A protein affects the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]25108166
D006861Hydrogen Peroxide[Hydrogen Peroxide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein15142122
D006861Hydrogen PeroxideHydrogen Peroxide promotes the reaction [MAPT results in decreased expression of BCL2 protein]28526263
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of BCL2 mRNA21347231|2224567
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of BCL2 protein12672908|2009634
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of BCL2 protein8781438
D006861Hydrogen PeroxideHydrogen Peroxide results in increased phosphorylation of BCL2 protein15142122
D006861Hydrogen Peroxide[Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA20606027
D006861Hydrogen Peroxide[Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of BCL2 protein20606027
D006861Hydrogen Peroxidemyricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]23639522
D006861Hydrogen PeroxideQuercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]12672908|2510816
D006861Hydrogen PeroxideRELA protein promotes the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA]21347231
D006861Hydrogen PeroxideRELA protein promotes the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]21347231
D006861Hydrogen Peroxidewortmannin inhibits the reaction [[Hydrogen Peroxide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein]15142122
D006861Hydrogen Peroxidewortmannin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of BCL2 protein]15142122
D006861Hydrogen PeroxideZinc Sulfate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]20096349
D006861Hydrogen PeroxideBCL2 protein affects the susceptibility to Hydrogen Peroxide15746559
D006861Hydrogen PeroxideGrape Seed Proanthocyanidins inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]25242411
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of BCL2 mRNA27057282
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of BCL2 protein25242411
D006861Hydrogen Peroxideprocyanidin B2 affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]27057282
D006861Hydrogen Peroxide"2-(4-((dimethylamino)methyl)benzylidene)-5,6-dimethoxy-2,3-dihydroinden-1-one inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]"19345205
D006861Hydrogen Peroxide2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]]23352507
D006861Hydrogen Peroxide"3,5-dicaffeoylquinic acid methyl ester inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 mRNA]"25451577
D006861Hydrogen Peroxide5-aminoisoquinolinone inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]23352507
D006861Hydrogen Peroxidecalycopterin results in decreased susceptibility to [Hydrogen Peroxide results in decreased expression of BCL2 protein]22081883
D006861Hydrogen Peroxidedonepezil inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]19345205
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of BCL2 mRNA17204550|1757006
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of BCL2 protein17204550|1757006
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of BCL2 mRNA25451577
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of BCL2 protein14505808|1624967
D006861Hydrogen PeroxideHydrogen Peroxide results in increased expression of BCL2 protein16157298
D006861Hydrogen PeroxideIndomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]17570061
D006861Hydrogen PeroxideIndomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein]17570061
D006861Hydrogen PeroxideIsoflurane inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]16249675
D006861Hydrogen PeroxideMelatonin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]20041988
D006861Hydrogen PeroxideMethylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]17570061
D006861Hydrogen PeroxideMethylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein]17570061
D006861Hydrogen Peroxide[[pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide] which results in decreased expression of BCL2 protein19361538
D006861Hydrogen PeroxideQuercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]14505808
D006861Hydrogen PeroxideRLN2 protein affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]17204550
D006861Hydrogen PeroxideRLN2 protein affects the reaction [Hydrogen Peroxide affects the expression of BCL2 protein]17204550
C012353hydroperoxyisophosphamideBCL2 inhibits the reaction [hydroperoxyisophosphamide results in increased activity of CASP8 protein]11723234
C012353hydroperoxyisophosphamideBCL2 inhibits the reaction [hydroperoxyisophosphamide results in increased activity of CASP9 protein]11723234
C012353hydroperoxyisophosphamideBCL2 results in decreased susceptibility to hydroperoxyisophosphamide11723234
C031927hydroquinone[PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein28444915
D006877Hydroxamic AcidsHydroxamic Acids analog results in decreased expression of BCL2 protein26088127
D006877Hydroxamic AcidsHydroxamic Acids results in decreased expression of BCL2 protein25824412
C527042hydroxycamptothecinumBCL2 protein results in decreased susceptibility to hydroxycamptothecinum17439414
D002112CalcifediolCalcifediol results in increased expression of BCL2 mRNA21542014
D002112CalcifediolCalcifediol results in increased expression of BCL2 protein21542014
D002112CalcifediolKetoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA]21542014
D01979615-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]"25305180
D003900Desoxycorticosteroneacetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]22431579
D003900Desoxycorticosteroneatrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]22431579
D003900Desoxycorticosterone[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein22431579
C559745hyperforin dicyclohexylammoniumhyperforin dicyclohexylammonium results in decreased expression of BCL2 protein21376709
D019271Hypoxanthine[3-hydrogenkwadaphnin co-treated with Hypoxanthine] results in decreased expression of BCL2 protein21396949
D019271Hypoxanthine[3-hydrogenkwadaphnin co-treated with Hypoxanthine] results in increased expression of BCL2 protein21396949
D019271Hypoxanthine[Mycophenolic Acid co-treated with Hypoxanthine] results in decreased expression of BCL2 protein21396949
C000623387HZ-6d compoundHZ-6d compound results in decreased expression of BCL2 protein28919514
C056599icariinicariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
C056599icariinicariin affects the expression of BCL2 protein25472572
C026777ICI 118551[ICI 118551 co-treated with gemcitabine] results in decreased expression of BCL2 protein21570961
C404743IDN 5109IDN 5109 results in decreased expression of BCL216391850
C071362idoxifeneidoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2 protein]14659978
D007069IfosfamideBCL2 protein inhibits the reaction [Ifosfamide results in increased activity of CASP9 protein]11723234
D007069IfosfamideCarnitine inhibits the reaction [Ifosfamide results in decreased expression of BCL2 mRNA]23213347
D007069IfosfamideIfosfamide results in decreased expression of BCL2 mRNA23213347
C467077ilimaquinoneilimaquinone results in decreased expression of BCL2 protein24930757
D000068877Imatinib Mesylate[Imatinib Mesylate co-treated with saikosaponin] results in decreased expression of BCL2 protein23994742
D000068877Imatinib MesylateImatinib Mesylate results in decreased expression of BCL2 protein23994742
C056493imiquimodimiquimod results in decreased expression of BCL2 protein20033192
C428264indioside Dindioside D results in decreased expression of BCL2 protein18376857
C027185indirubin[arsenic disulfide co-treated with indirubin] results in decreased expression of BCL2 mRNA25789073
C016517indole-3-carbinolindole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2 protein]15811958
C016517indole-3-carbinolindole-3-carbinol results in decreased expression of BCL216082211
D007213IndomethacinIndomethacin results in decreased expression of BCL2 mRNA10785260|1172143
D007213IndomethacinIndomethacin results in decreased expression of BCL2 protein10785260|1867861
D007213Indomethacin[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA28628672
D007213IndomethacinIndomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]17570061
D007213IndomethacinIndomethacin inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein]17570061
D007213IndomethacinIndomethacin results in decreased expression of BCL2 mRNA19220725|2215701
D007213IndomethacinIndomethacin results in decreased expression of BCL2 protein18375387
D007213IndomethacinLansoprazole inhibits the reaction [Indomethacin results in decreased expression of BCL2 protein]18375387
D007213IndomethacinMelatonin inhibits the reaction [Indomethacin results in decreased expression of BCL2 mRNA]19220725
D007213Indomethacintryptamine analog inhibits the reaction [Indomethacin results in decreased expression of BCL2 mRNA]22157011
D007455Iodine[Diatrizoate co-treated with Iodine] results in increased expression of BCL2 protein17173243
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2 mRNA25613284
C054871ioversolioversol results in decreased expression of BCL2 mRNA16828304
C054871ioversolirbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA]16828304
C081309irbesartanirbesartan inhibits the reaction [ioversol results in decreased expression of BCL2 mRNA]16828304
C506002ircinin-1ircinin-1 results in decreased expression of BCL2 mRNA16163705
C506002ircinin-1ircinin-1 results in decreased expression of BCL2 protein16163705
C051890irinotecanBCL2 protein affects the susceptibility to irinotecan18949393
C051890irinotecan[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in decreased expression of BCL2 protein15754201
C051890irinotecan[Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 mRNA16391804
C051890irinotecan[Fluorouracil co-treated with irinotecan] results in decreased expression of BCL2 protein16391804
D007501IronIron results in decreased expression of BCL2 protein16957011
D007501Iron[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein19620254
D007501Ironresveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein]19620254
D058085Iron CompoundsIron Compounds results in increased expression of BCL2 protein28483490
D0150561-Methyl-3-isobutylxanthine[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of BCL2 mRNA28628672
C549713isocarbophosisocarbophos analog results in decreased expression of BCL2 protein20688129
D007529Isoflavones[Curcumin co-treated with Isoflavones] results in decreased expression of BCL2 protein18640131
D007529Isoflavones[Folic Acid co-treated with Isoflavones] results in increased expression of BCL2 protein20060418
D007529IsoflavonesIsoflavones results in decreased expression of BCL2 protein25035168
D007529IsoflavonesIsoflavones results in increased expression of BCL2 mRNA25035168
D007530IsofluraneDexmedetomidine inhibits the reaction [Isoflurane results in decreased expression of BCL2 protein]20003127
D007530IsofluraneIsoflurane inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]16249675
D007530IsofluraneIsoflurane promotes the reaction [Oxygen deficiency results in increased expression of BCL2 protein]16249675
D007530IsofluraneIsoflurane results in decreased expression of BCL2 protein20003127
D007531IsoflurophateIsoflurophate results in increased expression of BCL2 mRNA21840330
C040920isoliquiritigeninisoliquiritigenin results in decreased phosphorylation of BCL2 protein23747687
D007538Isoniazid[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein21419764
D007538IsoniazidUrsodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein]21419764
D007545IsoproterenolIsoproterenol results in decreased expression of BCL2 protein15052282
D007545Isoproterenol2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]24954035
D007545Isoproterenolechinocystic acid affects the reaction [Isoproterenol affects the expression of BCL2 mRNA]19573579
D007545IsoproterenolHesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]]24954035
D007545IsoproterenolHesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]24954035
D007545IsoproterenolIsoproterenol results in decreased expression of BCL2 protein12791704|2749181
D007545IsoproterenolIsoproterenol results in increased expression of BCL2 mRNA11218852
D007545Isoproterenol[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein24954035
D017964Itraconazole[arsenic trioxide co-treated with Itraconazole] results in decreased expression of BCL227784375
C544151jinfukangCisplatin promotes the reaction [jinfukang results in decreased expression of BCL2 mRNA]27392435
C544151jinfukangjinfukang promotes the reaction [Cisplatin results in decreased expression of BCL2 mRNA]27392435
C098607JP8 aviation fuelJP8 aviation fuel results in decreased expression of BCL2 protein11222086
C561695(+)-JQ1 compound(+)-JQ1 compound affects the expression of BCL2 mRNA26733615
C561695(+)-JQ1 compound[(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BCL2 mRNA27169980
C561695(+)-JQ1 compound(+)-JQ1 compound inhibits the reaction [BRD4 protein binds to BCL2 promoter]24435446|2625444
C561695(+)-JQ1 compound(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 mRNA]25725100
C561695(+)-JQ1 compound(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of BCL2 mRNA]26733615
C561695(+)-JQ1 compound(+)-JQ1 compound promotes the reaction [ponatinib results in decreased expression of BCL2 protein]25053825
C561695(+)-JQ1 compound(+)-JQ1 compound promotes the reaction [quizartinib results in decreased expression of BCL2 protein]25053825
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of BCL2 mRNA22802445|2308692
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of BCL2 protein24435446|2505382
C561695(+)-JQ1 compound(+)-JQ1 compound results in increased expression of BCL2 mRNA25762632
C561695(+)-JQ1 compoundMYC protein inhibits the reaction [(+)-JQ1 compound results in decreased expression of BCL2 mRNA]23403638
C561695(+)-JQ1 compound[panobinostat co-treated with (+)-JQ1 compound] results in decreased expression of BCL2 protein24435446
C561695(+)-JQ1 compoundpanobinostat promotes the reaction [(+)-JQ1 compound affects the expression of BCL2 mRNA]26733615
C561695(+)-JQ1 compoundponatinib promotes the reaction [(+)-JQ1 compound results in decreased expression of BCL2 protein]25053825
C561695(+)-JQ1 compoundquizartinib promotes the reaction [(+)-JQ1 compound results in decreased expression of BCL2 protein]25053825
C561695(+)-JQ1 compoundBCL2 protein affects the susceptibility to (+)-JQ1 compound27406984
C561695(+)-JQ1 compound(+)-JQ1 compound affects the expression of BCL227406984
C006552kaempferolkaempferol results in decreased expression of BCL2 protein19028473
C524169kaempferol 7-O-glucosidekaempferol 7-O-glucoside results in decreased expression of BCL2 protein18343026
C046438kahweol acetate[TNFSF10 protein co-treated with kahweol acetate] results in decreased expression of BCL2 protein20403343
C046438kahweol acetateBCL2 protein inhibits the reaction [[TNFSF10 protein co-treated with kahweol acetate] results in increased cleavage of PARP1 protein]20403343
C046438kahweol acetateBCL2 protein results in decreased susceptibility to [TNFSF10 protein co-treated with kahweol acetate]20403343
D007608Kainic Acid"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]"25453207
D007608Kainic Acid"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione promotes the reaction [Valproic Acid inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]]"25453207
D007608Kainic AcidKainic Acid results in decreased expression of BCL2 protein25453207
D007608Kainic AcidValproic Acid inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]25453207
C468270Kangen-karyuKangen-karyu inhibits the reaction [Fructose results in increased expression of BCL2 protein]17883899
C468270Kangen-karyuKangen-karyu results in increased expression of BCL2 protein17331322
D007654KetoconazoleKetoconazole inhibits the reaction [Calcifediol results in increased expression of BCL2 mRNA]21542014
C439304KMUP 1KMUP 1 results in increased expression of BCL2 protein19962417
C063302KN 62KN 62 inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]24905940
C045492kolavironkolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 mRNA]21333729
C045492kolavironkolaviron inhibits the reaction [Atrazine results in decreased expression of BCL2 protein]21333729
C045492kolavironkolaviron results in decreased expression of BCL2 protein21333729
C045492kolavironkolaviron inhibits the reaction [Atrazine affects the expression of BCL2]21726175
C473250KR-31612KR-31612 affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]11805214
C000620717kuntai capsulekuntai capsule results in increased expression of BCL2 protein27845267
C500368labedipinedilol Alabedipinedilol A results in decreased expression of BCL2 protein19056458
C067713lactacystinlactacystin inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein]18544562
C067713lactacystinlactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein]19361538
C067713lactacystinlactacystin results in decreased expression of BCL2 protein18640276
C067713lactacystinSirolimus inhibits the reaction [lactacystin results in decreased expression of BCL2 protein]18640276
C047781lamotriginelamotrigine results in increased expression of BCL2 mRNA18719996
C047781lamotriginelamotrigine results in increased expression of BCL2 protein18719996
D064747LansoprazoleLansoprazole inhibits the reaction [Diatrizoate Meglumine results in decreased expression of BCL2 mRNA]28412091
D064747LansoprazoleLansoprazole inhibits the reaction [Indomethacin results in decreased expression of BCL2 protein]18375387
C477361LAQ824BCL2 protein results in decreased susceptibility to LAQ82416189296
C008259lauryl gallatelauryl gallate results in decreased expression of BCL2 protein21856409
D007854LeadLead results in decreased expression of BCL2 mRNA24960059
D007854LeadLead results in decreased expression of BCL2 protein22129743|2496005
D007854LeadPlant Extracts inhibits the reaction [Lead results in decreased expression of BCL2 protein]22129743
C008261lead acetatelead acetate affects the expression of BCL2 protein26542248
C008261lead acetatelead acetate results in decreased expression of BCL2 protein26498409
C008261lead acetateNFE2L2 protein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]26498409
C008261lead acetatelead acetate results in increased expression of BCL2 mRNA22609695
C008261lead acetateAscorbic Acid promotes the reaction [lead acetate results in increased expression of BCL2 protein]17959157
C008261lead acetate[Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein25031709
C008261lead acetateGenistein inhibits the reaction [lead acetate results in decreased expression of BCL2 protein]26797587
C008261lead acetatelead acetate affects the expression of BCL2 mRNA18618274
C008261lead acetatelead acetate results in decreased expression of BCL2 mRNA23146751|2496005
C008261lead acetatelead acetate results in decreased expression of BCL2 protein23146751
C008261lead acetatelead acetate results in increased expression of BCL2 protein17959157|1902672
C008261lead acetate[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein26396915
C029891lead chloridelead chloride results in decreased expression of BCL2 protein24419708
C017461lead nitratelead nitrate results in decreased expression of BCL2 mRNA27746373
C017461lead nitratelead nitrate results in decreased expression of BCL2 protein23451106
C017461lead nitratemangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein]23451106
C038753leptomycin Bleptomycin B inhibits the reaction [Tretinoin results in decreased expression of BCL2 protein]14592536
D016729LeuprolideLeuprolide results in increased expression of BCL2 mRNA18829022
C523615levistolide A[levistolide A co-treated with PDGFB protein] results in decreased expression of BCL2 protein17520522
C541528licochalcone Blicochalcone B results in decreased expression of BCL2 protein24384411
D017705LignansLignans analog results in decreased expression of BCL2 protein26620693
D017705LignansLignans results in decreased expression of BCL2 protein26620693
C008281limonenelimonene results in decreased expression of BCL2 protein12921557
D001556Lindane[Lindane co-treated with Estradiol] results in increased expression of BCL2 protein18174961
D001556LindaneLindane results in decreased expression of BCL2 protein14688026
D001556LindaneLindane results in increased expression of BCL2 mRNA14688026
D001556LindaneLindane results in increased expression of BCL2 protein14688026|1817496
D001556LindaneLindane promotes the reaction [BECN1 protein binds to BCL2 protein]19041923
D044243Linoleic Acids, Conjugated"Linoleic Acids, Conjugated results in decreased expression of BCL2 protein"15961301
D044243Linoleic Acids, Conjugated"Linoleic Acids, Conjugated results in decreased expression of BCL2 protein"20155912
D008043Linseed OilLinseed Oil results in decreased expression of BCL2 mRNA19904759
C002385linsidominelinsidomine results in decreased expression of BCL216291239
C002385linsidominelinsidomine results in decreased expression of BCL2 protein23174672
C002385linsidomineMT1A inhibits the reaction [linsidomine results in decreased expression of BCL2]16291239
C002385linsidominePlant Extracts inhibits the reaction [linsidomine results in decreased expression of BCL2 protein]23174672
C002385linsidominelinsidomine results in decreased expression of BCL2 protein12880480
C002385linsidomine[linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 mRNA7706495
C002385linsidomine[linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 protein7706495
C002385linsidomineSelegiline inhibits the reaction [linsidomine results in decreased expression of BCL2 protein]12880480
D008055LipidsLipids inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]25445725
C433788lipopolysaccharide, E. coli O26-B6"lipopolysaccharide, E. coli O26-B6 promotes the reaction [FOXO3 protein binds to BCL2 promoter]"26470730
C433788lipopolysaccharide, E. coli O26-B6"lipopolysaccharide, E. coli O26-B6 results in decreased expression of BCL2 mRNA"26470730
C433788lipopolysaccharide, E. coli O26-B6"lipopolysaccharide, E. coli O26-B6 results in decreased expression of BCL2 protein"26470730
C433788lipopolysaccharide, E. coli O26-B6"FOXO3 protein affects the reaction [lipopolysaccharide, E. coli O26-B6 results in decreased expression of BCL2 mRNA]"26470730
C433788lipopolysaccharide, E. coli O26-B6"lipopolysaccharide, E. coli O26-B6 results in decreased expression of BCL2 mRNA"26470730
D008070Lipopolysaccharides"adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [Bucladesine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]"16822680
D008070Lipopolysaccharidesalpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]11805214
D008070LipopolysaccharidesBucladesine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]16822680
D008070Lipopolysaccharidescilostazol inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]16822680
D008070Lipopolysaccharides[Dehydroascorbic Acid co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein20166893
D008070Lipopolysaccharides(+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 mRNA]25725100
D008070LipopolysaccharidesKR-31612 affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]11805214
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of BCL2 protein11805214|1682268
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL2 mRNA25725100
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL2 protein20166893
D008070Lipopolysaccharideslipoxin A4 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]23063943
D008070Lipopolysaccharides"N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]"11805214
D008070Lipopolysaccharides"2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]"27523796
D008070LipopolysaccharidesAHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA]22273745
D008070Lipopolysaccharidesbaicalein inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]20850421
D008070LipopolysaccharidesCASP1 protein affects the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA]]22273745
D008070LipopolysaccharidesCASP1 protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA]22273745
D008070Lipopolysaccharides[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein20558151
D008070Lipopolysaccharidesgentiopicroside inhibits the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of BCL2 protein]20558151
D008070Lipopolysaccharides[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form20850421
D008070Lipopolysaccharides[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein10205001
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of BCL2 protein23170834|2752379
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL2 protein21299906
D008070LipopolysaccharidesMYD88 protein affects the reaction [[TNFAIP3 gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of BCL2 mRNA]24453940
D008070Lipopolysaccharidesnotoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]23170834
D008070Lipopolysaccharides[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA22273745
D008070LipopolysaccharidesSilymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]20850421
D008070LipopolysaccharidesTacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]10205001
D008070Lipopolysaccharides[TNFAIP3 gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased expression of BCL2 mRNA24453940
D008070Lipopolysaccharides"zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]"27523796
D008070LipopolysaccharidesApigenin inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]25557508
D008070LipopolysaccharidesBezafibrate inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein]12704018
D008070Lipopolysaccharides[Diosmin co-treated with Lipopolysaccharides] results in increased expression of BCL2 protein21477647
D008070LipopolysaccharidesLipopolysaccharides affects the expression of BCL2 mRNA21127968
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of BCL2 protein23200736|2497309
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL2 protein12704018|2150475
D008070LipopolysaccharidesSialic Acids inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]24973090
D008070Lipopolysaccharidestetramethylpyrazine inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein]21586279
D008070Lipopolysaccharidestigecycline inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]23200736
D008070LipopolysaccharidesLipopolysaccharides results in increased expression of BCL2 mRNA21645290
C040527lipoxin A4lipoxin A4 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]23063943
D017706LisinoprilLisinopril results in decreased expression of BCL210075388
D008094LithiumLithium affects the expression of BCL2 mRNA18835332
D008094LithiumLithium inhibits the reaction [Ethanol results in decreased expression of BCL2 mRNA]21878650
D008094LithiumLithium inhibits the reaction [APP protein alternative form results in decreased expression of BCL2 protein]10762662
D008094LithiumLithium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]20455018
D008094LithiumLithium inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]19149911
D008094LithiumLithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA]18976035
D008094LithiumLithium results in increased expression of BCL215581403
D008094LithiumLithium results in increased expression of BCL2 mRNA16288908
D008094LithiumLithium results in increased expression of BCL2 protein10762662
D018021Lithium ChlorideLithium Chloride results in increased expression of BCL2 mRNA19101580
D018021Lithium ChlorideLithium Chloride results in increased expression of BCL2 protein18830594
D018021Lithium ChlorideLithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 mRNA]19408126
D018021Lithium ChlorideLithium Chloride inhibits the reaction [Etoposide results in decreased expression of BCL2 protein]19408126
D018021Lithium ChlorideLithium Chloride results in increased expression of BCL2 mRNA17404573
C000589248LL-202LL-202 results in decreased expression of BCL2 protein24752227
C529490locostatinlocostatin inhibits the reaction [didymin results in decreased expression of BCL2 protein]27899290
C115354lonafarniblonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2 protein]15090542
C115354lonafarniblonafarnib promotes the reaction [Bortezomib results in increased cleavage of BCL2 protein modified form]16118318
C581034longikaurin Alongikaurin A results in decreased expression of BCL2 protein28801140
C016371lonidamineBCL2 protein inhibits the reaction [[arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of CASP8 protein]21889928
C016371lonidamineBCL2 protein inhibits the reaction [arsenic trioxide promotes the reaction [lonidamine results in increased cleavage of and results in increased activity of CASP9 protein]]21889928
C016371lonidamineBCL2 protein inhibits the reaction [lonidamine promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of CASP9 protein]]21889928
D019808LosartanLosartan affects the expression of BCL2 protein22000973
D019808LosartanLosartan promotes the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA]15502641
D019808LosartanLosartan results in decreased expression of BCL2 protein12623880
D019808LosartanLosartan results in increased expression of BCL2 protein19298698|2115371
D019808LosartanLosartan inhibits the reaction [AGT protein results in increased expression of BCL2 mRNA]17563572
D019808LosartanLosartan inhibits the reaction [AGT protein results in increased expression of BCL2 protein]17563572
D008148LovastatinLovastatin results in decreased expression of BCL2 protein10473109|1209426
D008148LovastatinMevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein]12094262
D008148LovastatinLovastatin results in decreased expression of BCL2 protein11178870
D008148LovastatinMevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein]11178870
C010480lupeollupeol inhibits the reaction [mancozeb results in decreased expression of BCL2 mRNA]27235710
D014975LuteinLutein results in decreased expression of BCL2 protein17455471
D047311Luteolin2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Luteolin results in decreased expression of BCL2 protein]27474067
D047311LuteolinLuteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2 protein]25448439
D047311LuteolinLuteolin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D047311LuteolinLuteolin results in decreased expression of BCL2 protein27474067
C094099LY 293111LY 293111 results in decreased expression of BCL2 mRNA16151469
C094099LY 293111LY 293111 results in decreased expression of BCL2 protein16151469
C094099LY 293111LY 293111 results in decreased expression of BCL2 protein modified form16151469
C520284Ly-364947Ly-364947 inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23542815
C520284Ly-364947Ly-364947 inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23542815
C015329lycopenelycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA]27871895
C015329lycopenelycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
C015329lycopenelycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA]27871895
C015329lycopene[S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
C032881lysophosphatidic acidlysophosphatidic acid analog results in increased expression of BCL2 protein23251428
C032881lysophosphatidic acidlysophosphatidic acid results in increased expression of BCL2 protein23251428
C048341mafosfamideBCL2 inhibits the reaction [mafosfamide results in increased activity of CASP8 protein]11723234
C048341mafosfamideBCL2 protein inhibits the reaction [mafosfamide results in increased cleavage of PARP1 protein]11723234
C048341mafosfamideBCL2 protein results in decreased susceptibility to mafosfamide11723234
C048341mafosfamideBCL2 inhibits the reaction [mafosfamide results in increased activity of CASP3 protein]11723234
D008277Magnesium OxideMagnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D008277Magnesium Oxide[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D058185Magnetite Nanoparticles[arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 mRNA24738333
D058185Magnetite Nanoparticles[arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BCL2 protein24738333
D058185Magnetite Nanoparticlesbromotetrandrine promotes the reaction [[Magnetite Nanoparticles co-treated with Daunorubicin] results in decreased expression of BCL2 protein]19421372
D058185Magnetite Nanoparticlesbromotetrandrine promotes the reaction [Magnetite Nanoparticles promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]]19421372
D058185Magnetite Nanoparticles[Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 mRNA21720514
D058185Magnetite Nanoparticles[Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 protein21720514
D058185Magnetite Nanoparticles[Daunorubicin co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2 mRNA19918366
D058185Magnetite Nanoparticles[Magnetite Nanoparticles co-treated with Daunorubicin] promotes the reaction [bromotetrandrine results in decreased expression of BCL2 protein]19421372
D058185Magnetite Nanoparticles[Magnetite Nanoparticles co-treated with Daunorubicin] results in decreased expression of BCL2 protein19421372
D058185Magnetite NanoparticlesMagnetite Nanoparticles promotes the reaction [bromotetrandrine promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]]19421372
D058185Magnetite NanoparticlesMagnetite Nanoparticles promotes the reaction [Daunorubicin results in decreased expression of BCL2 mRNA]19421372
C005498magnololmagnolol inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]26756313
C005095malachite greenmalachite green results in increased expression of and affects the localization of BCL2 protein10840942
D008294MalathionMalathion results in decreased expression of BCL2 mRNA23774768
C030290malonic acidmalonic acid results in decreased expression of BCL2 mRNA16242643
C065861malvidinmalvidin results in decreased expression of BCL2 protein15964118
C013099mancozeblupeol inhibits the reaction [mancozeb results in decreased expression of BCL2 mRNA]27235710
C013099mancozebmancozeb results in decreased expression of BCL2 mRNA27235710
C013099mancozebmancozeb results in decreased expression of BCL2 protein22289270
C013099mancozebalpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]16005924
C013099mancozebmancozeb results in decreased expression of BCL2 protein16005924
D008344ManebManeb results in increased expression of BCL2 mRNA18266926
D008344ManebManeb results in increased expression of BCL2 protein18266926
D008344Maneb[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA23963992
D008344ManebMelatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA]23963992
D008344ManebSilymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA]23963992
D008345ManganeseManganese deficiency results in decreased expression of BCL2 mRNA24578216
D008345ManganeseManganese deficiency results in decreased expression of BCL2 protein24578216
C025340manganese chloridemanganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]28856835
C025340manganese chloridemanganese chloride results in increased expression of and results in decreased phosphorylation of BCL2 protein28856835
C025340manganese chloridemanganese chloride results in increased nitrosation of BCL2 protein28856835
C025340manganese chlorideN-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]]28856835
C025340manganese chlorideN-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [manganese chloride results in increased expression of and results in decreased phosphorylation of BCL2 protein]28856835
C025340manganese chlorideN-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [manganese chloride results in increased nitrosation of BCL2 protein]28856835
C025340manganese chloride[Plant Extracts co-treated with manganese chloride] affects the expression of BCL2 protein26064043
C025340manganese chloridemanganese chloride results in decreased expression of and affects the localization of BCL2 protein21704098
C025340manganese chloridemanganese chloride results in decreased expression of BCL2 mRNA17623882
C025340manganese chloridemanganese chloride results in decreased expression of BCL2 protein25732873
C097284manganese(III)-tetrakis(4-benzoic acid)porphyrinmanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Curcumin results in increased ubiquitination of and results in increased degradation of BCL2 protein]20127174
C097284manganese(III)-tetrakis(4-benzoic acid)porphyrinmanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]18088078
C097284manganese(III)-tetrakis(4-benzoic acid)porphyrinmanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein]18544562
C097284manganese(III)-tetrakis(4-benzoic acid)porphyrinmanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [sodium bichromate results in increased ubiquitination of BCL2 protein]18544562
C501277Mangifera indica extractMangifera indica extract inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]21420233
C013592mangiferinmangiferin inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]21420233
C013592mangiferin"mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"24095822
C013592mangiferinmangiferin inhibits the reaction [lead nitrate results in decreased expression of BCL2 protein]23451106
C013592mangiferinmangiferin inhibits the reaction [Galactosamine results in decreased expression of BCL2 protein]22118634
C021053mangostinmangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]26357513
C021053mangostinmangostin results in decreased expression of BCL2 protein24480042
D008353MannitolMannitol results in increased expression of BCL2 protein15786717
D000069997Mastic Resin[Mastic Resin co-treated with gemcitabine] results in decreased expression of BCL2 protein20523344
C034244matrinearsenic trioxide promotes the reaction [matrine results in decreased expression of BCL2 protein]23700110
C034244matrinematrine promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23700110
C034244matrinematrine results in decreased expression of BCL2 protein23700110
D008463MebendazoleBCL2 protein affects the susceptibility to Mebendazole18667591
D008463MebendazoleMebendazole results in increased phosphorylation of BCL2 protein18667591
D008463Mebendazole[Mebendazole results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]18667591
D008464MecamylamineMecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA]16835749
D008466MechlorethamineMechlorethamine results in decreased expression of BCL2 protein16738803|2228522
C011907melaminemelamine results in decreased expression of BCL2 protein22915474
D008549MelarsoprolMelarsoprol results in decreased expression of BCL2 mRNA9226155
D008549MelarsoprolMelarsoprol results in decreased expression of BCL2 protein9226155
D008550Melatonin[Doxorubicin co-treated with Melatonin] results in decreased expression of BCL2 protein20333787
D008550MelatoninMelatonin affects the localization of BCL2 protein18339127
D008550Melatonin[Melatonin co-treated with Tretinoin] results in decreased expression of BCL2 protein10965999
D008550MelatoninMelatonin inhibits the reaction [Cisplatin affects the expression of BCL2 protein]24799992
D008550MelatoninMelatonin promotes the reaction [Puromycin results in decreased expression of BCL2 protein]21244482
D008550MelatoninMelatonin results in increased expression of BCL2 protein18078454
D008550Melatonin[Tretinoin co-treated with Melatonin] results in decreased expression of BCL2 protein9649124
D008550MelatoninMelatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA]23963992
D008550MelatoninMelatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein]21138475
D008550MelatoninMelatonin results in decreased expression of BCL2 protein14690559
D008550MelatoninMelatonin results in increased expression of BCL2 protein12220328
D008550MelatoninMelatonin inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]18724894
D008550MelatoninMelatonin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]20041988
D008550MelatoninMelatonin inhibits the reaction [Indomethacin results in decreased expression of BCL2 mRNA]19220725
D008550MelatoninMelatonin inhibits the reaction [Methionine results in decreased expression of BCL2 protein]16213988
D008550MelatoninMelatonin inhibits the reaction [sodium arsenite results in increased activity of BCL2 protein]18715270
D008550MelatoninMelatonin inhibits the reaction [sodium arsenite results in increased expression of BCL2 protein]17645694
D008550MelatoninMelatonin results in decreased expression of BCL2 mRNA16499559
D008550Melatonin[Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein14993511
D008550MelatoninMelatonin inhibits the reaction [APP protein results in decreased expression of BCL2 mRNA]15854745
D008555MelittenMelitten results in decreased expression of BCL2 protein21456063|2202726
D008555MelittenMelitten affects the reaction [TGFB1 protein affects the localization of BCL2 protein]21871910
D008555MelittenMelitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 mRNA]21354845
D008555MelittenMelitten inhibits the reaction [[IL6 protein co-treated with IL6R protein] results in increased expression of BCL2 protein]21354845
D008558MelphalanMelphalan results in decreased expression of BCL2 protein22285227
D015122Mercaptopurine[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D015122MercaptopurineMercaptopurine results in decreased expression of BCL2 protein9058596
D008627Mercuric ChlorideMercuric Chloride results in increased expression of BCL2 protein11068922
D008627Mercuric ChlorideMercuric Chloride results in decreased expression of BCL2 mRNA23202902
D008627Mercuric ChlorideMercuric Chloride results in decreased expression of BCL2 protein21373768
D008627Mercuric ChlorideBerberine inhibits the reaction [Mercuric Chloride results in decreased expression of BCL2 protein]24751971|2560069
D008627Mercuric ChlorideMercuric Chloride results in decreased expression of BCL2 protein24751971|2560069
D008627Mercuric ChlorideMercuric Chloride results in increased expression of BCL2 mRNA8872981
D008628MercuryMercury results in decreased expression of BCL2 protein21186712
C100076mesoxalonitrileBCL2 protein results in decreased susceptibility to mesoxalonitrile12730627
C100076mesoxalonitrilePK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to mesoxalonitrile]12730627
D009921MetaproterenolMetaproterenol results in decreased expression of BCL2 protein15052282
D008687MetforminCisplatin promotes the reaction [Metformin results in decreased expression of BCL2 protein]21388661
D008687MetforminMetformin results in decreased expression of BCL2 protein21388661
D008687MetforminMetformin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA]26492952
D008694MethamphetamineBBC3 protein affects the reaction [Methamphetamine results in decreased expression of BCL2 protein]26524635
D008694MethamphetamineMethamphetamine results in decreased expression of BCL2 mRNA23820845
D008694MethamphetamineMethamphetamine results in decreased expression of BCL2 protein26524635
D008694Methamphetamine"[N-Methyl-3,4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA"23820845
D008694MethamphetamineBCL2 protein affects the susceptibility to Methamphetamine12050851
D008694MethamphetamineMethamphetamine results in decreased expression of BCL2 protein11457507
D008694MethamphetamineNOS1 protein affects the reaction [Methamphetamine results in decreased expression of BCL2 protein]11457507
D008694MethamphetamineSOD1 protein affects the reaction [Methamphetamine results in decreased expression of BCL2 protein]11457507
D008694MethamphetamineBBC3 protein affects the reaction [Methamphetamine results in decreased expression of BCL2 protein]26524635
D008694MethamphetamineLithium inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]19149911
D008694MethamphetamineMethamphetamine results in decreased expression of BCL2 protein15276877|1914991
D008694Methamphetamineolanzapine inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]15276877
D008694MethamphetamineValproic Acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]19149911
C008390methionalBCL2 protein affects the susceptibility to methional8611183
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of and results in increased expression of BCL220938992
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCL2 gene20938992
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2 mRNA20938992
D008715MethionineMelatonin inhibits the reaction [Methionine results in decreased expression of BCL2 protein]16213988
D008715MethionineMethionine results in decreased expression of BCL2 protein16213988
D003915DextromethorphanDextromethorphan results in decreased expression of BCL2 protein28916251
D003915Dextromethorphantraxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2 protein]28916251
D008727MethotrexateAspirin inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]23799623
D008727Methotrexate[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D008727MethotrexateMethotrexate affects the expression of BCL2 mRNA23792648|2533030
D008727MethotrexateMethotrexate results in decreased expression of BCL2 mRNA17132110
D008727MethotrexateMethotrexate results in decreased expression of BCL2 protein23799623
D008727MethotrexateSOD2 protein polymorphism affects the reaction [Methotrexate affects the expression of BCL2 mRNA]25330300
D008727Methotrexate18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]28414158
D008727Methotrexate[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 mRNA25009784
D008727Methotrexate[Aspartame co-treated with Methotrexate] results in decreased expression of BCL2 protein25009784
D008727MethotrexateChlorogenic Acid inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]28479099
D008727MethotrexateMethotrexate results in decreased expression of BCL2 mRNA18803016
D008727MethotrexateMethotrexate results in decreased expression of BCL2 protein18803016|2841415
D008727MethotrexateTGFA protein inhibits the reaction [Methotrexate results in decreased expression of BCL2 mRNA]18803016
D008727MethotrexateTGFA protein inhibits the reaction [Methotrexate results in decreased expression of BCL2 protein]18803016
D008727MethotrexateMethotrexate results in decreased expression of BCL2 mRNA23406595
D008727MethotrexateMethotrexate results in decreased expression of BCL2 protein23406595
D008731MethoxychlorBCL2 protein results in decreased susceptibility to Methoxychlor14973267|1608152
D008731Methoxychlor[ESR1 gene mutant form results in increased susceptibility to Methoxychlor] which results in increased expression of BCL2 mRNA22306526
D008731MethoxychlorMethoxychlor metabolite results in increased expression of BCL2 protein15525693
D008731MethoxychlorMethoxychlor results in decreased expression of BCL2 mRNA16081520
D008731MethoxychlorMethoxychlor results in increased expression of BCL2 protein15525693
D008730MethoxsalenMethoxsalen inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein]22743290
D008730MethoxsalenMethoxsalen results in decreased expression of BCL2 protein22796345
C587228methyl 3-hydroxyimino-11-oxoolean-12-en-28-oatemethyl 3-hydroxyimino-11-oxoolean-12-en-28-oate affects the expression of BCL2 protein24291674
C555027methyl 5-chloro-4,5-didehydrojasmonate"methyl 5-chloro-4,5-didehydrojasmonate results in decreased expression of BCL2 protein"20696234
C553655methyl antcinate Amethyl antcinate A results in decreased expression of BCL2 protein20557081
C042405methyl caffeatemethyl caffeate binds to and results in decreased expression of BCL2 protein26415618
D008748MethylcholanthreneMethylcholanthrene results in increased expression of BCL2 mRNA23273579
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of BCL2 mRNA27746373
C004925methylmercuric chloridemethylmercuric chloride results in increased expression of BCL2 mRNA28001369
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of BCL2 mRNA23202902
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of BCL2 protein28821999
D008767Methylmercury CompoundsAcetylcysteine inhibits the reaction [Methylmercury Compounds results in decreased expression of BCL2 mRNA]21549813
D008767Methylmercury CompoundsMethylmercury Compounds results in decreased expression of BCL2 mRNA21549813
D008767Methylmercury CompoundsMethylmercury Compounds results in decreased expression of BCL2 protein21549813
D008767Methylmercury CompoundsBCL2 protein results in decreased susceptibility to Methylmercury Compounds7940596
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of BCL2 protein16019050
D018817N-Methyl-3,4-methylenedioxyamphetamine"[N-Methyl-3,4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2 mRNA"23820845
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of BCL2 mRNA"23820845
D018817N-Methyl-3,4-methylenedioxyamphetamine"N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of BCL2 mRNA"20188158
D008769MethylnitronitrosoguanidineEugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 mRNA]20434464
D008769MethylnitronitrosoguanidineEugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2 protein]20434464
D008769MethylnitronitrosoguanidineMethylnitronitrosoguanidine results in decreased expression of BCL2 protein16019050
D008769MethylnitronitrosoguanidineMethylnitronitrosoguanidine results in increased expression of BCL2 mRNA20434464
D008769MethylnitronitrosoguanidineMethylnitronitrosoguanidine results in increased expression of BCL2 protein20434464
D008769Methylnitronitrosoguanidinelycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D008769Methylnitronitrosoguanidine[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein16030430
D008769Methylnitronitrosoguanidine[S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D008769MethylnitronitrosoguanidineS-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D008770MethylnitrosoureaMethylnitrosourea results in increased expression of BCL2 mRNA15240709|2446305
D008770Methylnitrosourea[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein22465879
D008770MethylnitrosoureaFGF1 protein modified form inhibits the reaction [Methylnitrosourea results in decreased expression of BCL2 protein]16011256
D008770Methylnitrosourea[Methylnitrosourea co-treated with Estradiol] results in increased expression of BCL2 mRNA20732338
D008770Methylnitrosourea[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA20732338
D008770Methylnitrosourea[Methylnitrosourea co-treated with Progesterone] results in increased expression of BCL2 mRNA20732338
D008770MethylnitrosoureaMethylnitrosourea results in decreased expression of BCL2 protein16011256|1604794
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA17266988|2094689
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein21295016|2149715
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA24399507
D0156551-Methyl-4-phenylpyridinium"2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]"21497157
D0156551-Methyl-4-phenylpyridinium2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [amentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]28185818
D0156551-Methyl-4-phenylpyridinium"8-phenyl-6a,7,8,9,9a,10-hexahydro-6H-isoindolo(5,6-g)quinoxaline-7,9-dione inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]"20946892
D0156551-Methyl-4-phenylpyridiniumamentoflavone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]28185818
D0156551-Methyl-4-phenylpyridiniumchikusetsusaponin V inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]25073091
D0156551-Methyl-4-phenylpyridiniumginkgetin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]25968939
D0156551-Methyl-4-phenylpyridiniumINS protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]26364587
D0156551-Methyl-4-phenylpyridiniummangostin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]26357513
D0156551-Methyl-4-phenylpyridiniumNDFIP1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]26300475
D0156551-Methyl-4-phenylpyridiniumNDFIP1 protein inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]26300475
D0156551-Methyl-4-phenylpyridiniumQuercetin inhibits the reaction [squamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]21295016
D0156551-Methyl-4-phenylpyridiniumrosiglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]17266988
D0156551-Methyl-4-phenylpyridiniumsphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA]24399507
D0156551-Methyl-4-phenylpyridiniumsquamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]21295016
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA26300475
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein12880480|2630047
D0156551-Methyl-4-phenylpyridinium[1-Methyl-4-phenylpyridinium co-treated with Quercetin] results in increased expression of BCL2 mRNA19466539
D0156551-Methyl-4-phenylpyridinium[1-Methyl-4-phenylpyridinium co-treated with resveratrol] results in increased expression of BCL2 mRNA19466539
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA19524685|2705330
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein18496573|1913504
D0156551-Methyl-4-phenylpyridiniumAmitriptyline inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]19135049
D0156551-Methyl-4-phenylpyridinium"benserazide, levodopa drug combination inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]"27053303
D0156551-Methyl-4-phenylpyridinium"Drugs, Chinese Herbal inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]"19524685
D0156551-Methyl-4-phenylpyridinium"Drugs, Chinese Herbal inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]"19524685
D0156551-Methyl-4-phenylpyridiniumML 9 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]24358303
D0156551-Methyl-4-phenylpyridiniumMRS 1845 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]24358303
D0156551-Methyl-4-phenylpyridiniumpeoniflorin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]27053303
D0156551-Methyl-4-phenylpyridiniumsodium bisulfide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]21800153
D0156551-Methyl-4-phenylpyridiniumSTIM1 mutant form inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]24358303
D0156551-Methyl-4-phenylpyridiniumTranylcypromine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]19135049
D0156551-Methyl-4-phenylpyridinium[[Selegiline results in increased expression of TXN] which results in increased expression of BCL2] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium16099847
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein"23911879|2409582
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"2,3,5,4'-tetrahydroxystilbene 2-O-glucopyranoside inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"23911879
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"amentoflavone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"28185818
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"benserazide, levodopa drug combination inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"28185818
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"CNB 001 inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"24995576
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 mRNA]"24768735
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 protein]"24768735
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"ginkgetin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"25968939
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"mangiferin inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of BCL2 protein]"24095822
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 mRNA"24768735
D0156321-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine"[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 protein"24768735
D008775MethylprednisoloneMethylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]17570061
D008775MethylprednisoloneMethylprednisolone inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2 protein]17570061
C008493methylselenic acidmethylselenic acid affects the expression of BCL2 protein12017302
D014290MetipranololMetipranolol inhibits the reaction [Zinc results in increased expression of BCL2 protein]16799065
D014290MetipranololMetipranolol inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein]16799065
D008798Mevalonic AcidMevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein]12094262
D008798Mevalonic AcidMevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2 protein]11178870
C078588microcystinmicrocystin results in increased expression of BCL212411203
C063855microcystin RRmicrocystin RR results in decreased expression of BCL2 protein20196164
D052998MicrocystinsMicrocystins results in decreased expression of BCL2 mRNA19760617
D052998MicrocystinsMicrocystins results in decreased expression of BCL2 protein19760617
D008874MidazolamMidazolam results in increased expression of BCL217715682
D015735MifepristoneMifepristone inhibits the reaction [Dexamethasone results in increased expression of BCL2]21244764
D015735MifepristoneMifepristone results in decreased expression of BCL2 mRNA16009178
D015735MifepristoneMifepristone results in decreased expression of BCL2 protein16525653|1663834
D015735MifepristoneMifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 mRNA]16644695
D015735MifepristoneMifepristone inhibits the reaction [Dexamethasone results in decreased expression of BCL2 protein]16644695
C059896miglustatmiglustat inhibits the reaction [ST8SIA1 protein results in increased expression of BCL2 protein]11574545
D008898MimosineMimosine affects the expression of BCL2 protein18058236
D008911Minocycline[Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2 protein] results in increased expression of BCL2 mRNA20606027
D008911Minocycline[Minocycline co-treated with Hydrogen Peroxide co-treated with TGFB2] results in increased expression of BCL2 protein20606027
D008911MinocyclineMinocycline results in increased expression of BCL2 mRNA15004018
D008911MinocyclineMinocycline results in increased expression of BCL2 protein15004018|1980790
D008911Minocycline[Minocycline results in increased expression of BCL2 protein] which binds to BAK1 protein15004018
D008911Minocycline[Minocycline results in increased expression of BCL2 protein] which binds to BAX protein15004018
D008911Minocycline[Minocycline results in increased expression of BCL2 protein] which binds to BID protein15004018
D008911MinocyclineSodium Azide inhibits the reaction [Minocycline results in increased expression of BCL2 protein]15004018
C000596409mirabijalone Emirabijalone E results in decreased expression of BCL2 protein24882730
D016685MitomycinMitomycin affects the expression of BCL219834285
D016685MitomycinMitomycin results in increased expression of BCL2 mRNA19757172
D016685MitomycinMitomycin results in increased expression of BCL2 protein11867586|1579387
D016685Mitomycinsilybin inhibits the reaction [Mitomycin affects the expression of BCL2]19834285
D016685MitomycinTamoxifen promotes the reaction [Mitomycin results in increased expression of BCL2 mRNA]19757172
D016685MitomycinBCL2 protein inhibits the reaction [Mitomycin results in increased cleavage of and results in increased activity of CASP8 protein]12181741
D016685MitomycinBCL2 protein inhibits the reaction [Mitomycin results in increased cleavage of and results in increased activity of CASP9 protein]12181741
D008942MitoxantroneBCL2 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein]8840993
D008942MitoxantroneBCL2 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein]8840993
D008942Mitoxantrone[Cladribine co-treated with Cyclophosphamide co-treated with Mitoxantrone] results in decreased expression of BCL2 protein15582267
D008942MitoxantroneMitoxantrone results in decreased expression of BCL2 mRNA8219202
C060893MK-886MK-886 inhibits the reaction [Nicotine results in increased expression of BCL2 protein]20061081
C056218ML 9ML 9 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]24358303
C016599mono-(2-ethylhexyl)phthalateMIR16-1 mRNA affects the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein]26597031
C016599mono-(2-ethylhexyl)phthalatemono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 mRNA12927354|2659703
C016599mono-(2-ethylhexyl)phthalatemono-(2-ethylhexyl)phthalate results in decreased expression of BCL2 protein24706461|2659703
C016599mono-(2-ethylhexyl)phthalate[mono-(2-ethylhexyl)phthalate co-treated with Estradiol] results in decreased expression of BCL2 mRNA24412242
D008999MonocrotophosMonocrotophos results in decreased expression of BCL2 mRNA20957986|2383343
D008999MonocrotophosMonocrotophos results in decreased expression of BCL2 protein20957986|2383343
D008999MonocrotophosMonocrotophos results in increased expression of BCL2 mRNA21445290
D008999MonocrotophosMonocrotophos results in increased expression of BCL2 protein21445290
D008999Monocrotophosresveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA]23833438
D008999Monocrotophosresveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein]23833438
C091888monoisoamyl-2,3-dimercaptosuccinate"[monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546
C091888monoisoamyl-2,3-dimercaptosuccinate"monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546|2337609
C091888monoisoamyl-2,3-dimercaptosuccinate"Succimer promotes the reaction [monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]]"23376091
C091888monoisoamyl-2,3-dimercaptosuccinate"monoisoamyl-2,3-dimercaptosuccinate affects the expression of BCL2 mRNA"19615344
C091888monoisoamyl-2,3-dimercaptosuccinate"monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"19615344
C406082monomethylarsonous acidCXCL8 protein affects the reaction [monomethylarsonous acid results in increased expression of BCL2 mRNA]22015448
C406082monomethylarsonous acidmonomethylarsonous acid results in increased expression of BCL2 mRNA22015448
C093875montelukastmontelukast inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]27702591
C008548morinmorin results in decreased expression of BCL2 mRNA28689916
C008548morinmorin inhibits the reaction [Acetaminophen results in decreased expression of BCL2 protein]26767949
C008548morinmorin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]19931519
C008548morinmorin inhibits the reaction [titanium dioxide results in decreased expression of BCL2 mRNA]28844848
D009020MorphineMorphine inhibits the reaction [BECN1 protein binds to BCL2 protein]20190558
D009020MorphineMorphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]12927789
D009020MorphineMorphine inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]17542780
D009020MorphineMorphine results in decreased expression of BCL2 protein10534122|1929287
D009020Morphine[[Morphine results in increased expression of BAX protein] co-treated with [Morphine results in decreased expression of BCL2 protein]] results in increased activity of CASP3 protein10534122
D009020MorphineNaloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]]12927789
D009020MorphinePDGFB protein inhibits the reaction [Morphine results in decreased expression of BCL2 protein]21483469
D009020MorphineLithium inhibits the reaction [Morphine results in decreased expression of BCL2 mRNA]18976035
D009020MorphineMorphine results in decreased expression of BCL2 mRNA18976035
D009020MorphineMorphine results in decreased expression of BCL2 protein12196588
C523799MRK 003MRK 003 results in decreased phosphorylation of BCL2 protein17804716
C107728MRS 1191[MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BCL2 protein]15345477
C503978MRS 1845MRS 1845 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]24358303
D009151Mustard GasMustard Gas results in decreased expression of BCL2 protein11428642|9665388
D009151Mustard GasMustard Gas affects the localization of BCL2 protein19560481
D009151Mustard GasMustard Gas results in decreased expression of BCL2 protein9302645
D009173Mycophenolic Acid[Mycophenolic Acid co-treated with Hypoxanthine] results in decreased expression of BCL2 protein21396949
D009173Mycophenolic AcidMycophenolic Acid inhibits the reaction [BCL2 protein results in decreased susceptibility to Dexamethasone]16505121
C040015myricetinmyricetin results in decreased expression of BCL2 protein15748703
C040015myricetinTetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein]15748703
C008577myricitrinmyricitrin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]23639522
C005246myristicinmyristicin results in decreased expression of BCL2 mRNA29174417
C455139myrtucommulone Amyrtucommulone A results in decreased expression of BCL2 mRNA26032814
C524250N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine"IL6 protein inhibits the reaction [N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased expression of BCL2 protein]"18638462
C524250N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine"N'-(11H-indolo(3,2-c)quinolin-6-yl)-N,N-dimethylethane-1,2-diamine results in decreased expression of BCL2 protein"18638462
C514580N1-(2-aminophenyl)-N8-phenyloctanediamideN1-(2-aminophenyl)-N8-phenyloctanediamide results in increased expression of BCL2 protein17341627
C092756N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)ureaN-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein]20374255
C451426N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide"MIR21 mRNA mutant form inhibits the reaction [N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of BCL2 protein]"23052036
C451426N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide"N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in decreased expression of BCL2 protein"23052036
C451426N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide"N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide results in increased expression of BCL2 mRNA"23052036
C475571N-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)phenyl)methanesulfonamide"BCL2 protein results in decreased susceptibility to N-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl)phenyl)methanesulfonamide"15475374
C080955N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in decreased expression of BCL2 mRNA19056168
C080955N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in decreased expression of BCL2 protein19056168
C080955N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of BCL2 mRNA19056168
C080955N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of BCL2 protein19056168
C080955N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamideN-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide promotes the reaction [Dihematoporphyrin Ether results in increased cleavage of BCL2 protein]16230411
C556398N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimideN-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimide promotes the reaction [TP53 protein binds to BCL2 promoter]21821060
C556398N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimideN-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimide results in decreased expression of BCL2 mRNA21821060
C556398N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimideN-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimide results in decreased expression of BCL2 protein21821060
C556398N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimideTP53 mutant form inhibits the reaction [N-(2-(dimethylamino)ethyl)-2-aminothiazonaphthalimide results in decreased expression of BCL2 protein]21821060
C482378N-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugateN-(2-hydroxypropyl)methacrylamide co-polymer-doxorubicin conjugate results in decreased expression of BCL2 protein16749867
C496401N-((3-(aminomethyl)phenyl)methyl)ethanimidamideN-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [manganese chloride promotes the reaction [BCL2 protein binds to BECN1 protein]]28856835
C496401N-((3-(aminomethyl)phenyl)methyl)ethanimidamideN-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [manganese chloride results in increased expression of and results in decreased phosphorylation of BCL2 protein]28856835
C496401N-((3-(aminomethyl)phenyl)methyl)ethanimidamideN-((3-(aminomethyl)phenyl)methyl)ethanimidamide inhibits the reaction [manganese chloride results in increased nitrosation of BCL2 protein]28856835
C084956N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosineN(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine results in decreased expression of BCL2 protein16025880
C035605nabumetonenabumetone results in decreased expression of BCL2 protein16019514
C064769N-acetylsphingosineBCL2 protein inhibits the reaction [N-acetylsphingosine results in decreased phosphorylation of and results in decreased activity of AKT1 protein]16215670
C064769N-acetylsphingosineBCL2 protein inhibits the reaction [N-acetylsphingosine results in increased cleavage of and results in increased activity of CASP3 protein]16215670
C064769N-acetylsphingosineBCL2 protein inhibits the reaction [N-acetylsphingosine results in increased degradation of PLCG1 protein]16215670
C064769N-acetylsphingosineN-acetylsphingosine results in decreased expression of BCL2 protein9295281
D009270NaloxoneNaloxone inhibits the reaction [Morphine inhibits the reaction [Dactinomycin results in decreased expression of BCL2 protein]]12927789
D009270NaloxoneNaloxone results in increased expression of BCL2 protein16004788
D019810Sodium AzideSodium Azide inhibits the reaction [Minocycline results in increased expression of BCL2 protein]15004018
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of BCL2 protein"28673683
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of BCL2 mRNA"22076105
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of BCL2 mRNA"21624382
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of BCL2 protein"22020378
D037742Nanotubes, Carbon"Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein]"22020378
C031721naphthalenenaphthalene results in increased expression of BCL2 protein14595851
D009281NaphthalenesNaphthalenes results in decreased expression of BCL2 protein17224139
C073873naphtho(1,2-b)furan-4,5-dione"2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BCL2 protein]"19747539
C073873naphtho(1,2-b)furan-4,5-dione"naphtho(1,2-b)furan-4,5-dione results in decreased expression of BCL2 protein"19747539|2019708
C073873naphtho(1,2-b)furan-4,5-dione"pyrazolanthrone inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BCL2 protein]"19747539
D0150581-Naphthylisothiocyanate1-Naphthylisothiocyanate results in increased expression of BCL2 mRNA12883083
C005273naringeninBCL2 protein results in decreased susceptibility to naringenin19124070
C005273naringeninethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate inhibits the reaction [BCL2 protein results in decreased susceptibility to naringenin]19124070
C005273naringeninnaringenin inhibits the reaction [Glucose results in decreased expression of BCL2 mRNA]23192364
C005273naringeninnaringenin inhibits the reaction [Glucose results in decreased expression of BCL2 protein]23192364
C005274naringinnaringin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]28422390
C005274naringinnaringin inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2 mRNA]21945202
C528561navitoclaxnavitoclax promotes the reaction [Arsenic results in decreased expression of BCL2 protein]26385919
C528561navitoclaxnavitoclax promotes the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]25157103
C528561navitoclaxnavitoclax binds to BCL2 protein23353698
C528561navitoclaxnavitoclax results in decreased activity of BCL2 protein26954606
C576077N-benzoyl-12-nitrodehydroabietylamine-7-oneN-benzoyl-12-nitrodehydroabietylamine-7-one results in decreased expression of BCL2 protein22743618
C546012N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamideN-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide results in decreased expression of BCL2 protein27470402
C438686N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine"N''-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-methyl-2-dimethoxymethyl-2H-benzopyran-4-yl)-N'-benzylguanidine inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]"11805214
D009498NeurotoxinsNeurotoxins results in decreased expression of BCL2 protein15190125
C026385n-hexanen-hexane metabolite results in increased expression of BCL2 protein17492505
D009532NickelNickel analog affects the expression of BCL2 protein23776134
D009532NickelNickel results in decreased expression of BCL2 protein28330870
D009532Nickel[Quercetin analog co-treated with Nickel] results in decreased expression of BCL2 protein20577783
D009532NickelNickel analog results in decreased expression of BCL2 protein27257140
C119536nickel acetateAcetylcysteine inhibits the reaction [nickel acetate results in decreased expression of BCL2 protein]22245127
C119536nickel acetatenickel acetate results in decreased expression of BCL2 protein22210268|2224512
C119536nickel acetatenickel acetate results in decreased expression of BCL2 protein11306741
C022838nickel chloridenickel chloride results in decreased expression of BCL2 mRNA24184595|2658559
C022838nickel chloridenickel chloride results in decreased expression of BCL2 protein24184595|2658559
C022838nickel chlorideBCL2 protein results in decreased susceptibility to nickel chloride23828460
C022838nickel chloridenickel chloride results in decreased expression of BCL2 mRNA17442357
C022838nickel chloridenickel chloride results in increased expression of BCL2 protein21837363
C022838nickel chloridenickel chloride results in decreased expression of BCL2 protein20391133
C550717nickel ferritenickel ferrite analog results in decreased expression of BCL2 mRNA25966046
C550717nickel ferritenickel ferrite results in decreased expression of BCL2 mRNA21382431
C028007nickel monoxidenickel monoxide analog results in decreased expression of BCL2 mRNA24139157
C017557nickel subsulfidenickel subsulfide results in decreased expression of BCL2 protein20112989
C029938nickel sulfatenickel sulfate results in increased expression of BCL2 protein21776270
C029938nickel sulfatenickel sulfate results in decreased expression of BCL2 protein23317420
C029938nickel sulfatesesamin inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]23317420
D009534Niclosamide[Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2 mRNA25988281
D009534NiclosamideNiclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2 protein]23894143
D009534Niclosamide[Niclosamide inhibits the reaction [Erlotinib Hydrochloride results in increased expression of BCL2 protein]] which results in increased susceptibility to Erlotinib Hydrochloride23894143
D009534NiclosamideNiclosamide inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]20215516
D009534NiclosamideNiclosamide results in decreased expression of BCL2 protein23894143|2563433
D009538NicotineCurcumin inhibits the reaction [Nicotine results in increased expression of BCL2 protein]20727180
D009538Nicotineedelfosine inhibits the reaction [Nicotine results in increased phosphorylation of BCL2 protein]12421819
D009538NicotineMK-886 inhibits the reaction [Nicotine results in increased expression of BCL2 protein]20061081
D009538NicotineNicotine inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 protein]22743290
D009538NicotineNicotine results in increased expression of BCL2 protein18448488|2006108
D009538NicotineNicotine results in increased expression of BCL2 protein modified form18676776
D009538NicotineNicotine results in increased phosphorylation of BCL2 protein12421819
D009538NicotineNicotine results in decreased expression of BCL2 mRNA15831280
D009538NicotineNicotine results in decreased expression of BCL2 mRNA20339300
D009543NifedipineNifedipine results in decreased expression of BCL210075388
D009543NifedipineNifedipine results in increased expression of and affects the localization of BCL2 protein10695937
D009543NifedipineNifedipine inhibits the reaction [Gentamicins results in decreased expression of BCL2 protein]19698708
C042198nimbolidenimbolide results in decreased expression of BCL2 mRNA20429769
C042198nimbolidenimbolide results in decreased expression of BCL2 protein20429769
C012655nimesulidenimesulide results in decreased expression of BCL2 mRNA18564172
C012655nimesulidenimesulide results in decreased expression of BCL2 protein18564172
C012655nimesulidenimesulide affects the localization of BCL2 protein19772912
C012655nimesulidenimesulide results in decreased expression of BCL2 protein19772912
D009553NimodipineNimodipine results in decreased expression of BCL2 protein17490525
D009568NitrendipineNitrendipine promotes the reaction [Gentamicins results in decreased expression of BCL2 protein]19698708
D009569Nitric Oxide"1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]"16980304
D009569Nitric OxideNitric Oxide results in decreased expression of BCL2 protein15126337
D009569Nitric OxideNitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein16980304
D009569Nitric Oxidepimagedine inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]16980304
D009569Nitric Oxide[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased expression of BCL2 protein10828028
D009569Nitric Oxide"[3,5-dimethoxy-4'-hydroxystilbene results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]"17135264
D009569Nitric Oxide[linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 mRNA7706495
D009569Nitric Oxide[linsidomine results in increased abundance of Nitric Oxide] which results in increased expression of BCL2 protein7706495
D009569Nitric OxideNitric Oxide affects the expression of BCL2 mRNA17135264
D009569Nitric Oxide[Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]17135264
D009569Nitric OxideNitric Oxide results in increased phosphorylation of and results in decreased activity of BCL2 protein16039061
D009589Nitrogen Oxides[Benzo(a)pyrene co-treated with Nitrogen Oxides] results in increased expression of BCL2 protein16041517
D005996NitroglycerinNitroglycerin results in decreased expression of BCL2 protein17678976
D009599NitroprussideNitroprusside results in decreased expression of BCL223665936
D009599NitroprussideNitroprusside results in decreased expression of BCL2 protein15708893
D009599Nitroprusside[Nitroprusside results in increased nitrosation of and results in decreased ubiquitination of and results in decreased degradation of BCL2 protein] which results in decreased susceptibility to Chromates16980304
D009599NitroprussideFGF2 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein]10203697
D009599NitroprussideIGF1 protein inhibits the reaction [Nitroprusside results in decreased expression of BCL2 protein]10203697
D009599NitroprussideNitroprusside results in decreased expression of BCL2 protein10203697
D026423S-Nitroso-N-AcetylpenicillamineMelatonin inhibits the reaction [S-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein]21138475
D026423S-Nitroso-N-AcetylpenicillamineS-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 mRNA17135264
D026423S-Nitroso-N-AcetylpenicillamineS-Nitroso-N-Acetylpenicillamine results in decreased expression of BCL2 protein21138475
D026422S-Nitrosoglutathione[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in decreased expression of BCL2 protein10828028
C000591546NKCT1 protein, Naja kaouthia"[Gold binds to NKCT1 protein, Naja kaouthia] which results in decreased expression of BCL2 protein"27836789
C000591546NKCT1 protein, Naja kaouthia"NKCT1 protein, Naja kaouthia results in decreased expression of BCL2 protein"27836789
C419410N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester"N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of BCL2 protein"21209419
C542681N,N-dimethylphytosphingosine"BCL2 results in decreased susceptibility to N,N-dimethylphytosphingosine"19481559
C542681N,N-dimethylphytosphingosine"N,N-dimethylphytosphingosine results in decreased expression of BCL2 protein"19481559
C061800N,N-dimethylsphingosine"N,N-dimethylsphingosine inhibits the reaction [ASAH2 protein results in increased expression of BCL2 protein]"15498114
C081306N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide"N,N-di-n-hexyl-2-(4-fluorophenyl)indole-3-acetamide results in decreased expression of BCL2 protein"15519653
C008655N'-nitrosonornicotineMecamylamine inhibits the reaction [N'-nitrosonornicotine results in increased expression of BCL2 mRNA]16835749
C008655N'-nitrosonornicotineN'-nitrosonornicotine results in increased expression of BCL2 mRNA16582591|1683574
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]"19887557
C044387N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine"Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]"19887557
D015739NocodazoleNocodazole analog results in decreased expression of BCL2 protein28412508
D015739NocodazoleNocodazole results in increased phosphorylation of BCL2 protein15907805
D015739NocodazoleTYMP inhibits the reaction [Nocodazole results in increased phosphorylation of BCL2 protein]15907805
C025256nonylphenolnonylphenol results in increased expression of BCL2 protein24604882
C069741norcantharidinnorcantharidin results in increased phosphorylation of BCL2 protein21266192
D009638NorepinephrineAcetylcysteine inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein]17041759
D009638NorepinephrineN-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea inhibits the reaction [Norepinephrine results in decreased expression of BCL2 protein]20374255
D009638NorepinephrineNorepinephrine results in decreased expression of BCL2 protein14732211|1704175
C024319norethindrone enanthate[norethindrone enanthate co-treated with estradiol valerate] results in decreased expression of BCL2 mRNA18829022
D016912LevonorgestrelLevonorgestrel results in decreased expression of BCL2 protein16019350
D009665NoscapineNoscapine promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]20674069
D009665NoscapineNoscapine results in decreased expression of BCL2 protein20674069
C072936notoginsenoside R1notoginsenoside R1 inhibits the reaction [Excitatory Amino Acid Agonists results in decreased expression of BCL2 protein]19224577
C072936notoginsenoside R1notoginsenoside R1 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]23170834
C072936notoginsenoside R1"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]"25305180
C072936notoginsenoside R1notoginsenoside R1 inhibits the reaction [APP protein modified form results in decreased expression of BCL2 protein]24975829
C072936notoginsenoside R1notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]25305180
C072936notoginsenoside R1notoginsenoside R1 results in increased expression of BCL220023602
C086491NS 1619NS 1619 inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]21413024
C482205nutlin 3nutlin 3 results in decreased expression of BCL220422343
C501177NVP-AEW541BCL2 protein inhibits the reaction [[Dasatinib co-treated with NVP-AEW541] promotes the reaction [BAX protein binds to BAX protein]]20664932
C501177NVP-AEW541[Dasatinib co-treated with NVP-AEW541] results in decreased expression of BCL2 protein20664932
C000594859nymphayolnymphayol inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]25289771
C107010O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate"O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of BCL2 mRNA]"12540782
C064976O(6)-benzylguanine[temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of BCL2 protein20980775
C064976O(6)-benzylguanineTRP53 protein mutant form inhibits the reaction [[temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of BCL2 protein]20980775
C067207obacunoneobacunone results in decreased expression of BCL2 mRNA25592883
C067207obacunoneobacunone results in decreased expression of BCL2 protein21333732|2559288
C411188obacunone glucosideobacunone glucoside results in decreased expression of BCL2 mRNA25592883
C411188obacunone glucosideobacunone glucoside results in decreased expression of BCL2 protein25592883
C520962obatoclaxobatoclax results in decreased activity of BCL2 protein26954606
C464660obeticholic acidobeticholic acid results in increased expression of BCL2 mRNA27939613
C408162oblimersen[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA15867202
C408162oblimersen[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein15867202
C408162oblimersenoblimersen results in decreased expression of BCL2 protein11095261|1724111
C025589ochratoxin ABCL2 protein results in decreased susceptibility to ochratoxin A20549612
C025589ochratoxin Aochratoxin A results in decreased expression of BCL2 mRNA24755393
C025589ochratoxin Aochratoxin A results in decreased expression of BCL2 protein20549612
C025589ochratoxin Aochratoxin A results in decreased expression of BCL2 mRNA12700408
C025589ochratoxin Aochratoxin A results in increased expression of BCL2 mRNA23208426
C025589ochratoxin Aochratoxin A affects the expression of BCL2 mRNA28528741
C025589ochratoxin Aochratoxin A results in decreased expression of BCL2 mRNA29080797
C025589ochratoxin ATLR4 protein affects the reaction [ochratoxin A affects the expression of BCL2 mRNA]28528741
D019787Linoleic AcidLinoleic Acid affects the reaction [Azoxymethane affects the expression of BCL2 protein]22467055
D019787Linoleic Acid[Linoleic Acid co-treated with Glucose] affects the reaction [Azoxymethane affects the expression of BCL2 protein]22467055
C016627octyl gallateoctyl gallate results in decreased expression of BCL2 protein21856409
C474055octylphenoloctylphenol promotes the reaction [Streptozocin results in decreased expression of BCL2 protein]24781736
C474055octylphenoloctylphenol results in increased expression of BCL2 mRNA24781736
C474055octylphenoloctylphenol results in increased expression of BCL2 protein24781736
C474055octylphenol[Streptozocin co-treated with octylphenol] results in increased expression of BCL2 mRNA24781736
D016627OxidopamineOxidopamine results in decreased expression of BCL2 protein25446857
D016627Oxidopaminepyrazolanthrone inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
D016627Oxidopaminesalvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
D016627OxidopamineSB 203580 inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
D016627Oxidopamine"5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron(III) chloride inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]"21397656
D016627OxidopamineOxidopamine results in decreased expression of BCL2 protein16480889|2139765
D016627Oxidopaminesalvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
D016627OxidopamineTea inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]16480889
D019319Okadaic AcidOkadaic Acid results in decreased expression of BCL2 protein18937299
D019319Okadaic AcidOkadaic Acid results in increased phosphorylation of BCL2 protein7654318
C076029olanzapineolanzapine inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]15276877
C076029olanzapineolanzapine results in increased expression of BCL2 mRNA15126120
C076029olanzapineolanzapine results in increased expression of BCL2 protein15126120
C013168olaquindoxCDKN1A protein affects the reaction [olaquindox results in decreased expression of BCL2 protein]28757460
C013168olaquindoxolaquindox results in decreased expression of BCL2 mRNA21549799
C013168olaquindoxolaquindox results in decreased expression of BCL2 protein21549799|2875746
D009828Oleanolic AcidOleanolic Acid analog results in decreased expression of BCL2 protein26612655
C002769oleuropeinoleuropein inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]28595958
C031004oligomycin Aoligomycin A inhibits the reaction [bisphenol A results in increased expression of BCL2 protein]24909818
D009842OligopeptidesOligopeptides analog results in decreased expression of BCL2 protein24875536
D000069463Olive Oil[Olive Oil co-treated with Sulindac] results in decreased expression of BCL2 protein15309441
D000069463Olive Oil"Olive Oil inhibits the reaction [1,2-Dimethylhydrazine results in increased expression of BCL2 protein]"15309441
D000069463Olive OilOlive Oil results in decreased expression of BCL2 protein15309441
C507134ON 01910ON 01910 results in decreased expression of BCL2 protein25472472
C009618O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate"O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of BCL2 mRNA"27117976
C016340o,p'-DDT"fulvestrant inhibits the reaction [o,p'-DDT results in increased expression of BCL2 protein]"10545406
C016340o,p'-DDT"o,p'-DDT results in increased expression of BCL2 mRNA"22609851
C016340o,p'-DDT"o,p'-DDT results in increased expression of BCL2 protein"10545406
C016340o,p'-DDT"o,p'-DDT results in increased expression of BCL2 mRNA"22937105
D016566Organoselenium CompoundsOrganoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]25301743
C011959oridoninoridonin results in decreased expression of BCL2 protein16019488
D065108Ornithine Decarboxylase InhibitorsOrnithine Decarboxylase Inhibitors inhibits the reaction [ODC1 protein results in increased expression of BCL2 protein]16520895
D065108Ornithine Decarboxylase InhibitorsOrnithine Decarboxylase Inhibitors results in decreased expression of BCL2 protein16520895
D008939Mitotane[Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein9815696
D008939MitotaneMitotane results in increased expression of BCL2 mRNA23485034
C030110oxaliplatinoxaliplatin results in decreased expression of BCL2 mRNA23792648
C030110oxaliplatinoxaliplatin results in decreased expression of BCL2 protein16024531
C030110oxaliplatinoxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein19428505
C030110oxaliplatinSB 203580 inhibits the reaction [oxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
C030110oxaliplatinU 0126 inhibits the reaction [oxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
C015407oxalomalic acidoxalomalic acid results in decreased expression of BCL2 protein16785314
C552952oxazolinodaunorubicinoxazolinodaunorubicin affects the expression of BCL2 mRNA27780733
D010100OxygenCurcumin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]23452621
D010100Oxygenicariin inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
D010100OxygenNiacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
D010100Oxygen[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein25472572
D010100OxygenOxygen deficiency promotes the reaction [HIF1A mutant form results in decreased expression of BCL2]24860939
D010100OxygenOxygen deficiency results in decreased expression of BCL2 mRNA26516004
D010100OxygenOxygen deficiency results in increased expression of BCL2 mRNA23452621
D010100OxygenPlant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]23452621
D010100Oxygenresveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
D010100Oxygenresveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]23452621
D010100OxygenSIRT1 mutant form promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
D010100Oxygencyclopamine inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]27481074
D010100Oxygencyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]27481074
D010100OxygenMIR210 mRNA inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA]23108914
D010100OxygenOxygen deficiency affects the expression of BCL2 protein24680926
D010100Oxygen[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 mRNA23108914
D010100Oxygen[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein23108914|2468224
D010100Oxygen[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA27481074
D010100Oxygenpolydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]27481074
D010100Oxygenresveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24682241
D010100OxygenU 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24682241
D010100Oxygen"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid inhibits the reaction [notoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]]"25305180
D010100OxygenIsoflurane promotes the reaction [Oxygen deficiency results in increased expression of BCL2 protein]16249675
D010100Oxygennotoginsenoside R1 inhibits the reaction [[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein]25305180
D010100Oxygen[Oxygen co-treated with [Oxygen deficiency co-treated with Glucose deficiency]] results in decreased expression of BCL2 protein25305180
D010100Oxygen[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein24058562
D010100Oxygen[Oxygen deficiency co-treated with Glucose deficiency] affects the expression of BCL2 mRNA23637816
D010100OxygenOxygen deficiency results in decreased expression of BCL2 mRNA11042672|2593756
D010100OxygenOxygen deficiency results in decreased expression of BCL2 protein11042672
D010100OxygenOxygen deficiency results in increased expression of BCL2 protein10657591|1624967
D010100OxygenOxygen results in increased expression of BCL2 protein22148982
D010100OxygenPhenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]11042672
D010100OxygenPhenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]11042672
D010100OxygenQuercetin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]26476374
D010100OxygenQuercetin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]26476374
D010100Oxygenresveratrol inhibits the reaction [Oxygen results in increased expression of BCL2 protein]22148982
D010100Oxygensodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]24058562
D010100OxygenTrimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]25937560
D010100OxygenValproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]22711276
D010100Oxygenvorinostat inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]22711276
D010100Oxygen[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein24840287
D010100Oxygenresveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24840287
D010121OxytocinOxytocin results in increased expression of BCL2 protein23707249
D010126OzoneOzone results in increased expression of BCL2 protein23988432
D017239Paclitaxel"3,3'-diindolylmethane promotes the reaction [Paclitaxel results in decreased expression of BCL2 protein]"16580691
D017239Paclitaxelaspartyl-glutamyl-valyl-aspartal inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11160861
D017239PaclitaxelBCL2 mRNA results in decreased susceptibility to Paclitaxel16322897
D017239PaclitaxelBCL2 protein affects the susceptibility to Paclitaxel20610805
D017239PaclitaxelBCL2 protein mutant form results in increased susceptibility to Paclitaxel20610805
D017239PaclitaxelBCL2 protein results in decreased susceptibility to Paclitaxel16275990
D017239PaclitaxelCurcumin inhibits the reaction [Paclitaxel results in increased expression of BCL2 protein]16243823
D017239Paclitaxel[CXCL8 results in increased expression of BCL2 mRNA] which results in decreased susceptibility to Paclitaxel21742513
D017239Paclitaxel[CXCL8 results in increased expression of BCL2 protein] which results in decreased susceptibility to Paclitaxel21742513
D017239PaclitaxelCycloheximide inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11726273
D017239PaclitaxelCyclosporine promotes the reaction [Paclitaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein]12086014
D017239PaclitaxelDactinomycin inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11726273
D017239PaclitaxelDoxorubicin promotes the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]16168113
D017239Paclitaxel[fisetin co-treated with Paclitaxel] results in increased expression of BCL2 mRNA26884726
D017239PaclitaxelGenistein inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]15907805
D017239PaclitaxelMAP3K1 protein affects the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11160861
D017239PaclitaxelMAPK8 protein affects the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11160861
D017239PaclitaxelPaclitaxel affects the localization of BCL2 protein12126962
D017239Paclitaxel[Paclitaxel co-treated with sorafenib] results in decreased expression of BCL2 protein19664330
D017239PaclitaxelPaclitaxel results in decreased activity of BCL2 protein10881025
D017239PaclitaxelPaclitaxel results in decreased degradation of BCL2 protein12126962
D017239PaclitaxelPaclitaxel results in decreased expression of and affects the phosphorylation of BCL2 protein10822281
D017239PaclitaxelPaclitaxel results in decreased expression of BCL2 mRNA10822281
D017239PaclitaxelPaclitaxel results in decreased expression of BCL2 protein10822281|1086109
D017239PaclitaxelPaclitaxel results in increased cleavage of BCL2 protein10822281
D017239PaclitaxelPaclitaxel results in increased expression of BCL2 mRNA26884726
D017239PaclitaxelPaclitaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein12086014
D017239PaclitaxelPaclitaxel results in increased phosphorylation of BCL2 protein10502406|1088102
D017239Paclitaxel[Paclitaxel results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BAX protein]11726273
D017239Paclitaxel[Paclitaxel results in increased phosphorylation of BCL2 protein] which results in increased susceptibility to Cisplatin12709826
D017239Paclitaxel[pifithrin co-treated with Paclitaxel] results in increased phosphorylation of BCL2 protein18516295
D017239PaclitaxelQuercetin inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11597122
D017239Paclitaxelresveratrol inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]12510025
D017239PaclitaxelStaurosporine inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]15907805
D017239Paclitaxel[Tretinoin co-treated with Paclitaxel] results in decreased expression of BCL2 protein17701358
D017239Paclitaxel[Tretinoin co-treated with Paclitaxel] results in increased phosphorylation of BCL2 protein18098270
D017239PaclitaxelTYMP inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]15907805
D017239PaclitaxelBCL2 protein inhibits the reaction [Paclitaxel results in increased activity of CASP9 protein]14726646
C000588809paederosidic acidMAPK8 protein affects the reaction [paederosidic acid results in decreased expression of BCL2 protein]28185768
C000588809paederosidic acidpaederosidic acid results in decreased expression of BCL2 protein28185768
C013638paeonolpaeonol inhibits the reaction [Epirubicin results in decreased expression of BCL2 protein]26646421
D019308Palmitic AcidPalmitic Acid results in decreased expression of BCL215945276
D019308Palmitic AcidPalmitic Acid results in decreased expression of BCL215945276
C019248pamidronatepamidronate results in decreased expression of BCL2 protein10780527
C482884panduratin Apanduratin A results in decreased expression of BCL2 protein16497706
C496932panobinostat(+)-JQ1 compound promotes the reaction [panobinostat affects the expression of BCL2 mRNA]26733615
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BCL2 mRNA"27188386
C496932panobinostatpanobinostat affects the expression of BCL2 mRNA26733615
C496932panobinostat[panobinostat co-treated with (+)-JQ1 compound] results in decreased expression of BCL2 protein24435446
C496932panobinostatpanobinostat promotes the reaction [(+)-JQ1 compound affects the expression of BCL2 mRNA]26733615
C496932panobinostatpanobinostat results in decreased expression of BCL2 mRNA26272509
C496932panobinostatpanobinostat results in decreased expression of BCL2 protein24435446
D010261ParaoxonParaoxon results in decreased expression of BCL2 mRNA27117976
D010269ParaquatBCL2 protein results in decreased susceptibility to Paraquat15475374
D010269ParaquatParaquat results in decreased expression of BCL2 mRNA18836921|2646811
D010269ParaquatParaquat results in decreased expression of BCL2 protein26686574
D010269ParaquatParaquat results in increased expression of BCL2 mRNA22230393
D010269Paraquatsalvin inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]26686574
D010269ParaquatAKT1 protein affects the reaction [Paraquat results in decreased expression of BCL2 protein]28115273
D010269ParaquatGPX1 protein affects the reaction [Paraquat affects the expression of BCL2 mRNA]12654481
D010269Paraquat[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA23963992
D010269ParaquatMelatonin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA]23963992
D010269ParaquatParaquat results in decreased expression of BCL2 protein28115273|2905469
D010269ParaquatSilymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA]23963992
D010269ParaquatSilymarin inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]29054699
D010269ParaquatDocosahexaenoic Acids inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]12714668
D010269ParaquatNFE2L2 mutant form inhibits the reaction [Paraquat results in decreased expression of BCL2 mRNA]22678742
D010269Paraquat[Paraquat co-treated with decitabine] results in decreased expression of BCL2 protein22796470
D010269ParaquatParaquat results in decreased expression of BCL2 mRNA22678742|2688726
D010269ParaquatParaquat results in decreased expression of BCL2 protein12714668
C084656paricalcitol[paricalcitol co-treated with arsenic trioxide] results in decreased expression of BCL215781666
C002669parthenolideparthenolide promotes the reaction [SC-203048 results in decreased expression of BCL2 mRNA]21928377
C002669parthenolideparthenolide promotes the reaction [SC-203048 results in decreased expression of BCL2 protein]21928377
C002669parthenolide[parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein20154269
C002669parthenolide[[parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Tamoxifen20154269
C002669parthenolideparthenolide results in decreased expression of BCL2 mRNA21928377
C002669parthenolideparthenolide results in decreased expression of BCL2 protein21928377
C002669parthenolideSC-203048 promotes the reaction [parthenolide results in decreased expression of BCL2 mRNA]21928377
C002669parthenolideSC-203048 promotes the reaction [parthenolide results in decreased expression of BCL2 protein]21928377
D052638Particulate MatterParticulate Matter results in decreased expression of BCL2 mRNA24139157|2685686
D052638Particulate MatterParticulate Matter results in increased expression of BCL2 mRNA24769257
D052638Particulate MatterParticulate Matter results in increased expression of BCL2 protein20850422
D052638Particulate Matter[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of BCL2 protein28013216
D052638Particulate Matter2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Particulate Matter results in decreased expression of BCL2 protein]26472149
D052638Particulate MatterParticulate Matter results in decreased expression of BCL2 mRNA20025942
D052638Particulate MatterParticulate Matter results in decreased expression of BCL2 protein26472149
D052638Particulate MatterParticulate Matter results in increased expression of BCL2 mRNA24216475
D052638Particulate MatterSB 239063 inhibits the reaction [Particulate Matter results in decreased expression of BCL2 protein]26472149
C000610380p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane"p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane results in decreased expression of BCL2 protein"26035713
C410127PCB 180"[2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in decreased expression of BCL2 protein"21291966
C410127PCB 180PCB 180 affects the cleavage of BCL2 protein25659934
C410127PCB 180PCB 180 results in decreased expression of BCL2 protein21291966
D000068437Pemetrexed[Cisplatin co-treated with Pemetrexed co-treated with Valproic Acid] results in decreased expression of BCL2 protein19351772
D000068437Pemetrexed[Cisplatin co-treated with Pemetrexed co-treated with vorinostat] results in decreased expression of BCL2 protein19351772
D010396PenicillaminePenicillamine results in decreased expression of BCL2 mRNA22843330
D010396PenicillaminePenicillamine results in decreased expression of BCL2 protein22843330
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in decreased expression of BCL2 mRNA22024335
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in decreased expression of BCL2 protein22024335
C046012pentanalpentanal results in decreased expression of BCL2 mRNA26079696
D010424PentobarbitalPentobarbital results in increased expression of BCL217715682
C015423peoniflorinpeoniflorin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]27053303
D010455PeptidesPeptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]23994092
C101816perfluoro-n-nonanoic acidperfluoro-n-nonanoic acid results in decreased expression of BCL2 mRNA19196829|1964651
C101816perfluoro-n-nonanoic acidperfluoro-n-nonanoic acid results in decreased expression of BCL2 protein19878704
C101814perfluoro-n-undecanoic acidperfluoro-n-undecanoic acid results in increased expression of BCL2 mRNA23602845
C076994perfluorooctane sulfonic acidMIR155 mRNA promotes the reaction [perfluorooctane sulfonic acid results in decreased expression of BCL2 protein]26844784
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA19468714
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of BCL2 protein26844784
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA21115943|2356291
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in increased expression of BCL2 mRNA23562911
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of BCL2 mRNA24616003
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of BCL2 protein24616003|2684478
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of BCL2 mRNA19468714
C023036perfluorooctanoic acidperfluorooctanoic acid results in decreased expression of BCL2 protein28219760
C032208perillyl alcoholperillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]19161993
D026023PermethrinPermethrin results in increased expression of BCL2 mRNA mutant form28624474
D030421Peroxynitrous AcidCurcumin inhibits the reaction [Peroxynitrous Acid results in decreased expression of BCL2 mRNA]20869986
D030421Peroxynitrous AcidCurcumin inhibits the reaction [Peroxynitrous Acid results in decreased expression of BCL2 protein]20869986
D030421Peroxynitrous AcidPeroxynitrous Acid results in decreased expression of BCL2 mRNA20869986
D030421Peroxynitrous AcidPeroxynitrous Acid results in decreased expression of BCL2 protein20869986
D037342Pertussis ToxinPertussis Toxin inhibits the reaction [dehydroepiandrosterone-bovine serum albumin results in increased expression of BCL2 protein]16407456
D037342Pertussis ToxinPertussis Toxin inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2 protein]16407456
D037342Pertussis ToxinPertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2 protein]16407456
C539933pevonedistatpevonedistat affects the expression of BCL2 mRNA24634471
D015232DinoprostoneDinoprostone results in increased expression of BCL2 protein9443418
D015232DinoprostoneDinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]]25432964
C058305phenethyl isothiocyanatephenethyl isothiocyanate results in decreased expression of BCL2 protein16054126
D010634PhenobarbitalPhenobarbital inhibits the reaction [MYC protein results in decreased expression of BCL2 protein]10449034
D010634PhenobarbitalPhenobarbital results in increased expression of BCL2 protein10426811
D010634PhenobarbitalPhenobarbital results in increased expression of BCL2 mRNA23273579
D010634PhenobarbitalPhenobarbital results in increased expression of BCL2 protein17456340
D010656PhenylephrineBCL2 protein affects the reaction [Phenylephrine results in increased expression of TIMP1 protein]19910689
D010656PhenylephrinePhenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]11042672
D010656PhenylephrinePhenylephrine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 protein]11042672
D010656PhenylephrinePhenylephrine results in increased expression of BCL2 mRNA19910689
D010656PhenylephrinePhenylephrine results in increased expression of BCL2 protein19910689
D010656PhenylephrinePTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 mRNA]19910689
D010656PhenylephrinePTHLH protein affects the reaction [Phenylephrine results in increased expression of BCL2 protein]19910689
C005435phenylmethylpyrazolonephenylmethylpyrazolone inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA]26111763
D010672PhenytoinPhenytoin results in increased expression of and affects the localization of BCL2 protein10695937
D010672PhenytoinPhenytoin results in decreased expression of BCL2 mRNA9118846
D010696PhloroglucinolPhloroglucinol results in increased expression of BCL2 protein20188716
D010696PhloroglucinolPhloroglucinol metabolite results in decreased expression of BCL2 protein22796323
D010713Phosphatidylcholines[rubitecan co-treated with Phosphatidylcholines] results in decreased expression of BCL2 protein21695227
C030090phosphoramide mustardphosphoramide mustard results in decreased expression of BCL2 protein26708502
D054735Phosphorothioate OligonucleotidesPhosphorothioate Oligonucleotides results in decreased expression of BCL2 protein16498393
C107448phthalocyanine Pc 4phthalocyanine Pc 4 results in decreased expression of BCL2 protein16007152
D010798PhycocyaninPhycocyanin inhibits the reaction [Galactose results in decreased expression of BCL2 protein]23036742
D064209PhytochemicalsPhytochemicals inhibits the reaction [Bleomycin results in decreased expression of BCL2 mRNA]26093215
C522973PI103BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]]20856197
C522973PI103BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP3 protein]]20856197
C522973PI103BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP8 protein]]20856197
C522973PI103BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased cleavage of CASP9 protein]]20856197
C522973PI103BCL2 protein inhibits the reaction [PI103 promotes the reaction [Doxorubicin results in increased expression of and results in increased activity of BAX protein]]20856197
C522973PI103BCL2 protein results in decreased susceptibility to [Doxorubicin co-treated with PI103]20856197
C522973PI103PI103 results in increased expression of BCL2 protein19810100
C121565pifithrin[pifithrin co-treated with Paclitaxel] results in increased phosphorylation of BCL2 protein18516295
C121565pifithrinpifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 mRNA]15547111
C121565pifithrinpifithrin inhibits the reaction [Azacitidine results in decreased expression of BCL2 protein]15547111
C121565pifithrinpifithrin inhibits the reaction [Reactive Oxygen Species results in decreased expression of BCL2 protein]26884717
C121565pifithrinpifithrin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]19887573
C121565pifithrinpifithrin inhibits the reaction [arsenic trioxide results in increased expression of BCL2 mRNA]17487067
C121565pifithrinpifithrin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18775851
D010862PilocarpinePilocarpine results in decreased expression of BCL2 protein19429016
D010862PilocarpineGHRL protein inhibits the reaction [Pilocarpine results in decreased expression of BCL2 protein]19429016
C004479pimagedinepimagedine inhibits the reaction [Nitric Oxide results in increased nitrosation of and results in decreased degradation of BCL2 protein]16980304
C004479pimagedinepimagedine results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein16980304
C004479pimagedine[pimagedine results in decreased nitrosation of and results in increased ubiquitination of and results in increased degradation of BCL2 protein] which results in increased susceptibility to Chromates16980304
C004479pimagedinepimagedine inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein]17786558
C004479pimagedine[pimagedine results in decreased activity of NOS2 protein] which results in decreased expression of BCL2 mRNA17135264
D010868PimozidePimozide results in decreased expression of BCL2 mRNA12130671
C032727piperidinepiperidine inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]17706638
C008922piperinepiperine results in decreased expression of BCL2 protein28341137
C006253pirinixic acidpirinixic acid results in increased expression of BCL2 protein10426811
C006253pirinixic acidpirinixic acid affects the expression of BCL2 protein16912651
C006253pirinixic acidlactacystin inhibits the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein]19361538
C006253pirinixic acid[[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide19361538
C006253pirinixic acid[[pirinixic acid results in increased expression of UCP2 protein] which results in increased abundance of Hydrogen Peroxide] which results in decreased expression of BCL2 protein19361538
C006253pirinixic acid[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein19361538
C006253pirinixic acidPotassium Cyanide promotes the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein]19361538
C078524PIXY321 fusion protein, recombinant"PIXY321 fusion protein, recombinant results in decreased expression of BCL2 mRNA"1450413
C037850PK 11195PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to alachlor]12730627
C037850PK 11195PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Antimycin A]12730627
C037850PK 11195PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to mesoxalonitrile]12730627
C037850PK 11195PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to pyridaben]12730627
C037850PK 11195PK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Rotenone]12730627
C037850PK 11195PK 11195 results in decreased expression of BCL2 protein15519653
C037850PK 11195PK 11195 results in decreased expression of BCL211266385
D010936Plant ExtractsBCL2 mutant form inhibits the reaction [Plant Extracts results in decreased susceptibility to AGT protein]23994555
D010936Plant Extracts[Plant Extracts co-treated with trichostatin A] results in decreased expression of BCL2 protein18709356
D010936Plant ExtractsPlant Extracts inhibits the reaction [AGT protein results in decreased expression of BCL2 mRNA]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [AGT protein results in decreased expression of BCL2 protein]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of AGTRAP protein]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of BAX mRNA]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of CYBA mRNA]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of CYBA protein]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of ICAM1 protein]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased expression of VCAM1 protein]]23994555
D010936Plant ExtractsPlant Extracts inhibits the reaction [linsidomine results in decreased expression of BCL2 protein]23174672
D010936Plant ExtractsPlant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]23452621
D010936Plant ExtractsPlant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]27050144
D010936Plant ExtractsPlant Extracts inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]20971099
D010936Plant ExtractsPlant Extracts results in decreased expression of BCL2 mRNA23911803
D010936Plant ExtractsPlant Extracts results in decreased expression of BCL2 protein20670616|2453406
D010936Plant ExtractsPlant Extracts results in increased expression of BCL2 mRNA16962711
D010936Plant ExtractsPlant Extracts results in increased expression of BCL2 protein16962711
D010936Plant Extracts[Plant Extracts co-treated with manganese chloride] affects the expression of BCL2 protein26064043
D010936Plant Extracts"[Plant Extracts co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"20103723
D010936Plant ExtractsPlant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BCL2 protein]25449198
D010936Plant ExtractsPlant Extracts inhibits the reaction [Benzo(a)pyrene results in decreased expression of BCL2 protein]28032951
D010936Plant ExtractsPlant Extracts inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]23279844
D010936Plant ExtractsPlant Extracts inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]23994094
D010936Plant ExtractsPlant Extracts inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]27723467
D010936Plant ExtractsPlant Extracts results in decreased expression of BCL2 mRNA20653974
D010936Plant ExtractsPlant Extracts results in decreased expression of BCL2 protein20653974|2086902
D010936Plant ExtractsTRP53 protein promotes the reaction [Plant Extracts inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]]27723467
D010936Plant ExtractsPlant Extracts affects the expression of BCL2 protein18097624
D010936Plant ExtractsPlant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of BCL2 mRNA]25446862
D010936Plant ExtractsPlant Extracts inhibits the reaction [decamethrin results in decreased expression of BCL2 protein]28595958
D010936Plant ExtractsPlant Extracts inhibits the reaction [Lead results in decreased expression of BCL2 protein]22129743
D010936Plant ExtractsPlant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]19772912
D010936Plant ExtractsPlant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]19772912
D010936Plant ExtractsPlant Extracts results in decreased expression of BCL2 mRNA20521779
D010936Plant ExtractsPlant Extracts results in increased expression of BCL223994555
D010938Plant OilsPlant Oils results in decreased expression of BCL2 protein15961301
D010938Plant OilsPlant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 mRNA]22393308
D010938Plant OilsPlant Oils inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]22393308
D010984Platinum[Gold analog co-treated with Platinum] results in decreased expression of BCL2 mRNA25846798
D017671Platinum CompoundsBCL2 affects the susceptibility to Platinum Compounds21844884
C422648pluronic block copolymer p85pluronic block copolymer p85 inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA]15939500
C531249Poly(amidoamine)Poly(amidoamine) results in decreased expression of BCL2 protein19643170
C017645polyaspartate[Fluorouracil co-treated with Chitosan co-treated with polyaspartate] results in decreased expression of BCL2 protein18567086
C058229polydatincyclopamine inhibits the reaction [polydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]]27481074
C058229polydatinpolydatin promotes the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in increased expression of BCL2 mRNA]27481074
D011092Polyethylene Glycols[Silver analog co-treated with Polyethylene Glycols] results in increased expression of BCL2 mRNA27021274
D011094Polyethyleneimine[Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2 mRNA25988281
D011070Poly I-CPoly I-C results in decreased expression of BCL2 protein21418039
C043435polylactic acid-polyglycolic acid copolymer[polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in decreased expression of BCL2 mRNA24070738
C043435polylactic acid-polyglycolic acid copolymer[polylactic acid-polyglycolic acid copolymer co-treated with Apigenin] results in decreased expression of BCL2 protein24070738
D059808Polyphenols[Polyphenols co-treated with Bleomycin] results in increased expression of BCL2 mRNA26800624
D059808PolyphenolsPolyphenols results in decreased expression of BCL2 protein12481898
D011134PolysaccharidesPolysaccharides results in decreased expression of BCL2 mRNA23911803
C545373ponatinib(+)-JQ1 compound promotes the reaction [ponatinib results in decreased expression of BCL2 protein]25053825
C545373ponatinibponatinib promotes the reaction [(+)-JQ1 compound results in decreased expression of BCL2 protein]25053825
C545373ponatinibponatinib results in decreased expression of BCL2 protein25053825
D011166PorphyrinsPorphyrins results in increased expression of BCL2 mRNA26468117
D011190Potassium CyanideBCL2 protein results in decreased susceptibility to Potassium Cyanide19361538
D011190Potassium Cyanide[[pirinixic acid results in increased expression of UCP2 protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Potassium Cyanide19361538
D011190Potassium CyanidePotassium Cyanide promotes the reaction [[pirinixic acid results in increased expression of UCP2 protein] which results in increased degradation of BCL2 protein]19361538
D011192Potassium DichromatePotassium Dichromate results in decreased expression of BCL2 protein19219935
D011192Potassium DichromateAscorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2 protein]21262251
D011192Potassium Dichromatecarvedilol inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2 protein]25245570
D011192Potassium DichromatePotassium Dichromate affects the localization of BCL2 protein21262251
D011192Potassium DichromatePotassium Dichromate results in decreased expression of BCL2 protein21262251|2524557
D045542PQQ CofactorPQQ Cofactor inhibits the reaction [Rotenone affects the expression of BCL2 protein]24755484
D045542PQQ CofactorPQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]26276080
C058808praeruptorin C"praeruptorin C inhibits the reaction [Amino Acids, Peptides, and Proteins results in decreased expression of BCL2 protein]"23313464
C432807pramanicinBCL2 protein affects the susceptibility to pramanicin23441183
C432807pramanicinpramanicin analog results in decreased expression of BCL2 mRNA23441183
C432807pramanicinpramanicin analog results in decreased expression of BCL2 protein23441183
D017035Pravastatin[LDLR gene mutant form results in increased susceptibility to Pravastatin] which affects the expression of BCL2 protein26875785
C023617pregna-4,17-diene-3,16-dione"pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of BCL2 mRNA]"15322087
D011285Pregnenolone CarbonitrilePregnenolone Carbonitrile results in increased expression of BCL2 mRNA19162173
D011335Proadifen[Proadifen co-treated with Cisplatin] results in decreased expression of BCL2 protein26721606
D044945ProanthocyanidinsProanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]18611398
D044945ProanthocyanidinsProanthocyanidins inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18611398
D011339Probenecid"geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 mRNA]"24768735
D011339Probenecid"geraniol inhibits the reaction [[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 protein]"24768735
D011339Probenecid"[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 mRNA"24768735
D011339Probenecid"[Probenecid co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of BCL2 protein"24768735
D011341ProbucolProbucol inhibits the reaction [APP protein modified form results in decreased expression of BCL2 mRNA]26111763
C479580procyanidin B2procyanidin B2 affects the reaction [Diquat affects the expression of BCL2 mRNA]27057282
C479580procyanidin B2procyanidin B2 affects the reaction [Hydrogen Peroxide affects the expression of BCL2 mRNA]27057282
D011374Progesterone"[Progesterone co-treated with Estrogens, Conjugated (USP)] results in increased expression of BCL2 protein"15779298
D011374Progesterone[Estradiol co-treated with Progesterone co-treated with Methylnitrosourea] results in increased expression of BCL2 protein22465879
D011374Progesterone[Methylnitrosourea co-treated with Progesterone co-treated with Estradiol] results in increased expression of BCL2 mRNA20732338
D011374Progesterone[Methylnitrosourea co-treated with Progesterone] results in increased expression of BCL2 mRNA20732338
D011374Progesterone[Progesterone co-treated with estradiol valerate] results in decreased expression of BCL2 mRNA18829022
D011374ProgesteroneProgesterone results in increased expression of BCL2 mRNA15941375
D011374ProgesteroneProgesterone results in increased expression of BCL2 protein15941375
D011374ProgesteroneProgesterone results in increased expression of BCL217510236
C029658propionic acidBee Venoms inhibits the reaction [propionic acid results in decreased expression of BCL2 mRNA]26048086
C029658propionic acidpropionic acid results in decreased expression of BCL2 mRNA26048086
D015742PropofolAcetylcysteine inhibits the reaction [Propofol results in decreased expression of BCL2 protein]28804952
D015742PropofolPropofol results in decreased expression of BCL2 protein28804952
D015742PropofolPropofol results in increased expression of BCL2 protein21786383
D015742PropofolPropofol results in increased expression of BCL2 protein16004787
D015742PropofolPropofol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]22015447
D015742PropofolPropofol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]24810525
D015742PropofolPropofol results in increased expression of BCL223353162
D015742PropofolPropofol results in increased expression of BCL2 mRNA19703415
D015742PropofolPropofol results in increased expression of BCL2 protein19703415
D015742Propofol[resveratrol co-treated with Propofol] results in increased expression of BCL223353162
D015742Propofolwortmannin inhibits the reaction [Propofol results in increased expression of BCL2 protein]19703415
D011433PropranololPropranolol results in increased expression of BCL2 mRNA11218852
C487679protectin D1protectin D1 results in increased expression of BCL2 protein16077186
C009091protocatechuic acidprotocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]18082360
C095781protolichesterinic acidprotolichesterinic acid results in decreased expression of BCL2 protein22063921
C107773pterostilbene[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein18852136
C107773pterostilbenepterostilbene results in decreased expression of BCL2 mRNA20152895|2493665
C107773pterostilbenepterostilbene results in decreased expression of BCL2 protein20152895
C107773pterostilbeneRELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein]18852136
C107773pterostilbenepterostilbene results in increased expression of BCL2 protein20681671
C527556Pt(O,O'-acac)(gamma-acac)(DMS)"Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 mRNA"21420390
C527556Pt(O,O'-acac)(gamma-acac)(DMS)"Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein"21420390
C527556Pt(O,O'-acac)(gamma-acac)(DMS)"[Pt(O,O'-acac)(gamma-acac)(DMS) results in increased activity of PRKCE protein] which results in decreased expression of BCL2 protein"21420390
C527556Pt(O,O'-acac)(gamma-acac)(DMS)"pyrazolanthrone inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein]"21420390
C527556Pt(O,O'-acac)(gamma-acac)(DMS)"Quinazolines inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein]"21420390
C527556Pt(O,O'-acac)(gamma-acac)(DMS)"SB 203580 inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein]"21420390
C033607puerarinarsenic trioxide promotes the reaction [puerarin results in decreased expression of BCL2 mRNA]20416161
C033607puerarinpuerarin results in decreased expression of BCL2 mRNA20416161
C033607puerarinpuerarin results in decreased expression of BCL2 protein16055262
C033607puerarinpuerarin inhibits the reaction [cadmium acetate results in decreased expression of BCL2 mRNA]27717697
C033607puerarinpuerarin inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]27717697
C033607puerarinpuerarin inhibits the reaction [[Ethanol co-treated with Carbon Tetrachloride] results in increased expression of BCL2 mRNA]16426832
C526689punarnavinepunarnavine results in decreased expression of BCL2 mRNA20192578
D011691PuromycinMelatonin promotes the reaction [Puromycin results in decreased expression of BCL2 protein]21244482
D011691PuromycinPuromycin results in decreased expression of BCL2 protein21244482
D011692Puromycin Aminonucleoside[Puromycin Aminonucleoside co-treated with Melatonin] results in increased expression of BCL2 protein14993511
D011692Puromycin AminonucleosidePuromycin Aminonucleoside results in increased expression of BCL2 protein15113391|1615278
D011700PutrescinePutrescine results in decreased expression of BCL2 protein17606387
C547322((Py-3')TPP-Ru(phen)2Cl)Cl((Py-3')TPP-Ru(phen)2Cl)Cl results in increased expression of BCL2 protein19958751
C432165pyrazolanthrone"pyrazolanthrone inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
C432165pyrazolanthrone"pyrazolanthrone inhibits the reaction [6-(N,N-dimethylamino)-2-(naphthalene-1-yl)-4-quinazolinone results in increased phosphorylation of BCL2 protein]"23212307
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2 protein]19540902
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [arsenic trioxide results in increased phosphorylation of BCL2 protein]18412143
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]14724571|1731784
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [fosbretabulin results in increased phosphorylation of BCL2 protein]24321340
C432165pyrazolanthrone"pyrazolanthrone inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BCL2 protein]"19747539
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
C432165pyrazolanthrone"pyrazolanthrone inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein]"21420390
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein]19954742
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Cardiotoxins results in increased phosphorylation of BCL2 protein]17786558
C432165pyrazolanthronepyrazolanthrone results in decreased expression of BCL2 protein25560393
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]24577723|2504395
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA]20920558
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein]20920558
C432165pyrazolanthronepyrazolanthrone results in decreased phosphorylation of BCL2 protein24833599
C432165pyrazolanthronepyrazolanthrone results in increased phosphorylation of and results in decreased activity of BCL2 protein19428505
C432165pyrazolanthronepyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
D011722PyrethrinsPyrethrins affects the expression of BCL2 protein27939866
C428725pyridabenBCL2 protein results in decreased susceptibility to pyridaben12730627
C428725pyridabenPK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to pyridaben]12730627
D011732Pyridoxal PhosphatePyridoxal Phosphate results in decreased expression of BCL2 protein16690808
C009131pyrimidin-2-one beta-ribofuranosidepyrimidin-2-one beta-ribofuranoside affects the cleavage of BCL2 protein19459041
C009131pyrimidin-2-one beta-ribofuranosidepyrimidin-2-one beta-ribofuranoside results in decreased expression of BCL2 protein23320119
C005719pyrovaleronepyrovalerone analog results in decreased expression of BCL2 protein28578026
C020972pyrrolidine dithiocarbamic acidpyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BCL2 mRNA]21161674
C020972pyrrolidine dithiocarbamic acidpyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA]16139439
C020972pyrrolidine dithiocarbamic acidpyrrolidine dithiocarbamic acid results in increased phosphorylation of BCL2 protein12482581
C020972pyrrolidine dithiocarbamic acidAcetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA]22085843
C020972pyrrolidine dithiocarbamic acidAcetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein]22085843
C020972pyrrolidine dithiocarbamic acid[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 mRNA22085843
C020972pyrrolidine dithiocarbamic acid[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2 protein22085843
C020972pyrrolidine dithiocarbamic acid[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA20920558
C020972pyrrolidine dithiocarbamic acid[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein20920558
C020972pyrrolidine dithiocarbamic acidpyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 mRNA]20920558
C020972pyrrolidine dithiocarbamic acidpyrazolanthrone inhibits the reaction [[cupric chloride binds to pyrrolidine dithiocarbamic acid] which results in decreased expression of BCL2 protein]20920558
C020972pyrrolidine dithiocarbamic acidBCL2 protein results in decreased susceptibility to pyrrolidine dithiocarbamic acid10658192
D011765PyruvaldehydePyruvaldehyde results in decreased expression of BCL2 protein26577515
D011765Pyruvaldehydesalvin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein]26577515
C000594493qingre zaoshi liangxue fangqingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA]24637189
C000594493qingre zaoshi liangxue fangqingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein]24637189
C587274Qing Ye DanQing Ye Dan inhibits the reaction [Testosterone results in increased expression of BCL2 protein]27866977
D011791Quartz[Ascorbic Acid co-treated with Quartz] results in increased expression of BCL2 mRNA27381660
D011794QuercetinQuercetin inhibits the reaction [cyanoginosin LR results in decreased expression of BCL2 protein]24594009
D011794QuercetinQuercetin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]21262342
D011794QuercetinAKT1 protein inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]20386985
D011794QuercetinBCL2 protein inhibits the reaction [[arsenic trioxide co-treated with Quercetin] results in increased cleavage of and results in increased activity of CASP8 protein]18359480
D011794Quercetin[Cisplatin co-treated with Quercetin] results in decreased expression of BCL2 protein16082193
D011794QuercetinDDIT3 protein affects the reaction [Quercetin results in decreased expression of BCL2 protein]25611565
D011794Quercetin[Dihydrotestosterone co-treated with Curcumin co-treated with Quercetin] results in increased expression of BCL2 protein27132804
D011794QuercetinNFE2L2 protein inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]25896339
D011794Quercetin[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein18852136
D011794QuercetinQuercetin affects the expression of BCL2 protein15975156
D011794Quercetin[Quercetin analog co-treated with Gold analog] results in decreased expression of BCL2 protein27470402
D011794Quercetin[Quercetin analog co-treated with Nickel] results in decreased expression of BCL2 protein20577783
D011794QuercetinQuercetin analog results in decreased expression of BCL2 protein25289772
D011794QuercetinQuercetin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D011794QuercetinQuercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]12672908|2510816
D011794QuercetinQuercetin inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]11597122
D011794QuercetinQuercetin inhibits the reaction [squamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]21295016
D011794QuercetinQuercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]27050144
D011794QuercetinQuercetin metabolite results in decreased expression of BCL2 protein16280456
D011794QuercetinQuercetin promotes the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]23711929
D011794QuercetinQuercetin results in decreased expression of BCL221867607
D011794QuercetinQuercetin results in decreased expression of BCL2 mRNA10437144|2220087
D011794QuercetinQuercetin results in decreased expression of BCL2 protein10437144|1468802
D011794QuercetinQuercetin results in increased expression of BCL2 mRNA23727915
D011794QuercetinQuercetin results in increased phosphorylation of BCL2 protein16059641
D011794Quercetin[Quercetin results in increased susceptibility to Cisplatin] which results in decreased expression of BCL2 protein16619537|2561156
D011794QuercetinRELA protein affects the reaction [[pterostilbene co-treated with Quercetin] results in decreased expression of BCL2 protein]18852136
D011794Quercetinsalubrinal inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]25611565
D011794Quercetintauroursodeoxycholic acid inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]25611565
D011794Quercetin"Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"21294050
D011794Quercetin"Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"21294050
D011794Quercetin3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [Quercetin results in decreased expression of BCL2 mRNA]17135264
D011794QuercetinDoxorubicin inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]15538571
D011794QuercetinQuercetin affects the reaction [Catechin affects the expression of BCL2 mRNA]26363153
D011794QuercetinQuercetin inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]27260466
D011794QuercetinQuercetin results in decreased expression of BCL224275163
D011794QuercetinQuercetin results in decreased expression of BCL2 mRNA25543474
D011794QuercetinQuercetin results in decreased expression of BCL2 protein15538571|1703945
D011794Quercetin[Quercetin results in decreased expression of NOS2 mRNA] inhibits the reaction [Nitric Oxide results in increased expression of BCL2 mRNA]17135264
D011794Quercetin[Quercetin results in decreased phosphorylation of CREB1 protein] which results in decreased expression of BCL2 mRNA17135264
D011794QuercetinTetradecanoylphorbol Acetate promotes the reaction [Quercetin results in decreased expression of BCL2 protein]15538571
D011794Quercetin[1-Methyl-4-phenylpyridinium co-treated with Quercetin] results in increased expression of BCL2 mRNA19466539
D011794Quercetin2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Quercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]]21803128
D011794Quercetin"alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide inhibits the reaction [Quercetin analog results in decreased expression of BCL2 protein]"23907460
D011794QuercetinQuercetin affects the expression of BCL2 protein22000973
D011794QuercetinQuercetin affects the reaction [Glucose affects the expression of BCL2 protein]22524206
D011794QuercetinQuercetin analog results in decreased expression of BCL2 protein23907460
D011794QuercetinQuercetin inhibits the reaction [aluminum lactate affects the localization of BCL2 protein]26944603
D011794QuercetinQuercetin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]27389774
D011794QuercetinQuercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 mRNA]23281070
D011794QuercetinQuercetin inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of BCL2 protein]23281070
D011794QuercetinQuercetin inhibits the reaction [[Dithionite co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]21803128
D011794QuercetinQuercetin inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]24902966
D011794QuercetinQuercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 mRNA]24316378
D011794QuercetinQuercetin inhibits the reaction [estradiol 3-benzoate results in increased expression of BCL2 protein]24316378
D011794QuercetinQuercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]14505808
D011794QuercetinQuercetin inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]26476374
D011794QuercetinQuercetin inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]26476374
D011794QuercetinQuercetin inhibits the reaction [Thioacetamide affects the expression of BCL2 protein modified form]21885874
D011794QuercetinQuercetin inhibits the reaction [triptolide affects the expression of BCL2 protein]26277538
D011794QuercetinQuercetin results in decreased expression of BCL2 protein23281070
D011794QuercetinQuercetin results in increased expression of BCL2 mRNA23281070
C523166quercetin 3-O-beta-(2''-galloyl)-rhamnopyranosidequercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]23711929
C523166quercetin 3-O-beta-(2''-galloyl)-rhamnopyranosidequercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [7-ketocholesterol results in decreased expression of BCL2 protein]25845326
D011799Quinazolines"Quinazolines inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein]"21420390
C502851quinocetonequinocetone results in increased expression of BCL2 mRNA27046791
C004532quinonequinone results in decreased expression of BCL2 protein20499891
C544967quizartinib(+)-JQ1 compound promotes the reaction [quizartinib results in decreased expression of BCL2 protein]25053825
C544967quizartinibquizartinib promotes the reaction [(+)-JQ1 compound results in decreased expression of BCL2 protein]25053825
C544967quizartinibquizartinib results in decreased expression of BCL2 protein25053825
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride affects the expression of BCL2 protein16009171
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride results in decreased expression of BCL2 mRNA16566921|2094540
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride results in decreased expression of BCL2 protein16566921|1722016
D020849Raloxifene HydrochlorideRaloxifene Hydrochloride results in increased expression of BCL2 protein16973256
D017257RamiprilRamipril affects the expression of BCL2 protein10728395
D011899RanitidineRanitidine inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]19723537
D017382Reactive Oxygen Species[cyanoginosin LR results in increased abundance of Reactive Oxygen Species] which results in increased expression of BCL2 mRNA24376844
D017382Reactive Oxygen SpeciesBCL2 mutant form promotes the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]23994555
D017382Reactive Oxygen Species[[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in decreased expression of BCL2 protein27634759
D017382Reactive Oxygen SpeciesFlavonoids inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]]23994555
D017382Reactive Oxygen Speciespifithrin inhibits the reaction [Reactive Oxygen Species results in decreased expression of BCL2 protein]26884717
D017382Reactive Oxygen SpeciesPlant Extracts inhibits the reaction [BCL2 mutant form promotes the reaction [AGT protein results in increased abundance of Reactive Oxygen Species]]23994555
D017382Reactive Oxygen SpeciesReactive Oxygen Species results in decreased expression of BCL2 mRNA25800948
D017382Reactive Oxygen SpeciesReactive Oxygen Species results in decreased expression of BCL2 protein26884717
D017382Reactive Oxygen Species[sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in decreased expression of BCL2 protein23660334
D017382Reactive Oxygen Species[Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased cleavage of BCL2 protein17136320
D012110ReserpineIAPP protein inhibits the reaction [Reserpine results in decreased expression of BCL2 protein]19463876
D012110ReserpineReserpine results in decreased expression of BCL2 protein19463876
D012116Resins, Plant"Resins, Plant results in decreased expression of BCL2 protein"27268964
C059514resveratrolAcetylcysteine inhibits the reaction [arsenic trioxide promotes the reaction [resveratrol results in decreased expression of BCL2 protein]]26772155
C059514resveratrolAcetylcysteine inhibits the reaction [resveratrol promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]]26772155
C059514resveratrolAcetylcysteine inhibits the reaction [resveratrol results in decreased expression of BCL2 protein]26772155
C059514resveratrol[allyl sulfide co-treated with resveratrol] results in decreased expression of BCL2 mRNA18512326
C059514resveratrolarsenic trioxide promotes the reaction [resveratrol results in decreased expression of BCL2 protein]26772155
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol affects the localization of CYCS protein]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol promotes the reaction [[CASP3 protein results in increased cleavage of aspartyl-glutamyl-valyl-aspartyl-p-nitroanilide] which results in increased chemical synthesis of 4-nitroaniline]]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to CREBBP protein]]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to DAXX protein]]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SP100 protein]]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to SUMO1 protein]]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol promotes the reaction [PML protein binds to TP53 protein]]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC2 protein]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in decreased expression of BIRC3 protein]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in decreased expression of CASP3 protein]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in increased activity of CASP3 protein]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]19631782
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PLCG1 protein]11577002
C059514resveratrolBCL2 protein inhibits the reaction [resveratrol results in increased degradation of PLCG1 protein]11577002
C059514resveratrolBCL2 protein results in decreased susceptibility to resveratrol11577002|1963178
C059514resveratrol[Benzo(a)pyrene co-treated with resveratrol] results in decreased expression of BCL2 mRNA24289642
C059514resveratrol[Doxorubicin co-treated with resveratrol] results in decreased expression of BCL2 mRNA26969377
C059514resveratrol[Doxorubicin co-treated with resveratrol] results in decreased expression of BCL2 protein26969377
C059514resveratrolMIR21 mRNA inhibits the reaction [resveratrol results in decreased expression of BCL2 protein]23359184|2453522
C059514resveratrolNQO2 protein promotes the reaction [resveratrol results in decreased expression of BCL2 protein]19661309
C059514resveratrolpyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BCL2 mRNA]21161674
C059514resveratrolresveratrol analog results in decreased expression of BCL2 protein25776512
C059514resveratrol"[resveratrol co-treated with beta-1,3-glucan] results in increased expression of BCL2 mRNA"17690738
C059514resveratrol[resveratrol co-treated with Glucose] results in increased expression of BCL2 protein24218232
C059514resveratrolresveratrol inhibits the reaction [[Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2 protein]19620254
C059514resveratrolresveratrol inhibits the reaction [cudraflavone B results in decreased expression of BCL2 protein]23881456
C059514resveratrolresveratrol inhibits the reaction [Dopamine results in decreased expression of BCL2 protein]17603292
C059514resveratrolresveratrol inhibits the reaction [MIR21 mRNA results in increased expression of BCL2 protein]23359184
C059514resveratrolresveratrol inhibits the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
C059514resveratrolresveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 mRNA]23452621
C059514resveratrolresveratrol inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]12510025
C059514resveratrolresveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]25991017
C059514resveratrolresveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]25991017
C059514resveratrolresveratrol promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]26772155
C059514resveratrolresveratrol promotes the reaction [sorafenib results in decreased expression of BCL2 protein]26911335
C059514resveratrolresveratrol promotes the reaction [temozolomide results in decreased expression of BCL2 protein]22530672
C059514resveratrolresveratrol results in decreased expression of BCL216209266|2174396
C059514resveratrolresveratrol results in decreased expression of BCL2 mRNA15633232|1948499
C059514resveratrolresveratrol results in decreased expression of BCL2 protein12060119|1263248
C059514resveratrol[resveratrol results in decreased expression of MTA1 protein] which results in decreased expression of BCL2 protein19810103
C059514resveratrolresveratrol results in increased expression of BCL2 mRNA17261084|1859201
C059514resveratrolresveratrol results in increased expression of BCL2 protein18592012|1954976
C059514resveratrolvorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]]19631782
C059514resveratrolvorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]]19631782
C059514resveratrolvorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to resveratrol]19631782
C059514resveratrolresveratrol results in increased expression of BCL2 protein27070252
C059514resveratrol"[Ellagic Acid co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"20103723
C059514resveratrol"[Plant Extracts co-treated with resveratrol] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"20103723
C059514resveratrol"resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"18791811
C059514resveratrolresveratrol inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]27260466
C059514resveratrolresveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]22763982
C059514resveratrolresveratrol inhibits the reaction [ERCC6 gene mutant form results in decreased expression of BCL2 protein]25440059
C059514resveratrolresveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24682241
C059514resveratrolresveratrol results in decreased expression of BCL2 mRNA15637762
C059514resveratrolresveratrol results in decreased expression of BCL2 protein15637762|1820172
C059514resveratrolresveratrol results in increased expression of BCL2 mRNA18819863|2287864
C059514resveratrolresveratrol results in increased expression of BCL2 protein23090186|2511635
C059514resveratrolzinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]22763982
C059514resveratrol[1-Methyl-4-phenylpyridinium co-treated with resveratrol] results in increased expression of BCL2 mRNA19466539
C059514resveratrol"(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]]"26054749
C059514resveratrol[MRS 1191 results in decreased activity of ADORA3 protein] inhibits the reaction [resveratrol results in increased phosphorylation of BCL2 protein]15345477
C059514resveratrol[resveratrol co-treated with Propofol] results in increased expression of BCL223353162
C059514resveratrolresveratrol inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]24492640
C059514resveratrolresveratrol inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2 protein]19073162
C059514resveratrolresveratrol inhibits the reaction [Gallic Acid results in decreased expression of BCL2 protein]19723098
C059514resveratrolresveratrol inhibits the reaction [Glucose results in decreased expression of BCL2 protein]26054749
C059514resveratrolresveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 mRNA]23833438
C059514resveratrolresveratrol inhibits the reaction [Monocrotophos results in decreased expression of BCL2 protein]23833438
C059514resveratrolresveratrol inhibits the reaction [Oxygen results in increased expression of BCL2 protein]22148982
C059514resveratrolresveratrol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]25714330
C059514resveratrolresveratrol results in decreased expression of BCL224534837
C059514resveratrolresveratrol results in decreased expression of BCL2 mRNA24092990
C059514resveratrolresveratrol results in increased expression of BCL215345477|2335316
C059514resveratrolresveratrol results in increased expression of BCL2 protein20861279|2111172
C059514resveratrolresveratrol results in increased phosphorylation of BCL2 protein15345477
C059514resveratrol[resveratrol co-treated with Curcumin] inhibits the reaction [IL1B protein results in decreased expression of BCL2 protein]19889203
C059514resveratrolresveratrol inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24840287
C059514resveratrolresveratrol promotes the reaction [TNFSF10 protein results in decreased expression of BCL2 protein]21209944
C059514resveratrolTNFSF10 protein promotes the reaction [resveratrol results in decreased expression of BCL2 protein]21209944
C540615retigeric acid Bretigeric acid B results in decreased expression of BCL2 protein20692244
D015474IsotretinoinIsotretinoin results in decreased expression of BCL216909596
D015474IsotretinoinIsotretinoin results in decreased expression of BCL2 protein16109544
D015474IsotretinoinIsotretinoin results in increased expression of BCL2 mRNA21159604
D015474IsotretinoinIsotretinoin results in increased expression of BCL2 protein21159604
D015474IsotretinoinIsotretinoin results in decreased expression of BCL218652567
D015474IsotretinoinIsotretinoin results in decreased expression of BCL2 mRNA18380168
C009172rhodiolosiderhodioloside results in increased expression of BCL2 mRNA24072175
C009172rhodioloside2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]]28465020
C009172rhodiolosiderhodioloside inhibits the reaction [Colistin results in decreased expression of BCL2 protein]28465020
C009172rhodiolosiderhodioloside inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]24072175
C009172rhodiolosiderhodioloside results in increased expression of BCL2 protein24072175
C547185riccardin Driccardin D results in decreased expression of BCL2 protein24069304
D012293RifampinRifampin results in increased expression of BCL2 protein11958592
D012293Rifampin[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein21419764
D012293RifampinUrsodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein]21419764
D019782RiluzoleRiluzole results in increased expression of BCL2 protein20885006
D019438RitonavirRitonavir results in decreased expression of BCL2 protein19386116
C046649ropiniroleropinirole results in increased expression of BCL2 protein18242171
C037663ropivacaineBCL2 protein inhibits the reaction [ropivacaine results in increased cleavage of CASP3 protein]15538973
C037663ropivacaineBCL2 protein inhibits the reaction [ropivacaine results in increased cleavage of PARP1 protein]15538973
C037663ropivacaineBCL2 protein results in decreased susceptibility to ropivacaine15538973
C104586roscovitineroscovitine inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2 protein]18501396
C530393rosemarinic acidrosemarinic acid inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]21526214
C089730rosiglitazone2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in decreased expression of BCL2 protein]17461445
C089730rosiglitazone[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in decreased expression of BCL2 mRNA19056168
C089730rosiglitazone[N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide co-treated with rosiglitazone] results in decreased expression of BCL2 protein19056168
C089730rosiglitazonerosiglitazone inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 mRNA]17266988
C089730rosiglitazonerosiglitazone results in decreased expression of BCL2 mRNA19056168|1995521
C089730rosiglitazonerosiglitazone results in decreased expression of BCL2 protein17018897|1746144
D000068718Rosuvastatin CalciumRosuvastatin Calcium results in decreased expression of BCL2 protein20852871
D012402RotenoneBCL2 protein results in decreased susceptibility to Rotenone12730627
D012402RotenonePK 11195 inhibits the reaction [BCL2 protein results in decreased susceptibility to Rotenone]12730627
D012402RotenonePQQ Cofactor inhibits the reaction [Rotenone affects the expression of BCL2 protein]24755484
D012402RotenonePQQ Cofactor inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]26276080
D012402RotenoneRanitidine inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]19723537
D012402Rotenoneresveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]25991017
D012402Rotenoneresveratrol inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]25991017
D012402RotenoneRotenone affects the expression of BCL2 protein24755484
D012402RotenoneRotenone results in decreased expression of BCL2 mRNA23963993|2599101
D012402RotenoneRotenone results in decreased expression of BCL2 protein19539006|1972353
D012402RotenoneRotenone results in increased expression of BCL2 mRNA16679036|1681510
D012402RotenoneRotenone results in increased expression of BCL2 protein16679036|1681510
D012402RotenoneTranexamic Acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]19539006
D012402RotenoneRotenone results in decreased expression of BCL2 mRNA26806867
D012402RotenoneRotenone results in increased expression of BCL225481089
D012402RotenoneRotenone results in increased expression of BCL2 mRNA23186747
D012402RotenoneAntiparkinson Agents inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]21807080
D012402Rotenonebaicalin inhibits the reaction [Rotenone affects the expression of BCL2 protein]25423838
D012402RotenoneBibenzyls inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]27180985
D012402Rotenoneprotocatechuic acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]18082360
D012402RotenoneRotenone affects the expression of BCL2 protein25423838
D012402RotenoneRotenone results in decreased expression of BCL2 mRNA21807080|2550246
D012402RotenoneRotenone results in decreased expression of BCL2 protein18082360|2544667
D012402RotenoneRotenone results in increased expression of BCL2 mRNA18817789
D012402Rotenonesaxagliptin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]25446674
D012402RotenoneUrsodeoxycholic Acid inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]25502462
C085746rottlerinrottlerin results in decreased expression of BCL2 protein22902833
C085746rottlerin2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]]25895139
C085746rottlerinrottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]25895139
D015575RoxithromycinRoxithromycin results in decreased expression of BCL2 protein12921874
C086511RU 58668RU 58668 affects the expression of BCL2 protein15868441
C079905rubitecan[rubitecan co-treated with Phosphatidylcholines] results in decreased expression of BCL2 protein21695227
C079905rubitecanrubitecan results in decreased expression of BCL2 protein21695227
D012431RutinRutin affects the expression of BCL2 protein15975156
D012431RutinRutin inhibits the reaction [Glucose results in increased degradation of and results in decreased expression of BCL2 protein]19557821
D012431RutinRutin results in decreased expression of BCL2 protein28811126
D012431RutinRutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 mRNA]26062544
C039961S-(1,2-dichlorovinyl)cysteine"S-(1,2-dichlorovinyl)cysteine results in increased expression of BCL2 protein"15967204
D012451SafroleSafrole results in decreased expression of BCL2 protein21591240
C025759saikosaponin[Imatinib Mesylate co-treated with saikosaponin] results in decreased expression of BCL2 protein23994742
C025759saikosaponinsaikosaponin promotes the reaction [SB 203580 results in decreased expression of BCL2 protein]23994742
C025759saikosaponinsaikosaponin results in decreased expression of BCL2 protein23994742
C025759saikosaponinAcetaminophen promotes the reaction [saikosaponin results in increased expression of BCL2 mRNA]25265579
C025759saikosaponinsaikosaponin results in increased expression of BCL2 mRNA25265579
C065299S-allylcysteineS-allylcysteine results in decreased expression of BCL2 protein17155983
C065299S-allylcysteine[S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
C065299S-allylcysteineS-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D000068299Salmeterol XinafoateSalmeterol Xinafoate results in decreased expression of BCL2 mRNA14687023
D000068299Salmeterol XinafoateSalmeterol Xinafoate results in decreased expression of BCL2 protein14687023
C036617salsolinolsalsolinol results in decreased expression of BCL2 protein23261589
C036617salsolinolBCL2 protein results in decreased susceptibility to salsolinol11502874
C496827salubrinalsalubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]20686688
C496827salubrinalsalubrinal inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]25611565
C496827salubrinalAcetylcysteine inhibits the reaction [salubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]]21616140
C496827salubrinalsalubrinal promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]21616140
C066201salvianolic acid Asalvianolic acid A inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]28391263
C076944salvianolic acid B2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]]23201927
C076944salvianolic acid Bsalvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2 protein]23201927
C076944salvianolic acid Bsalvianolic acid B inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]28495616
C076944salvianolic acid Bsalvianolic acid B results in increased expression of BCL2 protein23201927
C018381salvinAcetylcysteine inhibits the reaction [salvin results in decreased expression of BCL2 protein]28918123
C018381salvinsalvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
C018381salvinsalvin inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]26686574
C018381salvinsalvin inhibits the reaction [Pyruvaldehyde results in decreased expression of BCL2 protein]26577515
C018381salvinsalvin results in decreased expression of BCL2 protein28918123
C018381salvinsalvin inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
C005705sanguinarinesanguinarine results in decreased expression of BCL2 protein22215411
C005705sanguinarine[sanguinarine results in increased chemical synthesis of Reactive Oxygen Species] which results in decreased expression of BCL2 protein23660334
C005705sanguinarineNQO1 protein inhibits the reaction [sanguinarine results in decreased expression of BCL2 mRNA]24300172
C005705sanguinarineNQO1 protein inhibits the reaction [sanguinarine results in decreased expression of BCL2 protein]24300172
C005705sanguinarinesanguinarine results in decreased expression of BCL2 mRNA24300172
C005705sanguinarinesanguinarine results in decreased expression of BCL2 protein24300172
D012503SaponinsSaponins inhibits the reaction [Carbon Tetrachloride results in decreased expression of BCL2 protein]23994094
D012503SaponinsSaponins inhibits the reaction [Galactose results in decreased expression of BCL2 protein]25892055
C044363sappanchalconesappanchalcone results in decreased expression of BCL2 protein21963806
D012524SarinSarin results in decreased expression of BCL2 protein27639427
D012524SarinSarin results in increased expression of BCL2 mRNA27639427
C410958sauchinonesauchinone results in decreased expression of BCL2 protein27871897
C502994saxagliptinsaxagliptin inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]25446674
C093642SB 203580saikosaponin promotes the reaction [SB 203580 results in decreased expression of BCL2 protein]23994742
C093642SB 203580SB 203580 affects the reaction [Emodin affects the expression of BCL2 protein]27032576
C093642SB 203580"SB 203580 inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in decreased expression of BCL2 protein]"24036456
C093642SB 203580SB 203580 inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]25446857
C093642SB 203580"SB 203580 inhibits the reaction [Pt(O,O'-acac)(gamma-acac)(DMS) results in decreased expression of BCL2 protein]"21420390
C093642SB 203580SB 203580 promotes the reaction [arsenic trioxide results in decreased expression of BCL2 protein]16818652
C093642SB 203580SB 203580 results in decreased expression of BCL2 protein23994742
C093642SB 203580SB 203580 inhibits the reaction [chloroacetic acid results in decreased expression of BCL2 mRNA]23103613
C093642SB 203580SB 203580 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
C093642SB 203580SB 203580 inhibits the reaction [oxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
C417521SB 216763SB 216763 results in increased expression of BCL2 mRNA16288908
C406525SB 239063SB 239063 inhibits the reaction [Particulate Matter results in decreased expression of BCL2 protein]26472149
C572332SC-203048parthenolide promotes the reaction [SC-203048 results in decreased expression of BCL2 mRNA]21928377
C572332SC-203048parthenolide promotes the reaction [SC-203048 results in decreased expression of BCL2 protein]21928377
C572332SC-203048SC-203048 promotes the reaction [parthenolide results in decreased expression of BCL2 mRNA]21928377
C572332SC-203048SC-203048 promotes the reaction [parthenolide results in decreased expression of BCL2 protein]21928377
C572332SC-203048SC-203048 results in decreased expression of BCL2 mRNA21928377
C572332SC-203048SC-203048 results in decreased expression of BCL2 protein21928377
C115461SC 560SC 560 promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2 protein]25432964
C534628SCH 23390SCH 23390 inhibits the reaction [Cocaine results in increased phosphorylation of BCL2 protein]19879923
C033585schizandrol Bschizandrol B promotes the reaction [Acetaminophen results in increased expression of BCL2 protein]25319358
C033585schizandrol Bschizandrol B results in increased expression of BCL2 protein25319358
D012601Scopolamine HydrobromideScopolamine Hydrobromide results in decreased expression of BCL2 mRNA26434561
D012601Scopolamine HydrobromideScopolamine Hydrobromide results in decreased expression of BCL2 protein17120751
D012604Scorpion VenomsScorpion Venoms results in decreased expression of BCL2 protein19913524
C524947Scutellaria barbata extractScutellaria barbata extract results in decreased expression of BCL2 protein15369734
C090142secoisolariciresinol diglucosidesecoisolariciresinol diglucoside results in decreased expression of BCL2 mRNA19904759
D012642SelegilineSelegiline inhibits the reaction [linsidomine results in decreased expression of BCL2 protein]12880480
D012642Selegiline[Selegiline results in increased expression of TXN] which results in increased expression of BCL216099847
D012642Selegiline[[Selegiline results in increased expression of TXN] which results in increased expression of BCL2] which results in decreased susceptibility to 1-Methyl-4-phenylpyridinium16099847
D012643SeleniumSelenium inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 mRNA]25035189
D012643Selenium[Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D012643SeleniumSelenium analog inhibits the reaction [Diazinon results in decreased expression of BCL2 mRNA]27920530
D012643SeleniumSelenium results in decreased expression of BCL2 protein17523932
D012643SeleniumSelenium inhibits the reaction [Cadmium results in decreased expression of BCL2 protein]19135140
D064588Selenium OxidesSelenium Oxides results in decreased expression of BCL215485790
D064588Selenium OxidesSelenium Oxides results in decreased expression of BCL2 protein11342237
C002979selenomethylselenocysteineselenomethylselenocysteine results in decreased expression of BCL2 mRNA19360359
C002979selenomethylselenocysteine[selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein19360359
C002979selenomethylselenocysteineselenomethylselenocysteine results in decreased expression of BCL2 protein11396176
C078903seocalcitolseocalcitol affects the expression of BCL2 protein16080513
C078903seocalcitolseocalcitol results in decreased expression of BCL2 protein9528999
C078903seocalcitolseocalcitol results in decreased expression of BCL2 protein12446453
D017632Asbestos, Serpentine"[Asbestos, Serpentine results in decreased susceptibility to Asbestos, Serpentine] which results in increased expression of BCL2 mRNA"22608188
D017632Asbestos, Serpentine"[Asbestos, Serpentine results in decreased susceptibility to Asbestos, Serpentine] which results in increased expression of BCL2 protein"22608188
D017632Asbestos, Serpentine"BCL2 protein affects the susceptibility to Asbestos, Serpentine"16850164
D020280SertralineSertraline results in decreased expression of BCL2 protein24194395
D020280SertralineSertraline affects the expression of BCL2 protein18403212
C054125sesaminsesamin inhibits the reaction [nickel sulfate results in decreased expression of BCL2 protein]23317420
C054125sesaminsesamin affects the reaction [Glucose affects the expression of BCL2 protein]22524206
C516024SH-6 compoundSH-6 compound results in decreased expression of BCL2 protein17289836
C016101shikoninshikonin results in decreased expression of BCL2 protein25591861
C040115shogaolshogaol results in decreased expression of BCL2 protein18384088
C058254sibutraminesibutramine results in decreased expression of BCL2 protein27838152
D000068677Sildenafil CitrateSildenafil Citrate inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]15811867
D000068677Sildenafil CitrateSildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]20574430
D000068677Sildenafil CitrateSildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D000068677Sildenafil CitrateSildenafil Citrate results in increased expression of BCL218373738
D000068677Sildenafil CitrateTadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D000068677Sildenafil CitrateTestosterone promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D000068677Sildenafil CitrateTestosterone promotes the reaction [Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D000068677Sildenafil CitrateTestosterone promotes the reaction [Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D012822Silicon DioxideAscorbic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2 mRNA]22245848
D012822Silicon DioxideAscorbic Acid inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2 protein]22245848
D012822Silicon DioxideSilicon Dioxide results in decreased expression of BCL2 mRNA22245848|2535159
D012822Silicon DioxideSilicon Dioxide results in decreased expression of BCL2 protein21723938|2224584
D012822Silicon DioxideAHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA]22273745
D012822Silicon DioxideCASP1 protein affects the reaction [AHR protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA]]22273745
D012822Silicon DioxideCASP1 protein affects the reaction [[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA]22273745
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of BCL2 mRNA26263183
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of BCL2 protein26263183
D012822Silicon Dioxide[Silicon Dioxide co-treated with Lipopolysaccharides] results in decreased expression of BCL2 mRNA22273745
D012834SilverSilver analog affects the expression of BCL2 mRNA24849675
D012834SilverSilver analog affects the expression of BCL2 protein24849675
D012834Silver[Silver analog co-treated with Citric Acid] results in increased expression of BCL2 mRNA27021274
D012834Silver[Silver analog co-treated with Polyethylene Glycols] results in increased expression of BCL2 mRNA27021274
D012834SilverSilver results in decreased expression of BCL2 mRNA21611810
D012834SilverSilver results in decreased expression of BCL2 mRNA27131904
D018030Silver CompoundsSilver Compounds results in decreased expression of BCL2 protein21182908
C440975silybin[silybin co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA21969006
C440975silybinsilybin inhibits the reaction [Mitomycin affects the expression of BCL2]19834285
C440975silybinsilybin results in decreased expression of BCL2 mRNA21969006
D012838SilymarinSilymarin inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in decreased expression of BCL2 protein modified form]20850421
D012838SilymarinSilymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of BCL2 mRNA]23963992
D012838SilymarinSilymarin inhibits the reaction [Paraquat results in decreased expression of BCL2 protein]29054699
D012838SilymarinSilymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]19772912
D012838SilymarinSilymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]19772912
D012839SimazineSimazine results in decreased expression of BCL2 mRNA25461544
D019821Simvastatingeranylgeranyl pyrophosphate inhibits the reaction [Simvastatin results in decreased expression of BCL2 mRNA]18031796
D019821SimvastatinSimvastatin inhibits the reaction [TNF protein results in increased expression of BCL2 protein]17277159
D019821SimvastatinSimvastatin promotes the reaction [NFATC3 protein binds to BCL2 promoter]20369390
D019821SimvastatinSimvastatin results in decreased expression of BCL2 mRNA17901590|1803179
D019821SimvastatinSimvastatin results in decreased expression of BCL2 protein17901590|1852190
D019821SimvastatinSimvastatin results in increased expression of BCL2 protein17241114
D019821SimvastatinSimvastatin results in decreased expression of BCL2 mRNA25300705
D019821SimvastatinSimvastatin results in increased expression of BCL2 mRNA17241114
D019821SimvastatinSimvastatin results in increased expression of BCL2 protein17241114
D019821SimvastatinSimvastatin results in decreased expression of BCL2 protein25300705
D019821SimvastatinSimvastatin results in decreased expression of BCL222134829
D019821SimvastatinSimvastatin results in increased expression of BCL2 mRNA20369390
D019821SimvastatinSimvastatin results in increased expression of BCL2 protein20369390
D020123Sirolimus[Curcumin co-treated with Sirolimus] results in decreased expression of BCL219373661
D020123SirolimusSirolimus inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein]15571967
D020123SirolimusSirolimus promotes the reaction [Ethanol results in increased expression of BCL2 protein]21410490
D020123SirolimusSirolimus results in decreased expression of BCL2 mRNA19764996
D020123SirolimusSirolimus results in decreased expression of BCL2 protein19815708
D020123Sirolimus[Sirolimus co-treated with IL2 protein] results in increased expression of BCL2 mRNA11355896
D020123SirolimusSirolimus inhibits the reaction [lactacystin results in decreased expression of BCL2 protein]18640276
C439060sirtinolsirtinol promotes the reaction [cudraflavone B results in decreased expression of BCL2 protein]23881456
C000619853SM-1 compound[SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 mRNA28599477
C000619853SM-1 compound[SM-1 compound co-treated with Fluorouracil] results in decreased expression of BCL2 protein28599477
C000619853SM-1 compoundSM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BCL2 mRNA]28599477
C000619853SM-1 compoundSM-1 compound results in decreased expression of BCL2 mRNA28599477
D012906SmokeSmoke analog affects the expression of BCL2 mRNA26546778
C118258SN50 peptideSN50 peptide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein]18508827
C118258SN50 peptideSN50 peptide results in decreased expression of BCL2 protein12466137
C118258SN50 peptideSN50 peptide results in decreased expression of BCL2 mRNA10567332
C534922SNX 2112SNX 2112 results in decreased expression of BCL2 protein23777986
C009277sodium arsenatesodium arsenate results in increased expression of BCL2 mRNA21795629
C017947sodium arsenite"[2,3-dimercaptosuccinic acid monocyclohexyl ester co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546
C017947sodium arsenite"2,3-dimercaptosuccinic acid monocyclohexyl ester inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546|2337609
C017947sodium arsenite"[monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546
C017947sodium arsenite"monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546|2337609
C017947sodium arsenitesodium arsenite results in decreased expression of BCL2 mRNA18163546|2337609
C017947sodium arsenite[Succimer analog co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]18163546
C017947sodium arseniteSuccimer analog inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]18163546
C017947sodium arseniteSuccimer inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]18163546
C017947sodium arsenite"Succimer promotes the reaction [2,3-dimercaptosuccinic acid monocyclohexyl ester inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]]"23376091
C017947sodium arsenite"Succimer promotes the reaction [monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]]"23376091
C017947sodium arsenite2-tert-butylhydroquinone inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]26878773
C017947sodium arseniteAcetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]19082730
C017947sodium arsenite"monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"19615344
C017947sodium arseniteroscovitine inhibits the reaction [sodium arsenite results in increased phosphorylation of BCL2 protein]18501396
C017947sodium arsenitesodium arsenite affects the methylation of BCL2 gene28589171
C017947sodium arsenitesodium arsenite affects the phosphorylation of BCL2 protein18501396
C017947sodium arsenite[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein19082730
C017947sodium arsenitesodium arsenite results in decreased expression of BCL2 mRNA19615344|2033913
C017947sodium arsenitesodium arsenite results in decreased expression of BCL2 protein26878773|2851269
C017947sodium arsenitesodium arsenite results in increased expression of BCL2 mRNA12679051|1696627
C017947sodium arsenitesodium arsenite results in increased expression of BCL2 protein20390378|2443121
C017947sodium arseniteSTAT3 protein promotes the reaction [sodium arsenite results in increased expression of BCL2 protein]28444938
C017947sodium arsenite"Drugs, Chinese Herbal inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]"28757890
C017947sodium arsenitePlant Extracts inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]27723467
C017947sodium arsenitesodium arsenite results in decreased expression of BCL2 protein11035063|2033667
C017947sodium arseniteTRP53 protein promotes the reaction [Plant Extracts inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]]27723467
C017947sodium arsenitechelerythrine inhibits the reaction [sodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]]12690470
C017947sodium arseniteCurcumin inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]24952339
C017947sodium arseniteMelatonin inhibits the reaction [sodium arsenite results in increased activity of BCL2 protein]18715270
C017947sodium arseniteMelatonin inhibits the reaction [sodium arsenite results in increased expression of BCL2 protein]17645694
C017947sodium arsenite[sodium arsenite co-treated with Cadmium Chloride co-treated with lead acetate] results in decreased expression of BCL2 protein26396915
C017947sodium arsenitesodium arsenite inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]12690470
C017947sodium arsenitesodium arsenite results in decreased expression of BCL2 mRNA20830294|2449720
C017947sodium arsenitesodium arsenite results in decreased expression of BCL2 protein14514659|1942926
C017947sodium arsenitesodium arsenite results in increased activity of BCL2 protein18715270
C017947sodium arsenitesodium arsenite results in increased expression of BCL2 protein17645694
C017947sodium arseniteTaurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]20830294
C017947sodium arseniteTaurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]19429265|1961656
C017947sodium arseniteTaurine inhibits the reaction [sodium arsenite results in increased expression of BCL2 protein]20830294
C017947sodium arsenitetrans-3-(4'-hydroxyphenyl)-2-propenoic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]24497207
C016104sodium bichromate"6-anilino-5,8-quinolinedione inhibits the reaction [sodium bichromate results in increased ubiquitination of BCL2 protein]"18544562
C016104sodium bichromateBCL2 protein affects the susceptibility to sodium bichromate19556603
C016104sodium bichromateFBP1 protein inhibits the reaction [sodium bichromate results in increased expression of BCL2 protein]28624442
C016104sodium bichromatelactacystin inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein]18544562
C016104sodium bichromatemanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein]18544562
C016104sodium bichromatemanganese(III)-tetrakis(4-benzoic acid)porphyrin inhibits the reaction [sodium bichromate results in increased ubiquitination of BCL2 protein]18544562
C016104sodium bichromatesodium bichromate results in decreased expression of BCL2 protein18544562|1955660
C016104sodium bichromatesodium bichromate results in increased expression of BCL2 protein28624442
C016104sodium bichromatesodium bichromate results in increased ubiquitination of BCL2 protein18544562
C016104sodium bichromateCAT protein inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein]20298709
C016104sodium bichromatesodium bichromate results in decreased expression of BCL2 protein20298709|2104799
C016104sodium bichromateTRP53 mutant form inhibits the reaction [sodium bichromate results in decreased expression of BCL2 protein]20298709
C016104sodium bichromatesodium bichromate affects the expression of BCL2 mRNA11960910
C016104sodium bichromateBCL2 protein results in decreased susceptibility to sodium bichromate18544562
C025451sodium bisulfide2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [sodium bisulfide results in increased expression of BCL2 protein]21800153
C025451sodium bisulfideGlyburide inhibits the reaction [sodium bisulfide results in increased expression of BCL2 protein]21800153
C025451sodium bisulfidesodium bisulfide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]21800153
C025451sodium bisulfidesodium bisulfide inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of BCL2 protein]24058562
C025451sodium bisulfidesodium bisulfide inhibits the reaction [uranyl acetate results in decreased expression of BCL2 protein]26991019
C025451sodium bisulfidesodium bisulfide results in increased expression of BCL2 protein21800153
D012965Sodium Chlorideacetovanillone inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]22431579
D012965Sodium Chlorideatrasentan inhibits the reaction [[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein]22431579
D012965Sodium Chloride[Desoxycorticosterone co-treated with Sodium Chloride] results in decreased expression of BCL2 protein22431579
D012965Sodium Chloridelycopene inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D012965Sodium Chloride[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein16030430
D012965Sodium Chloride[S-allylcysteine co-treated with lycopene] inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D012965Sodium ChlorideS-allylcysteine inhibits the reaction [[Methylnitronitrosoguanidine co-treated with Sodium Chloride] results in increased expression of BCL2 protein]16030430
D020358Sodium Cholate"[Cholesterol, Dietary co-treated with Sodium Cholate] results in decreased expression of BCL2 protein"27394961
C028982sodium chromate(VI)sodium chromate(VI) results in increased expression of BCL2 mRNA14971655
D012969Sodium Fluoride[Sodium Fluoride inhibits the reaction [CA2 protein binds to BAD protein]] promotes the reaction [BAD protein binds to BCL2 protein]21708216
D012969Sodium FluorideSodium Fluoride promotes the reaction [BAD protein binds to BCL2 protein]21708216
D012969Sodium Fluoridelycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA]27871895
D012969Sodium FluorideSodium Fluoride results in decreased expression of BCL2 mRNA27871895
D012969Sodium FluorideSodium Fluoride results in decreased expression of BCL2 protein23578390
D012969Sodium Fluoridelycopene inhibits the reaction [Sodium Fluoride results in decreased expression of BCL2 mRNA]27871895
D012969Sodium FluorideSodium Fluoride affects the reaction [Gentamicins affects the expression of BCL2 mRNA]26779593
D012969Sodium FluorideSodium Fluoride results in decreased expression of BCL2 mRNA27871895
D012977Sodium NitriteCarnosine inhibits the reaction [Sodium Nitrite results in decreased expression of BCL2 protein]28266762
D012977Sodium NitriteSodium Nitrite results in decreased expression of BCL2 mRNA28833918
D012977Sodium NitriteSodium Nitrite results in decreased expression of BCL2 protein28266762
D018038Sodium SeleniteSodium Selenite inhibits the reaction [Aflatoxin B1 results in decreased expression of BCL2 mRNA]25261862
D018038Sodium Selenite"[Sodium Selenite co-treated with (1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane] results in decreased expression of BCL2 protein"28757135
D018038Sodium SeleniteSodium Selenite promotes the reaction [Buthionine Sulfoximine results in decreased expression of BCL2 mRNA]17989939
D018038Sodium SeleniteSodium Selenite results in decreased expression of BCL2 mRNA16542727|1798993
D018038Sodium SeleniteSodium Selenite inhibits the reaction [2-cresol results in increased expression of BCL2 mRNA]21705299
D018038Sodium Selenite"Sodium Selenite inhibits the reaction [cholestane-3,5,6-triol results in increased expression of BCL2 mRNA]"16039982
D018038Sodium SeleniteSodium Selenite results in increased expression of BCL2 protein18209489
D018038Sodium SeleniteSodium Selenite inhibits the reaction [Cadmium Chloride promotes the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]]26607349
D018038Sodium SeleniteSodium Selenite inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2 protein]26607349
D018038Sodium SeleniteSodium Selenite inhibits the reaction [MIR125A mRNA mutant form results in decreased expression of BCL2 protein]26607349
D053260SootSoot results in increased expression of BCL2 mRNA23634900
C471405sorafenib[Paclitaxel co-treated with sorafenib] results in decreased expression of BCL2 protein19664330
C471405sorafenibresveratrol promotes the reaction [sorafenib results in decreased expression of BCL2 protein]26911335
C471405sorafenib[sorafenib co-treated with Vitamin K 1] results in decreased expression of BCL2 protein20301194
C471405sorafenibsorafenib inhibits the reaction [Acids results in increased expression of BCL2 protein]18512153
C471405sorafenibsorafenib inhibits the reaction [Taurocholic Acid results in increased expression of BCL2 protein]18512153
C471405sorafenibsorafenib promotes the reaction [destruxin B results in decreased expression of BCL2 protein]24434019
C471405sorafenibsorafenib results in decreased expression of BCL2 mRNA26409325
C471405sorafenibsorafenib results in decreased expression of BCL2 protein17991738|1987858
C471405sorafenibsorafenib results in increased cleavage of BCL2 protein16109713
C471405sorafenibBCL2 protein results in decreased susceptibility to sorafenib28673964
D013024Soybean OilSoybean Oil results in increased expression of BCL2 protein15309441
D013096SpermineSpermine results in decreased expression of BCL2 protein16151648
D013096SpermineSpermine results in increased expression of BCL2 protein17606387
C060506sphingosine 1-phosphatesphingosine 1-phosphate inhibits the reaction [1-Methyl-4-phenylpyridinium results in increased expression of BCL2 mRNA]24399507
D013141Spiro CompoundsSpiro Compounds analog results in decreased expression of BCL2 protein25320076
D013148SpironolactoneSpironolactone results in increased expression of BCL2 protein20082611
D013148SpironolactoneSpironolactone results in increased expression of BCL2 protein19114643
C088106spiroquinazolinespiroquinazoline analog results in decreased expression of BCL2 mRNA25743751
C088106spiroquinazolinespiroquinazoline analog results in decreased expression of BCL2 protein25743751
C084439squamosamideQuercetin inhibits the reaction [squamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]]21295016
C084439squamosamidesquamosamide inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]21295016
C525423SRT2183SRT2183 results in increased expression of BCL2 mRNA23681230
C023599stannous chloride[stannous chloride results in increased activity of HMOX1 protein] which results in increased expression of BCL2 protein16959961
C517409statticstattic results in decreased expression of BCL2 protein24627483|2561156
D019311StaurosporineStaurosporine inhibits the reaction [Paclitaxel results in increased phosphorylation of BCL2 protein]15907805
D013267StilbenesStilbenes analog results in decreased expression of BCL2 mRNA25980588
D013267StilbenesStilbenes analog results in decreased expression of BCL2 protein25980588
D013311Streptozocinbisphenol A promotes the reaction [Streptozocin results in decreased expression of BCL2 protein]24781736
D013311StreptozocinEthinyl Estradiol promotes the reaction [Streptozocin results in decreased expression of BCL2 protein]24781736
D013311Streptozocinmontelukast inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]27702591
D013311Streptozocinoctylphenol promotes the reaction [Streptozocin results in decreased expression of BCL2 protein]24781736
D013311Streptozocin[Streptozocin co-treated with bisphenol A] results in increased expression of BCL2 mRNA24781736
D013311Streptozocin[Streptozocin co-treated with Ethinyl Estradiol] results in increased expression of BCL2 mRNA24781736
D013311Streptozocin[Streptozocin co-treated with octylphenol] results in increased expression of BCL2 mRNA24781736
D013311StreptozocinStreptozocin inhibits the reaction [Cisplatin results in increased expression of BCL2 protein]25665769
D013311StreptozocinStreptozocin results in decreased expression of BCL2 protein24781736|2770259
D013311Streptozocin2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]24954035
D013311StreptozocinAngiotensin-Converting Enzyme Inhibitors inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]22429817
D013311Streptozocinarjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2 protein]19682444
D013311StreptozocinAscorbic Acid inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]18758938
D013311StreptozocinCurcumin inhibits the reaction [Streptozocin affects the expression of BCL2 protein]25541178
D013311StreptozocinDiazoxide inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]20650802
D013311Streptozocin"Drugs, Chinese Herbal inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]"15587404
D013311Streptozocin"Drugs, Chinese Herbal inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]"15587404
D013311Streptozocinfasudil inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]22429817
D013311StreptozocinHesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]]24954035
D013311StreptozocinHesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein]24954035
D013311StreptozocinOrganoselenium Compounds inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]25301743
D013311StreptozocinPropofol inhibits the reaction [Streptozocin results in decreased expression of BCL2 protein]24810525
D013311StreptozocinSildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]20574430
D013311StreptozocinSildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D013311StreptozocinStreptozocin affects the expression of BCL2 protein25541178
D013311Streptozocin[Streptozocin co-treated with Isoproterenol] affects the expression of BCL2 protein24954035
D013311StreptozocinStreptozocin results in decreased expression of BCL2 mRNA15587404|1690947
D013311StreptozocinStreptozocin results in decreased expression of BCL2 protein15056984|1558740
D013311StreptozocinStreptozocin results in increased expression of BCL2 protein15976052|1968244
D013311StreptozocinTadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]20574430
D013311StreptozocinTadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D013311StreptozocinTestosterone inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]20574430
D013311StreptozocinTestosterone promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D013311StreptozocinTestosterone promotes the reaction [Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D013311StreptozocinTestosterone promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D013311StreptozocinTestosterone promotes the reaction [Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D020058StyreneStyrene results in increased expression of BCL2 protein15212811
C013690styrene oxidestyrene oxide affects the expression of BCL2 mRNA11230554
C013690styrene oxidestyrene oxide results in decreased expression of BCL2 protein12663515
D004113Succimer"[2,3-dimercaptosuccinic acid monocyclohexyl ester co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546
D004113Succimer"[monoisoamyl-2,3-dimercaptosuccinate co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]"18163546
D004113Succimer[Succimer analog co-treated with Succimer] inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]18163546
D004113SuccimerSuccimer analog inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]18163546
D004113SuccimerSuccimer inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]18163546
D004113Succimer"Succimer promotes the reaction [2,3-dimercaptosuccinic acid monocyclohexyl ester inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]]"23376091
D004113Succimer"Succimer promotes the reaction [monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]]"23376091
D012460SulfasalazineBCL2 protein inhibits the reaction [Sulfasalazine affects the localization of AIFM1 protein]12381674
C016766sulforafan[Eugenol results in increased activity of sulforafan] which results in decreased expression of BCL221382956
C016766sulforafan[sulforafan results in increased activity of Eugenol] which results in decreased expression of BCL221382956
D013467SulindacSulindac results in decreased expression of BCL2 protein15793875
D013467Sulindac[Sulindac results in increased abundance of Reactive Oxygen Species] which results in increased cleavage of BCL2 protein17136320
D013467SulindacSulindac results in decreased expression of BCL2 protein10223192
D013467Sulindac[Olive Oil co-treated with Sulindac] results in decreased expression of BCL2 protein15309441
C025462sulindac sulfidesulindac sulfide results in decreased expression of BCL2 protein18678619
C473643sulphoraphenesulphoraphene results in decreased expression of BCL2 mRNA29247643
C473643sulphoraphenesulphoraphene results in decreased expression of BCL2 protein28346727
D013501Surface-Active Agents[Surface-Active Agents co-treated with glyphosate] results in decreased expression of BCL2 protein23099315
C009365surfactin peptideAcetylcysteine inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein]19954742
C009365surfactin peptidepyrazolanthrone inhibits the reaction [surfactin peptide results in decreased expression of BCL2 protein]19954742
C009365surfactin peptidesurfactin peptide results in decreased expression of BCL2 protein19954742
C013270swertiamarinswertiamarin inhibits the reaction [Testosterone results in increased expression of BCL2 protein]27866977
D014284TriiodothyronineTriiodothyronine promotes the reaction [tamibarotene results in decreased expression of BCL2 mRNA]11201846
D014284TriiodothyronineTriiodothyronine results in increased expression of BCL2 protein16021636
D014284TriiodothyronineTriiodothyronine results in increased expression of BCL2 protein16021636
D013605T-2 ToxinBentonite promotes the reaction [[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of BCL2 mRNA]25296281
D013605T-2 Toxin[HT-2 toxin co-treated with T-2 Toxin] results in increased expression of BCL2 mRNA25296281
D013605T-2 ToxinT-2 Toxin results in increased expression of BCL2 protein19524637
D013605T-2 ToxinT-2 Toxin results in increased expression of BCL2 mRNA21296132
D013605T-2 ToxinT-2 Toxin results in increased expression of BCL2 protein21296132
D013619TacrineTacrine results in increased expression of BCL2 protein12579951
D016559TacrolimusTacrolimus inhibits the reaction [[Lipopolysaccharides co-treated with IFNG protein] results in decreased expression of BCL2 protein]10205001
D016559TacrolimusTacrolimus results in increased expression of BCL2 protein10205001
D016559Tacrolimus[Tacrolimus co-treated with 3-nitropropionic acid] affects the localization of BCL2 protein15571979
D000068581TadalafilTadalafil inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]20543097
D000068581TadalafilSildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D000068581TadalafilTadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]20574430
D000068581TadalafilTadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D000068581TadalafilTestosterone promotes the reaction [Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D000068581TadalafilTestosterone promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D000068581TadalafilTestosterone promotes the reaction [Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
C061133tamibarotenetamibarotene affects the expression of BCL2 mRNA15498508
C061133tamibarotenetamibarotene results in decreased expression of BCL2 mRNA11201846|1549850
C061133tamibaroteneTriiodothyronine promotes the reaction [tamibarotene results in decreased expression of BCL2 mRNA]11201846
D013629Tamoxifen[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2 mRNA22046442
D013629Tamoxifen[2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2 protein22046442
D013629TamoxifenARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]20305694
D013629Tamoxifen[[parthenolide results in decreased activity of RELA protein] which results in decreased expression of BCL2 protein] which results in increased susceptibility to Tamoxifen20154269
D013629TamoxifenRELA protein inhibits the reaction [Tamoxifen results in decreased expression of BCL2 protein]20154269
D013629Tamoxifen[Tamoxifen co-treated with AG 1879] results in increased expression of BCL2 protein17186241
D013629Tamoxifen[Tamoxifen co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein17767197
D013629TamoxifenTamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 mRNA]16051634
D013629TamoxifenTamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]20305694
D013629TamoxifenTamoxifen inhibits the reaction [Glucose inhibits the reaction [[KCNMA1 protein binds to KCNMB1 protein] which results in decreased expression of BCL2 protein]]21413024
D013629TamoxifenTamoxifen promotes the reaction [BCAR1 protein mutant form results in decreased expression of BCL2 protein]19330798
D013629TamoxifenTamoxifen promotes the reaction [Doxorubicin results in increased expression of BCL2 mRNA]19757172
D013629TamoxifenTamoxifen promotes the reaction [Mitomycin results in increased expression of BCL2 mRNA]19757172
D013629TamoxifenTamoxifen promotes the reaction [Vindesine results in increased expression of BCL2 mRNA]19757172
D013629TamoxifenTamoxifen results in decreased expression of BCL2 mRNA20549698
D013629TamoxifenTamoxifen results in decreased expression of BCL2 protein10785588|1776719
D013629TamoxifenTP53 protein promotes the reaction [Tamoxifen results in decreased expression of BCL2 mRNA]20549698
D013629TamoxifenYC137 inhibits the reaction [ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]]20305694
D013629Tamoxifen[BCL2 co-treated with Tamoxifen] results in increased expression of FASL protein15606891
D013629Tamoxifen[BCL2 co-treated with Tamoxifen] results in increased phosphorylation of JUN protein15606891
D013629TamoxifenTamoxifen results in decreased expression of BCL2 protein17343880
D013629Tamoxifen[Tamoxifen results in increased expression of MIR16 mRNA] which results in decreased expression of BCL2 protein17343880
C112765tanespimycintanespimycin results in decreased expression of BCL2 protein16923571|2867368
C021751tanshinonetanshinone results in decreased expression of BCL2 protein16009009|1988561
C402343tariquidartariquidar promotes the reaction [triptolide results in decreased expression of BCL2 protein]26134275
D013654TaurineTaurine inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
D013654TaurineTaurine inhibits the reaction [Alloxan results in decreased expression of BCL2 protein]22138235|2309280
D013654TaurineTaurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]20830294
D013654TaurineTaurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2 protein]19429265|1961656
D013654TaurineTaurine inhibits the reaction [sodium arsenite results in increased expression of BCL2 protein]20830294
D013654TaurineTaurine inhibits the reaction [Acetaminophen results in increased expression of BCL2 protein modified form]20166895
C030141taurine-ursodeoxycholate conjugatetaurine-ursodeoxycholate conjugate inhibits the reaction [TGFB1 protein results in decreased expression of BCL2 mRNA]14514686
C030141taurine-ursodeoxycholate conjugatetaurine-ursodeoxycholate conjugate inhibits the reaction [TGFB1 protein results in decreased expression of BCL2 protein]14514686
D013656Taurocholic Acidsorafenib inhibits the reaction [Taurocholic Acid results in increased expression of BCL2 protein]18512153
D013656Taurocholic AcidTaurocholic Acid results in increased expression of BCL2 protein18512153
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid inhibits the reaction [[APP gene mutant form co-treated with PSEN1 gene mutant form] results in decreased expression of BCL2 protein]16923170
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid inhibits the reaction [APP gene mutant form results in decreased expression of BCL2 protein]16923170
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid inhibits the reaction [Quercetin results in decreased expression of BCL2 protein]25611565
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid results in increased expression of BCL2 mRNA12721362
C031655tauroursodeoxycholic acidtauroursodeoxycholic acid results in increased expression of BCL2 protein15255934
C086827tazarotenetazarotene results in decreased expression of BCL2 protein16109552|1619628
D013662Tea[Tea co-treated with Bleomycin] results in increased expression of BCL2 mRNA26800624
D013662TeaTea inhibits the reaction [Oxidopamine results in decreased expression of BCL2 protein]16480889
C087114tebuconazoletebuconazole results in decreased expression of BCL2 protein26852204
C084178telmisartantelmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA]24831514
C047246temozolomideresveratrol promotes the reaction [temozolomide results in decreased expression of BCL2 protein]22530672
C047246temozolomidetemozolomide analog results in decreased expression of BCL2 protein19363609
C047246temozolomidetemozolomide results in decreased expression of BCL2 protein22530672
C047246temozolomide[temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of BCL2 protein20980775
C047246temozolomideTRP53 protein mutant form inhibits the reaction [[temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of BCL2 protein]20980775
C003959TEMPOTEMPO results in decreased expression of BCL2 protein25882087
C001803tempoltempol affects the expression of BCL2 protein24550650
C401859temsirolimustemsirolimus results in decreased expression of BCL2 mRNA19764996
C041226TerazosinTerazosin results in decreased expression of BCL2 protein12883741
D016593TerfenadineTerfenadine analog results in decreased expression of BCL2 protein19289568
D016593TerfenadineTerfenadine results in decreased expression of BCL2 protein12244568
C559687tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester)"Acetylcysteine inhibits the reaction [tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BCL2 protein]"22704995
C559687tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester)"tert-butyl-2-(4,5-dihydrogen-4,4,5,5-tetramethyl-3-O-1H-imidazole-3-cationic-1-oxyl-2-pyrrolidine-1-carboxylic ester) affects the expression of BCL2 protein"22704995
D013739Testosteronegingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]18030663
D013739Testosteronepyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA]16139439
D013739Testosterone[Testosterone co-treated with Calcitriol] results in decreased expression of BCL2 mRNA21592394
D013739TestosteroneTestosterone results in decreased expression of BCL2 mRNA21592394
D013739TestosteroneTestosterone results in decreased expression of BCL2 protein10455518
D013739TestosteroneTestosterone results in increased expression of BCL2 protein18030663
D013739Testosteronegingerol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]18030663
D013739TestosteroneTestosterone results in increased expression of BCL2 protein18030663
D013739Testosteronechrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA]29247772
D013739Testosteronedapoxetine inhibits the reaction [Testosterone results in increased expression of BCL2 protein]27687055
D013739TestosteroneFinasteride inhibits the reaction [Testosterone results in increased expression of BCL2 protein]25714330|2768705
D013739TestosteroneMetformin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA]26492952
D013739TestosteroneQing Ye Dan inhibits the reaction [Testosterone results in increased expression of BCL2 protein]27866977
D013739Testosteroneresveratrol inhibits the reaction [Testosterone results in increased expression of BCL2 protein]25714330
D013739Testosteroneswertiamarin inhibits the reaction [Testosterone results in increased expression of BCL2 protein]27866977
D013739TestosteroneTestosterone deficiency results in increased expression of BCL2 mRNA20850791
D013739TestosteroneTestosterone deficiency results in increased expression of BCL2 protein20850791
D013739TestosteroneTestosterone inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]20574430
D013739TestosteroneTestosterone inhibits the reaction [Testosterone deficiency results in increased expression of BCL2 protein]20850791
D013739TestosteroneTestosterone promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D013739TestosteroneTestosterone promotes the reaction [Sildenafil Citrate promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D013739TestosteroneTestosterone promotes the reaction [Tadalafil inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]20574430
D013739TestosteroneTestosterone promotes the reaction [Tadalafil promotes the reaction [Sildenafil Citrate inhibits the reaction [Streptozocin results in decreased expression of BCL2 mRNA]]]20574430
D013739TestosteroneTestosterone results in increased expression of BCL2 mRNA26492952|2924777
D013739TestosteroneTestosterone results in increased expression of BCL2 protein25714330|2768705
C534735tetraarsenic tetrasulfide[tetraarsenic tetrasulfide co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA26110921
C534735tetraarsenic tetrasulfide[tetraarsenic tetrasulfide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein26110921
C534735tetraarsenic tetrasulfidetetraarsenic tetrasulfide promotes the reaction [Celecoxib results in decreased expression of BCL2 protein]26586936
C534735tetraarsenic tetrasulfidetetraarsenic tetrasulfide promotes the reaction [Cisplatin results in decreased expression of BCL2 protein]26586936
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of BCL2 mRNA24596333
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of BCL2 mRNA22677475
C020806tetrabromobisphenol Atetrabromobisphenol A results in decreased expression of BCL2 protein27592553
C000591600tetrachlorobenzoquinonetetrachlorobenzoquinone results in decreased expression of BCL2 protein26901245
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of BCL2 protein9677421
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of BCL2 mRNA20044593
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of BCL2 mRNA21570461
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA19770486|1993321
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of BCL2 mRNA15965093|1952067
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of BCL2 protein15965093
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of BCL2 mRNA15965093
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of BCL2 protein15965093
D013750TetrachloroethyleneTetrachloroethylene affects the expression of BCL2 protein16010555
D013750TetrachloroethyleneTetrachloroethylene results in decreased expression of BCL2 protein12160929
C117155tetracycline CMT-3Celecoxib promotes the reaction [tetracycline CMT-3 results in increased expression of BCL2 protein]15688368
C117155tetracycline CMT-3tetracycline CMT-3 results in decreased expression of BCL2 protein16039551
C117155tetracycline CMT-3tetracycline CMT-3 results in increased expression of BCL2 protein15688368
D013755Tetradecanoylphorbol Acetateedelfosine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]9295281
D013755Tetradecanoylphorbol Acetate[Graphite analog co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of BCL2 protein25446327
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate inhibits the reaction [myricetin results in decreased expression of BCL2 protein]15748703
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in decreased expression of BCL2 protein]19631781
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate results in decreased expression of BCL2 protein11139146
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate results in increased expression of BCL2 protein24073338|9295281
D013755Tetradecanoylphorbol Acetate[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA16979875
D013755Tetradecanoylphorbol Acetate2-methoxyacetaldehyde promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]10221278
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate results in increased expression of BCL2 protein10221278
D013755Tetradecanoylphorbol Acetateperillyl alcohol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2 protein]19161993
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate promotes the reaction [Quercetin results in decreased expression of BCL2 protein]15538571
D013755Tetradecanoylphorbol AcetateTetradecanoylphorbol Acetate results in increased expression of BCL2 protein19161993
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2 mRNA25613284
C040733tetraethoxysilanedecitabine inhibits the reaction [tetraethoxysilane analog results in increased methylation of BCL2 promoter]27362941
C040733tetraethoxysilanetetraethoxysilane analog results in decreased expression of BCL2 mRNA27362941
C040733tetraethoxysilanetetraethoxysilane analog results in decreased expression of BCL2 protein27362941
C040733tetraethoxysilanetetraethoxysilane analog results in increased methylation of BCL2 promoter27362941
C014215tetrahydropalmatinetetrahydropalmatine results in decreased expression of BCL2 protein20109541
C050950tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complextetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex affects the expression of BCL2 protein16002045
C050950tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complextetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex inhibits the reaction [Adenosine Triphosphate results in increased expression of BCL2 protein]17997382
C050950tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complextetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex results in decreased expression of BCL2 protein17997382
C017953tetramethylpyrazinetetramethylpyrazine inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2 protein]21586279
D007978LevamisoleLevamisole results in decreased expression of BCL2 protein11139434
C009438tetrandrineBCL2 protein affects the susceptibility to tetrandrine18495333
C009438tetrandrineCYP3A5 protein promotes the reaction [tetrandrine results in decreased expression of BCL2 protein]26302866
C009438tetrandrinetetrandrine results in decreased expression of BCL2 mRNA18495333
C009438tetrandrinetetrandrine results in decreased expression of BCL2 protein26302866|2682249
C020809tetrathiomolybdatetetrathiomolybdate analog results in increased expression of BCL2 mRNA19323979
C020809tetrathiomolybdatetetrathiomolybdate analog results in increased expression of BCL2 protein19323979
D013792Thalidomide[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 mRNA15867202
D013792Thalidomide[oblimersen co-treated with Thalidomide co-treated with Dexamethasone] results in decreased expression of BCL2 protein15867202
D013792ThalidomideThalidomide results in decreased expression of BCL2 protein15982930
C026995thallium acetatethallium acetate results in decreased expression of BCL2 protein15965099
C042172thallium nitrateEGF protein inhibits the reaction [thallium nitrate results in increased expression of BCL2 protein]27412756
C042172thallium nitratethallium nitrate analog results in increased expression of BCL2 protein19371624
C042172thallium nitratethallium nitrate results in increased expression of BCL2 protein19371624|2741275
D019284ThapsigarginThapsigargin promotes the reaction [arsenite results in decreased expression of BCL2 protein]26677073
D019284ThapsigarginThapsigargin results in decreased expression of BCL2 protein25611565
D019284ThapsigarginThapsigargin results in decreased phosphorylation of BCL2 protein25611565
D019284ThapsigarginThapsigargin results in increased expression of BCL2 mRNA22378314
C056068theaflavintheaflavin results in decreased expression of BCL2 protein17499812
C056068theaflavintheaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of BCL2 mRNA]18656336
D013806TheophyllineIL4 protein inhibits the reaction [Theophylline results in decreased expression of BCL2 protein]8822937
D013806Theophylline[Theophylline co-treated with Cisplatin] results in decreased expression of BCL2 protein10891529|1564513
D013806Theophylline[Theophylline co-treated with gemcitabine] results in decreased expression of BCL2 protein15645133
D013806TheophyllineTheophylline results in decreased expression of BCL2 mRNA8822937
D013806TheophyllineTheophylline results in decreased expression of BCL2 protein10877050|1089152
D013853Thioacetamide[TXNIP gene mutant form co-treated with Thioacetamide] results in increased expression of BCL2 protein20713078
D013853Thioacetamidechloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]29133031
D013853Thioacetamidechloroquine diphosphate promotes the reaction [Doxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]29133031
D013853Thioacetamide[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA23830814
D013853ThioacetamideDoxorubicin inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]29133031
D013853ThioacetamideDoxorubicin promotes the reaction [chloroquine diphosphate inhibits the reaction [Thioacetamide results in increased expression of BCL2 mRNA]]29133031
D013853ThioacetamideQuercetin inhibits the reaction [Thioacetamide affects the expression of BCL2 protein modified form]21885874
D013853ThioacetamideThioacetamide affects the expression of BCL2 protein21885874
D013853ThioacetamideThioacetamide results in increased expression of BCL2 mRNA29133031
D013853ThioacetamideThioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA]23830814
D013859ThiocarbamatesThiocarbamates results in decreased expression of BCL2 protein20209498
D008063Thioctic AcidBCL2 protein results in decreased susceptibility to Thioctic Acid16990509
D008063Thioctic AcidThioctic Acid inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein]21600978
D008063Thioctic AcidThioctic Acid inhibits the reaction [Zinc Oxide analog results in decreased expression of BCL2 protein]27544635
D008063Thioctic AcidThioctic Acid results in increased degradation of and results in decreased expression of BCL2 protein16990509
D008063Thioctic AcidThioctic Acid inhibits the reaction [Dietary Fats results in decreased expression of BCL2 mRNA]27260466
D008063Thioctic AcidThioctic Acid inhibits the reaction [[Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of BCL2 mRNA]23830814
D013883ThiostreptonThiostrepton results in decreased expression of BCL2 protein22321511
C100040thiosulfinic acidsthiosulfinic acids results in decreased expression of BCL2 protein19446247
D013852ThiotepaThiotepa results in decreased expression of BCL2 protein10822281
D013852ThiotepaThiotepa results in increased cleavage of BCL2 protein10822281
D013852ThiotepaThiotepa results in increased expression of BCL2 protein10822281
D013893ThiramThiram affects the expression of BCL2 mRNA24235232
D013893ThiramThiram results in decreased expression of BCL2 mRNA17954590
D013893ThiramVEGFA protein affects the reaction [Thiram affects the expression of BCL2 mRNA]24235232
C557007thymiplatinBCL2 protein results in decreased susceptibility to thymiplatin20981665
D013943ThymolThymol results in decreased expression of BCL2 protein21640085
C003466thymoquinone[Benzo(a)pyrene co-treated with thymoquinone] results in decreased expression of BCL2 mRNA24289642
C003466thymoquinonethymoquinone results in decreased expression of BCL2 protein21609759
C003466thymoquinonethymoquinone affects the reaction [Ethanol affects the expression of BCL2 mRNA]29085585
C003466thymoquinonethymoquinone inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]29085585
C119092tigecyclinetigecycline inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]23200736
C066185tingenin Btingenin B results in decreased phosphorylation of BCL2 protein27720947
C009495titanium dioxideMIR34A mRNA inhibits the reaction [titanium dioxide results in increased expression of BCL2 mRNA]27226226
C009495titanium dioxideMIR34A mRNA inhibits the reaction [titanium dioxide results in increased expression of BCL2 protein]27226226
C009495titanium dioxidetitanium dioxide results in decreased expression of BCL2 mRNA19486931|2311187
C009495titanium dioxidetitanium dioxide results in decreased expression of BCL2 protein20362650|2311187
C009495titanium dioxidetitanium dioxide results in increased expression of BCL2 mRNA27226226
C009495titanium dioxidetitanium dioxide results in increased expression of BCL2 protein27226226
C009495titanium dioxidetitanium dioxide results in decreased expression of BCL2 mRNA20381595
C009495titanium dioxidetitanium dioxide results in decreased expression of BCL2 protein20381595
C009495titanium dioxidetitanium dioxide results in increased expression of BCL2 mRNA27760801
C009495titanium dioxidemorin inhibits the reaction [titanium dioxide results in decreased expression of BCL2 mRNA]28844848
C009495titanium dioxidetitanium dioxide results in decreased expression of BCL2 mRNA28844848
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of BCL2 mRNA28111298
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased expression of BCL2 protein22003194
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in increased expression of BCL2 protein27589885
D024505TocopherolsBCL2 protein results in decreased susceptibility to Tocopherols16001965
D024505TocopherolsTocopherols results in increased expression of BCL2 mRNA8970189
D024505TocopherolsTocopherols results in increased expression of BCL2 protein8970189
C036454toosendanintoosendanin results in decreased expression of BCL2 protein23111283
D019772TopotecanTopotecan results in decreased expression of BCL2 mRNA17132110
D014108Tosylphenylalanyl Chloromethyl KetoneAcetylcysteine inhibits the reaction [Tosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein]19679660
D014108Tosylphenylalanyl Chloromethyl KetoneTosylphenylalanyl Chloromethyl Ketone results in increased cleavage of BCL2 protein19679660
D014148Tranexamic AcidTranexamic Acid inhibits the reaction [Rotenone results in decreased expression of BCL2 protein]19539006
C496197trans-10,cis-12-conjugated linoleic acid"trans-10,cis-12-conjugated linoleic acid results in decreased expression of BCL2 mRNA"15888570
C495469trans-3-(4'-hydroxyphenyl)-2-propenoic acidtrans-3-(4'-hydroxyphenyl)-2-propenoic acid inhibits the reaction [sodium arsenite results in decreased expression of BCL2 mRNA]24497207
D014191TranylcypromineTranylcypromine inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2 protein]19135049
C095106traxoprodil mesylatetraxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2 protein]28916251
D014212Tretinoin"[1,5-dihydroxyisoquinoline co-treated with Tretinoin] results in decreased expression of BCL2 protein"10713328
D014212Tretinoin[Calcitriol co-treated with Tretinoin] results in decreased expression of BCL2 protein10713328
D014212Tretinoin[IDH1 protein affects the susceptibility to Tretinoin] which affects the expression of BCL2 protein26951332
D014212Tretinoinleptomycin B inhibits the reaction [Tretinoin results in decreased expression of BCL2 protein]14592536
D014212Tretinoin[Melatonin co-treated with Tretinoin] results in decreased expression of BCL2 protein10965999
D014212Tretinoin[Tretinoin co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA15894607
D014212Tretinoin[Tretinoin co-treated with IFNG protein] results in decreased expression of BCL2 protein17960384
D014212Tretinoin[Tretinoin co-treated with Melatonin] results in decreased expression of BCL2 protein9649124
D014212Tretinoin[Tretinoin co-treated with Paclitaxel] results in decreased expression of BCL2 protein17701358
D014212Tretinoin[Tretinoin co-treated with Paclitaxel] results in increased phosphorylation of BCL2 protein18098270
D014212Tretinoin[Tretinoin co-treated with zoledronic acid] results in decreased expression of BCL2 protein20349282
D014212TretinoinTretinoin results in decreased expression of BCL216909596
D014212TretinoinTretinoin results in decreased expression of BCL2 mRNA12644474|1549850
D014212TretinoinTretinoin results in decreased expression of BCL2 protein10713328|1243124
D014212TretinoinTretinoin results in increased expression of BCL2 mRNA21934132|2372400
D014212TretinoinTretinoin results in increased expression of BCL2 protein10750663
D014212TretinoinTretinoin results in increased phosphorylation of BCL2 protein18098270
D014212Tretinoin[troglitazone co-treated with Tretinoin] results in decreased expression of BCL2 protein9671760
D014212TretinoinTretinoin results in decreased expression of BCL2 protein11851873|1251383
D014212TretinoinTretinoin results in decreased expression of BCL2 protein17962954
C011559tributyltintributyltin results in decreased expression of BCL2 protein25743928
C011559tributyltinPRKCD gene mutant form inhibits the reaction [tributyltin results in decreased expression of BCL2 protein]25895139
C011559tributyltintributyltin affects the expression of BCL2 protein22223438
C011559tributyltinAcetylcysteine inhibits the reaction [tributyltin results in decreased expression of BCL2 protein]26079211
C011559tributyltintributyltin results in decreased expression of BCL2 protein23743147|2607921
C005830tributyrintributyrin results in decreased expression of BCL2 mRNA11876963
D014236TrichlorfonTetradecanoylphorbol Acetate inhibits the reaction [Trichlorfon results in decreased expression of BCL2 protein]19631781
D014236TrichlorfonTrichlorfon results in decreased expression of BCL2 protein19631781
D014241TrichloroethyleneTrichloroethylene results in decreased expression of BCL2 protein12160929
D014241TrichloroethyleneTrichloroethylene results in increased activity of BCL2 protein12160929
C012589trichostatin ABCL2 protein results in decreased susceptibility to trichostatin A21527555
C012589trichostatin A"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]"19887557
C012589trichostatin A[Plant Extracts co-treated with trichostatin A] results in decreased expression of BCL2 protein18709356
C012589trichostatin ASLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]19887557
C012589trichostatin Atrichostatin A results in decreased expression of BCL2 mRNA23770000
C012589trichostatin Atrichostatin A results in decreased expression of BCL2 protein16010430|1988755
C012589trichostatin Atrichostatin A results in increased expression of BCL2 mRNA24935251
C012589trichostatin A"Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]"19887557
C012589trichostatin Atrichostatin A inhibits the reaction [Benzene results in decreased expression of BCL2 mRNA]21143203
D014266TrientineCopper Sulfate inhibits the reaction [Trientine results in increased expression of BCL2 protein]14513838
D014266TrientineTrientine results in decreased expression of BCL2 protein11369509
D014266TrientineTrientine results in increased expression of BCL2 protein14513838
D014268TrifluoperazineTrifluoperazine results in decreased expression of BCL2 protein21475906
D014285Triiodothyronine, Reverse"alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein]"16135673
D014285Triiodothyronine, Reverse"Triiodothyronine, Reverse results in increased activity of BCL2 protein"16135673
D014292TrimetazidineTrimetazidine inhibits the reaction [Oxygen deficiency results in decreased expression of BCL2 mRNA]25937560
C046488trimethyltin2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]]25895139
C046488trimethyltinmagnolol inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]26756313
C046488trimethyltinrottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2 protein]25895139
C046488trimethyltintrimethyltin results in decreased expression of BCL2 protein25895139|2675631
C040533trimethyltin chloride3-(4-methylphenylsulfonyl)-2-propenenitrile promotes the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C040533trimethyltin chloridebenzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C040533trimethyltin chloridepyrazolanthrone inhibits the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C040533trimethyltin chloridetrimethyltin chloride results in decreased expression of BCL2 protein23423712
C040533trimethyltin chloridetrimethyltin chloride results in increased expression of BCL2 protein19655806
C040533trimethyltin chlorideU 0126 inhibits the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
D014302Trinitrobenzenesulfonic AcidLosartan promotes the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA]15502641
D014302Trinitrobenzenesulfonic AcidMesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA]24637189
D014302Trinitrobenzenesulfonic AcidMesalamine inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein]24637189
D014302Trinitrobenzenesulfonic Acidqingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA]24637189
D014302Trinitrobenzenesulfonic Acidqingre zaoshi liangxue fang inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of BCL2 protein]24637189
D014302Trinitrobenzenesulfonic Acidtelmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA]24831514
D014302Trinitrobenzenesulfonic AcidTrinitrobenzenesulfonic Acid results in decreased expression of BCL2 mRNA15502641|2483151
D014302Trinitrobenzenesulfonic AcidTrinitrobenzenesulfonic Acid results in increased expression of BCL2 mRNA24637189
D014302Trinitrobenzenesulfonic AcidTrinitrobenzenesulfonic Acid results in increased expression of BCL2 protein24637189
C030665triphenyltintriphenyltin results in decreased expression of BCL2 protein25743928
C050414tripterinetripterine results in decreased expression of BCL2 protein21466843
C001899triptolideABCB1A mutant form promotes the reaction [triptolide results in decreased expression of BCL2 protein]26134275
C001899triptolidetariquidar promotes the reaction [triptolide results in decreased expression of BCL2 protein]26134275
C001899triptolidetriptolide results in decreased expression of BCL2 protein25169008|2613427
C001899triptolidetriptolide results in increased expression of BCL2 protein26990902
C001899triptolideNFE2L2 protein inhibits the reaction [triptolide results in decreased expression of BCL2 protein]25169008
C001899triptolideQuercetin inhibits the reaction [triptolide affects the expression of BCL2 protein]26277538
C001899triptolidetriptolide affects the expression of BCL2 protein26277538
C001899triptolidetriptolide results in decreased expression of BCL2 protein25169008
C084079triptonidetriptonide results in decreased expression of BCL2 protein28666825
C016805tris(1,3-dichloro-2-propyl)phosphate"4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]"27816613
C016805tris(1,3-dichloro-2-propyl)phosphate"4-phenylbutyric acid promotes the reaction [Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]"27816613
C016805tris(1,3-dichloro-2-propyl)phosphate"Acetylcysteine inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]"27816613
C016805tris(1,3-dichloro-2-propyl)phosphate"Acetylcysteine promotes the reaction [4-phenylbutyric acid inhibits the reaction [tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein]]"27816613
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 mRNA"27816613
C016805tris(1,3-dichloro-2-propyl)phosphate"tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BCL2 protein"27816613
C541743tris(2,3-dibromopropyl)isocyanurate"tris(2,3-dibromopropyl)isocyanurate results in decreased expression of BCL2 protein"26558450
C541743tris(2,3-dibromopropyl)isocyanurate"tris(2,3-dibromopropyl)isocyanurate results in decreased expression of BCL2 protein"26558450
C057693troglitazone[troglitazone co-treated with Tretinoin] results in decreased expression of BCL2 protein9671760
C057693troglitazonetroglitazone results in decreased expression of BCL2 mRNA16149072|1714393
C057693troglitazonetroglitazone results in decreased expression of BCL2 protein15100737|1614907
C057693troglitazonetroglitazone results in decreased expression of BCL2 mRNA15767042
C057693troglitazonetroglitazone results in increased expression of BCL2 protein12840598
C005865troxerutin"epoxomicin inhibits the reaction [troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein]]"25639565
C005865troxerutin"troxerutin inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of BCL2 protein]"25639565
C005865troxerutintroxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 mRNA]28916335
C005865troxerutintroxerutin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in decreased expression of BCL2 protein]28916335
D014361Trypsin InhibitorsTrypsin Inhibitors results in decreased expression of BCL2 mRNA19481592
D014361Trypsin InhibitorsTrypsin Inhibitors results in decreased expression of BCL2 protein19481592
C030820tryptaminetryptamine analog inhibits the reaction [Indomethacin results in decreased expression of BCL2 mRNA]22157011
C051084tubeimoside I[tubeimoside I co-treated with Cisplatin] results in decreased expression of BCL2 protein21687949
D014403TubocurarineTubocurarine inhibits the reaction [PTMA protein results in decreased expression of BCL2]16644063
D014415TunicamycinTunicamycin results in decreased expression of BCL2 mRNA17127020
D014415TunicamycinTunicamycin results in increased expression of BCL2 mRNA17127020
C113580U 0126"2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine promotes the reaction [U 0126 results in decreased expression of BCL2 protein]"22101421
C113580U 0126U 0126 affects the reaction [Emodin affects the expression of BCL2 protein]27032576
C113580U 0126U 0126 inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of BCL2 protein]18508827
C113580U 0126U 0126 inhibits the reaction [docetaxel results in increased phosphorylation of BCL2 protein]17317842
C113580U 0126U 0126 inhibits the reaction [gemcitabine results in decreased expression of BCL2 protein]15476743
C113580U 0126U 0126 inhibits the reaction [trimethyltin chloride results in decreased expression of BCL2 protein]23423712
C113580U 0126"U 0126 promotes the reaction [2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine results in decreased expression of BCL2 protein]"22101421
C113580U 0126U 0126 promotes the reaction [docetaxel results in increased phosphorylation of and results in decreased activity of BCL2 protein]14506750
C113580U 0126U 0126 results in decreased expression of BCL2 protein22101421
C113580U 0126U 0126 inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]22269103
C113580U 0126U 0126 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] results in decreased expression of BCL2 protein]24682241
C113580U 0126U 0126 inhibits the reaction [cadmium acetate results in decreased expression of BCL2 protein]24577723|2504395
C113580U 0126U 0126 inhibits the reaction [Cisplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
C113580U 0126U 0126 inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]18775851
C113580U 0126U 0126 inhibits the reaction [oxaliplatin results in increased phosphorylation of and results in decreased activity of BCL2 protein]19428505
C000592878UMI-77UMI-77 analog binds to BCL2 protein24019208
C000592878UMI-77UMI-77 binds to BCL2 protein24019208
C005460uranyl acetatesodium bisulfide inhibits the reaction [uranyl acetate results in decreased expression of BCL2 protein]26991019
C005460uranyl acetateuranyl acetate inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]12690470
C005460uranyl acetateuranyl acetate results in decreased expression of BCL2 protein26991019
C005460uranyl acetateuranyl acetate results in increased expression of BCL2 protein12690470
D014502Uranyl Nitrate[MT1 gene mutant form co-treated with MT2 gene mutant form] promotes the reaction [Uranyl Nitrate results in decreased expression of BCL2 protein]26148447
D014502Uranyl NitrateUranyl Nitrate results in decreased expression of BCL2 protein26148447
D014520UrethaneIFNG protein inhibits the reaction [Urethane results in decreased expression of BCL2 mRNA]11091364
D014520UrethaneUrethane results in decreased expression of BCL2 mRNA11091364
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid results in decreased expression of BCL217461466
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid inhibits the reaction [[Isoniazid co-treated with Rifampin] results in decreased expression of BCL2 protein]21419764
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid inhibits the reaction [Rotenone results in decreased expression of BCL2 mRNA]25502462
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of BCL2 mRNA]14514686
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid inhibits the reaction [TGFB1 protein results in decreased expression of BCL2 protein]14514686
D014580Ursodeoxycholic AcidUrsodeoxycholic Acid results in decreased expression of BCL2 protein15970352
C005466ursolic acidursolic acid inhibits the reaction [BCL2 protein binds to BECN1 protein]24802810
C005466ursolic acidursolic acid results in decreased expression of BCL2 protein16012738
C005466ursolic acidursolic acid results in increased phosphorylation of BCL2 protein24802810
C005466ursolic acid[ursolic acid results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BECN1 protein]24802810
C073339usnic acidusnic acid results in decreased expression of BCL2 protein22285236|2507806
D014635Valproic Acid[Cisplatin co-treated with Pemetrexed co-treated with Valproic Acid] results in decreased expression of BCL2 protein19351772
D014635Valproic Acid[Valproic Acid co-treated with arsenic trioxide] results in decreased expression of BCL2 mRNA25815518
D014635Valproic Acid[Valproic Acid co-treated with arsenic trioxide] results in decreased expression of BCL2 protein25815518
D014635Valproic AcidValproic Acid results in decreased expression of BCL2 mRNA23179753
D014635Valproic AcidValproic Acid results in increased expression of BCL2 mRNA19101580|2493525
D014635Valproic Acid"4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione promotes the reaction [Valproic Acid inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]]"25453207
D014635Valproic AcidABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to Valproic Acid]19060243
D014635Valproic AcidBCL2 protein results in decreased susceptibility to Valproic Acid19060243
D014635Valproic AcidValproic Acid inhibits the reaction [Kainic Acid results in decreased expression of BCL2 protein]25453207
D014635Valproic AcidValproic Acid results in increased expression of BCL2 mRNA9098922
D014635Valproic AcidValproic Acid affects the expression of BCL2 protein15379904
D014635Valproic AcidValproic Acid inhibits the reaction [Methamphetamine results in decreased expression of BCL2 protein]19149911
D014635Valproic AcidValproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]22711276
D042442Vascular Endothelial Growth FactorsVascular Endothelial Growth Factors deficiency results in decreased expression of BCL2 protein10960447
C459559vaticanol CBCL2 protein results in decreased susceptibility to vaticanol C12844481
D001335Vehicle EmissionsVehicle Emissions results in decreased expression of BCL2 mRNA26856867
D001335Vehicle Emissions[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of BCL2 protein28013216
D001335Vehicle EmissionsVehicle Emissions results in increased methylation of BCL2 gene25487561
D001335Vehicle EmissionsVehicle Emissions affects the methylation of BCL2 gene25560391
D001335Vehicle EmissionsVehicle Emissions results in decreased expression of BCL2 protein17240030
D001335Vehicle EmissionsVehicle Emissions results in increased expression of BCL2 mRNA24216475
C551177vemurafenib[(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BCL2 mRNA27169980
C579720venetoclaxvenetoclax results in decreased activity of BCL2 protein26214592
D000069470Venlafaxine HydrochlorideVenlafaxine Hydrochloride results in decreased expression of BCL2 mRNA25423262
D014700Verapamil[Verapamil co-treated with gambogic acid] results in decreased expression of BCL2 protein24373880
C570018vicanicinvicanicin results in decreased expression of BCL2 protein22063921
C502012vildagliptin"[2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol co-treated with vildagliptin] inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]"28807765
C502012vildagliptinvildagliptin inhibits the reaction [Dietary Fats results in decreased expression of BCL2 protein]28807765
D014750VincristineBCL2 protein results in decreased susceptibility to Vincristine20162574
D014750Vincristine[Doxorubicin co-treated with Dexamethasone co-treated with Vincristine co-treated with Cytarabine co-treated with Mercaptopurine co-treated with Methotrexate co-treated with Cyclophosphamide co-treated with Enzymes and Coenzymes] results in increased expression of BCL2 protein21182165
D014750Vincristine[Doxorubicin co-treated with Vincristine co-treated with Etoposide co-treated with Mitotane] results in decreased expression of BCL2 protein9815696
D014750Vincristine[MIR497 results in decreased expression of BCL2 protein] which results in increased susceptibility to Vincristine21258880
D014750VincristineTYMP inhibits the reaction [Vincristine results in increased phosphorylation of BCL2 protein]15907805
D014750VincristineVincristine results in increased phosphorylation of BCL2 protein15907805
D014751VindesineTamoxifen promotes the reaction [Vindesine results in increased expression of BCL2 mRNA]19757172
D014751VindesineVindesine results in increased expression of BCL2 mRNA19757172
D014757Viper VenomsViper Venoms results in decreased expression of BCL2 mRNA27613483
D014757Viper VenomsViper Venoms results in decreased expression of BCL2 protein25417048|2761348
D014801Vitamin AVitamin A results in decreased expression of BCL2 protein16216918
D012256RiboflavinRiboflavin results in decreased expression of BCL2 protein12654180
D009536Niacinamide[Berberine co-treated with Niacinamide] results in decreased expression of BCL2 protein26712469
D009536NiacinamideNiacinamide promotes the reaction [[Oxygen co-treated with Oxygen deficiency] results in decreased expression of BCL2 protein]25472572
D009536Niacinamide"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D009536Niacinamide"[Butyric Acid co-treated with Niacinamide co-treated with Glucaric Acid] inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D009536Niacinamide"Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 mRNA]"25478867
D009536Niacinamide"Niacinamide inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BCL2 protein]"25478867
D002762CholecalciferolCholecalciferol results in increased expression of BCL2 protein18628207
D014810Vitamin EVitamin E inhibits the reaction [cinnamic aldehyde results in decreased expression of BCL2 protein]15566391
D014810Vitamin E[Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein16933212
D014810Vitamin E"Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein]"22020378
D014810Vitamin EVitamin E results in increased expression of BCL2 mRNA27353299
D010837Vitamin K 1[sorafenib co-treated with Vitamin K 1] results in decreased expression of BCL2 protein20301194
D010837Vitamin K 1Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein]27212383
D010837Vitamin K 1[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein27212383
D024482Vitamin K 2Vitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein]27212383
D024483Vitamin K 3Acetylcysteine inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein]19082730
D024483Vitamin K 3EUK-134 inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein]25005833
D024483Vitamin K 3[sodium arsenite co-treated with Vitamin K 3] results in decreased expression of BCL2 protein19082730
D024483Vitamin K 3Vitamin K 3 results in decreased expression of BCL2 protein25005833
D024483Vitamin K 3Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 mRNA]19265712
D024483Vitamin K 3Acetaminophen inhibits the reaction [Vitamin K 3 results in decreased expression of BCL2 protein]19265712
D024483Vitamin K 3Vitamin K 3 results in decreased expression of BCL2 mRNA19265712
D024483Vitamin K 3Vitamin K 3 results in decreased expression of BCL2 protein19265712
D055549Volatile Organic CompoundsVolatile Organic Compounds results in decreased expression of BCL2 mRNA21234782
C111237vorinostatBCL2 protein inhibits the reaction [vorinostat results in increased activity of CASP3 protein]21527555
C111237vorinostatBCL2 protein inhibits the reaction [vorinostat results in increased cleavage of PARP1 protein]21527555
C111237vorinostatBCL2 protein results in decreased susceptibility to vorinostat15897598|2152755
C111237vorinostatBCL2 results in decreased susceptibility to vorinostat10597302
C111237vorinostat[Bortezomib co-treated with vorinostat] results in increased cleavage of BCL2 protein15173093
C111237vorinostat[Cisplatin co-treated with Pemetrexed co-treated with vorinostat] results in decreased expression of BCL2 protein19351772
C111237vorinostat[Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in decreased expression of BCL2 protein15754201
C111237vorinostatTNFSF10 protein promotes the reaction [vorinostat results in decreased expression of BCL2 mRNA]19509267
C111237vorinostatTNFSF10 protein promotes the reaction [vorinostat results in decreased expression of BCL2 protein]19509267
C111237vorinostat[vorinostat co-treated with arsenic trioxide] results in decreased expression of BCL2 protein27189198
C111237vorinostat[vorinostat co-treated with Bortezomib] results in decreased expression of BCL2 protein17351739
C111237vorinostat[vorinostat co-treated with TNFSF10 protein] results in decreased expression of BCL2 protein19643600
C111237vorinostatvorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of and results in increased activity of CASP3 protein]]19631782
C111237vorinostatvorinostat inhibits the reaction [BCL2 protein inhibits the reaction [resveratrol results in increased cleavage of PARP1 protein]]19631782
C111237vorinostatvorinostat inhibits the reaction [BCL2 protein results in decreased susceptibility to resveratrol]19631782
C111237vorinostatvorinostat inhibits the reaction [TNF protein results in increased expression of BCL2 protein]16377638
C111237vorinostatvorinostat results in decreased expression of BCL2 mRNA19509267|2718838
C111237vorinostatvorinostat results in decreased expression of BCL2 protein15897598|1614494
C111237vorinostatABT-737 inhibits the reaction [BCL2 protein results in decreased susceptibility to vorinostat]19060243
C111237vorinostatBCL2 protein results in decreased susceptibility to vorinostat19060243
C111237vorinostat[vorinostat co-treated with MYC protein] results in decreased expression of BCL2 mRNA17331788
C111237vorinostat[vorinostat co-treated with MYC protein] results in decreased expression of BCL2 protein17331788
C111237vorinostatvorinostat inhibits the reaction [Oxygen deficiency results in increased expression of BCL2 protein]22711276
C111237vorinostatvorinostat results in decreased expression of BCL2 protein18310471
C017967W 7W 7 inhibits the reaction [bisphenol A results in decreased expression of BCL2 protein]24905940
D014859WarfarinVitamin K 2 inhibits the reaction [[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein]27212383
D014859Warfarin[Warfarin co-treated with Vitamin K 1] results in decreased expression of BCL2 protein27212383
C528002Weichang'anWeichang'an results in decreased expression of BCL2 mRNA17498489|1816129
C528002Weichang'anWeichang'an results in decreased expression of BCL2 protein18161298|1820525
C009684withaferin Awithaferin A results in decreased expression of BCL2 protein20438634|2125683
D054358WithanolidesWithanolides inhibits the reaction [Doxorubicin results in increased expression of BCL2 protein]17520333
C085514wogoninwogonin inhibits the reaction [IL1B protein results in decreased expression of BCL2 protein]28688942
C085514wogonin[wogonin co-treated with Fluorouracil] results in decreased expression of BCL2 protein20570612
C085514wogoninwogonin results in decreased expression of BCL2 protein20570612
C009687wortmanninwortmannin inhibits the reaction [Ethanol results in increased expression of BCL2 protein]21410490
C009687wortmanninwortmannin inhibits the reaction [[Hydrogen Peroxide co-treated with arsenic trioxide] results in decreased expression of BCL2 protein]15142122
C009687wortmanninwortmannin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of BCL2 protein]15142122
C009687wortmanninwortmannin inhibits the reaction [Propofol results in increased expression of BCL2 protein]19703415
C068244xanthoangelolxanthoangelol affects the expression of BCL2 protein27908776
C104536xanthohumolxanthohumol results in decreased expression of BCL226297991
C104536xanthohumolxanthohumol results in decreased expression of BCL2 protein15995977|2356249
D014978XenonXenon results in increased expression of BCL2 protein16034370
C078549xestospongin Bxestospongin B inhibits the reaction [BCL2 protein binds to BECN1 protein]19325567
C078549xestospongin BBCL2 mutant form promotes the reaction [xestospongin B inhibits the reaction [ITPR1 protein binds to BECN1 protein]]19325567
C078549xestospongin BBCL2 protein inhibits the reaction [xestospongin B inhibits the reaction [ITPR1 protein binds to BECN1 protein]]19325567
C108830Y 27632Y 27632 inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]20878077
C108830Y 27632Y 27632 results in increased expression of BCL2 mRNA20878077
C493272YC137YC137 inhibits the reaction [ARTN protein inhibits the reaction [fulvestrant inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]]20305694
C493272YC137YC137 inhibits the reaction [ARTN protein inhibits the reaction [Tamoxifen inhibits the reaction [Estradiol results in increased expression of BCL2 protein]]]20305694
C493272YC137YC137 results in decreased activity of BCL2 protein20305694
D015018YtterbiumYtterbium analog results in decreased expression of BCL2 protein19632212
C029659zearalenolzearalenol results in decreased expression of BCL2 protein23376438
C029659zearalenolzearalenol results in increased expression of BCL2 protein23376438
D015029ZeranolZeranol inhibits the reaction [Homocysteine results in decreased expression of BCL2 protein]16757814
D015029ZeranolZeranol results in increased expression of BCL2 protein27224899
C403304zerumbonezerumbone analog results in decreased expression of BCL2 protein28987329
C403304zerumbonezerumbone results in decreased expression of BCL2 mRNA16007145
C403304zerumbonezerumbone inhibits the reaction [[2-aminofluorene co-treated with Diethylnitrosamine] results in increased expression of BCL2 protein]20452335
D015215ZidovudineBCL2 protein affects the susceptibility to Zidovudine9850737
D015215Zidovudine"Drugs, Chinese Herbal promotes the reaction [Zidovudine results in decreased expression of BCL2 mRNA]"17696246
D015215ZidovudineZidovudine results in decreased expression of BCL2 mRNA17696246
D015215ZidovudineZidovudine results in increased expression of BCL2 mRNA9850737
D015215Zidovudine[Zidovudine co-treated with Lamivudine] results in decreased expression of BCL2 mRNA18313992
D015032ZincAcetylcysteine inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein]21600978
D015032ZincThioctic Acid inhibits the reaction [Zinc deficiency results in decreased expression of BCL2 protein]21600978
D015032ZincZinc affects the expression of BCL2 mRNA12107073|1697987
D015032Zinc[Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2 mRNA16979875
D015032ZincZinc deficiency results in decreased expression of BCL2 protein21600978
D015032Zinc"Zinc inhibits the reaction [N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [SLC39A6 mutant form inhibits the reaction [trichostatin A results in decreased expression of BCL2 protein]]]"19887557
D015032ZincZinc results in decreased expression of BCL2 protein16472982
D015032Zinc[Zinc results in increased localization of [IKBKB protein binds to NFKBIA protein]] which results in increased expression of BCL2 protein17029595
D015032ZincZinc deficiency results in decreased expression of BCL2 protein20101602
D015032Zinc"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc results in increased expression of BCL2 protein]"16799065
D015032ZincMetipranolol inhibits the reaction [Zinc results in increased expression of BCL2 protein]16799065
D015032ZincZinc results in increased expression of BCL2 protein16799065
D015032ZincZinc results in increased expression of BCL2 protein11781163
C016837zinc chloride[Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2 protein16624386
C016837zinc chloridezinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 mRNA]17786326
C016837zinc chloridezinc chloride inhibits the reaction [cobaltous chloride results in decreased expression of BCL2 protein]17786326
C016837zinc chloridezinc chloride inhibits the reaction [cobaltous chloride results in increased expression of BCL2 mRNA]19714248
C016837zinc chloridezinc chloride inhibits the reaction [Doxorubicin results in increased expression of BCL2 mRNA]19714248
D017967Zinc CompoundsZinc Compounds results in decreased expression of BCL2 mRNA24035972
D017967Zinc CompoundsZinc Compounds results in decreased expression of BCL2 protein24035972
D015034Zinc OxideThioctic Acid inhibits the reaction [Zinc Oxide analog results in decreased expression of BCL2 protein]27544635
D015034Zinc OxideZinc Oxide analog results in decreased expression of BCL2 protein27544635
D015034Zinc OxideZinc Oxide analog results in decreased expression of BCL2 mRNA25680694
D015034Zinc OxideZinc Oxide analog results in decreased expression of BCL2 protein24614525
C017803zinc protoporphyrin"zinc protoporphyrin inhibits the reaction [2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]]"27523796
C017803zinc protoporphyrinzinc protoporphyrin inhibits the reaction [resveratrol inhibits the reaction [Doxorubicin results in decreased expression of BCL2 protein]]22763982
D019287Zinc SulfateZinc Sulfate inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]20096349
D019287Zinc Sulfate"6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein]"16799065
D019287Zinc SulfateMetipranolol inhibits the reaction [Zinc Sulfate results in increased expression of BCL2 protein]16799065
D019287Zinc SulfateZinc Sulfate results in increased expression of BCL2 protein16799065
C013738zingeronezingerone inhibits the reaction [Ethanol results in decreased expression of BCL2 protein]28442378
D015039ZiramZiram results in decreased expression of BCL2 protein28973382
C000588918ziyuglycoside IIMAPK8 mutant form inhibits the reaction [ziyuglycoside II results in decreased expression of BCL2 protein]24680927
C000588918ziyuglycoside IIziyuglycoside II results in decreased expression of BCL2 protein24680927
C088658zoledronic acidBCL2 protein results in decreased susceptibility to zoledronic acid11986784
C088658zoledronic acid[Tretinoin co-treated with zoledronic acid] results in decreased expression of BCL2 protein20349282
C088658zoledronic acidzoledronic acid affects the expression of BCL2 mRNA19036117
C088658zoledronic acid[zoledronic acid co-treated with docetaxel] results in decreased expression of BCL2 protein19103299
C088658zoledronic acidzoledronic acid results in decreased expression of BCL2 mRNA24714768|2887133
C088658zoledronic acidzoledronic acid results in increased expression of BCL2 mRNA18225567
C088658zoledronic acid[zoledronic acid co-treated with Doxorubicin] results in decreased expression of BCL2 protein19789217
C088658zoledronic acidzoledronic acid results in decreased expression of BCL2 mRNA28871336
D015054ZymosanTNFRSF1A gene mutant form inhibits the reaction [Zymosan results in decreased expression of BCL2 protein]17724436
D015054ZymosanZymosan results in decreased expression of BCL2 protein17724436

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0002020protease binding-IDA10620603  
GO:0005515protein binding-IPI7954800  9305631  9334338  9388232  9463381  9660918  
9973195  10837489  11054413  11060313  11126360  11278245  
11463391  12624108  12667443  12901880  14739602  15225643  
15694340  15733859  16697956  16790527  17074758  17289999  
17418785  17446862  17525735  17692808  18719108  18835031  
18981409  19050071  19074266  19180116  19223583  19521340  
19706527  19706769  19959994  20010695  20849813  21139567  
21199865  21358617  21444675  21454712  21458670  21671007  
23431138  23541952  23845444  23954414  24034250  24472739  
26004684  
GO:0008134transcription factor binding-IEA-  
GO:0015267channel activity-IDA9219694  
GO:0016248channel inhibitor activity-IDA9219694  
GO:0031625ubiquitin protein ligase binding-IPI20889974  
GO:0042802identical protein binding-IPI9463381  18835031  
GO:0042803protein homodimerization activity-IBA21873635  
GO:0042803protein homodimerization activity-IPI9111042  
GO:0043565sequence-specific DNA binding-IDA12086670  
GO:0046982protein heterodimerization activity-IBA21873635  
GO:0046982protein heterodimerization activity-IPI9111042  
GO:0051434BH3 domain binding-IPI9111042  
GO:0051721protein phosphatase 2A binding-IEA-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000209protein polyubiquitination-IDA16717086  
GO:0001503ossification-IEA-  
GO:0001541ovarian follicle development-IEA-  
GO:0001656metanephros development-IEA-  
GO:0001658branching involved in ureteric bud morphogenesis-IEA-  
GO:0001662behavioral fear response-IEA-  
GO:0001782B cell homeostasis-IEA-  
GO:0001836release of cytochrome c from mitochondria-ISS9843949  
GO:0001836release of cytochrome c from mitochondria-NAS9027314  
GO:0001952regulation of cell-matrix adhesion-IEA-  
GO:0002320lymphoid progenitor cell differentiation-IEA-  
GO:0002326B cell lineage commitment-IEA-  
GO:0002931response to ischemia-IEA-  
GO:0003014renal system process-IEA-  
GO:0006470protein dephosphorylation-IEA-  
GO:0006582melanin metabolic process-IEA-  
GO:0006808regulation of nitrogen utilization-IEA-  
GO:0006915apoptotic process-IDA36599  8022822  
GO:0006959humoral immune response-TAS1908951  
GO:0006974cellular response to DNA damage stimulus-IMP17875758  
GO:0007015actin filament organization-IEA-  
GO:0007409axonogenesis-IEA-  
GO:0007565female pregnancy-NAS11530860  
GO:0007569cell aging-IEA-  
GO:0008584male gonad development-IEA-  
GO:0008625extrinsic apoptotic signaling pathway via death domain receptors-IDA10597216  
GO:0008630intrinsic apoptotic signaling pathway in response to DNA damage-IBA21873635  
GO:0008631intrinsic apoptotic signaling pathway in response to oxidative stress-IEA-  
GO:0009314response to radiation-NAS15799693  
GO:0009636response to toxic substance-IDA16307838  16717086  
GO:0009791post-embryonic development-IEA-  
GO:0010039response to iron ion-IDA11264898  
GO:0010224response to UV-B-IEA-  
GO:0010332response to gamma radiation-IEA-  
GO:0010468regulation of gene expression-IEA-  
GO:0010507negative regulation of autophagy-TAS18309324  
GO:0010523negative regulation of calcium ion transport into cytosol-IEA-  
GO:0010559regulation of glycoprotein biosynthetic process-IEA-  
GO:0014031mesenchymal cell development-IEA-  
GO:0014042positive regulation of neuron maturation-IEA-  
GO:0014911positive regulation of smooth muscle cell migration-IEA-  
GO:0018105peptidyl-serine phosphorylation-IEA-  
GO:0018107peptidyl-threonine phosphorylation-IEA-  
GO:0019221cytokine-mediated signaling pathway-TAS-  
GO:0021747cochlear nucleus development-IEA-  
GO:0022612gland morphogenesis-IEA-  
GO:0022898regulation of transmembrane transporter activity-IDA9219694  
GO:0030279negative regulation of ossification-IEA-  
GO:0030307positive regulation of cell growth-IDA8022822  
GO:0030308negative regulation of cell growth-IEA-  
GO:0030318melanocyte differentiation-IEA-  
GO:0030336negative regulation of cell migration-IEA-  
GO:0030890positive regulation of B cell proliferation-IMP17875758  
GO:0031069hair follicle morphogenesis-IEA-  
GO:0031103axon regeneration-IEA-  
GO:0031647regulation of protein stability-IEA-  
GO:0032469endoplasmic reticulum calcium ion homeostasis-TAS18309324  
GO:0032835glomerulus development-IEA-  
GO:0032848negative regulation of cellular pH reduction-IDA10506221  
GO:0033033negative regulation of myeloid cell apoptotic process-IEA-  
GO:0033077T cell differentiation in thymus-IEA-  
GO:0033138positive regulation of peptidyl-serine phosphorylation-IEA-  
GO:0033689negative regulation of osteoblast proliferation-IEA-  
GO:0034097response to cytokine-IDA9184696  
GO:0035094response to nicotine-IDA12421819  
GO:0035265organ growth-IEA-  
GO:0040018positive regulation of multicellular organism growth-IEA-  
GO:0042100B cell proliferation-IDA1373874  
GO:0042149cellular response to glucose starvation-IEA-  
GO:0042493response to drug-IDA36599  
GO:0042493response to drug-IMP17875758  
GO:0042542response to hydrogen peroxide-IEA-  
GO:0043029T cell homeostasis-IEA-  
GO:0043066negative regulation of apoptotic process-IBA21873635  
GO:0043066negative regulation of apoptotic process-IDA1373874  7650367  7772249  8050499  8080725  9027314  9219694  10506221  10620603  15776018  20041405  
GO:0043066negative regulation of apoptotic process-IGI9660918  
GO:0043066negative regulation of apoptotic process-IMP7772249  17289999  21212266  
GO:0043066negative regulation of apoptotic process-TAS-  
GO:0043085positive regulation of catalytic activity-IEA-  
GO:0043375CD8-positive, alpha-beta T cell lineage commitment-IEA-  
GO:0043496regulation of protein homodimerization activity-IDA9111042  
GO:0043497regulation of protein heterodimerization activity-IDA9111042  
GO:0043524negative regulation of neuron apoptotic process-IDA7546744  
GO:0043583ear development-IEA-  
GO:0045069regulation of viral genome replication-IEA-  
GO:0045636positive regulation of melanocyte differentiation-IEA-  
GO:0046671negative regulation of retinal cell programmed cell death-IEA-  
GO:0046902regulation of mitochondrial membrane permeability-ISS9843949  
GO:0048041focal adhesion assembly-IEA-  
GO:0048536spleen development-IEA-  
GO:0048538thymus development-IEA-  
GO:0048546digestive tract morphogenesis-IEA-  
GO:0048599oocyte development-IEA-  
GO:0048743positive regulation of skeletal muscle fiber development-IEA-  
GO:0048753pigment granule organization-IEA-  
GO:0048873homeostasis of number of cells within a tissue-IEA-  
GO:0050853B cell receptor signaling pathway-IMP17875758  
GO:0051384response to glucocorticoid-IEA-  
GO:0051402neuron apoptotic process-TAS16167175  
GO:0051607defense response to virus-IDA10620603  
GO:0051881regulation of mitochondrial membrane potential-ISS9843949  
GO:0051902negative regulation of mitochondrial depolarization-TAS9027314  
GO:0051924regulation of calcium ion transport-IDA8022822  
GO:0055085transmembrane transport-IEA-  
GO:0070059intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress-IDA15776018  
GO:0071456cellular response to hypoxia-IEA-  
GO:0072593reactive oxygen species metabolic process-IEA-  
GO:0097192extrinsic apoptotic signaling pathway in absence of ligand-IBA21873635  
GO:0097192extrinsic apoptotic signaling pathway in absence of ligand-IEA-  
GO:0098609cell-cell adhesion-IEA-  
GO:1900740positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway-TAS-  
GO:2000134negative regulation of G1/S transition of mitotic cell cycle-IEA-  
GO:2000378negative regulation of reactive oxygen species metabolic process-IEA-  
GO:2000811negative regulation of anoikis-IMP15006356  
GO:2001234negative regulation of apoptotic signaling pathway-IMP20097879  
GO:2001240negative regulation of extrinsic apoptotic signaling pathway in absence of ligand-IGI8358790  
GO:2001243negative regulation of intrinsic apoptotic signaling pathway-IBA21873635  
GO:2001243negative regulation of intrinsic apoptotic signaling pathway-IDA11684014  
GO:2001244positive regulation of intrinsic apoptotic signaling pathway-TAS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005634nucleus-IDA7546744  7896880  
GO:0005654nucleoplasm-IDA-  
GO:0005737cytoplasm-IDA7546744  11530860  
GO:0005739mitochondrion-IDA7896880  9027314  
GO:0005741mitochondrial outer membrane-IBA21873635  
GO:0005741mitochondrial outer membrane-IDA8402648  9027314  
GO:0005741mitochondrial outer membrane-TAS-  
GO:0005783endoplasmic reticulum-IDA8402648  
GO:0005789endoplasmic reticulum membrane-IEA-  
GO:0005829cytosol-IEA-  
GO:0016020membrane-IDA7896880  
GO:0031965nuclear membrane-IDA1502141  8402648  
GO:0032991protein-containing complex-IMP15733859  
GO:0043209myelin sheath-IEA-  
GO:0046930pore complex-IDA9219694  
KEGG ID KEGG Term
hsa04141Protein processing in endoplasmic reticulum
hsa04210Apoptosis
hsa04510Focal adhesion
hsa04722Neurotrophin signaling pathway
hsa05014Amyotrophic lateral sclerosis (ALS)
hsa05145Toxoplasmosis
hsa05200Pathways in cancer
hsa05210Colorectal cancer
hsa05215Prostate cancer
hsa05222Small cell lung cancer
Reactome ID Reactome Term Evidence
R-HSA-109581ApoptosisTAS
R-HSA-109606Intrinsic Pathway for ApoptosisTAS
R-HSA-111447Activation of BAD and translocation to mitochondria TAS
R-HSA-111453BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 membersTAS
R-HSA-114452Activation of BH3-only proteinsTAS
R-HSA-1280215Cytokine Signaling in Immune systemTAS
R-HSA-162582Signal TransductionTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168256Immune SystemTAS
R-HSA-168643Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathwaysTAS
R-HSA-449147Signaling by InterleukinsTAS
R-HSA-5357801Programmed Cell DeathTAS
R-HSA-622312InflammasomesTAS
R-HSA-6785807Interleukin-4 and 13 signalingTAS
R-HSA-844455The NLRP1 inflammasomeTAS
R-HSA-8939211ESR-mediated signalingTAS
R-HSA-9006931Signaling by Nuclear ReceptorsTAS
R-HSA-9018519Estrogen-dependent gene expressionTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
17693666Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck. (2007 Sep)Chen KCarcinogenesis
18676844RUNX3 methylation reveals that bladder tumors are older in patients with a history of smoking. (2008 Aug 1)Wolff EMCancer Res
21878650miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. (2011 Oct 28)Yadav SJ Biol Chem
25484085Autophagy and ethanol neurotoxicity. (2014)Luo JAutophagy
22187149The -938A/A genotype of BCL2 gene is associated with esophageal cancer. (2012 Dec)Liu ZMed Oncol
26043790Cocaine-mediated microglial activation involves the ER stress-autophagy axis. (2015)Guo MLAutophagy
27203547Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer. (2016 Aug 2)Mitsui YOncotarget
15210690Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. (2004 Sep 17)Jin ZJ Biol Chem
23981442Stress-response pathways are altered in the hippocampus of chronic alcoholics. (2013 Nov)McClintick JNAlcohol
23325812Cigarette smoke exposure elicits increased autophagy and dysregulation of mitochondrial dynamics in murine granulosa cells. (2013 Mar)Gannon AMBiol Reprod
24967145Bcl2 Family Functions as Signaling Target in Nicotine-/NNK-Induced Survival of Human Lung Cancer Cells. (2014)Deng XScientifica (Cairo)
25165809Effects of maternal smoking on the placental expression of genes related to angiogenesis and apoptosis during the first trimester. (2014)Kawashima APLoS One
29414845Protective Effects of Olive Leaf Extract on Acrolein-Exacerbated Myocardial Infarction via an Endoplasmic Reticulum Stress Pathway. (2018 Feb 7)Xu YInt J Mol Sci
19903766Nicotine enhances the antiapoptotic function of Mcl-1 through phosphorylation. (2009 Dec)Zhao JMol Cancer Res
21212151Interactions between genetic polymorphisms in the apoptotic pathway and environmental factors on esophageal adenocarcinoma risk. (2011 Apr)Wu ICCarcinogenesis
27669169Genetic Modifiers of Progression-Free Survival in Never-Smoking Lung Adenocarcinoma Patients Treated with First-Line Tyrosine Kinase Inhibitors. (2017 Mar 1)Chang ISAm J Respir Crit Care Med
22986747SIRT1 pathway dysregulation in the smoke-exposed airway epithelium and lung tumor tissue. (2012 Nov 15)Beane JCancer Res
21367451Cigarette smoke induces oxidative stress and apoptosis in normal term fetal membranes. (2011 Apr)Menon RPlacenta
23977251Genetic variation in BCL2 3'-UTR was associated with lung cancer risk and prognosis in male Chinese population. (2013)Xu PPLoS One
29315347Long-term ethanol exposure: Temporal pattern of microRNA expression and associated mRNA gene networks in mouse brain. (2018)Osterndorff-Kahanek EAPLoS One
24586750The association between smoking and ectopic pregnancy: why nicotine is BAD for your fallopian tube. (2014)Horne AWPLoS One
15026372Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides. (2004 Mar 15)Roulland SCancer Res
17561354Role of BCL2 (ala43thr), CCND1 (G870A) and FAS (A-670G) polymorphisms in modulating the risk of developing esophageal cancer. (2007)Jain MCancer Detect Prev
9576088Evidence of apoptosis in human carotid atheroma. (1998 Apr)Konstadoulakis MMJ Vasc Surg
25894374K-Ras promotes the non-small lung cancer cells survival by cooperating with sirtuin 1 and p27 under ROS stimulation. (2015 Sep)Cheng DTumour Biol
26875702Synovial sarcoma presenting as a lung mass and diagnosed by cytology. (2016 May)Pyden ADDiagn Cytopathol
23991993B-cell Lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese population. (2013)Li QAsian Pac J Cancer Prev
27589885Paternal exposure to cigarette smoke condensate leads to reproductive sequelae and developmental abnormalities in the offspring of mice. (2016 Oct)Esakky PReprod Toxicol
12968312[Solitary fibrous pseudopapillary tumor of the lung: pulmonary fibroadenoma and adenofibroma revisited]. (2003 Jun)Cavazza APathologica
26744613Study of regulatory promoter polymorphism (-248 G>A) of Bax gene in patients with gastric cancer in the northern provinces of Iran. (2016 Winter)Mirmajidi SHGastroenterol Hepatol Bed Bench
23349696Wnt5a is associated with cigarette smoke-related lung carcinogenesis via protein kinase C. (2013)Whang YMPLoS One
20727180Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent. (2010 Aug 20)Puliyappadamba VTMol Cancer
28959653p-Benzoquinone initiates non-invasive urothelial cancer through aberrant tyrosine phosphorylation of EGFR, MAP kinase activation and cell cycle deregulation: Prevention by vitamin C. (2017)Ganguly SToxicol Rep
28713991Pien Tze Huang Gan Bao attenuates carbon tetrachlorideinduced hepatocyte apoptosis in rats, associated with suppression of p53 activation and oxidative stress. (2017 Sep)Zhao JMol Med Rep
18037991Maternal exposure to polycyclic aromatic hydrocarbons diminishes murine ovarian reserve via induction of Harakiri. (2007 Dec)Jurisicova AJ Clin Invest
23599765Abnormal methylation of seven genes and their associations with clinical characteristics in early stage non-small cell lung cancer. (2013 Apr)Zhao YOncol Lett
19690778Malignant fibrous histiocytoma of larynx with giant cell: case report and histological-clinical considerations. (2009)Anghelina FRom J Morphol Embryol
18203686Increased pancreatic beta-cell apoptosis following fetal and neonatal exposure to nicotine is mediated via the mitochondria. (2008 Jun)Bruin JEToxicol Sci
25533722Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritis. (2014 Dec 23)Churchman SMArthritis Res Ther
22520577Nicotine stimulates proliferation and inhibits apoptosis in colon cancer cell lines through activation of survival pathways. (2012 Nov)Cucina AJ Surg Res
26271547BCL2-like 11 intron 2 deletion polymorphism is not associated with non-small cell lung cancer risk and prognosis. (2015 Oct)Cho ENLung Cancer
25884493Association of the FAM46A gene VNTRs and BAG6 rs3117582 SNP with non small cell lung cancer (NSCLC) in Croatian and Norwegian populations. (2015)Etokebe GEPLoS One
28622040Analysis of differential genetic expression in endometrial polyps of postmenopausal women. (2017 Oct)Troncon JKClimacteric
24483236Rapamycin inhibits acrolein-induced apoptosis by alleviating ROS-driven mitochondrial dysfunction in male germ cells. (2014 Apr)He XCell Prolif
20467194Vitamin C prevents cigarette smoke induced atherosclerosis in guinea pig model. (2010 Aug 31)Ray TJ Atheroscler Thromb
22904681Long-term smoking mediated down-regulation of Smad3 induces resistance to carboplatin in non-small cell lung cancer. (2012 Jul)Samanta DNeoplasia
21487404Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties. (2011 May 10)Yip NCBr J Cancer
16646270[Biomonitoring of nurses occupationally exposed to antineoplastic drugs: the IMEPA Project]. (2005 Sep-Dec)Bolognesi CEpidemiol Prev